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ZUSAMMENFASSUNG-SUMMARY  X 
 
ZUSAMMENFASSUNG 
 
Cyclin-abhängige Protein Kinasen (CDKs) regulieren wichtige Kontrollpunkte und Übergangphase im 
Zellzyklus. Die Aktivierung von CDKs erfolgt durch die Phosphorylierung eines in deren T-Schleife 
lokalisierten, konservierten Threonin-Rests durch CDK-aktivierende Kinasen (CAKs), die ihrerseits 
auf analoge Weise durch CAK-aktivierende Kinasen (CAKAKs) aktiviert werden. CDKF1, eine 
pflanzenspezifische CAKAK, phosphoryliert Berichten zufolge zwei der drei in Arabidopsis 
bekannten CAKs (CDKD2 und CDKD3). Im Rahmen unserer Arbeit konnte gezeigt werden, dass in 
E. coli überexprimierte und aufgereinigte CDKF;1 und CDKD Kinase, ohne eine Bindung mit 
Cyclinen einzugehen, autoaktiviert sind und dass CDKF;1 für die Phosphorylierung aller drei 
Arabidopsis CDKDs (CDKD;1, CDKD;2 und CDKD;3) verantwortlich ist. Weiterhin konnten wir 
feststellen, dass CDKF;1 und CDKD;2 benötigt sind für die Phosphorylierung der CTD Domäne der 
grössten Arabidopsis RNA POLYMERASE II (RNAP II) Untereinheit, welche aus 15 konsensus und 
26 variablen YSPTSPS tandem heptapeptid repeats besteht. Diesbezüglich zeigen unsere Daten, dass 
CDKD;2 die Phosphorylierung an der Serine-5 Position der CTD Domäne vermittelt, was auf eine 
mögliche Rolle von CDKD;2 in der Transkriptionsinitiation sowie dem 5’ capping naszierender RNAs 
schliessen läßt. Die Phosphorylierung an der Serine-7 Position der CTD Domäne hingegen wird von 
CDKF;1 durchgeführt. Darüber hinaus konnten wir feststellen, dass eine Verringerung der Serine-7 
CTD Phosphorylierung, wie sie in der cdkf;1 Mutanten beobachtet wird, verursacht Defekte in der 
Transkription und während der Entwicklung, und reduziert auch die Produktion kleiner RNAs, wie 
miR156, miR165, miR172, ta-siRNA1 (TAS1), und COPIA. Zusätzlich konnte aufgezeigt werden, 
dass CDKF;1 kann auch das VirD2 Protein in vitro phosphorylieren. VirD2 ist kovalent mit dem 5’-
Ende von Agrobakterium transferiert einzelsträngiger DNA (T-DNA/T-Strang) verbunden und 
vermittelt deren Integration in das Genom des Zellkerns der Planzenwirtszelle. Es wurde früher 
gezeigt, dass VirD2 mit der TATA-Box-bindenden Untereinheit (TBP) von RNAPII interagiert, und 
dass es in vivo von einer CTD-assoziierten CAK-ähnlichen Protein Kinase phosphoryliert wird. 
Andere Studien mit Arabidopsis CAKs haben gezeigt, dass CDKF;1 zusammen mit CDKD;2 und 
cyclin H Teil des TFIIH Komplexes sind, welcher an Genom und transkriptions-gekoppelter 
Exzisionsreparatur beteiligt ist. Unsere Daten zeigen, dass Mutationen verursachen die Inaktivierung 
von CDKF;1 oder seines CAK Substrats CDKD;2, zu einer dramatischen Verringerung der 
Tumorbildung durch Agrobacterium tumefaciens C58 führen. Dies läßt den Schluss zu, dass CDKD;2 
ein wichtiger Vermittler der VirD2 Phosphorylierung durch CDKF;1 ist. Wir vermuten dass diese 
Phosphorylierung ist unerlässlich damit VirD2 mit dem TFIIH-komplex interagieren kann, der die 
Reparatur-Rekombination zwischen 5’-Ende des T-Stranges und der Ziel Sequenz im Wirtchromosom 
vermittelt. 
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SUMMARY 
 
Cyclin-dependent protein kinases (CDKs) control checkpoint transitions of the cell cycle. Activation 
of CDKs requires phosphorylation of a conserved threonine residue in their T-loops by CDK-
activating kinases (CAKs) that are analogously activated by CAK-activating kinases (CAKAKs). 
CDKF;1, a plant specific CAKAK, is reported to phosphorylate two of three known Arabidopsis 
CAKs (CDKD;2 and CDKD;3). Here we show that CDKF;1 and CDKDs purified from E. coli are 
auto-activated without cyclin binding and that CDKF;1 phosphorylates all three Arabidopsis CDKDs 
(CDKD;1, CDKD;2, and CDKD;3). We found that CDKF;1 and CDKD;2 are required for 
phosphorylation of the CTD domain of Arabidopsis RNA POLYMERASE II (RNAPII) largest 
subunit, which comprises of 15 consensus and 26 variant YSPTSPS tandem heptad repeats. CDKD;2 
mediates Serine-5 phosphorylation of the CTD, suggesting its possible role in the control of 
transcription initiation and 5’ capping of nascent RNAs. CDKF;1 phosphorylates the Serine-7 residue 
of CTD heptapeptide repeats. Reduction of CTD-phosphorylation on Serine-7 in the cdkf;1 mutant 
causes overall defects in transcription and development, as well as in the production of small RNAs, 
including miR156, miR165, miR172, ta-siRNA1 (TAS1), and COPIA. CDKF;1 can also phosphorylate 
in vitro the VirD2 protein, which is covalently bound to the 5’-end of single-stranded intermediate of 
Agrobacterium transferred DNA (T-DNA/T-strand) and mediates its integration into the nuclear 
genomes of plant host cells. Previous data indicate that VirD2 interacts with the TATA-box-binding 
subunit of RNAPII and is phosphorylated in vivo by a CTD-associated CAK-like protein kinase. 
Studies of Arabidopsis CAKs show that CDKD;2 is found in association with cyclin H and CDKF;1 as 
part of the TFIIH complex, which is implicated in global genome and transcription-coupled repair. 
Our data demonstrate that mutations inactivating either CDKF;1 or its CAK substrate CDKD;2 result 
in dramatic reduction of tumour formation mediated by Agrobacterium tumefaciens C58. This 
suggests that CDKD;2 is an important mediator of VirD2 phosphorylation by CDKF;1, which is likely 
required for VirD2 recruitment to the TFIIH complex implicated in repair-recombination between the 
5’-end of the T-strand and target sequences in the host chromosomes. 
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1. INTRODUCTION 
Plants utilize interconnected regulatory networks for perception and transduction of different external 
and internal signals. Environmental and hormonal signals play pivotal roles in the regulation of plant 
homeostatic control systems. When an input signal surpasses a certain threshold, the interconnected 
signalling networks provide the possibility for appropriate adjustment of specific network balance and 
corresponding response output. Regulatory proteins that act at the network interfaces (i.e., hubs) are 
usually capable to modulate multiple pathways. Although, many key regulatory functions in plants are 
encoded by functionally equivalent duplicated genes or larger gene families, genetic studies have also 
identified evolutionally conserved single copy genes implicated in multidisciplinary regulatory 
functions, inactivation of which causes dramatic effects in plant development. One of these in 
Arabidopsis is the CDKF;1 protein kinase gene, which functions as major signalling hub in 
coordination of transcription, cell cycle and several signalling pathways. Inactivation of CDKF;1 gene 
by T-DNA insertion mutations in this work revealed its important roles in the control of activation of 
cyclin-dependent kinase-activating kinases (CAKs/CDKDs), phosphorylation of C-terminal 
heptapeptide repeats RNAPII largest subunit, transcription, biogenesis of small RNAs and T-DNA 
transformation mediated by the Agrobacterium VirD2 protein. The following sections provide a brief 
overview on our current knowledge on these specific pathways. 
 
1.1. Cell cycle control 
Cell growth and division are coordinated by a cyclic series of regulatory events during successive 
phases (G1, S, G2, and M) of the cell cycle. The exit from cell cycle may also mark the onset of cell 
differentiation processes indicating that, in addition to controlling cell division, cell cycle regulators 
play essential roles in the development and growth of multicellular organisms. Due to unique features 
of plants, such as post-embryonic initiation of organ development and sessile life style, changes in 
environmental conditions have profound effects on their development and growth. Cell cycle 
regulators modulate the normal balance between plant growth and development by causing specific 
structural changes and modifying the growth rate in response to changing environment (Cockcroft et 
al., 2000; Menges et al., 2002; De Jager et al., 2005). 
A great variety of components and mechanisms has been characterized in the regulation of 
plant cell cycle progression. These include, for example, the cyclin-dependent protein kinases (CDKs) 
and their noncatalytic cyclin subunits, CDK inhibitors, retinoblastoma tumour suppressors, E2F/DP 
transcription factors, CDK subunit (CKS) proteins, positive and negative regulatory effects of 
phosphorylation, and proteolysis of multiple regulatory proteins (Morgan, 1995; Kaldis et al., 1996; 
De Veylder et al., 1997; Michael et al., 1998; Verkest et al., 2005; Del Pozo et al., 2006). The onset of 
cell differentiation, accompanied by endoreduplication in plant cells, is concomitant with reduction of 
the activity of mitotic-phase associated CDK-cyclin complexes. Therefore, the mechanisms 
coordinating mitosis with transition to endocycle play important roles in plant development (Park et 
INTRODUCTION  2 
 
al., 1995; Cebolla et al., 1999; Sun et al., 1999; De Veylder et al., 2001, 2002; Vinardell et al., 2003; 
Gonzalez et al., 2004; Verkest et al., 2005a; Vlieghe et al., 2005). 
 
1.1.1. Plant cyclin-dependent protein kinases (CDKs) 
Cyclin-dependent protein kinases (CDKs) are evolutionarily conserved and represent the main 
regulatory core of eukaryotic cell cycle. The catalytic activity of CDKs is regulated by 
phosphorylation events and binding of noncatalytic partners, including cyclins and CDK inhibitors 
(Gould et al., 1991; Solomon et al., 1992; Dewitte and Murray, 2003; Shimotohno et al., 2004). In 
plants, there are seven known classes of CDKs named CDKA to CDKG. Based on our current 
knowledge CDKAs, CDKBs, CDKDs, and CDKFs are involved in the regulation of cell cycle 
progression (Vandepoele et al., 2002; Francis, 2007). CDKA, which is closely related to yeast 
Cdc2/CDC28 and human CDK1/2/3, contains a conserved PSTAIRE motif in the cyclin-binding 
domain (Colasanti et al., 1991; Hirt et al., 1993; Joubés et al., 2000a) and controls both G1 to S and 
G2 to M checkpoint transitions (Hemerly et al., 1995; Reichheld et al., 1999; Menges and Murray, 
2002). CDKB is a plant specific CDK class that consists of two subgroups, CDKB1 (PPTALRE) and 
CDKB2 (P(P/S)TTLRE). CDKBs are involved in the control of G2 to M transition (Porceddu et al., 
2001; Menges et al., 2002, Francis, 2007). 
 The first plant CDK-activating protein kinase (CDKD;1/R2) has been isolated from rice and 
is closely related to human CDK7/p40MO15, fission yeast Mcs6/Crk1/Mop1 and budding yeast Kin28p 
(Buck et al., 1995; Damagnez et al., 1995; Feaver et al., 1997). The latter CDK-activating kinases 
(CAKs) interact with cyclin H (i.e., human CycH and yeast Mcs2/Ccl1) subunits that positively 
regulate their kinase activities through stabilizing the catalytic sites. The cyclin H-kinase complex is 
further stabilized by a conserved RING finger protein (Pmh1, Rig2p/Tfb3p and MAT1) in yeast and 
metazoans. Putative MAT1 homologues are also found in Arabidopsis and rice. Whereas interaction 
between rice MAT1 and CDKD;1/R2 is unknown so far (Umeda et al., 2005), CDKD;2 binding of a 
MAT1 homolog has been reported in Arabidopsis in vivo (Leene et al., 2007; Leene et al., 2008). 
Similarly to the heterotrimeric human CDK7-CycH-MAT1 and fission yeast 
Mcs6/Crk1/Mop1-Mcs2-Pmh1 kinases, rice CDKD;1 kinase phosphorylates in vitro the C-terminal 
heptapeptide repeat domain (CTD) of the largest subunit of RNAPII, as well as a conserved threonine 
residue within the T-loops of CDKs (i.e., CDK2/CDKA), which is necessary for their activation. 
Arabidopsis contains three CAKs (CDKD;1, CDKD;2, and CDKD;3). CDKD;2 and CDKD;3 
phosphorylate human CDK2 and the RNAPII CTD with different specificities in vitro, while CDKD;1 
does not seem to have these kinase activities (Umeda et al., 1998; Shimotonho et al., 2003). 
Arabidopsis CDKDs are also reported to interact with At;CycH;1 and their kinase activities are 
increased upon binding of cyclin H1 in insect cells as suggested by in vitro kinase assays 
(Shimotonho, 2004).  
Homologues of the plant specific kinase CDKF;1 were identified in rice, Arabidopsis, leafy 
spurge, and soybean. Arabidopsis CDKF;1 (At;CDKF;1) activates human CDK2 and Arabidopsis 
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CAKs (At;CDKD;2 and At;CDKD;3) through phosphorylation of their T-loops in vitro. At;CDKF;1 
does not interact with At;CycH;1 and, according to Shimotonho et al. (2003), cannot phosphorylate 
the CTD of RNAPII. However, interestingly, Arabidopsis CDKF;1 suppresses the temperature 
sensitive cakts mutations in budding yeast (Umeda et al., 1998), while budding yeast Kin28p-Ccl1p-
Rig2p/Tfb3p kinase (CAK kinase) phosphorylates RNAPII CTD, but has no CAK activity. Leafy 
spurge Ee;CDKF;1 has intramolecular autophosphosphorylation activity, which is suggested to be 
controlled by phosphorylation of its Thr291 and Thr296 residues (Chao et al., 2006).  
 
1.2. The CTD code 
In analogy to human CDK7, Arabidopsis CDKD;2 and CDKD;3 may control transcription by 
phosphorylation of the CTD domain of the RNAPII largest subunit, which consists of highly 
conserved heptapeptide repeats. The number of CTD heptapeptide repeats and their deviation from the 
consensus sequence (YSPTSPS) increase evolutionally. Saccharomyces cerevisiae has 26 conserved 
heptapeptide repeats, while human RNAPII CTD carries 52 repeats. Of these, 21 repeats are exactly 
conserved, whereas the remaining 31 show deviation from the consensus sequence (Chapman et al., 
2004). RNAPII CTD of Arabidopsis thaliana contains 15 consensus and 26 divergent heptapeptide 
repeats. The divergent repeats are located in the C-terminal end of the CTD domain, as in the human 
enzyme (Nawrath et al., 1990). Previous experiments demonstrate that the CTD domain is essential for 
cell viability (Nonet et al., 1987; Zehring et al., 1988; Corden, 1990; Stiller and Cook, 2004). In 
addition, the CTD domain has a unique structure that is very hydrophilic and flexible. This disordered 
nature of CTD provides a possibility for interaction with many proteins according to the induced fit 
model. This model predicts that changes in the phosphorylation pattern of CTD conferred by various 
CTD kinases regulate its interaction with binding proteins involved in mRNA processing during the 
transcription cycle (Cagas and Corden, 1995; Bienkiewicz et al., 2000; Meinhart et al., 2005). 
Phosphorylation patterns of RNAPII CTD with pinpoint accuracy orchestrate its association 
with numerous nuclear factors, which are necessary for transcription initiation, elongation, and 
termination, as well as co-transcriptional RNA processing, including 5'-capping, 3’-polyadenylation, 
and splicing. These molecular codes are determined by collaboration of CTD kinases and 
phosphatases during transcription. The reversible serine phosphorylation sites (Serine-2, Serine-5, and 
Serine-7) in the heptapeptide repeats are main determinants of activity of RNAPII CTD domain. 
However, these serine phosphorylation sites are not functionally equivalent (Hemali et al., 2006; 
Chapman et al., 2007).  
Unphosphorylated RNAPII CTD is recruited by the transcription pre-initiation complex to 
promoter regions of genes. Subsequently, the Serine-5 residues of CTD are phosphorylated in the 
promoter-proximal regions by Kin28 and CDK7, representing components of the TFIIH complex in 
yeast and mammals, respectively. A peak of phosphoserine-5 residues on the CTD is detected at the 
5’-end of the transcribed gene and is reduced gradually as transcription proceeds along the gene. 
Phosphorylation of Serine-5 residues of the CTD repeat facilitates promoter clearing, as well as the 
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recruitment and activation of capping enzymes that attach a methylguanosine cap to the 5’-ends of 
nascent transcripts when they are about 25 bases long (Jove and Manley, 1984; Ho and Shuman, 1999; 
Perales and Bentley, 2009; Komarnitsky et al., 2000; Meinhart, 2005; Yu et al., 1997; Cho et al., 1997; 
Phatnani and Greenleaf, 2006; Lolli, 2009). Interaction of CTD with capping enzymes enhances 5’-
capping of pre-mRNA and facilitates the transition to the transcription elongation phase (Schroeder et 
al., 2000; McCracken et al., 1977a; Gao and Gross, 2008).  
Following Serine-5 phosphorylation, CTD heptapeptide repeats of human RNAPII largest 
subunit undergo Serine-2 phosphorylation by CDK9/CTK-1, a catalytic subunit of POSITIVE 
ELONGATION FACTOR b (PTEFb), during the elongation phase (Price, 2000; Ahn et al., 2004; 
Peterlin and Price, 2006; Egloff and Murphy, 2008). Phorphorylation of Serine-2 residues of CTD 
repeats increases as the RNAPII progresses toward the 3’-end of the transcribed gene. 
Hyperphosphorylated RNAPII (RNAP IIO), carrying phosphoserine-2 and phosphoserine-5 in its CTD 
repeats, interacts with components of the spliceosome and strongly stimulates pre-mRNA splicing. By 
contrast, hypophosphorylated RNAPII (RNAP IIA) negatively regulates splicing (Chabot et al., 1995; 
Mortillaro et al., 1996; Kim et al., 1997; Hirose et al., 1999; Damgaard et al., 2008). Furthermore, 
immunohistochemistry experiments demonstrate that truncations of the CTD inhibit the accumulation 
of spliced pre-mRNA variants (Hirose and Manley, 2000). 
 In addition to capping and splicing, 3’-end processing of pre-mRNAs and transcription 
termination are also prevented by truncation of the RNAPII CTD in transient transfection assays 
(McCracken et al., 1997b). The CTD domain interacts specifically with cleavage-polyadenylation 
factors and enhances 3’-end processing of pre-mRNAs in vivo (McCracken et al., 1997b; Hirose and 
Manley, 1998; Hirose and Manley, 2000). In yeast, the Pcf11p subunit of cleavage-polyadenylation 
factor A (CFIA) preferentially binds to heptapeptide repeats containing phosphoserine-2 (Licatalosi et 
al., 2002; Meinhart and Cramer, 2004). Similarly, the yeast Rtt103 protein, which is co-purified with 
cleavage-polyadenylation factors, also binds to CTD repeats containing phosphoserine-2. Furthermore, 
Yhh1p, a subunit of cleavage and polyadenylation specificity factor (CPSF) also binds to 
phosphorylated CTD using a yet unknown molecular recognition code (Dichtl et al., 2002; Egloff and 
Murphy, 2008). It is therefore not surprising that inhibition of CDK9 CTD kinase in Drosophila cells 
in vivo negatively regulates 3’-end processing of transcribed pre-mRNAs (Ni et al., 2004).  
 Chapman et al. (2007) demonstrated that heptapeptide repeats of the CTD domain are also 
phosphorylated at Serine-7 during transcription. They showed that the Serine-7 phosphorylation level 
is high at promoters and gradually increases along the transcribed genes. Simultaneously, Egloff and 
Murphy (2007) found that Serine-7 substitution with alanine in either 25 or 48 consensus CTD repeats 
inhibits proper 3’-end processing and transcription of the small noncoding nuclear RNA U2-globin. 
However, alanine replacement of CTD Serine-7 residues did not affect the transcription and 
processing of protein-coding genes, such as the gene encoding the heterogeneous nuclear 
ribonucleoprotein K. Phosphorylated Serine-7 is required for recruitment of the snRNA specific 
integrator complex, which mediates 3’-end processing in vivo. Interestingly, the CDK7/Kin28 Serine-5 
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kinases were recently reported to phosphorylate also Serine-7 residues of CTD repeats (Akhtar et al., 
2009; Glover-Cutter et al., 2008). This finding is an important milestone in unraveling of the 
molecular code of CTD. 
 Phosphorylation of heptapeptide repeats of RNAPII CTD does not always have positive 
effect on transcription. For example, the CDK8-CyclinC CTD-kinase negatively regulates 
transcription by phosphorylating Serine-5 residues, which prevents complete assembly of the RNAPII 
pre-initiation complex at promoter regions of transcribed genes. On the other hand, CDK8-Cyclin C 
also phosphorylates the cyclin H regulatory subunit of CDK7, and thereby inhibits transcription 
stimulatory activity of the TFIIH-associated CDK7 CTD-kinase (Akoulitchev et al., 2000). 
 
1.3. Small RNA biogenesis pathways 
Based on functional similarities between conserved CTD kinases, it is expected that mutations 
influencing proper maintenance of the CTD code may also affect the biogenesis of certain small RNAs 
in plants as in mammals. Compared to animals, in plants somewhat diversified pathways have evolved 
to produce noncoding small RNAs (approximately 18-25 nucleotides). Plant small RNAs post-
transcriptionally regulate a broad range of biological functions, including the control of flowering-time 
and development, chromatin modification, metabolism, and immunity responses (Xie et al., 2004; 
Voinnet, 2009; Pedersen and David, 2008; Aukerman and Sakai, 2003; Mallory et al., 2004; Schmitz 
et al., 2007; Fornara and Coupland, 2009).  
Two major classes of plant small RNAs are the microRNAs (miRNAs) and short interfering 
RNAs (siRNAs). Although both groups are intimately similar, their precursors and biogenesis are 
different. miRNAs are processed from stem-loop precursors transcribed by RNAPII. The siRNA 
family is comprised of three known classes: trans-acting siRNAs (ta-siRNAs), natural-anisense 
transcript-derived siRNAs (nat-siRNAs) and repeat-associated siRNAs (ra-siRNAs). The endogenous 
source of ta-siRNAs are RNAPII transcribed transcripts (e.g., TAS1, 2 and 3 mRNAs) that are cleaved 
by an AGO1-bound specific microRNA and converted to double-stranded RNA (dsRNA) by the 
RNA-dependent RNA polymerase RDR6 prior cleavage by DCL4 (DICER-LIKE 4). In comparison, 
primary nat-siRNAs represent dsRNA regions of overlapping antisense transcripts cleaved by DCL2 
(DICER-LIKE 2), whereas ra-siRNAs are processed from transcribed repeat-derived dsRNAs by 
DCL3. In addition to these dsRNAs precursors, transcripts from viruses, transgenes and transposons 
may also be converted to dsRNA precursors and processed to siRNAs (Vaucheret, 2005; Vazquez, 
2006; Voinnet, 2009; Mallory et al., 2008). 
Primary miRNA transcripts (pri-miRNAs) may undergo splicing, and are polyadenylated in 
plants before being processed by the DICER-Like RIBONUCLEASE III 1 (DCL1) in the nucleus. The 
miRNA located in a dsRNA region of pri-miRNA hairpin is cleaved by DCL1 producing a 2-nt 
overhang at the 3’end of miRNA:miRNA* duplex. Interaction of DCL1 with the dsRNA-binding 
protein HYPONASTIC LEAVES 1 (HYL1) is essential for proper trimming and maturation of 
miRNAs. In addition, the DCL1-HYL1 complex contains SERRATE, a DCL1-interacting protein, 
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which appears to control microRNA processing in interaction with the ABH1/CBP80 and CBP20 core 
subunits of the cap-binding complex. The nuclear RNA-binding protein DWADLE (DDL) is another 
DCL1-interacting factor, which is likely implicated in pri-miRNAs stabilization. Whereas the se, hyl1, 
cbp80, and cbp 20 mutants show enhanced pri-miRNAs accumulation and decreased mature miRNA 
levels, the ddl mutant has low levels of pri-miRNAs and mature microRNAs (Bartel, 2004; Kurihara 
and Watanabe, 2004; Vazquez et al., 2004; Han et al., 2004; Kurihara et al., 2006, Voinnet et al., 
2009; Fang and  Spector, 2007; Gregory et al., 2008; Laubinger et al., 2008; Voinnet et al., 2009; 
Allen et al., 2004; Fahlgren et al., 2007; Dunoyer et al., 2007). 
The 3’-terminal ribose residue of each miRNA:miRNA* duplex strand is methylated by the 
HUA ENHANCER 1 (HEN1), a S-adenosyl methionine-methyltransferase providing protection from 
polyuridylation and degradation (Yu et al., 2005; Li et al., 2005; Yang et al., 2006; Voinnet et al., 
2009). Subsequently, HASTY (HST), a plant ortologue of animal miRNA transporter Exportin 5, 
exports the methylated miRNA:miRNA* duplex into the cytoplasm (Park et al., 2002; Park et al., 
2005) where miRNAs are incorporated into the RNA-induced silencing complex (RISC, Boutet et al., 
2003; Yu et al., 2005). Previous studies in Arabidopsis showed that the RISC complex recognizes 
near-perfect or perfect complementary targets of miRNAs. ARGONAUTE 1 (AGO1), a RISC 
component with slicer activity, cleaves the target mRNA in the middle of its miRNA complementary 
sequence (Llave et al., 2002; Vaucheret et al., 2004; Jones-Rhoades et al., 2006; Vazquez et al., 2006; 
Baumberger and Baulcombe, 2005; Hutvagner and Zamore, 2002; Song et al., 2004). Moreover, there 
were few reports, which were indicating that the AGO1-microRNA RISC complex inhibits translation 
of certain mRNAs in Arabidopsis, similarly to RISC complexes in animals (Aukerman and Sakai, 
2003; Bari et al., 2006; Chen, 2003; Gandikota et al., 2007). However, recent results show widespread 
translational repression not only by plant miRNAs, but also siRNAs (Brodersen et al., 2008; Voinnet, 
2009, Lanet et al., 2009). 
Like miRNAs, ta-siRNAs are originated from none-protein coding genes transcribed by 
RNAPII. The mRNAs derived from such ta-siRNA source TAS genes are processed by miRNA-guided 
cleavage. Therefore, subunits of the DCL1-complex involved in miRNAs biogenesis are also required 
for biogenesis of the ta-siRNAs. Cleaved TAS transcripts are converted to dsRNAs by RDR6 and 
SUPRESSOR OF GENE SILENCING 3 (SGS3; Peragine et al., 2004; Vazquez et al., 2004; Allen et 
al., 2005; Yoshikawa et al., 2005). DCL4 in interaction with the dsRNA-binding protein DRB4 
processes the RDR6-derived dsRNAs into siRNA duplexes (Xie et al., 2005; Adenot et al., 2006; 
Vazquez, 2006). The mature 21nt ta-siRNAs are then mostly loaded into AGO1 (Baumberger and 
Baulcombe, 2005; Rubio-Somoza, et al., 2009; Voinnet, 2009). There are four known TAS genes in 
Arabidopsis, which yield ta-siRNAs upon cleavage of their transcripts by specific miRNAs. TAS1 and 
TAS2 derived ta-siRNA biogenesis is driven by miR173, ta-siRNA formation from TAS4 mRNA is 
guided by miR828, and AGO7-mediated cleavage of TAS3 transcript requires miR393 (Axtell et al., 
2006; Howell et al., 2007; Yoshikawa et al., 2005; Montgomery et al., 2008). 
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Compared to ta-siRNAs, the natural antisense nat-siRNAs are originated from two convergent 
and overlapping antisense transcripts. Transcription of the first two nat-siRNAs identified in 
Arabidopsis (nat-siRNA-SRO5 and nat-siRNA-ATGB2) was found to be stress inducible (Borsani et 
al., 2005; Katiyar-Agarwal et al., 2006). Stress induction of the SRO5 and ATGB2 genes results in 
dsRNA formation with overlapping transcripts of the neighbouring P5CDH (for SRO5) and PPRL (for 
ATGB2) genes, respectively. The dsRNAs segment formed by these transcripts is cleaved by DCL2 
into a 24nt primary ta-siRNA, which is targeted by a yet unknown AGO protein to the P5CDH or 
PPRL transcripts. Following dsRNA formation catalysed by RDR6, SGS3 and the NRDP1a subunit of 
Pol IVa, the double-stranded P5CDH and PPRL RNAs are processed by DCL1 into 21nt siRNAs 
(Borsani et al., 2005; Katiyar-Agarwal et al., 2006; Herr et al., 2005; Onodera et al., 2005; Vazquez, 
2006).  
Repeat-associated siRNAs (ra-siRNAs) represent specialized type of siRNAs, which have 
evolved for maintenance of DNA and histone methylation on certain perfect or imperfect 
complementary regions of the genome, including transposons, repetitive DNA elements, and 
transcribed intergenic and noncoding sequences. Although, RNAP IVa/Pol IV is the main DNA 
polymerase in ra-siRNA production, it appears that primary sources of these siRNAs are transcripts 
resulting from RNAPII activity. Since DNA sequences encoding ra-siRNAs consist of tandem 
sequence repeats, the primary source of ra-siRNA biogenesis is likely a hairpin-loop of dsRNA 
resulting from transcription of an inverted repeat. However, it is also possible that repeat-derived 
dsRNA formation involves a yet unknown RNA-dependent RNAP. Processing of dsRNA substrates to 
24nt ra-siRNAs/heterochromatic-siRNAs requires DCL3 and subsequent 3’-methylation of the 
products by HEN1. Silencing of complementary loci by ra-siRNAs is mediated by nuclear AGO4-
conatining RITS (RNA-Induced Transcriptional Silencing) complexes that carry associated 
components of RNAP IVb/Pol V (e.g., RDM2, NRPD1, NRPE1, NRPD2a) and trigger si-RNA-
mediated DNA methylation in interplay with components of the Polycomb repressing complex 2 and 
histone 4 K27 and K4 methylases. Therefore, siRNA-dependent DNA methylation (RdDM) is also 
dependent on the functions of DNA methylases and associated chromatin factors, including the 
DOMAINS REARRANGED METHYLTRANSFERASEs DRM1 and DRM2; 
CHROMOMETHYLASE3 (CMT3), DIRECTED DNA METHYLATION1 (DRD1) and 
DEFECTIVE IN MERISTEM SILENCING3 (DMS3). Recently, Wierzbicki et al. (2009) proposed 
that nascent Pol V transcripts are also implicated in driving the AGO4 effector complex to target loci. 
The current RdDM model suggests that following replication and DNA methylation, the methylated 
loci are transcribed by Pol IV and the primary transcripts are converted to dsRNAs by RDR2. These 
dsRNAs are processed into mature 24nt ra-siRNA by DCL3, methylated by HEN1, and loaded into 
RISC-like RITS complexes containing AGO4 and Pol V, which scan the genomic DNA to drive DNA 
methylation at target loci carrying complementary sequences. The accumulation of ra-siRNA is 
dependent on DNA methylation of the target loci that are transcribed by Pol IV. Therefore, RNA-
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directed DNA methylation (RdDM) implies a positive feedback loop (Vazquez, 2006; Matzke et al., 
2009; Wierzbicki et al., 2008; Cao et al., 2003; Zilberman et al., 2003).  
 
1.4. Small RNAs and flowering time control 
During their life cycle, plants utilize several complex pathways to coordinate transitions through 
different developmental phases. Among these, the juvenile to adult and vegetative to reproductive 
phase transitions are best studied, including genetic dissection of the regulatory pathways. Small 
RNAs and proteins involved in their biogenesis play important roles throughout the developmental 
phase transitions. Mutations of DCL4, HST, RDR6, AGO1, AGO7 and SGS3 accelerate the transition 
from juvenile to adult phase suggesting that these small RNA biogenesis factors regulate the phase 
transition during vegetative development (Peragine et al., 2004; Telfer and Poethig, 1998; Xie et al., 
2005; Hunter et al., 2003). On the other hand, the dcl1dcl3 and hen1 mutations confer late flowering 
phenotype, which correlates with an increase in the expression of the floral repressor FLC 
(FLOWERING LOCUS C; Schmitz et al., 2007; Xie et al., 2003; Liu et al., 2004). Moreover, there are 
three known miRNAs (miR172, 156, and 159) that are directly involved in flowering time regulation. 
GIGANTEA (GI), a circadian clock-controlled gene, regulates flowering time by modulating the 
proteolysis of CDF repressor of CO transcription. At the same time, GI positively regulates the levels 
of miR172. Through a CO-independent pathway, miR172 negatively controls the expression of a set 
of AP2-like transcription factors (TARGET OF EAT1, TOE1; TOE2, TOE3; SCHLAFMÜTZE, SMZ, 
SCHNARCHZAPFEN, SNZ) that act as flowering time repressors (Jung et al., 2007). TOE1 to TOE3, 
SMZ and SNZ inhibit the transcription of floral integrator genes FLOWERING LOCUS T (FT) and 
SUPRESSOR OF OVEREXPRESSION OF CONSTANTS 1 (SOC1). miR172 represses the expression 
of these AP2-like transcription factors by translational inhibition rather than cleavage of their mRNAs 
(Schmid et al., 2003; Aukerman and Sakai, 2003; Mathieu et al., 2009; Chen, 2003; Kasschau et al., 
2003; Schwab et al., 2005). Intriguingly, TOE1 and TOE2 positively regulate the transcription of pri-
miR172 precursor, which provides a feedback regulatory loop. In contrast to miR156, miR172 levels 
are high in adult phase and low during the juvenile phase. Transcription of pri-miR172 precursor is 
also positively regulated by the transcription factors SQUAMOSA PROMOTER BINDING 
PROTEIN LIKE 9 (SPL9) and SPL10, which are targeted by miRNA156. In Arabidopsis, 10 members 
of the SPL family carry complementary sequences with miR156 (SPL2, SPL3, SPL4, SPL5, SPL6, 
SPL9, SPL10, SPL11, SPL13, and SPL15) and most likely repressed through translational inhibition. 
In contrast to miR172, the abundance of miR156 is high during the juvenile phase, when it represses 
the SPL transcription factors. As the plant ages, the level of miR156 decreases by yet unknown 
mechanisms (i.e., despite the activation of pri-miR156 transcription by SPL9 and SPL10) and 
consequently the levels of SPL transcription factors are being increased. SPL9 and SPL10 also 
activate the transcription of pri-miRNA172 precursor and thereby enhance FT and SOC1 expression. 
On the other hand, SPL3 and SPL9 enhance the expression of floral homeotic genes AP1, LEAFY 
(LFY), FRUITFUL (FUL), and AGAMOUS-LIKE 42 (AGL42) stimulating flower development. 
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Thereby, the SPL family facilitates both juvenile to adult and adult to reproductive transition phases 
(Gandikota et al., 2007; Fornara and Coupland, 2009; Wu et al., 2009; Yamaguchi et al., 2009; Wang 
et al., 2009).  
The plant hormone gibberellin regulates flowering via two independent DELLA-mediated 
pathways. On one hand, GA targets DELLA proteins [GIBBERELLIN INSENSITIVE (GAI) and 
REPRESSOR OF ga1-3 (RGA)] to the proteasomal degradation system and consequently enhances 
the expression of LFY and SOC1 by a miR159/MYB33-independent pathway. On the other hand, GA 
inhibits LFY expression by enhancing the accumulation of miR159, which represses the LHY-
activating transcription factor MYB33 through mRNA cleavage. Overexpression of miR159 creates 
therefore a late flowering phenotype in short days (Quesada et al., 2005; Mutasa-Göttgens and 
Hedden, 2009; Achard et al., 2004). 
 
1.5. Agrobacterium-mediated transformation and plant cell factors  
The results described in this thesis demonstrate that mutations in two CTD kinases have also a 
dramatic effect on the process of Agrobacterium-induced tumour formation in plants. Genetic 
transformation mediated by Agrobacterium is widely studied and used in higher plants (Gelvin, 2003). 
A conservation of host factors involved in Agrobacterium-mediated transformation is suggested by the 
fact that agrobacteria can also transform other eukaryotes, including fungi (Janyce et al., 2005), sea 
urchins (Citovsky et al., 2007) and human cells (Ziemenowicz et al., 2000; Tzfira et al., 2004).  
During transformation, Agrobacterium transfers a well-defined segment of its Ti (tumour-
inducing) plasmid, the T-DNA, into eukaryotic cells, where it is stably integrated into the host 
genome. The mechanism of Agrobacterium-mediated transformation is only partially understood. 
Host-released signals, particularly phenolics and sugar compounds in combination with acidic pH and 
temperature (Brencic and Winans, 2005), are perceived by Agrobacterium through VirA, a 
transmembrane histidine protein kinase. VirA trans-phosphorylates the VirG transcription factor, 
which acts as response regulator activating the expression of virulence (vir) genes by binding to vir-
boxes in their promoters (Gao te al., 2006; Stock et al., 2000). Boundaries of the transferred DNA (T-
DNA) in the Ti plasmid are defined by specific cis-elements corresponding to 25bp direct repeats. The 
vir gene products VirC1 and VirC2 bind to overdrive sequences adjacent to T-DNA borders and help 
targeting the VirD1/D2 complex that introduces single-stranded nicks at the 25bp border repeats. 
During this process, VirD2 forms a covalent bond with the 5' end of lower strand of the T-DNA, the 
T-strand, which is released by a subsequent strand-replacement DNA synthesis proceeding from the 
right border to the position of similarly nicked left border (Gelvin, 2000; Tzfira et al., 2004). The 
VirD2-coupled T-strand, as well as the VirE2, VirE3, VirF, and VirD5 proteins are transported into 
host plant through a VirB/D4 type 4 secretion system (T4SS T-pili). Upon transfer, the single-stranded 
DNA binding protein VirE2 assembles as polymer on the T-strand, covering it on its entire length and 
providing effective nuclease protection. Nuclear localization sequences (NLS) in both VirD2 and 
VirE2 guarantee rapid translocation of the T-strand into the nuclei of host cells (Gelvin, 1998; 
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Mccullens and Binns, 2006). Additionally, host factors including importin α (Ballas and Citovsky, 
1997), the VirE2-binding bZIP transcription factor VIP1 (Tzfira et al., 2002) and several protein 
kinases (Tao et al., 2004) also play important roles in nuclear import of the T-strand complex (i.e., T-
complex). Once inside of the plant cell nucleus, VirF likely forms a SCFVirF E3 ubiquitin ligase 
complex, which destabilizes the T-complex through targeting VirE2 and VIP1 to proteasomal 
degradation (Munro et al., 2007; Schrammeijer et al., 2001). Subsequently, the T-stand may be 
converted to double-stranded DNA and integrated into the host genome by non-homologous end-
joining (NHEJ) and illegitimate recombination mechanisms (Chilton and Que, 2003). Several studies 
indicate that other host factors, such as VIP2 (Anand et al., 2007b), and histones H3 (Anand et al., 
2007a) and H2A (Mysore et al., 2000; Li et al., 2005) are also required for T-DNA integration. 
Nonetheless, the precise mechanism by which the T-DNA is integrated into the host chromosomes is 
thus far largely unknown.  
The analysis of plant chromosomal junctions of T-DNA insertions demonstrated that the 3' 
end of integrating T-strand features almost always some limited sequence homology (i.e., micro 
homology) with the pre-insertion target sites, which often suffer deletions  during T-DNA integration 
(Mayerhofer et al., 1991; Tinland et al., 1995). Sequence compilations of 3’-end junctions of T-DNA 
insertions are completely consistent with formation of the junctions by non-homologous end-joining 
(NHEJ, Kohli et al., 1999). However, genetic and molecular analyses of knockout mutations in genes 
encoding Arabidopsis NHEJ components indicates that this pathway is not essential for T-DNA 
integration (Gallego et al., 2003), although the rate of transformation is significantly reduced by the 
NHEJ mutations. In contrast to the 3’-end, the 5' end junctions of T-DNA insertions in most plant 
hosts appear to be very precise and well conserved, reflecting the position of covalently bound VirD2 
protein (Tinland et al., 1995). Therefore, the available data suggest that the 3’ and VirD2-linked 
5’ends of the T-DNA are recombined into the host genome probably by different mechanisms. 
Although VirD2 is expected to play a pivotal role in interaction of the 5’-end of the T-DNA with host 
target sites, using in vitro studies Ziemienowicz et al. (2000) showed that ligation of VirD2-bound 
oligonucleotides to target sequences by T4 DNA ligase was less efficient than ligation of free 
oligonucleotides. It is thus likely that the release of covalently bound VirD2 protein from the 5’-end of 
the T-strand requires some modification of VirD2 by nuclear host factors. 
 In T-DNA transformed plant populations selected for the expression of T-DNA encoded 
antibiotic resistance marker genes, T-DNA integration was found to occur preferentially into promoter 
regions of plant genes (Alonso et al., 2003; Szabados et al., 2002). This suggest that the VirD2 pilot 
protein can interact with plant host factors that are associated with promoter sequences that carry open 
chromatin regions accessible to T-DNA integration (Citovsky et al., 2007). Studies by Bakó et al 
(2003) demonstrated that in fact the VirD2 protein interacts with the TATA-box binding protein TBP 
in vivo, and that VirD2 is phosphorylated by the RNAPII CTD-binding CDK2-activating kinase 
CAK2Ms in alfalfa cells. The fact that Arabidopsis TBP differs only with few non-conserved amino 
acids from fungal, insect, animal, and human TBPs suggests that interaction of VirD2 with TBP is 
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probably involved in precise integration of the 5’-end of T-DNA into the genomes of different 
organisms (Lacroix et al., 2006). TBP is recruited to mismatches and serves as binding platform for 
TFIIH, which is recognized by other repair and chromatin remodelling factors involved in the removal 
of lesions present in the DNA strand by a transcription-dependent mechanism called transcription-
coupled repair (TCR) or global genome repair (GGR, Laine and Egly, 2006). Interaction of VirD2 
with TBP may thus target VirD2 to the nucleotide excision repair complex that assumingly carries an 
associated CAK VirD2 kinase. 
 
1.6. Aims of the study 
Major goal of the present study was to perform functional characterization of the Arabidopsis CDKF;1 
protein kinase. To achieve this goal, the study included the following genetic and biochemical 
approaches: 
 
• Isolation and characterization of T-DNA insertion mutations in the CDKF;1, CDKD;1, 
CDKD;2 and CDKD;3 genes.  
In these experiments, we have identified at least two T-DNA insertion mutations in CDKF;1 and each 
member of the CDKD gene family using PCR-based mutant screens and sequencing the junctions of 
T-DNA insertions in the target genes. Subsequently, we have performed phenotypical characterization 
of the T-DNA insertion mutants, including the documentation of developmental defects and assays of 
their altered responses to plant hormones, and metabolic and environmental factors. Mutations 
inactivating the individual CDKD genes permitted normal seedling development due to functional 
redundancy of three CDKDs in Arabidopsis, whereas inactivation of the unique CDKF;1 gene by 
insertion mutations lead to dramatic developmental defects. To assess the effects of inactivation of all 
CDKD genes, we have initiated the construction of triple mutants. 
 
• Biochemical characterization of CDKF;1 protein kinase. 
To identify potential substrates of CDKF;1, first we have performed a series of in vitro protein kinase 
assays. For these purpose, CDKF;1, CDKD;1, CDKD;2 and CDKD;3 have been purified to apparent 
homogeneity as N-terminal thioredoxin fusion proteins from E. coli. We have found that all four 
kinases underwent partial autophosphorylation and showed various levels of activity in vitro. In 
contrast to Shimothono et al. (2003), we have observed that CDKF;1 phosphorylated not only 
CDKD;2 and CDKD;3, but also CDKD;1, as well as the CTD domain of the largest subunit of 
RNAPII. Using wild type and mutated versions of the CTD consensus heptapeptide as kinase 
substrate, we have determined the specificity of CTD phosphorylation by CDKF;1 and CDKD;2. 
These assays indicated that CDKD;2 mediates phosphorylation of the Serine-5 residue, whereas 
CDKF;1 can phosphorylate Serine-7 residues of the CTD heptapeptide repeats. Using monoclonal 
antibodies against phosphoserine residues of CTD repeats, we have confirmed a reduction of Serine-5 
CTD phosphorylation in the cdkd;2 insertion mutant in vivo. Analogously, we have observed that 
during early seedling development (i.e., until day 7) the cdkf;1 mutation causes a remarkable reduction 
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of Serine-7 phosphorylation, whereas during later stages of plant development it also affects the levels 
of Serine-2 and Serine-5 phosphorylation. This observation has supported our data indicating that 
CDKF;1 is an upstream activator of CDKD;2 and therefore affects indirectly Serine-5 phosphorylation 
of the CTD. The fact that the cdkf;1 mutant exhibits very low level of Serine-2 phosphorylation of 
CTD repeats suggests a possible involvement of a yet unknown CDKF;1-activated downstream CTD 
kinase. 
 
• Analysis of transcriptional changes by Affymetrix microarray profiling in the cdkf;1 mutant. 
To determine the effect of CDKF;1 mutation on genome-wide transcription and correlate this with the 
observed dramatic alterations of developmental, light and hormonal regulatory pathways, we have 
performed a comparative Affymetrix transcript profiling experiment using 7 days old wild type and 
cdkf;1-1 mutant seedlings. At this early stage, wild type and cdkf;1-1 mutant seedlings showed 
comparable growth and development despite a root elongation defect in the mutant. Standard analysis 
of the Affymetrix data using the GeneSpring software indicated that at p>0.05 confidence level only 
845 genes showed at least 2-fold or higher changes in transcript levels between the mutant and wild 
type, while by lowering the cut off value to 1.5-fold resulted in 2385 genes showing significant change 
in transcription in the ckdf;1-1 mutant. To confirm that the observed changes in transcript levels lower 
than 2-fold were reproducible and meaningful, we performed confirmatory quantitative real-time 
(qRT-PCR) assays to measure precisely the mRNA levels of 132 genes from different pathways. This 
indicated less than 25% variation between 80% of Affymetrix and qRT-PCR data and revealed that the 
cdkf;1-1 mutation resulted in down-regulation of genes encoding key enzymes in the biogenesis 
pathways of microRNAs, ta-siRNAs, nat-siRNAs and ra-siRNAs. This observation has been 
confirmed by testing the transcript levels of selected representatives of all four small RNA classes 
using northern RNA hybridizations. All genes showing altered transcription in the cdkf;1 mutant were 
sorted to GO terms and pathways by literature mining, to correlate genome-wide transcriptional 
changes with the reduction of CTD Serine-7 phosphorylation during early seedling development in the 
cdkf;1-1mutant. 
 
• Determination of effects of cdkf;1 and cdkd mutations on Agrobacterium mediated tumour 
formation. 
Bakó et al. (2003) has demonstrated that a CTD-associated CDKD-like protein kinase mediates the 
phosphorylation of VirD2 pilot protein of Agrobacterium T-DNA in alfalfa cells. Therefore, we were 
interested to determine how the cdkd;1, cdkd;2, cdkd;3, and cdkf;1 knockout mutations affect the 
process of Agrobacterium-mediated plant cell transformation. We have found that the cdkf;1-1 and 
cdkd;2-1 mutations dramatically reduce the number of tumours incited by an oncogenic 
Agrobacterium tumefaciences C58 strain in hypocotyls of Arabidopsis seedlings. The deficiency of 
tumorigenesis in these mutants suggested that both CDKF;1 and CDKD;2 play a role in the 
recognition and modification of VirD2, and thereby in the process of T-DNA integration. In fact, we 
found that CDKF;1 can phosphorylate the VirD2 protein at multiple positions in vitro. This, together 
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with the finding that Arabidopsis and rice CDKF;1 kinases co-purify with CDKD;2 and cyclin H (Van 
Leene et al., 2007; Ding et al., 2009) provides a basis for further studying how CDKF;1 and CDKD2 
regulate the function of VirD2 during the process of T-DNA integration. 
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2. MATERIALS AND METHODS 
 
2.1. Materials 
2.1.1. Chemicals 
Chemicals used in the experiments were purchased from Sigma, Bio-Rad, Merck, Roche, Roth, GE 
Healthcare, PerkinElmer, Duschefa, Biomol, Boehringer, and Gibco, unless otherwise stated. General 
solutions and buffers were prepared as described by Sambrook and Russell (2001), unless otherwise 
stated. 
 
2.1.2. Enzymes 
All enzymes were used according to the manufacturer’s instructions unless otherwise stated. 
 
Taq DNA polymerase, recombinant 
AccuprimeTM Taq DNA polymerase High 
Fidelity 
Platinum Pfx DNA polymerase  
TaKaRa LA TaqTM 
RNase-Free DNase Set 
Restriction endonucleases 
Gateway BP Clonase Enzyme  
Gateway LR Clonase Enzyme 
T4 polynucleotide kinase 
T4 DNA ligase 
Antarctic phosphatase 
Protease Inhibitor Cocktails for plant cell and 
tissue extracts 
RNase A 
Invitrogen, Karlsruhe, Germany 
Invitrogen, Karlsruhe, Germany 
 
Invitrogen, Karlsruhe, Germany 
TaKaRa Biomedicals, Shiga, Japan 
Qiagen, Hilden, Germany 
New England Biolabs, Frankfurt 
Invitrogen, Karlsruhe, Germany 
Invitrogen, Karlsruhe, Germany 
New England Biolabs, Frankfurt 
New England Biolabs, Frankfurt 
New England Biolabs, Frankfurt 
Sigma, St. Louis, MO, USA 
 
Boehringer, Mannheim, Germany 
 
2.1.3. Kits 
Nucleospin Plasmid QuickPure Kit 
QIAquick PCR Purification Kit 
QIAquick Nucleotide Removal Kit 
QIAquick Gel Extraction Kit 
RNeasy Plant Mini Kit 
Transcriptor First Strand cDNA Synthesis Kit 
iQTM Supermix 
Macherey-Nagel, Germany 
Qiagen, Hilden, Germany 
Qiagen, Hilden, Germany 
Qiagen, Hilden, Germany 
Qiagen, Hilden, Germany 
Roche, Manheim, Germany 
Bio-Rad, München, Germany  
 
MATERIALS and METHODS   15 
 
 
2.1.4. Bacterial strains 
2.1.4.1. E. coli strains 
DH10b  
DB3.1  
BL21(DE3)pLysS 
XL10-Gold 
 
Invitrogen, Karlsruhe, Germany 
Invitrogen, Karlsruhe, Germany 
Novagen, Madison, WI 
Stratagene, La Jolla, USA 
 
 
2.1.4.2. Agrobacterium strains 
C58 
GV3101/pMP90RK 
GV3101/pPMP90 
wild type 
rifampicin, gentamicin and kanamycin resistant 
rifampicin and gentamycin resistant (Koncz and Schell, 1986) 
 
 
2.1.5. Vectors 
pET201 
pPCV6NFHyg 
pDONR201 
N-TAPI 
pER8GW-XVE (Hyg) 
pBluescript II SK+ 
pENTR1A 
pGEX4T-2 
Horváth, M. 2007 (Ph.D. thesis) 
Koncz et al., 1989 
Invitrogen, Karlsruhe, Germany 
Rohila et al., 2004 
Zuo et al., 2000 
Stratagene, La Jolla, USA 
Invitrogen, Karlsruhe, Germany 
Amersham Biosciences GmbH, Freiburg, 
Germany 
 
2.1.6. Hormones 
Name 
ß-estradiol 
 
1-Aminocyclopropane-1-carboxylic acid (ACC) 
 
Ethephon 
Abscisic acid (ABA) 
 
6-Benzylaminopurine (BAP) 
 
Gibberellin (GA3) 
 
Indole 3-acetic acid (IAA) 
 
 
Kinetin 
 
 
Stock solution 
10 mM in DMSO 
 
1 mM in H2O 
 
50 mg/ml in methanol 
1 mg/ml in methanol 
 
1 mg/ml in 1N NaOH 
 
10 mM in ethanol 
 
2 mg/ml in 0.5 M HCl, adjusting pH 5.8 
with 0.5 M KOH 
 
1 mg/ml in 0.5 M HCl, adjusting pH 3.0 
with 0.5 M KOH 
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1-naphtylacetic acid (NAA) 1 mg/ml in 0.5 M KOH, adjusting pH 7 
to 8 with 0.5 M HCl 
The hormone stock solutions were filter sterilized and stored at -20°C 
2.1.7. Oligonucleotides 
2.1.7.1. Oligonucleotides for cloning 
D1FE 
D1RB 
D2FN 
D2RB 
D3FN 
D3RB 
F1FX 
F1RN 
HFNB 
HRSB 
Uni5 
Uni3 
FFG 
FRG 
AGGAGCGCCGAATTCGGGATCCATGGAACAGCCGAAGAAAGTTGCT 
CCTGCCTGGTCGTCGACGGATCCTAGGAACTCGAGATCAAGTTTCCTCTTCA 
GAGCGCCGAGCTAGCGGATCCCTCGAGATGTCGAAATCCGGCGATAATCAA 
TGCCTGGTCGCGGCCGCAGGATCCAGTGAATCCTTCAGGACCCATCACTCT 
GAGCGCCGAGCTAGCGGATCCATGCCGGAGCAGCCAAAGAAAGT 
CCTGCCTGGTCGTCGACGGATCCCTGGAACTCAAGATCGAGTTTCCTCTTC 
GAGCGCTGACTC GAG ATGGATAAACAACCGGCGACCAG 
CTGCTCGCGGCCGCGCTAGCATTGGGGAATTCTATTGTAAATCCACTACTGGTAG 
GAGCGCCGAGCTAGCGGATCCATGGCGGATTTTCAGACATCAACA 
CCTGCCTGGTCGTCGACGGATCCACCTATGGGTGGCGGTGCC 
GGGACAAGTTTGTACAAAAAAGCAGGCTTCGAAGGAGATAGAACCATG 
GGGGACCACTTTGTACAAGAAAGCTGGGTCTCCACCTCCGGATC 
GGAGATAGAACCATGGATAAACAACCGGCGACCAG 
TCCACCTCCGGATCTTCAGGGGAATTCTATTGTAAATCCACTACT 
 
2.1.7.2. Oligonucleotides for screening of T-DNA insertion mutants in Arabidopsis thaliana 
FISH1 
FISH2 
SALKLB 
GABI RB 
CAK1 5' 
CAK1 3' 
CAK2 5' 
CAK2 3' 
CAK3 5' 
CAK3 3' 
CAK4 5' 
CAK4 3' 
CTGGGAATGGCGAAATCAAGGCATC 
CAGTCATAGCCGAATAGCCTCTCCA 
TTTGGGTGATGGTTCACGTAGTGGG 
TTCCATTGCCCAGCTATCTGTCAC 
CAGGAAAGATCCGAAGAAAAGCGAC 
ATCAAGATGCTCAACCATGGACTCTG 
GAAAGATGATGACAAGCTATGCGGGAA 
AGGGCTTGCATGTAAGCACGGTAAGTC 
TCTGATGATGTGGGCACGAAAGCA 
GATGTGGCCGTACATTGGTCTTTAGAA 
GTTGAAAAAAGTGCCGTTAAATGGTCA 
CCTATACAACAAGATCACTGCTTCCCAAT 
 
 
2.1.7.3. Oligonucleotides used for RT-PCR 
Name Sequence (5'-3') Start Stop 
D1FA 
D1RA 
D1RB 
D1FC 
D1RC 
TCCGGAGATGGAACAGCCGA 
AATGCAGCCAGCAGCCCAAA 
TGGTTGGTCGGTTTGGTGGC 
GCTCCCAAGACCAGTTTCCAAGC 
GCACTGGTGATGGTTGGTCGG 
159 
759 
1306 
1071 
1316 
178 
740 
1287 
1093 
1296 
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Name Sequence (5'-3') Start Stop 
D2FA 
D2RA 
D2RB 
D2FC 
D2RC 
CCAATGTCGAAATCCGGCGA 
CAGCCTGCAGCCCAAACATCA 
GCTCGGAGGCCTTTGGTTCG 
CCCGCTCCACCATTACGTACCA 
CTCGGAGGCCTTTGGTTCGAG 
58 
656 
1024 
811 
1023 
77 
636 
1005 
832 
1003 
D3FA 
D3RA 
D3FB 
D3RB 
D3FC 
D3RC 
AACCCGAAAATGCCGGAGCA 
TGTCGGCGGGTGAGAGGAAA 
CGTTGCCTGCATATTCGCCG 
ACCCTCCCACGCTCAGGCAT 
CCGGAGCCGGAGCTCTCAAA 
CCTCCCACGCTCAGGCATCA 
193 
532 
786 
1226 
34 
1224 
212 
513 
805 
1207 
53 
1205 
F1FA 
F1RA 
F1FB 
F1RB 
F1FC 
CAACCGGCGACCAGTTGGAG 
CCGCAGCGAGATCCGACCTA 
ATCTCGCTGCGGTGATCCGA 
TGCTCAACCATGGACTCTGCCA 
GCCTTCCCAACCATTCAGGGG  
42 
336 
325 
1824 
1180 
 
61 
317 
344 
1803 
1200 
 
 
 
2.1.7.4. Oligonucleotides utilized for Real-time quantitative PCR 
Gene AGI Primer name Sequence 
Ubiquitin At3g62250 UbiF 
UbiR 
CCAGAAGGAATCGACGCTTCATCTC 
GAGAAGGATCGATCTACCGCTACAACAG 
Phot1 At3g45780 Pho1F 
Pho1R 
TGATGCCAACATGACACCAGAGG 
TGCAACGACAACTTGAGCAGCA 
Phot2 At5g58140 Phot2F 
Phot2R 
GGGCAGAGGGACAGTTGGGA 
TCTTCGGGCCGCGTATTAGC 
TLP1 At2g02710 TLP1E2F 
TLPE3RJ 
GGATTGGGAACAGTGTGAAGCGAG 
CTGGTAAGCATGGATTGGTTAATACGA 
NPH3L1 At3g15570 NPH3L1F 
NPH3L1F 
TCTGCAGCGCGGTGTTTGTC 
AACCCGAGCCTCTTCCACCG 
NPH3L2 At3g19850 NPH3L2F 
NPH3L2F 
CAGGTGGGTCAGATGGGTTCG 
CGGCGACTGAGAGGAGGCTG 
SOB3 At1g76500 SOB3F 
SOB3R 
CAGCGGCTCATGGGGCAAAT 
TGTCCTTGACCGGCTCCAGATG 
PHYA At1g09570 PHYA1F 
PYHA1R 
CATCCCTCAAGCAGCCCGTT 
CCCAGTGGAGCATCACGCAT 
PHYB 
 
At2g18790 
 
PHYBF 
PHYBR 
TCCCGCCAATTTTTGCTGCT 
CCCTCGAGGCTAACCCGCTT 
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Gene AGI Primer name Sequence 
PHYC 
 
At5g35840 
 
PHYCF 
PHYCR 
TGAAGGACCCCGAAAAGGCA 
CTCAATGCAGGCGTGAAGCG 
PHYD At4g16250 PHYDF 
PHYDR 
GGCCTCGCAGCGAAGTGATT 
TGCAGCTCGGGACTCGGTATC 
PHYE At4g18130 PHYEF 
PHYER 
GCGGGATACCCTGGTGCCAT 
TTTCCCACGGCAAGCTCCTG 
HY2 
 
At3g09150 HY2F 
HY2R 
GCGGGTTTCATGGAGCCTGAG 
CCCCATGGGAAAGTCTCAGCA 
HO2 
 
At2g26550 
 
HO2F 
HO2R 
TCGATTTATCGGGAGTTTTGCTGG 
CGTCCCGACTCCAGTGCTCC 
PIF3 At1g09530 
 
PIF3F 
PIF3R 
CGTGCCCTGCAAGAACTCATTCC 
CGATGAACCACCACGGCTCA 
PIF4 At2g43010 PIF4F 
PIF4R 
TCGGCTCCGATGATGTTCCC 
GCTGTCCCGCCGGTGAACTA 
AAR3 At1g59940 AAR3F 
AAR3R 
GTCACGGCGGTTGATAGCGG 
CGGCGAATCCACAAGCGAAG 
ARR12 At2g25180 AAR12F 
AAR12R 
TCGGTGTCCGCAGCCTTTCT 
TGTTATGTGCCGGGGGAGGA 
ARR14 At2g01760 AAR14F 
AAR14R 
GTGGTAGCCTCGAGACTGTTGTTGTTTC 
GAAACAGGACGGTTAGAAGCGGA 
ARR3 At2g41310 ARR3F 
ARR3F 
GCCGTCGAATTCGATAGATTGAAGGT 
TAGACAGAGGCGATTCCACCGTAGAG 
ARR9 At3g57040 ARR9F 
ARR9R 
GCAAGAATCAGCAGATGTTTAGAAGAAGG 
GTCGAATCTAGGACGTGCTCTATCAGTTG 
PRR5 At5g24470 PRR5F 
PRR5R 
CAGACGTGGAGGTTAGTGCGAGAGAC 
GGGTTGGCGTAGGGTATGAACTCTG 
PRR7 At5g02810 PRR7F 
PRR7R 
TCCCCCATAATCATCGCTCACA 
ACTTCCACTTCCGCTTCCACTACC 
APH1 At3g21510 APH1F 
APH1R 
GGGATTTTGGACAGCCAGTTCTTG 
GCCGGGATCATTCCACCAGAAG 
CCA1 At2g46830 CCA1F 
CCA1R 
CAATGCACGCCGCAGTAGAATC 
TTGAGTTTCCAACCGCATCCGT 
MATERIALS and METHODS   19 
 
Gene AGI Primer name Sequence 
LHY1 At1g01060 LHYE8F 
LHYE8R2 
CACGGGCACGCAAATCTTCA 
TTTGAGCCACAGGATGAGCGG 
CCR2 At2g21660 CCR2E1F 
CCR2E1R 
TGGCGTCCGGTGATGTTGAG 
GCCACCGCTTCCTCGTGACT 
CCR1 At4g39260 CCR1F 
CCR1R 
CTGAAGTTGAGTACCGGTGCTTTGTC 
CGTTCATCTCTTCAATCGCATCCC 
GI At1g22770 GIE12F 
GIE14R 
TCTTCTTCTGCGGGCAACTGATG 
TGAGGCGGCGTTGAAGAATCG 
WNK2 At3g22420 
 
WNK2E7F 
WNK2E7R 
CATGGAGTGTAGCGGTTGAGATGG 
ACCCGTTTGAAGCACACTCTCCA 
WNK6 At3g18750 
 
WNK6E9F 
WNK6E9R 
ACCCACCTGGAAAACCGATGTCA 
CTTTGGTGGCATCGACGCATTG 
CIR1 At5g37260 CIR1F 
CIR1R 
CCATTGAGATCCCGCCTCCA 
CTCATGTTGTTCATCTCAGTCACCGAC 
PAP2 At4g29080 PAP2F 
PAP2R 
GTGATGTCGGCTCGGGTTCTG 
CCCAAGGGACATCTCCGACCAG 
PAP1 At3g16500 PAP1F 
PAP1R 
GCCTCCGGTTCGTTCGTTCA 
ATGGAACATCCCCAACAAGCATCT 
AFR1 At2g24540 ARF1F 
ARF1R 
GCACGTGGCGAGAGATGAG 
AGCCAGTGAAAAGGGTTTTAGTGAA 
PKS1 At2g02950 PKS1F 
PKS1R 
CGTCGACTCGAAGCAGAGCG 
GCATGCGCATTTACACCCCA 
PKS2 At1g14280 PKS2F 
PKS2R 
CGCGCCTCAGAGACGGAAATC 
GGCGATTGCGTGTGAGAAACAG 
HY5 At5g11260 HY5E1F 
HY5E3R 
CATCAAGCAGCGAGAGGTCATCAAG 
GTCTAAGCATCTGGTTCTCGTTCTGAAG' 
HYH At3g17609 HYHE1F 
HYHc4R 
GAACTCGAGTTCGTCTTCTTCCCACA 
GCTGCTTAGAACACATGTTGATCCAGCT 
CIP1 At5g41790 CIP1F 
CIP1R 
GAGGAGAGGGGTAAGGAAGTGACATC 
CCCAATTCGTCGCAGTCCACA 
LZF1 At1g78600 
 
LZF1F 
LZF1R 
GCAGCAGCAGGAACAGCAGG 
CGCCCATGATGTCTCACCTCCC 
STH At2g31380 
 
STHF 
STHR 
CCCTCCCTGCGACATCTGCC 
GCAGCGGGTTGCTGAGTTGG 
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Gene AGI Primer name Sequence 
DCL1 At1g01040 E16F 
E17R 
GGTTCACTTATCCGAGGTGCTCAGAG 
CACCCTCTAGTTCACCATCCTCCATC 
DCL2 At3g03300 DCL2E23F 
DCL2E24R 
GCAAACCTGCACAAACACATCCTG 
ACTCAACTCGAACTGCCACTTCTGAC 
DCL3 At3g43920 DCL3E20F 
DCL3E22R 
CGTAAAACCTCGCTCGGGGATA 
CACGATTGGGTATCCTTAGGGTTATGG 
DCL4 At5g20320 DCL4E22F 
DCL4E22R 
AGCAGCAAAACCGCAAAATCCC 
CCTTTCTTCGTTGCTCTAGCCTCACC 
AGO1 At1g48410 AGO1E21F 
AGO1 3' 
CACTTCTCGACCTGCTCATTACCAC 
CGTGTGCTTCTACCAGCCATTCC 
AGO4 At2g27040 
 
AGO4E15F 
AGO4E23R 
CATTATCCTTGGGATGGATGTTTCAC 
CCAAGCTGAGCAGCTGCCAAGTG 
AGO6 At2g32940 
 
AGO6F 
AGO6R 
TCATGGGCCTCCAGGTCGGG 
TTCCGTGCCCTGCTTGTCCG 
AGO7 At1g69440 AGO7E2F 
AGO7E3R 
GAACTTGCCGTGTCTGCAAATCAGTAG 
CTGCCTCCAATACTCATCAAAGCCC 
RDR2 At4g11130 
 
RDR2E2F 
RDR2E4R 
GACGAAAAACCCATGTCTTCACCCT 
GGCTTTTTCAGGGTCACGGTCTG 
RDR6 At3g49500 RDR 5' 
RDR3' 
GGACCTGTACTTTGTGGCTTGGGA 
ACCCGTCTGTAAAGCCGACCCA 
HYL At1g09700 
 
HYLE1F 
HYLE3R 
GCTCGTGAAAATGACCTCCACTGATG 
GGTTCTTGCATAATCCCGTTTCGTG 
HASTY At3g05040 
 
HSTE1F 
HSTE6R 
GCGGTCCAATTCCTGGATTCTGTA 
GAGTAAGTCCCCGCAACAATAGCCT 
HEN1 At4g20910 HENE5F 
HENE9R 
GATACTGTGAGAATCCGCTCGCTCC 
GACAATCAGGAGCTTGGGGTGGAAC 
DRD1 At2g16390 
 
DRDF 
DRDR 
TGGCTGACGATCCTGGTGGCT 
CAGCTGCTGTGCCCGGTTCT 
miR162a At5g08185 
 
162a5’ 
162a3’ 
TAGTTGGAAGAAGAGTGAGAGTCGCTG 
AAGAAAGATACAAGAGGCAAACGCTGG 
miR165a At1g01183 
 
Pri165a5’ 
Pri165a3’ 
CTGCTAAGATCGATTATCATGAGGGTTAAG 
AATGTAACAATAAATGGTGATCAGAGGCAAT 
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Gene AGI Primer name Sequence 
miR172a At2g28056 
 
Pri172a5’ 
Pri172a3’ 
CTGTTTTTGCTTCCCCTCTGCCA 
GTGGATCTATTAATGTCTTGATAAAGACTGCC 
miR172b At5g04275 
 
Pri172b5’ 
Pri172b2R 
TTGCACCTCTCACTCCCTTTCTCTAACTA 
CAAGGGCTGACGTGTCAACTTATAAGTG 
miR172c At3g11435 
 
Pri172c5’ 
Pri172c3’ 
TTCCAGCAAAATGGTGCCGTCTT 
CCTCCGATCTGTGAATTCCTACAAAAAG 
TAS1a At2g27400 
 
TAS1AF 
TAS1AR 
TGAGCGCCGTCAAGCTCTGC 
ACAGAGAGGGCGACGGGAGG 
TAS1b At1g50055 
 
TAS1bF 
TAS1bR 
GAGATAGGTTCTTAGATCAGGTTCCGCTGT 
GTAATTGGCGGTAGACTTCATGACACATC 
TAS2 At2g39681 
 
TAS2F 
TAS2R 
GTTGGGTTTGGGAGTGAGTTTACGAG 
TTACAAGTGCAAAAGTGATGAACGCTC 
TAS3 At3g17185 
 
TAS3E1F 
TAS3E2R 
TTAGCGAGACCGAAGTTTCTCCAAG 
GCTCAGGAGGGATAGACAAGGTAGGAG 
 
KRP2 At3g50630 
 
KRPF 
KRPR 
ACGACGACGACGGTGAAACGA 
TCGTCTCCGACGCTCCTGCT 
SIM At5g04470 SIMF 
SIMR 
CCGCAGAAACCCCGTCCACC 
GGCCACCGTGATAGCCGTCG 
ZWI At5g65930 
 
ZWIF 
ZWIR 
ACCACAGTGTCTGATGCTGTTGAGGA 
TGTGCAGCATCGTCCCTCCCA 
AS1 At2g37630 AS1-1F 
AS1-2R 
ATGGAAGTTGCTCTTGAGTTTGGGATTA 
CCTGAAGACGGATCACAAGCCTCTG 
AS2 At1g65620 AS2-F1 
AS2-R2 
CCATCGAGAGCCTCAAAACCCAA 
GGCTTCTGTTGCTCAGAGGGGAAATA 
CO At5g15840 
 
COE1F 
COE1R 
GCTCAAGTTCACTCTGCCAATCGC 
AGGGAACAGCCACGAAGCAACC 
FLC At5g10140 
 
FLCE1F 
FLCE4R 
GGCAAGCTCTACAGCTTCTCCTCCG 
CACGGAGAGGGCAGTCTCAAGGTG 
FT At1g65480 
 
FT-F 
FT-R 
CACCAGGGTGGCGCCAGAAC 
TCCTCCGCAGCCACTCTCCC 
SOC1 At2g45660 
 
SOC1E6F 
SOC1E7R 
GAGAAAGCTCTAGCTGCAGAAAACGAG 
GGTAACCCAATGAACAATTGCGTCTCT 
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Gene AGI Primer name Sequence 
COL1 At5g15850 
 
COL1E1F 
COL1E1R 
TCAACGAGTTCCAATTCTGCCCA 
ACAACCATGAAGCCGCCTCTGC 
COL2 At3g02380 
 
COL2E1F 
COL2E1R 
CGATGAGGATGATCGAGAGGTTGCTT 
GACCCTAGCCTCCCTCTCCATTG 
COL9 At3g07650 
 
COL9E4F 
COL9E5R 
CAATGCCTGCTCACATTCAGTAACCC 
TGGTTGGGGTGAGAGGGTCGT 
CDF2 At5g39660 CDF2E1F 
CDF2E2R 
CGGTTTAGGACGAGAAGAAGGTGATG 
GCTGTTACATCGCGGACACGG 
AP2 At4g36920 
 
AP2E10F 
AP2R 
TTCCGGCGGCTGAGAACCAC 
GAGAGGAGGTTGGAAGCCATTTGTCT 
SMZ At3g54990 
 
SMF1 
SME5R 
CCGTGGAAGACAGTCACTGGTTGAA 
CCTAAGTGTTTGCACGAACTCCACC 
SNZ At2g39250 
 
SNZF1 
SNZE5R 
CAAGAAGCTCTCATTATCGTGGCGT 
AGCTTGCACTCGCTCGTCTAAGAGAT 
TOE1 At2g28550 
 
TOE1F1 
TOE1E5R 
GGAGAGGACCAAGGTCTAGAAGTTCACA 
GCGAAAACCCCGTGCTCTGTCTAC 
TOE2 At5g60120 TOE2F1 
TOE2E6R 
ATAGGTAGCGGGAGCGGTGGTG 
GCAGCTTCCCTTCCCTTCCATTG 
TOE3 At5g67180 
 
TOE3F1 
TOE3E6R 
GATAAAGAAGAGCCGACGTGGTCCTC 
CTAGCAGCTTCAATCTCGGTATCAAAGAG 
AP3 At3g54340 
 
AP3E4F 
AP3E7R 
GTGAGTGTTTGGACGAGCTTGACATTC 
GAGCGTAAGCACGTGACCCTTCG 
PI At5g20240 
 
PIE3F 
PIE6R 
TGTCGAGCACGCCATTGAACA 
CCTGAAGATTTGGCTGAATCGGTTG 
AGL24 At4g24540 
 
AGL24E1F 
AGL24E4R 
GAAGAGGAATCTTCAAGAAAGCCGAT 
CTCCAGCCGCTGCAACTCTTCT 
AG At4g18960 
 
AGE5F 
AGE8R 
GCAATTGATGGGTGAGACGATAGGG 
CTGGAGAGCGGTTTGGTCTTGG 
SVP At2g22540 
 
SVPE1F 
SVPE3R 
GTTCTCTGCGACGCCGATGTC 
CAATTTCTTTACTCATTCGGGCGTG 
SEP3 At1g24260 
 
SEP3E7R 
SEP3E8R 
AGATGCCACTCCAGCTGAACCCT 
CCATTCCATCTTGTTGCCCCTG 
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Gene AGI Primer name Sequence 
SEP4 At2g03710 
 
SEP3E7R 
SEP3E8R 
GGACAGTGATGCAGCACTTACTCAATC 
GTTGGTTGCATTTGCAGGATTGTG 
ATC At2g27550 
 
ATCE4F 
ATCE4R 
AGAGATAATCGGGTACGAGATGCCTC 
CGGTCTCACGCTGGCAGTTGAAG 
ULT1 At4g28190 
 
ULT1E2F 
ULT1E3R 
GGTTATCATTGGGGGCGAAAAGG 
GTGAAGTCGACACAAGTCTGGCAAGT 
SPL2 At5g43270 
 
SPL2E4F 
SPL2E5R 
CCAAAACCGCAAGAGCCGAGT 
GGGTTGGAGGTTGCTTGAGGG 
MYB33 At5g06100 
 
MYB3E3F 
MYB3E4R 
CCCTCCTCGAAGCGACTTTGG 
GGTGAATGTCGGTTTCCATAGAGAGG 
MYB101 
 
At2g32460 
 
MYB1E3F 
MYB1E3R 
CCTAAACCCGATCCCCGATTCTTC 
CCTCGAGACAAGGCTTGAGACTCC 
MAX1 At2g26170 
 
MAX1E4F 
MAX1E5R 
TGCAAGGGAAACTGCTAAAGAAGTGG 
ATCTCTGTCCAACACAGGCTCGTG 
MYB88 At2g02820 
 
MYB8E9F 
MYB8E9R 
GGCAACCTGATCTCCATGATTCACC 
CCAGTTGAGAGTAAACCCACTTGTTCC 
FLP At1g14350 
 
FLPE9F 
FLPE10R 
GCTCGTCCCGAAAAATCCTGATG 
GGACTCTTTTGCAAGGGGGTGG 
TRN2 At5g46700 
 
TRN2E1F 
TRN2E2R 
TGTACTTTTGGGTTGCCTTGTCGG 
ATCCACATTTTGTTGGGGGCTTG 
TRN1 At5g55540 
 
TRN1E2F 
TRN1E2R 
CATGTTATGCGAATTTAGGCGGG 
ACCCAATGCAGCAGCGACCC 
ATH1 At4g32980 
 
ATH1E2F 
ATH1E4R 
GTTTCGGTTCTACGGAATTGGATGTTC 
ATGCATTGCTTGGCTCATCATAACAG 
BEL1 At5g41410 
 
BEL1E2F 
BEL1E3R 
GACTCTTGTTGACGCTCATCCTTGG 
TCGTTCCATGGGTTGAGTTGTGAC 
BLH3 At1g75410 
 
BLH3E3F 
 
TCTCTCGCCATTTCCGCTGTTTAC 
TCGTGTTTGAGCTGAGATGTTTCCTG 
OFP16 At2g32100 
 
OFP16F 
OFP16R 
GTCCAATGCAATCACCGACTCACC 
GGAGAAAGCCCTGATGACGAACTTG 
RIK1 At3g29390  
 
RIK1E5F 
RIK1E7R 
CACATATCTGCCGCTGCCCAGT 
CGAGCAGCAACATTAGATGATGGGTC 
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Gene AGI Primer name Sequence 
ZAT6 At5g04340 
 
ZAT6F 
 
AGAAACCGTGACCTTGACCTGCC 
ACACTTCCTCCCCCGCCACC 
SHR At4g37650 
 
SHRF 
SHRR 
GAAGTCTTGGCCATTAACTGCGTAGG 
CCACGCACTAGCCCAAACCACC 
LPR1 
 
At1g71040 
 
LPR1E2F 
LPR1E3R 
GACGTGTCAAACGCCGTTCTCAC 
CTGAGTCGGATCGAATGGGTAAGATG 
SCL3 At1g50420 
 
SCL3F 
SCL3R 
GCAGCTGAGGCACGTGAGAATG 
TCTATACCCATCAAAACCGCACCCT 
CRF5 At2g46310 CRF5F 
CRF5R 
CTCTGGCTTGGGACTTTTGCGAC 
GTGGAATTCGTCGAGAAACAAAGGG 
CRF6 At3G61630 
 
CRF6F 
CRF6R 
TTCCTAACTCCGCCGACGCC 
ACACCAAACCCGCCGACGAT 
CGA1 At4g26150 
 
CGA1F 
CGA1R 
ACCACCAGCGACAGCAGCAA 
ATGACCGGTGGGGATACGCC 
ST1 At2g03760 
 
ST1F 
ST1R 
CATATCGCATCTTTCGCTCCCC 
TCTCGCGGCTTGCATACCAGTA 
CIPK20 At5g45820 
 
CIPK20F 
CIPK20R 
TGTTTGGTCTTGCGGGGTTGTG 
TCTTCACTCCTACATCGCTCTTCGTC 
ABA1 At5g67030 
 
ABI1E13F 
ABI1E15R 
GCGCATTGTGATCCCTTCGTCTC 
GCGGGAAAATTCGGTGTTGCTC 
NCED4 
 
At4g19170 
 
NCED4F 
NCED4R 
ACGTTTACGCGGCGATTGGAG 
GGCGATTTAGCGTCCATCACCAG 
CIPK14 At5g01820 
 
CIPK14F 
CIPK14R 
GCATTCCCAAGTGGACCTCACC 
CGCCGACACGATCTCCTCCA 
CIPK6 
 
At2g17290 
 
CIPK6E6F 
CIPK6E7F 
CAGCGAGTTTATTGCAGCGACGA 
GGAAACATTTGCATCCTCACCGA 
ATDR4 At1g73330 
 
ATDR4F 
ATDR4R 
CTTTGGCCGCACCCTCCCTA 
GGTAGGCCCAAGTCAAGCGGA 
ABF1 At1g49720 
 
ABF1E1F 
ABF1E4R 
GAATCCGCTGCTAGATCAAGGGCTC 
TGACTTCACCTTCTTACCACGGACC 
RHA2A 
 
At1g15100 
 
RHA2AF 
RHA2AR 
GACTAGCCAACATAATCGTTCTCGCC 
AATCCCTCCCAACGCTACGCTG 
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Gene AGI Primer name Sequence 
RHA2B 
 
At2g01150 
 
RHA2BF 
RHA2BR 
GTACCGCTACTCCGACAACGCAG 
TCACTGCCATGTCCCTGATGATG 
AFP2 At1g13740 
 
AFP2E1F 
AFP2E2R 
ACCGGCGGAGATGGAAGAGG 
GTTCCCTGGCTTCCGCTGTTC 
AFP3 At3g29575 
 
AFP3E1F 
AFP3E2R 
TGGTGGTCAACGATAGGTCAGGG 
TCTCGGGCTGAGATTGGGCAC 
SWEETIE 
 
At1g67140 
 
SWEE39F 
SWEE40R 
TTGCTGTCGCTTCCAGTAACACACC 
CCGGCTCCTCTTCAGCAACACT 
ADH1 At1g77120 
 
ADH1E5F 
ADH1E7R 
CGGATGGTGGGGTGGACAGG 
CCCATGGTGATGATGCAACGAATAC 
GBF3 At2g46270 
 
GBF3E10F 
GBF3E11R 
AGGAAAGTGGAAGCCTTGACAGCC 
TGCGGGGACTCTCTTTTCGGG 
AHB1 
 
At2g16060 
 
AHB1E2F 
AHB1E4R 
TCCAAAGCTCAAGCCTCACGCA 
GCCTGACCCCAAGCCACCTTC 
SLAH1 At1g62280 
 
SLAH1E1F 
SLAH1E2R 
CCAGTGGTTCACAACGGAGAAGAGA 
AAGCCCACCACGCGACATTGA 
ASA1 
 
At5g05730 
 
ASA1E8F 
ASA1E9R 
GGCAGGAACCAGCAAGAGAGGG 
CTGTTCCCACTGGTAAAGCCGCAC 
CYP79B2 
 
At4g39950 
 
CYP79E1F 
CYP79E2R 
TGCCGATGCTCACTGGACTTGA 
ACGGCGTTTGATGGATTGTCTGG 
ESM1 At3g14210 
 
ESM1E4F 
ESM1E5R 
TGGGAGCGAGTAAATTCGTGGTTC 
GCAACCATATGCATTGTGTGTCCC 
PLA2A 
 
At2g26560 
 
PLA2AE5F 
PLA2AE6R 
ACTGGGGATGCTGCTTCTGTTGA 
CTTTTGCATGAGGTGAACGAATGTCTC 
LOX1 At1g55020 
 
LOX1E7F 
LOX1E8R 
AAAACCACTGGACCTTCCCTGACC 
ACCAAACCTCAAGCCCATCCACTG 
OPR3 
 
At2g06050 
 
OPR3E2F 
OPR3E3R 
GGAAGCAAGTTGTGGAAGCAGTTCAC 
ACGTGGGAACCATCGGGCAA 
AOC4 
 
At1g13280 
 
AOC4E1F 
AOC4E2R 
GAGCAAGATCCACCACTTCCTCCAC 
CATGTTGGATCAAAACGCAGAGACC 
JAZ1 
 
At1g19180 
 
JAZ1E2F 
JAZ1E2R 
CCGACAACAACCATGAGTTTATTCCC 
TTGGGGAGGATTGGATTGGCTC 
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Gene AGI Primer name Sequence 
ST2A 
 
At5g07010 
 
ST2AF 
ST2AR 
CGACGTCCCGAAAGCCGAAG 
GGTTGCGAACGTTCTTGGACTGG 
PBS3 
 
At5g13320 
 
PBS3E3F 
PBS3E4R 
CCGTTGTCACTGGTTCAATGGGAC 
GTTGAGGTGTCAGCATAACTGGTGAAG 
EDS1 
 
At3g48090 
 
EDS1E4F 
EDS1E4R 
GAATACAAGCCAAAGTGTCAAGCCC 
CATATATGTAGCGGGTTGGTCTTCCTC 
 
2.1.8. Small RNAs probes for northern blot analysis 
U6 
COPIA 
TAS1 
miR156 
miR165 
miR172 
GCTAATCTTCTCTGTATCGTTCC 
TTATTGGAACCCGGTTAGGA 
TACGCTATGTTGGACTTAGAA 
GTGCTCTCTCTCTTCTGTCA 
GGGGGATGAAGCCTGGTCCGA 
ATGCAGCATCATCAAGATCT 
 
2.1.9. Plant materials 
All Arabidopsis thaliana lines used in this study were in the Columbia (Col-0) background. The 
different alleles of T-DNA insertion mutations in the CDKD;1, CDKD;2, and CDKD;3 genes were 
isolated from the SALK SiGNAL collection (http://signal.salk.edu). T-DNA insertion mutations in the 
CDKF;1 were collected from the SALK and GABI-Kat (http://www.gabi-kat.de) collections.  
 
2.2. Methods 
2.2.1. Plant growth conditions 
Arabidopsis plants were grown in MSAR medium (Koncz et al., 1994) in a controlled culture room at 
22°C with 120 mol/m2s light intensity and a photoperiod of 8 h light and 16 h dark. Seedlings from in 
vitro cultures were transferred into soil and grown under standard greenhouse conditions (long day: 
16h light/8 h of dark period; 22-24°C day temperature and 18°C night temperature, 80 to 120 mol/m2s 
light intensity). For crosses and Agrobacterium-mediated transformation, Arabidopsis seeds were 
sown in soil and plants were grown under short day condition (8h light/16h dark) for 14-16 days and 
then transferred to long day condition to induce flowering and produce seed.  
 
2.2.2. Crossing of Arabidopsis plants 
Upon removal all open flowers and young siliques from the inflorescence axis selected for crossing, 
the sepals and petals of 3 to 5 unopened flower buds were removed, and then these flowers were 
emasculated by dissecting the anthers a using magnifying glass headset and fine pair of forceps. The 
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stigma of the recipient flower was pollinated with pollen grains from open mature flowers of the donor 
plant. 
 
2.2.3. Seedling growth assays in different light regimes 
Seeds were sterilized by 5% calcium hypochlorite solution for 10 min, washed with sterile H2O and 
plated on MSAR medium. To induce seed germination, plates kept for 1 day at 4°C in the dark, 
followed by 1h exposure to red light. The germinating seedlings were either grown in complete 
darkness or subjected to constant red (12 mol/ m2s), far-red (6 mol/m2s), or blue light (2.5 mol/m2s) 
illumination for 7 days. As white light source, cool-white fluorescent tubes (photon irradiance of 400 
to 700 nm) were used at a fluence rate of 80 mol/m2s. Red, far-red, and blue lights were provided by 
light-emitting diodes (LEDs). To compare light responses of wild type control and mutant plants, 
hypocotyls lengths of at least 100 seedlings were measured.  
 
2.2.4. Phytohormone treatments 
Sterilized seeds were plated on MSAR medium containing different hormones, including: 50mg/l 
ethephon (ethylene generating chemical), 10 μM 1-aminocyclopropane-1-carboxylic acid (ACC, 
ethylene precursor), 0.1 μM brassinolide, 1 μM ABA (abscisic acid), 10 μM GA3 (gibberellin), 0.5 
mg/l 6-benzylaminopurine (BAP, cytokinin) with 0.05 mg/L 1-naphtaleneacetic acid (NAA) or 0.1 
BAP with 0.5 mg/l of NAA. Similarly, plant growth responses were also assayed in MSAR media 
containing either 5% sucrose or 3% glucose. In case of ethephon and ACC treatments, the germination 
assays were performed in the darkness at 22 °C for 7 days, while all other hormone assays were carries 
out by growing seedlings in the culture room (see: 2.2.1) for 7 days.  
 
2.2.5. Hypocotyl tumorigenesis assay 
Young seedlings of cdkf;1, cdkd;1, cdkd;2, and cdkd;3 mutant and wild type plants carrying four 
expanded leaves were used in hypocotyls tumorigenesis assays. The oncogenic Agrobacterium 
tumefaciences C58 strain was grown in YEB liquid medium to an OD600 0.6. The Agrobaterium 
culture was supplemented with 50 μM acetosyringone (pH 5.5) and injected into each hypocotyl by 
Femtotip (Eppendorf). 
 
2.2.6. Agrobacterium-mediated transformation of Arabidopsis thaliana by vacuum infiltration 
Arabidopsis plants were transformed by Agrobacterium using the vacuum infiltration method 
(Bechtold et al., 1993; Clough and Bent, 1998) with minor modifications. From bolting Arabidopsis 
plants grown in the greenhouse the siliques were removed, to reduce the background of untransformed 
seeds. Agrobacterium cultures grown in 500 ml YEB medium at 28°C to an OD600 of 0.8 to 1.0 were 
harvested by centrifugation (4°C, 10,000g) and resuspended in infiltration medium containing 4.3g/l 
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MS basal salt mixture, 1X B5 vitamin, 3% sucrose, 5 mM MES, 0.05μM BAP, and 0.005%(v/v) 
Silwet L-77. Arabidopsis plants were submerged in the Agrobacterium suspension followed by 
application of vacuum for 3 minutes. Subsequently, the plants were covered with plastic bags for 2 
days to secure for slow adaptation to lower humidity. Seeds were collected in paper bags, dried and 
subjected to selection for the Agrobacterium T-DNA encoded antibiotics resistance markers by 
germination on MSAR agar medium. 
 
2.2.7. General molecular biology techniques 
Standard molecular biological techniques, such as PCR amplification, agarose gel separation of DNA 
and RNA, restriction enzyme digestions, genomic DNA extraction, preparation of E. coli competent 
cells and purification of plasmid DNAs by CsCl-ethidium bromide equilibrium density gradient 
centrifugation were performed according to standard protocols described by Sambrook and Russell 
(2001). 
 
2.2.8. Construction of bacterial and plant expression vectors 
The cDNA fragments carrying CDKD coding sequences (i.e., both wild and T-loop mutated versions), 
as well as coding regions of CDKF;1 and CycH;1 cDNAs, were obtained by PCR amplification using 
plasmid clones of full-length cDNAs as templates. The full-length cDNA constructs were donated by 
Arp Schnittger, Strasburg. The PCR products were cloned in pET201, a bacterial expression vector 
providing a polylinker between coding sequences for an N-terminal thioredoxin and a C-terminal His6 
tag, by EcoRI-XhoI (CDKD;1), NheI-NotI (CDKD;2), NheI-XhoI (CDKD;3), SalI-NotI (CDKF;1), and 
NheI-XhoI (CycH;1) respectively. For expression of CDKF;1 kinase in plants, a PCR amplified cDNA 
sequence flanked by attB1 and attB2 sites was inserted by BP recombination into pDONR201 
(Invitrogen) and then by LR reaction cloned into the TAP-tagging expression vector N-TAPI (Rohila 
et al., 2004). 
 
2.2.9. Site-directed mutagenesis 
Site-directed mutagenesis of coding sequences was performed using a Quick Change Multi Site-
Directed Mutagenesis Kit (Stratagene) according to manufacture’s instructions. The mutagenesis 
procedure was based on PCR reactions that were carried out using either pET201-CDKD;1 or 
pDONR201-VirD2 DNAs as templates and one of more mutagenesis primers combined with the 
indicator primer provided by the manufacturer. Typically, the PCR reactions of 25 μl contained 50 ng 
plasmid DNA template, 100 ng of each mutagenesis primer, 1 μl of dNTP mixture, 2.5 μl of 10x 
QuickChange Multi reaction buffer, and 1 μl of QuickChange Multi enzyme blend. The PCR product 
was digested by DpnI at 37°C for 1 hour to digest the double –stranded non-mutated template DNA. 
After dialysis against ddH2O, the PCR products were transformed into XL-10 Gold Ultra Competent 
E. coli (Stratagene) cells, which were then plates on selective LB medium containing appropriate 
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antibiotics. From each transformation, plasmid DNA was purified from three independent recombinant 
clones and correct positions of the designed mutations (i.e., excluding any other change in the target 
sequences) were verified by sequencing. 
 
2.2.10. Purification of Arabidopsis proteins expressed in E.coli 
E.coli BL21 (DE3) pLysS cells carrying GST-CTD (Umeda et al., 1998) were grown at 28°C to OD600 
of 0.4-0.6. Expression of the GST-CTD protein expression was induced by 1mM IPTG for 4h at 37°C. 
The cells were harvested by centrifugation and then resuspended and sonicated in lysis buffer (50 mM 
NaH2PO4, 300 mM NaCl, 1mM PMSF, 0.1 mM benzamidine, 10 µg/ml aprotinin, 10 µg/ml leupeptin, 
pH 8.0). The cell lysate was subjected to centrifugation (Sorvall HB-4 rotor, 11000 rpm for 30min at 
4°C) and the cleared extract was used for protein purification. Affinity purification was carried out on 
gluthatione-Sepharose 4B (Amersham Biosciences) as described (Bakó et al, 2003). E.coli BL21 
(DE3) pLysS cells carrying pET201-thioredoxin-CDKDs-His6, pET201-thioredoxin-CDKF;1-His6, 
and pET201-thioredoxin-CycH;1-His6 were disrupted by sonication in lysis buffer and upon 
centrifugation (see above) the cleared extracts were applied on Ni-NTA agarose (Qiagen) according to 
the manufacturer instruction. Elution of matrix-bound proteins was performed by increasing the 
imidazol concentration in stepwise manner from 60 to 250 using 20 mM intervals. The protein profiles 
of fractions were visualized by SDS-PAGE and the fractions carrying the purified target proteins were 
collected. 
Lysis buffer (1 liter): 
50 mM NaH2PO4                                              6.90 g NaH2PO4·H2O (MW 137.99 g/mol) 
300 mM NaCl                             17.54 g NaCl (MW 58.44 g/mol) 
10 mM imidazole                         0.68 g imidazole (MW 68.08 g/mol) 
Adjust pH to 8.0 using NaOH. 
Wash buffer (1 liter): 
50 mM NaH2PO4                                            6.90 g NaH2PO4·H2O (MW 137.99 g/mol) 
300 mM NaCl                             17.54 g NaCl (MW 58.44 g/mol) 
20 mM imidazole                        1.36 g imidazole (MW 68.08 g/mol) 
Adjust pH to 8.0 using NaOH. 
Elution buffer (1 liter): 
50 mM NaH2PO4                                            6.90 g NaH2PO4·H2O (MW 137.99 g/mol) 
300 mM NaCl                             17.54 g NaCl (MW 58.44 g/mol) 
250 mM imidazole                      17.00 g imidazole (MW 68.08 g/mol) 
Adjust pH to 8.0 using NaOH. 
 
2.2.11. Immunaffinity purification of HA-VirD2 protein 
To purify the HA-VirD2 protein described by Bakó et al., 2003), an anti-HA Affinity Matrix (Roche) 
was used. E.coli BL21 (DE3) pLysS cells carrying the pET28a-HA-VirD2 plasmid were grown and 
induced by IPTG as described in 2.2.10 and then harvested cells by centrifugation, resuspended and 
sonicated in lysis buffer (20 mM Tris-HCl [pH 7.5], 0.1 mM EDTA; 150 mM NaCl; 1mM PMSF; 0.1 
mM benzamidine; 10 µg/ml aprotinin; 10 µg/ml leupeptin). The cleared extract was applied on HA 
matrix in a disposable chromatographic column and incubated on a rocker for 1h at 4°C. The flow 
through was collected for further analysis and the matrix was washed by 10 volumes of washing buffer 
(20 mM Tris-HCl [pH 7.5] 50 mM NaCl; 1mM PMSF; 0.1 mM benzamidine; 10 µg/ml aprotinin; 10 
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µg/ml leupeptin). During washing, the flow through was also collected for protein analysis. Lysis 
buffer containing 1mg/ml HA peptide was utilized as elution buffer. The eluted HA-VirD2 protein 
fraction was further purified by anion-exchange chromatography on a 1ml pre-packed HiTrap DEAE-
Sepharose FF anion exchange column (GE Helathcare). The column was equilibrated with Tris-HCl 
pH 8.0. Elution was carried out by increasing NaCl concentration (40-260 mM) in stepwise manner 
using 20mM intervals. The SDS-PAGE profile showed that fractions eluting with 80-120 mM NaCl 
contained the purified HA-VirD2 protein. 
 
2.2.12. Protein kinase assays 
Affinity purified wild type and mutant thioredoxin-CDKDs-His6, thioredoxin-CDKF;1-His6, 
thioredoxin-CycH;1-His6, and GST-CTD proteins were used in in vitro protein kinase assays. The 
kinase reactions contained 1-2µg substrate (i.e., CDKD;1, or CDKD;2 or CDKD;3 or GST-CTD or 
alternatively one of the CDKDs together with GST-CTD) and 0.25-0.5 µg thioredoxin-CDKF;1-His6 
protein in kinase-buffer (50 mM Tris-HCl [pH 8.0], 15 mM MgCl2, 1mM DTT, and 5 µCi [γ-
32P]ATP). The kinase reactions were incubated for 90 min at room temperature. The reactions were 
separated by SDS-PAGE and subsequently the dried gel was placed into an autoradiography cassette 
with a X-ray film and exposed for 15 min up to 4 h. 
 
2.2.13. Immunoblotting 
For western blot analysis, total protein extracts were prepared in protein extraction-buffer containing 
50 mM Tris-HCl (pH 7.5), 10% glycerol, 1 mM EDTA, 150 mM NaCl, and 0.2% Igepal. Protein 
concentration of tissue extracts were determined by Bradford assay (Bio-Rad) using a BSA dilution 
series as standard. The protein samples were subjected to size separation by SDS-PAGE 
electrophoresis and electro-transferred onto PVDF membranes (Millipore). Primary antibodies used 
for detection of various target proteins were: a mouse monoclonal antibody 4H8 (Abcam, ab5408), 
RNAPII mouse monoclonal antibody H14 (Covance), rat monoclonal antibody (rmAb) 3E10, rmAb 
3E8, and rmAb 4E12 (Chapman et al., 2007; Egloff et al., 2007). Protein detection was performed by 
autoradiography of Enhanced Chemoluminescence ECL (ECL) generated by horseradish peroxidase-
coupled secondary antibodies: goat anti-rat IgG (Sigma, A 9037), anti-mouse IgM (Sigma, A8786), 
and goat anti-mouse IgG (Thermo Scientific Pierce). 
 
2.2.14. Two dimensional protein gel electrophoresis 
IEF (iso-electric focussing) and SDS-PAGE were carried out according to Görg et al. (1998) with 
minor modifications. For IEF with a linear gradient (pH 3–10), IPG strips of 11 cm were rehydrated 
using rehydration buffer (8 M w/v urea, 2% w/v CHAPS, 0.28% w/v DTT, 2% v/v IPG buffers) in a 
rehydration tray at room temperature for 16h. For IPG strip of 11 cm, 40 µg protein was loaded and 
conducted at 20°C with Protean IEF Cell (Bio-Rad). The first equilibration was performed in a 
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solution containing 50 mM Tris-HCl (pH 8.8), 6 M urea, 30%(v/v) glycerol, 2% (w/v) SDS, and 1% 
(w/v) DTT, with a few grains of bromophenol blue. The second equilibration was performed as the 
first one, except that DTT was replaced with 2.5% (w/v) iodoacetamide. The second dimension was 
developed with a NuPAGE 4-12% Bis-Tris ZOOM gel (Invitrogen). The protein spots were stained 
using a phosphor-staining kit (Pro-Q Diamond Phosphoprotein gel stain, Invitrogen) followed by 
Coomassie PAGEBlue (Fermentas) staining according to the manufacturer’s protocols.  
 
2.2.15. Protein identification and database search 
The protein spots separated by two dimensional gel electrophoresis were selected and robotically 
punched from Coomassie stained gels using a Proteineer SPII system (Bruker Daltonics). The punched 
spots were then digested with trypsin and spotted on AnchorChip™ targets by a Proteineer dp robot 
(Bruker Daltonics). Peptide mass fingerprint (PMF) data were collected on an UltraflexIII MALDI 
ToF/ToF spectrometer (Bruker Daltonics) and used for database searches as described below. 
Following on-target recrystallization of the sample spots, MS/MS spectra were collected on selected 
precursors as described (Suckau, 2003) for verification of PMF identifications and for further sample 
elucidation. Both MS and MS/MS data were used to search against the May 2007 release of NCBI 
non-redundant database (http://www.ncbi.nlm.nih.gov) and version 8 of the TAIR Arabidopsis Protein 
database (www.arabidopsis.org) using MASCOT (http://www.matrixscience.com).  
 
2.2.16. Mass spectrometry analysis of CDKF;1 phosphorylated VirD2 
After kinase assay and two dimensional gel electrophoresis, the VirD2 spots were excised and 
subjected to the following treatment: The gel-plugs were rinsed with an ammonium bicarbonate 
buffer/acetonitrile 1:1 mixture to eliminate the CBB and the SDS. The proteins were reduced with 
DTT and alkylation of sulfhydryl groups was performed with iodoacetamide. Then the proteins were 
incubated with Promega side-chain protected porcine trypsin for approximately 4h. The resulting 
peptides were extracted. Phosphopeptides were enriched by TiO2. The digest was dried down and 
redissolved in 1 % TFA in 50 % acetonitrile and loaded on TiO2 beads suspended in the same solvent. 
After a few minutes of vortexing, the supernatant was discarded and the TiO2 beads were washed five 
times with the loading solvent. Phosphopeptides were eluted with 1% NH4OH. Samples were 
subjected before and after phosphopeptide enrichment to MALDI-TOF MS (Reflex III, Bruker) 
analysis using 2,5-dihydroxybenzoic acid (DHB) as matrix, and to LC-MS/MS analysis on an ion trap 
(XCT Plus, Agilent Technologies) equipped Q-TOF (Waters) mass spectrometer. Data were processed 
using the softwares XMass 5.1.5 (MALDI-TOF), Mascot Distiller 2.1.1.0 (Q-TOF) and DataAnalysis 
5.2 (for ion trap). Database searches were performed by Mascot v2.1 (http://www.matrixscience.com) 
on the NCBI 20071130 database (5678482 sequences). For MALDI-TOF MS data, monoisotopic 
masses with mass tolerance of ± 200 ppm, for Q-TOF data, monoisotopic masses with peptide mass 
tolerance of ± 50 ppm and fragment mass tolerance of ± 0.1 Da, and for ion trap data monoisotopic 
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masses with peptide mass tolerance of ± 1 Da and fragment mass tolerance of ± 0.8 Da were 
considered. No species restriction was used and two missed cleavages were permitted. Fixed 
modifications were: Cys carbamidomethylation; whereas variable modifications parameters were: 
acetylation of protein N-termini, methionine oxidation, pyroglutamic acid formation from N-terminal 
Gln residues and phosphorylation of amino acid residues. Subsequently, all data were also manually 
inspected. 
 
2.2.17. RT-PCR 
Total RNA was extracted by RNeasy Mini kit supplied with RNase-Free DNase set (Qiagen). Two 
micrograms of total RNA template was reverse-transcribed using a Transcriptor First Strand cDNA 
Synthesis Kit (Roche Applied Science) with gene-specific primer sets (primer sequences, see: 2.1 
Materials). The resulting cDNA:RNA hybrids were applied as templates to PCR amplify CDKD and 
CDKF;1 cDNAs. The PCR products were fractionated using agarose gel electrophoresis and stained 
with ethidium bromide. 
 
2.2.18. Real-time quantitative PCR 
Total RNA samples were prepared using RNAeasy columns (QIAGEN) and treated with RNase-Free 
DNase according to the manufacturer’s instructions. RNA (1 μg) was then reverse transcribed into 
cDNA using Transcriptor First Strand cDNA Synthesis Kit (Roche). The reaction mixture was diluted 
to 100 μl, and a 2.5 μl aliquot was used for each real-time PCR reaction performed with iQ Supermix 
(Bio-Rad) in a Bio-Rad iCycler iQ5. Ubiquitin UBQ5 (At3g62250) primers were used to generate a 
standard curve for quantification. The applied PCR conditions were 10 min at 95°C for enzyme 
activation, followed by 38 cycles: 95°C for 45 s, 60°C for 30 s, 72 for 3 min. 
 
2.2.19. Light microscopy 
Light microscopy was performed with Leica MZFLIII microscope and images were captured and 
processed with Diskus version 4.30.102 program. 
 
2.2.20. Confocal-laser-scannig microscopy 
Confocal-laser-scanning microscopy was performed with Leica TCS SP2 AOBS (Leica, Wetzlar, 
Germany) or LSM 510 META (Zeiss, Heidelberg, Germany). 
 
2.2.21. Pollen preparation for fluorescence analysis 
Anthers carrying mature pollen grains were collected from flowers and put in a droplet (15 μl) of 
DAPI solution (2.5 μg/ml of 4’,6-diamidino-2- phenylindole (DAPI); 0.01 % Tween; 5 % DMSO; 50 
mM PBS buffer, pH 7.2) on a microscopy slide. Cover slip was used to squash anthers in order to 
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release pollens. The slides were then kept in darkness until the rim of the cover slip was dry, and then 
sealed with nail polish. After 4-12 hours incubation at 4 °C in darkness, the preparations were 
inspected for DAPI fluorescence with UV filter. 
 
2.2.22. Flow cytometry for ploidy analysis 
Fluorescence-activated cell sorting (FACS) analysis was performed with leaf tissues of 2 to 3 weeks 
old wild type and cdkf;1-1 mutant seedlings. The samples were sliced with a razor blade in nuclear 
extraction buffer of the CyStain UV-Precise kit (Partec). All preparations were subsequently filtered 
through a 30µm filter and stained with nuclear staining solution (CyStain UV-precise kit by Partec) 
containing DAPI. We used a Partec flow cytometer with 405nm solid state laser for excitation and a 
440/40 band pass filter for recording of DAPI fluorescence. Data were evaluated using the Flomax 
software (Partec GmbH). 
 
2.2.23. Small RNA detection by northern RNA hybridization 
Detection of small RNAs was performed by northern blot analysis as described (Pall and Hamilton, 
2008). Total RNA extracts were prepared from 7 days old young seedlings using Trizol extraction 
(Sigma, T9424) according to manufacturer’s instructions. For comparison of expression levels of 
small RNAs in wild type and cdkf;1-1 mutant seedlings, 40 μg of total RNA was size separated in 15% 
polyacrylamide gels with 7M urea under denaturing condition and transferred to Hybond-NX 
membrane (Amersham Biosciences) by electroblotting. The RNA samples were cross-linked to the 
membrane using a EDC (1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (0.373g) in 10ml H2O 
containing 122.5 µl 1-methylimidazole for 1h at 60°C. Hybridization was carried out at 37°C using 
oligonucleotides complementary to specific small RNAs, which were labelled with γ32 ATP using T4 
polynucleotide kinase (New England Biolabs). 
 
2.2.24. Transcript profiling using Affymetrix Arabidopsis ATH1 microarrays 
Comparative microarray transcript profiling of cdkf;1 mutant and wild type was performed with 
Affymetrix ATH1 GeneChip microarrays. Short day-grown seedlings (7 DAG) were used for total 
RNA extraction using RNeasy Mini Kit (Qiagen). The hybridization probes were prepared and 
processed by the Affymetrix hybridization service at the MPIZ by generating three independent 
microarray datasets for both wild type and cdkf;1-1 samples. The microarray data analysis was 
performed using the GeneSpring GX10 (Agilent) software. According to MIAME standards, the data 
were first summarized using the RMA algorithm using a baseline to the median of all samples 
followed by quality control with principal component analysis (PCA). The raw data were filtered for 
expression by percentile (upper cut-off 100, lower cut-off 20) and then filtered for error at a 
coefficient variation <50%. Subsequent statistical analysis with TTest for unpaired samples included 
asymptotic p value computation using 100 permutations and Benjamin-Hochberg multiple testing for 
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false-discovery rate (FRD). Subsequently, the data were filtered allowing either 1.5 or 2-fold 
difference between control wild type and mutant transcript levels and subjected to further statistical 
analysis of Gene Onthology (GO) terms using a cut-off value <0.1. To assist proper annotation of data 
to pathways, the Significant Pathway analysis tool with a cut-off value of p-value <0.01 was used from 
the GeneSpring package, and then the data on pathway allocation of functions were combined with 
updated information obtained by mining the latest literature references in the PubMed and TAIR 
databases. 
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3. RESULTS 
3.1. Isolation and molecular characterization of cdkf;1 and cdkd mutations 
In a reverse genetic approach, different T-DNA insertion mutations identified in the SALK and GABI 
collections were used to study the roles of CDKF;1 and CDKD genes in plant development. Exact 
positions of the insertion mutations in the CDKF;1 and CDKD genes have been determined by PCR 
amplification of T-DNA boundaries using T-DNA border and gene specific primers and sequencing 
the obtained PCR products.  
 
3.1.1. Mutations in the CDKF;1 gene 
We have identified two independent T-DNA insertion mutations in the CDKF;1 gene. In both cdkf;1 
mutant alleles, cdkf;1-1 (GABI_315A10) and cdkf;1-2 (SALK_148336), the T-DNA insertion has 
been localized in exon2 of CDKF;1 gene.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. T-DNA junctions in the cdkf;1-1 (GABI_315A10) mutant. 
(A) An arrow shows the position of the integrated T-DNA. Black and red blocks depict untranslated and exon 
regions, respectively. Intron sequences are marked by black lines. Capital, small and bold capital letters represent 
border sequences, coding sequences, and filler DNA, respectively. (B) Amino acid sequence of CDKF;1 protein. 
The region shaded in grey is not translated due to interruption of the gene by the T-DNA insertion. Red letters 
indicate the position of the T-loop region. (C) Predicted sequence of C-terminally truncated CDKF;1 protein, 
which is fused to a T-DNA-encoded C-terminal peptide (highlighted in yellow) and possibly expressed due to 
transcription of the cdkf;1-1 allele from its native promoter. Positions of PCR primers used for RT-PCR analysis 
of transcribed regions of mutant allele are show above the scale bar. 
 
GABI 315A10LB RB
tctcctcttggATATTATTGTAAATGGC CAGTGTTTGAACCTAAGCCATCTACATTT
ACAatgccttcccaaccat 
MDKQPATSWSIHTRPEIIAKYEIFERVGSGAYADVYRARRLSDGLIVALKEIFDYQSAFR 60 
EIDALTILNGSPNVVVMHEYFWREEENAVLVLEFLRSDLAAVIRDGKRKKKVEGGDGFSV 120 
GEIKRWMIQILTGVDACHRNLIVHRDLKPGNMLISDDGVLKLADFGQARILMEHDIVASD 180 
ENQQAYKLEDKDGETSEPPEVIPDYENSPRQGSDGQEREAMSKDEYFRQVEELKAKQVVR 240 
DDTDKDSNVHDGDISCLATCTVSEMDDDLGRNSFSYDADEAVDDTQGLMTSCVGTRWFRP 300 
PELLYGSTMYGLEVDLWSLGCVFAELLSLEPLFPGISDIDQISRVTNVLGNLNEEVWPGC 360 
VDLPDYKSISFAKVESPLGIEGCLPNHSGDVISLLKKLICYDPASRATTMEMLNDKYLSE 420 
EPLPVPVSELYVPPTMSGPDEDSPRKWNDYREMDSDSDFDGFGPMNVKPTSSGFTIEFP  480 
MDKQPATSWSIHTRPEIIAKYEIFERVGSGAYADVYRARRLSDGLIVALKEIFDYQSAFR 60 
EIDALTILNGSPNVVVMHEYFWREEENAVLVLEFLRSDLAAVIRDGKRKKKVEGGDGFSV 120 
GEIKRWMIQILTGVDACHRNLIVHRDLKPGNMLISDDGVLKLADFGQARILMEHDIVASD 180 
ENQQAYKLEDKDGETSEPPEVIPDYENSPRQGSDGQEREAMSKDEYFRQVEELKAKQVVR 240 
DDTDKDSNVHDGDISCLATCTVSEMDDDLGRNSFSYDADEAVDDTQGLMTSCVGTRWFRP 300 
PELLYGSTMYGLEVDLWSLGCVFAELLSLEPLFPGISDIDQISRVTNVLGNLNEEVWPGC 360 
VDLPDYKSISFAKVESPLDIIVNGFMSGKSTWISNEYDGQYGEKERVITNFFSIQKCRCP 420 
QRYYKMKVHFDKTTNYDPSYL                                        442 
(A) 
(B) 
(C) 
PCR primers 
F1FA F1FC F1RB F1FB F1RA 
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In the cdkf;1-1 (GABI_315A10) mutant a single T-DNA insertion was located in exon2. The T-DNA 
used for generation of GABI insertion mutants carries a promoter of mannopine synthase 2’ gene in 
close vicinity of the left border (LB). Therefore, plant sequences in junction with LB are transcribed in 
the mutants. In the cdkf;1-1 allele this event may generate an antisense transcript from the 5’-coding 
domain of CDKF;1, whereas the T-DNA insertion prevents transcription of 3’-coding sequences as the 
right border (RB) region of the T-DNA does not carry promoter elements (Figures 1A and B). 
Theoretically, transcription of the cdkf;1-1 allele from its native promoter could result in the 
translation of an N-terminally truncated protein in fusion with a C-terminal peptide domain encoded 
by the LB segment of the T-DNA. If synthesized, this C-terminally truncated fusion protein is 
predicted to carry the catalytic domain of the kinase, including the T-loop sequences (Figure 1C). 
Sequencing of T-DNA border junctions in the cdkf;1-2 mutant revealed integration of an 
inverted T-DNA repeat flanked by LB junctions in exon 2. Sequences of T-DNA border junctions, 
illustrating the generation of short filler DNA sequences during T-DNA integration, are shown in 
Figure 2A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Analysis of T-DNA insert junctions in the cdkf;1-2 (SALK_148336) mutant. 
(A) An arrow shows the position of T-DNA insertion in exon2. Black and red blocks mark untranslated and exon 
sequences, respectively, whereas introns are labelled by black lines. Capital letters, small letters and bold capital 
letters represent T-DNA border sequences, coding sequences, and filler DNA, respectively. (B) Amino acid 
sequence of CDKF;1 protein. The region shaded in grey represents the predicted C-terminal domain, which is 
predicted to be transcribed and possibly translated from an internal start codon (highlighted by bold M) in the 
cdkf:1-2 mutant. Red letters indicate the T-loop region of CDKF;1 kinase. (C) Predicted sequence of the N-
terminal kinase domain, which could potentially be expressed in fusion with C-terminal T-DNA encoded peptide 
sequences (highlighted by yellow colour) in the cdkf;1-2 mutant. Positions of PCR primers used for RT-PCR 
analysis of transcribed regions of mutant allele are show above the scale bar. 
 
The T-DNA used for generation of SALK insertion mutants carries promoter and enhancer sequences 
from the Cauliflower Mosaic Virus 35S RNA gene near the left border (LB). Sequences of the tagged 
genes located downstream of the T-DNA left border junctions are therefore transcribed in the SALK 
mutants. This predicts that coding sequences located at 3’-downstream of the T-DNA integration site 
MDKQPATSWSIHTRPEIIAKYEIFERVGSGAYADVYRARRLSDGLIVALKEIFDYQSAFR 60 
EIDALTILNGSPNVVVMHEYFWREEENAVLVLEFLRSDLAAVIRDGKRKKKVEGGDGFSV 120 
GEIKRWMIQILTGVDACHRNLIVHRDLKPGNMLISDDGVLKLADFGQARILMEHDIVASD 180 
ENQQAYKLEDKDGETSEPPEVIPDYENSPRQGSDGQEREAMSKDEYFRQVEELKAKQVVR 240 
DDTDKDSNVHDGDISCLATCTVSEMDDDLGRNSFSYDADEAVDDTQGLMTSCVGTRWFRP 300 
PELLYGSTMYGLEVDLWSLGCVFAELLSLEPLFPGISDIDQISRVTNVLGNLNEEVWPGC 360 
VDLPDYKSISFAKVESPLGIEGCLPNHSGDVISLLKKLICYDPASRATTMEMLNDKYLSE 420 
EPLPVPVSELYVPPTMSGPDEDSPRKWNDYREMDSDSDFDGFGPMNVKPTSSGFTIEFP 
MDKQPATSWSIHTRPEIIAKYEIFERVGSGAYADVYRARRLSDGLIVALKEIFDYQSAFR 60 
EIDALTILNGSPNVVVMHEYFWREEENAVLVLEFLRSDLAAVIRDGKRKKKVEGGDGFSV 120 
GEIKRWMIQILTGVDACHRNLIVHRDLKPGNMLISDDGVLKLADFGQARILMEHDIVASD 180 
ENQQAYKLEDKDGETSEPPEVNNKLTLRQLNNTLRTFLMYWGGFSFHQ
SALK 148336LB LB
caccagaagttaATAACAAATTGACGC CACCACAATATTGTAACACATTGCGGA
ACACATTGCTGTGTTATTaagggtct
(A) 
(B) 
(C) 
F1FA F1FC F1RB F1FB F1RA 
PCR primers 
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in the cdkf;1-2 mutant are transcribed by the 35S promoter and possibly translated from an internal 
methionine start codon, resulting in an N-terminally truncated segment of CDKF;1 protein lacking the 
kinase catalytic domain (Figure 2B). On the other hand, transcription of the cdkf;1-2 allele from its 
native promoter could result in a translational gene fusion between 5’-coding sequences and the 5’ T-
DNA LB junction, and yield a fusion between part of the N-terminal kinase domain and a small C-
terminal T-DNA encoded peptide (Figure 2C).  
Despite these theoretical considerations, characterization of the cdkf;1-1 and cdkf;1-2 mutants 
revealed (see: 3.4.1) that both SALK and GABI T-DNA insertions in the CDKF;1 gene resulted in 
fully identical phenotypes. This excluded the possibility that predicted expression of a C-terminally 
truncated kinase from the cdkf;1-2 allele could confer a partial loss of function phenotype. 
 
3.1.2. Insertion mutations in the CDKD genes 
In public insertion mutant collections only a single T-DNA insertion (SALK_114643) was identified 
in the CDKD;1 gene. In the cdkd;1-1 mutant, integration of an inverted T-DNA repeat flanked by LB 
junctions has been identified in exon 5 (Figure 3A).  
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
Figure 3. Characterization of T-DNA insert junctions in the cdkd;1-1 (SALK_114643) mutant. 
(A) An arrow shows the position of integrated T-DNA. Black and red blocks depict untranslated and exon 
sequences, respectively. Introns are marked by black lines. Capital, small and bold capital letters indicate T-
DNA border sequences, coding sequences, and filler DNA, respectively. (B) Amino acid sequence of the 
CDKD;1 protein. The T-loop region is indicated by red letters. The truncated 3’ coding region could be 
transcribed by a 35S promoter located upstream of LB in the T-DNA. (C) Transcription of the cdkd;1-1 allele 
from its native promoter could lead to the synthesis of a fusion protein carrying the N-terminal kinase catalytic 
domain in fusion with a small T-DNA encoded C-terminal peptide marked in yellow. Positions of PCR primers 
used for RT-PCR analysis of transcribed regions of mutant allele are show above the scale bar. 
 
SALK 114643LB LB
ggttagtgaggatATATTGTGGTG CACCACAATTTGTGTTATTAAAAACG
TCCGCAATGTGTTTATTAAGTTgtct
agaatatc 
MEQPKKVADRYLKREVLGQGTYGVVFKATDTKNGETVAIKKIRLGKEKEGVNVTALREIK 60 
LLKELKHPHIIELIDAFPHKENLHIVFEFMETDLEAVIRDRNLYLSPGDVKSYLQMILKG 120 
LEYCHGKWVLHRDMKPNNLLIGPNGQLKLADFGLARIFGSPGRKFTHQVFARWYRAPELL 180 
FGAKQYDGAVDVWAAGCIFAELLLRRPFLQGNSDIDQLSKIFAAFGTPKADQWPDMICLP 240 
DYVEYQFVPAPSLRSLLPTVSEDALDLLSKMFTYDPKSRISIQQALKHRYFTSAPSPTDP 300 
LKLPRPVSKQDAKSSDSKLEAIKVLSPAHKFRRVMPDRGKSGNGFKDQSVDVMRQASHDG 360 
QAPMSLDFTILAERPPNRPTITSADRSHLKRKLDLEFL 399
MEQPKKVADRYLKREVLGQGTYGVVFKATDTKNGETVAIKKIRLGKEKEGVNVTALREIK 60 
LLKELKHPHIIELIDAFPHKENLHIVFEFMETDLEAVIRDRNLYLSPGDVKSYLQMILKG 120 
LEYCHGKWVLHRDMKPNNLLIGPNGQLKLADFGLARIFGSPGRKFTHQVFARWYRAPELL 180 
FGAKQYDGAVDVWAAGCIFAELLLRRPFLQGNSDIDQLSKIFAAFGTPKADQWPDMICLP 240 
DYVEYQFVPAPSLRSLLPTVSEDILWCKQIDA                             273 
(A) 
(B) 
(C) 
PCR primers 
D1FA D1RA D1FC D1RB/ D1RC 
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Due to transcription from 35S promoters of the T-DNA LB regions, an antisense 5’-transcript and a 
truncated 3’-transcript encoding the C-terminal cyclin-binding domain of CDKD;1 could be 
theoretically generated in the cdkd;1-1 mutant (Figure 3B). On the other hand, transcription of the 
cdkd;1-1 allele from its native promoter may lead to translation of a C-terminally truncated CDKD;1 
kinase, which carries the catalytic domain with the T-loop, but lacks the cyclin-binding regulatory 
domain (Figure 3C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Analysis of T-DNA insert junctions in the cdkd;2-1 and cdkd;2-2 mutants.  
(A1/A2) Arrows indicate the positions of integrated T-DNAs. Black and red blocks mark untranslated and exon 
sequences, whereas introns are shown by black lines. Capital, small and bold capital letters represent T-DNA 
border sequences, coding sequences, and filler DNAs, respectively. (B1/B2) Amino acid sequence of CDKD;2 
protein kinase. Red letters show the T-loop region. Regions shaded in grey represent C-terminal cyclin-binding 
domains of CDKD;2 that could theoretically be synthesized due to transcription of 3’ coding sequences in the 
cdkd;2-1 and cdkd;2-2 mutants. (C1/C2) Sequences of N-terminal kinase domains in fusion to T-DNA encoded 
peptides that may be expressed from truncated 5’-coding domains transcribed by the native CDKD;2 promoter in 
the cdkd;2-1 and cdkd;2-2 mutants. Positions of PCR primers used for RT-PCR analysis of transcribed regions 
of mutant allele are show above the scale bar in A1. 
SALK 063929LB LB
tcaagcgtttggtGTAAACAAATT CGTCCGCAATTTGTTTACTTTtactc
cagtaccttc 
MSKSGDNQPVDRYLRRQILGEGTYGVVYKATDTKTGKTVAVKKIRLGNQKEGVNFTALRE 60 
IKLLKELNHPHIVELIDAFPHDGSLHLVFEYMQTDLEAVIRDRNIFLSPGDIKSYMLMTL 120 
KGLAYCHKKWVLHRDMKPNNLLIGENGLLKLADFGLARLFGSPNRRFTHQVFATWYRAPE 180 
LLFGSRQYGAGVDVWAAGCIFAELLLRRPFLPGSTEIDQLGKIFQAFGTPVPSQWSDMIY 240 
LPDYMEFSYTPAPPLRTIFPMASDDALDLLAKMFIYDPRQRITIQQALDHRYFSSSPSPT 300 
EPGKLQIPASKGDALEPKASEQNQHGNSPAVLSPPGKMRRVMGPEGFT 349
MSKSGDNQPVDRYLRRQILGEGTYGVVYKATDTKTGKTVAVKKIRLGNQKEGVNFTALRE 60 
IKLLKELNHPHIVELIDAFPHDGSLHLVFEYMQTDLEAVIRDRNIFLSPGDIKSYMLMTL 120 
KGLAYCHKKWVLHRDMKPNNLLIGENGLLKLADFGLARLFGSPNRRFTHQVFATWYRAPE 180 
LLFGSRQYGAGVDVWAAGCIFAELLLRRPFLPGSTEIDQLGKIFQAFGVNKLTLRQLNNT 240 
LRTFLMYWGGFSFHQ                                              256 
(A2) 
(B2) 
(C2) 
MSKSGDNQPVDRYLRRQILGEGTYGVVYKATDTKTGKTVAVKKIRLGNQKEGVNFTALRE 60 
IKLLKELNHPHIVELIDAFPHDGSLHLVFEYMQTDLEAVIRDRNIFLSPGDIKSYMLMTL 120 
KGLAYCHKKWVLHRDMKPNNLLIGENGLLKLADFGLARLFGSPNRRFTHQVFATWYRAPE 180 
LLFGSRQYGAGVDVWAAGCIFAELLLRRPFLPGSTEIDQLGKIFQAFGTPVPSQWSDMIY 240 
LPDYMEFSYTPAPPLRTIFPMASDDALDLLAKMFIYDPRQRITIQQALDHRYFSSSPSPT 300 
EPGKLQIPASKGDALEPKASEQNQHGNSPAVLSPPGKMRRVMGPEGFT 349
MSKSGDNQPVDRYLRRQILGEGTYGVVYKATDTKTGKTVAVKKIRLGNQKEGVNFTALRE 60 
IKLLKELNHPHIVELIDAFPHDGSLHLVFEYMQTDLEAVIRDRNIFLSPGDIKSYMLMTL 120 
KGLAYCHKKWVLHRDMKPNNLLIGENGLLKLADFGLARLFGSPNRRFTHQVLML       175 
PCR primers 
D2FA D2RA D2FC D2RB/ D2RC 
SALK 065163LB LB
tgcatacctatgAGACGCTTAGA CAATATATCCtggtgattacaagttta 
(A1) 
(B1) 
(C1) 
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In the CDKD;2 gene two mutations were identified. Both cdkd;2-1 (SALK_065163) and cdkd;2-2 
(SALK_063929) mutations were caused by insertions of inverted T-DNA repeats flanked by LB 
junctions that were mapped in intron 2 and exon 5, respectively (Figure 4). In both cdKd;2 mutants, 
bidirectional transcription from 35S promoters of LB regions is expected to generate 5’ antisense and 
3’ sense transcripts. Analogously, transcription from the native CDKD;2 promoter is theoretically 
expected to generate 5’-truncated transcripts that encode a truncated N-terminal kinase catalytic 
domain without intact T-loop sequences in cdkd;2-1 and a full-length T-loop containing kinase 
domain in cdkd;2-2 in fusion with T-DNA encoded C-terminal peptides of different lengths. 
We have also obtained two independent T-DNA insertion mutations in the CDKD;3 gene (Figure 5). 
In the cdkd;3-1 (SALK_120536) mutant a single T-DNA insertion was mapped to the beginning of 
exon 3. As downstream of exon 3 the right border (RB) region of T-DNA (i.e., which lacks promoter 
elements) is found in junction with 3’ coding sequences of the cdkd;3-1 allele, transcription of these 
sequences is unlikely (Figure 5A1). Consequently, the cdkd;3-1 allele is expected to represent a 
genuine knockout mutation as the T-DNA insertion interrupts the coding region of kinase catalytic 
domain. By contrast, in the cdkd;3-2 mutant a single T-DNA insertion has replaced the translational 
stop codon by adding two new codons to the 3’-end of the coding sequence (Figure 5A2). This 
sequence change is not expected to influence the protein function, but interruption of 3’-untranslated 
sequences of CDKD;3 by the T-DNA insertion could potentially alter the stability of mRNA. This 
latter possibility was tested by a RT-PCR assay. 
 
3.1.3. Transcripts analysis of CDKF;1 and CDKD  genes in the T-DNA insertion mutants 
To examine transcription of mutant cdkf;1 and cdkd alleles, RT-PCR assays were performed with 
cDNA templates synthesized from RNA samples of homozygous T-DNA insertion mutant lines. In 
these assays, we have tested the transcription of 5’ and 3’ coding regions flanking the T-DNA 
insertions, as well as monitored the lack of full-length transcripts by designing specific oligonucleotide 
primers to the 5’ and 3’ ends of transcribed sequences (see: Figure 5A2). The results confirmed nearly 
predictions described above, indicating the activities of native promoters and transcription of truncated 
gene sequences through the activity of 35S promoter of SALK T-DNA LB junctions. The cdkd;1-1 
allele represented the only exception, where transcription of sequences located 3’-downstream of the 
right T-DNA LB junction in cdkd;1-1 (Figure 6, third panel, primers D1FC-D1RC) could not be 
detected. As transcribed 5’-domains of cdkd;1-1 allele could potentially be translated to truncated 
protein carrying the kinase domain with an intact T-loop, the assessment whether this mutation result 
only in a partial loss of function has to be delayed while suitable antibody become available. 
In the predicted leaky cdkd;3-2 (SALK_007756) mutant, the RT-PCR assay detected 
transcription of both 5’ and 3’ segments, as well as full-length sequences of the coding region, as 
expected (Figs. 5 and 6). However, the levels of all three PCR amplified transcript segments were less 
in the cdkd;3-2 mutant compared to wild type, indicating that the T-DNA insertion in the 3´ UTR lead 
indeed to some reduction in the amount of mRNA.  
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Figure 5. T-DNA junctions in the cdkd;3 mutants.  
(A1/A2) An arrow shows the position of integrated T-DNA. The positions of oligonucleotide primers used in 
PCR assays described in Figure 6 are shown above the scheme. The black and red blocks depict unteranslated 
and exon regions, respectively. The intron regions are marked by black lines. Capital, small and bold capital 
letters represent border sequences, coding sequences, and filler DNA, respectively. (B1) The sequence of 
CDKD;3 protein. The region shaded in grey is not translated because of T-DNA insertion. The red letters show 
T-loop region. (C1/C2) The sequence of CDKD;3 recombinant protein after T-DNA insertion. The highlighted 
yellow part is additional fused polypeptide to the first part of CDKF;1 protein. Positions of PCR primers used for 
RT-PCR analysis of transcribed regions of mutant allele are show above the scale bar in A2. 
 
 
 
 
SALK 120536LB RB
cagggatatATCAGGATATAT AATTCTCCGCTCagttgatggacagct 
MPEQPKKVADRYLKQEVLGQGTYGVVFKATDTKTEQTVAIKKIRLGKQREGVNITALREI 60 
KMLKELKHPHIILLIDAFPHKENLHLVFEFMETDLEAVIRDSNIFLSPADIKSYLLMTFK 120 
GLAYCHDKWVLHRDMKPNNLLIGVDGQLKLADFGLARIFGSPNRKFTHQVFARWYRAPEL 180 
LFGAKQYGAAVDVWAVACIFAELLLRRPFLQGNSDIDQLSKIFAAFGTPKADQWPDLTKL 240 
PDYVEYQFVPAPSLRSLFPAVSDDALDLLSKMFTYDPKARISIKQALEHRYFTSAPAPTD 300 
PAKLPKPVPKQDGKSSYGKHEAITVQSPPRKLRRVMPERGRVDSLKSHVDKDQQAPMSLD 360 
FTILAERPPNRPTITSADRSHLKRKLDLEFQ                              392 
MPEQPKKVADRYLKQEVLGQGTYGVVFKATDTKTEQTVAIKKIRLGKQREGVNITALREI 60 
KMLKELKHPHIILLIDAFPHKENLHLVFEFMETDLEAVIRDSNIFLSPADIKSYLLMTFK 120 
GLAYCHDKWVLHRDNQDILWCKQIDA                                   147 
(A1) 
(B1) 
(C1) 
SALK 007756LB RB
ttgagttccagtgACAAATTGAC CAGTGTTTAATTTGTTCAATTTgtaagac
MPEQPKKVADRYLKQEVLGQGTYGVVFKATDTKTEQTVAIKKIRLGKQREGVNITALREI 60 
KMLKELKHPHIILLIDAFPHKENLHLVFEFMETDLEAVIRDSNIFLSPADIKSYLLMTFK 120 
GLAYCHDKWVLHRDMKPNNLLIGVDGQLKLADFGLARIFGSPNRKFTHQVFARWYRAPEL 180 
LFGAKQYGAAVDVWAVACIFAELLLRRPFLQGNSDIDQLSKIFAAFGTPKADQWPDLTKL 240 
PDYVEYQFVPAPSLRSLFPAVSDDALDLLSKMFTYDPKARISIKQALEHRYFTSAPAPTD 300 
PAKLPKPVPKQDGKSSYGKHEAITVQSPPRKLRRVMPERGRVDSLKSHVDKDQQAPMSLD 360 
FTILAERPPNRPTITSADRSHLKRKLDLEFQTN                            392 
(A2) 
(C2) 
D3FA 
PCR primers 
D3FC D3RA D3FB D3RB/ D3RC 
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Figure 6. RT-PCR detection of transcription of T-DNA insertion mutant cdkf;1 and cdkd alleles. 
The first panels from the left show RT-PCR assays of transcription regions 5’ upstream (first lanes: primers 
F1FA-F1RA), 3’-downstream (third lanes: primers F1FC-F1RB), and overlapping the position (second lanes: 
primers F1FB-F1RB) of cdkf;1-1 T-DNA insertion in the wild type and mutant alleles. Next to the right, the 
same primer combinations were used to detect transcribed regions of cdkf;2-1 allele. The third and fourth panels 
show RT-PCR detection of transcription 5’ upstream (first lanes: primers D1FA-D1RA and D2FA-D2RA), 3’-
downstream (third lanes: primers D1FC-D1RC and D2FC-D2RC), and overlapping the position (second lanes: 
primers D1FA-D1RB and D2FA-D2RB) of T-DNA insertions in cdkd;1-1 and cdkd;2-2 using cDNA templates 
prepared from RNAs of wild type and cdkd mutants. The last panel to the right shows an RT-PCR assay of 
transcription 5’ upstream (first lane: primers D3FA-D3RA), 3’-downstream (second lanes: primers D3FB-
D3RB), and overlapping the position (third lane: primers D3FC-D3RC) of cdkd;3-2 T-DNA insertion in the wild 
type cdkd;3-2 mutant alleles. 
 
 
 
3.2. Analysis of phenotypic characteristics of the cdkf;1and cdkd mutants 
3.2.1. Phenotypic characterization of the cdkd mutants 
To assist the study of functional importance of the CDKD1, CDKD;2, and CDKD;3, protein kinases in 
Arabidopsis, we performed a preliminary characterization of cdkd knockout mutants. Different 
properties were surveyed including flowering time, root length, hypocotyls length, site shoots, and 
auxiliary shoots. There were no recognizable phenotypic changes in the individual cdkd mutants 
compared to wild type. The seeds of cdkd mutants germinated as wild type in the presence of 0.5% 
sucrose, 3% glucose, 50mg/l ethephon , 10 μM ACC, 0.1 μM brassinolide, 1 μM ABA, 10 μM GA3, 
and 0.5 mg/l 6-benzylaminopurine (BAP) plus 0.05 mg/L 1-naphtaleneacetic acid (NAA; i.e., shoot 
inducing hormone combination, which inhibits root formation), and 0.1 BAP plus 0.5 mg/l NAA (i.e., 
root/callus inducing hormone combination; data not shown). The lack of alterations in developmental, 
sugar and hormonal responses in the single cdkd mutants indicated that none of the three CDKD genes 
alone plays a distinguished role in these processes. Rather, the CDKD protein kinases appear to 
perform redundant and/or overlapping functions, where inactivation of one of the CDKDs by a T-
DNA insertion mutation is compensated by complementary function of another CDKD.  
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To confirm this conclusion, we have constructed cdkd;1-1, cdkd;2-1 (SALK_114643 and 
SALK_065163), cdkd;1-1, cdkd;3-2 (SALK_114643 SALK_007756), and cdkd;2-1, cdkd;3-2 
(SALK_065163 SALK_007756) double mutants and compared their developmental and hormonal 
responses. Again, we failed to find any recognizable phenotypic difference compared to wild type. 
However, the triple mutant cdkd;1-1, cdkd;2-1, cdkd;3-2 (SALK_114643, SALK_065163, 
SALK_007756), which carried the weak cdkd;3-2 allele, showed a significant reduction in seedling 
growth compared to wild type (Figure 7). This suggested that the cdkd;1-1 and cdkd;2-1 mutations are 
possibly null mutations as a slight reduction in CDKD;3 transcript levels by the cdkd;3-2 mutation in 
this background resulted in a clear retardation of growth and development. Whether or not cdkd;1-1 is 
indeed a genuine knockout mutation, will be soon determined by characterization of an alternative 
cdkd;1-1, cdkd;2-1, cdkd;3-1 (SALK_114643, SALK_065163, SALK_120536) triple mutant, which 
carries the putative cdkd;2-1 and cdkd;3-1 null mutations. In addition, there is a second, likely null 
cdkd;1-2 (MPI8258) allele available, which carries a T-DNA insertion in exon 2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. The leaky cdkd;3-2mutation causes a significant reduction of plant growth in the cdkd;1-1, 
cdkd;2-1 mutant background. 
The size of leaves and inflorescence stems of cdkd;1-1, cdkd;2-1, cdkd;3-2 (SALK_114643 SALK_065163 
SALK_007756) triple mutant seedlings (two pots to the left) are about 30-40% smaller compared to wild type. 
 
 
 
 
cdkd;1-1, cdkd;2-1, cdkd;3-2 wt 
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This allele has been previously identified by screening the insertion mutant collection of our 
laboratory (Shimotono et al., 2006) and can now be used for construction of a third combination of a 
cdkd;1-2, cdkd;2-1, cdkd;3-1 (MPI8258, SALK_065163, SALK_120536) triple mutant, in order to 
generate a complete allelic series. Preliminary characterization of cdkd mutations summarized above 
provides a basis for further dissection of CDKF;1-CDKD kinase regulatory circuit, from which the 
CDKF;1 function is characterized in detail in this work. 
 
3.2.2. Characterization of cdkf;1 mutants  
Seedlings carrying either the cdkf;1-1 (SALK_148336) or cdkf;1-2 (GABI_315A10) mutant allele 
showed completely identical alterations in all performed assays. Both cdkf;1 mutants were 
characterized by highly retarded development producing tiny plants with twisted and serrated leaves. 
Furthermore, the loss of CDKF;1 function resulted in inhibition of root elongation and reduction of the 
number of root hairs (Figure 8). The mutant plants have started to initiate flowering upon 56±10 days 
of vegetative development in long days, but this could be accelerated and achieved within 27±4 days 
using gibberellin treatment. The mutant inflorescences carried petalless, fully sterile male and female 
organs. Cross pollination with wild type failed to yield any seed.  
Scanning electron microscopic measurement of cell size showed that leaf epidermal cells of 
cdkf;1 mutants were 40-50% smaller compared to wild type. In addition, the cell numbers per leaf 
were also less in cdkf;1 compared to than wild type seedlings, indicating a lack of compensatory 
mechanism described for some cell cycle mutants (Inzé and De Veylder, 2006). Furthermore, instead 
of developing normal trichomes carrying three branches, most of the trichomes possessed only 2 
branches or remained unbranched (i.e., stichel-like) in both cdkf;1 mutants. These observations 
suggested that upon exit from the cell cycle the normal endoreduplication process, determining the 
final size distribution of leaf cells, could be affected by the cdkf;1 mutations. To test this possibility, a 
FACS analysis was performed. The results of DNA profiling indicated identical relative percentage of 
2C, 4C, 8C, and 16C cells in the cdkf;1 mutants compared to wild type. This observation demonstrated 
that the cdkf;1 mutations caused no endoreduplication defect. Nevertheless, the reduction of cell 
number in various organs (e.g., leaves, hypocotyls etc.) suggested a cell proliferation defect in the 
cdkf;1 mutants (Figure 9). 
To test possible effects of the cdkf;1-1 mutation on gametogenesis, the offspring of self 
pollinated hemizygous cdkf;1-1/+  T2 mutant families was examined. Instead of the expected 3:1 
Mendelian segregation of wild type and cdkf;1-1 mutant progeny, a distorted 4:1 segregation ratio was 
observed (Table 1). Therefore, male and female transmission efficiency of the cdkf;1-1 mutant allele, 
carrying a T-DNA encoded sulfadiazine resistance marker gene, was analyzed using reciprocal crosses 
between hemizygous cdkf;1-1/+ mutant and wild type plants. The efficiencies of female and male 
transmissions of cdkf;1-1 allele were 113% and 68%, respectively, which indicated a partial male 
transmission defect, as in case of pollination with the cdkf;1-1/+ parent the observed segregation ratio 
(0.68: 1) differed significantly from the expected 1:1 ratio (Table 2). 
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Figure 8. Morphological characteristics of the cdkf;1-1 knockout mutant.  
(A) Wild type (left) and cdkf;1-1 mutant (right) plants 18 days and one month after germination (gibberellin-
mediated flowering in cdkf;1-1), respectively. The mutant shows extremely reduced growth and development (B) 
A magnified picture of cdkf;1-1 mutant after induction of its flowering by gibberellin treatment.(C) Wild type 
and cdkf;1-1 mutant seedlings 12 days after germination. The mutant seedling displays significantly shorter root 
and retarded development. (D) Comparison of leaves of wild type (top row) and cdkf;1-1 mutant (bottom row) 
plants shown in (A). (E) One month old cdkf;1-1 mutant without gibberellin treatment (F) Trichomes with 
reduced branch number on serrated leaves of the cdkf;1-1 mutant. (G) The aberrant flower of cdkf;1-1 mutant. 
There are no real petals. (H) and (I) Comparison of carpels and stamens of wild type (left side) and cdkf;1-1 
mutant, respectively. (J) Scanning electron micrographs of cdkf;1-1 mutant leaf showing single and double 
branched trichomes. (K) and (L) Scanning electron micrographs of cotyledons of wild type and cdkf;1-1 mutant 
seedlings. The size of epidermal cells in the mutant leaves is smaller compared to wild type. 
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Figure 9. Flow cytometric analysis of nuclear DNA content of leaf cells of two and three weeks old wild 
type and cdkf;1-1 mutant seedlings. 
(A) Ploidy profiles of leaf cells of two weeks old wild type and cdkf;1-1 mutant seedlings. (B) Calculation of 
percentage of nuclear DNA content for each C-value class. (C) Nuclear DNA content of leaf cells of three weeks 
old wild type and cdkf;1-1 seedlings. (D) Calculation of percentage of nuclear DNA content for each C-value 
class. The error bars show the standard deviations of measurements.  
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Table 1. Self pollination of hemizygous cdkf;1-1/+ mutant yield a distorted segregation ratio of wild type 
and cdkf;1-1 mutant progeny. 
 
 wt and 
cdkf;1/+ 
cdkf;1/cdkf;1 Ratio 
Expected ratio 753 251 3:1 
Observed ratio 804 201 4:1 
 
 
 
Table 2. Male and female transmission efficiency of cdkf;1-1f allele determined by reciprocal crosses.  
TE (transmission efficiency) = SulfadiazineR/SulfadiazineS x 100. 
 
 
 
 
 
 
DAPI staining of pollens from hemizygous cdkf;1-1/+ plants indicated that some mature pollen grains 
had significantly smaller size compared to wild type but carried clearly recognizable generative cells 
(Figure 10). However, we could not detect a cell division defect in the abnormal pollen grains. 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Fluorescence microscopy of DAPI-stained mature pollen grains of wild type and hemizygous 
cdkf;1-1/+ plants.  
The white arrows show smaller pollen grains in the hemizygous cdkf;1-1/+ anthers. 
 
3.2.3. Genetic complementation of the cdkf;1-1 mutation 
To confirm that all observed phenotypic changes were indeed caused by the cdkf;1-1 T-DNA insertion 
mutation, a genetic complementation test was performed with a full-length CDKF;1 cDNAs cloned in 
pER8-GW and pN-TAPI vectors. The constructs were transferred into Agrobacterium GV3101 
(pMP90) and transformed by vacuum infiltration into sulfadiazine resistant hemizygous cdkf/1-1/+ 
(GABI_315A10) plants. The transformed T1 generation was selected on MSAR media containing 
 Crosses SulfadiazineR SulfadiazineS TE 
Female cdkf;1-1/+ x wt 87 76 113% 
Male wt x cdkf;1-1/+ 77 113 68% 
wt cdkf;1-1/+ 
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wt       cdkf;1-/-     cdkf;1-/-  
(35S-CDKF;1)           
either hygromycin (pER8-GW marker) or BASTA (pN-TAPI marker). Subsequently, all resistant 
seedlings were transferred onto sulfadiazine containing medium, in order to select for the antibiotic 
resistance marker of the cdkf;1-1 allele. T2 generation was analogous germinated on either 
hygromycin or BASTA containing medium, and then resistant plants were subjected to sulfadiazine 
selection and screened by PCR for homozygous status of the cdkf;1-1 mutation. Subsequent growth of 
seedlings carrying the pN-TAPI construct, conferring expression of CDKF;1 cDNA in fusion with 
coding sequences of an N-terminal TAP tag, revealed wild type phenotype indicating genetic 
complementation of the cdkf;1-1 mutation. Surprisingly, few lines carrying the CDKF;1 cDNA under 
the control of an estradiol-inducible promoter in the T-DNA of pER8-GW expression vector also 
yielded wild type homozygous cdkf;1-1 progeny, indicating leaky expression in the absence of 
estradiol induction (Figure 11). In any case, these assays demonstrated that expression of the CDKF;1 
cDNA by the CaMV 35S promoter is sufficient to confer genetic complementation of the cdkf;1-1 
mutation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Genetic complementation of the cdkf;1-1 mutation. 
Comparison of phenotypes of wild type (wt), pER8-GW -CDKF;1-cDNA containing homozygous cdkf;1-1 
mutant, and untransformed homozygous cdkf;1-1 mutant plants. Wild type phenotype of cdkf;1-1 homozygous 
plants expressing the CDKF;1 cDNA under the control of a CaMV 35S promoter in the pER-GW vector 
indicates successful genetic complementation of the mutation.  
 
3.3. Phosphorylation targets of CDKF;1 and CDKD protein kinases 
3.3.1. CDKF;1 phosphorylates the CDK-activating CDKD kinases  
Shimotonho et al., (2004) have previously found that CDKF;1 phosphorylates the T-loop of CDKD;2, 
and CDKD;3 in vitro, but failed to detect phosphorylation of CDKD;1 by CDKF;1. However, the fact 
that both T-loop sequences and predicted protein structures of all three Arabidopsis CDKD kinases are 
very similar (Figure 12) suggested a possible inconsistency in these results.  
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Figure 12. Multiple alignment of Arabidopsis CDKD protein kinase sequences.  
Conserved regions are depicted by black shading, whereas red rectangle frames the T-loop sequences. 
 
Therefore, we have repeated the CDKF;1 kinase assays with the CDKD substrates. We have used a N-
terminal thioredoxin and C-terminal His6 sandwich tagging technology for isolation of soluble and 
intact kinase proteins from E. coli BL 21. Recombinant CDKDs/CAKs (Trx-CDKD;1-His, Trx-
CDKD;2-His, and Trx-CDKD;3-His) were purified to apparent homogeneity (Figure 13) and used 
subsequently as substrates in kinase assays with [γ-32P]ATP and similarly purified CDKF;1/CAKAK.  
 
 
 
 
 
 
 
 
 
 
Figure 13. Purification of CDKF;1 and CDKD protein kinases fused to N-terminal thioredoxin and C-
terminal His6 tags, and isolation of a GST-CTD fusion protein carrying the C-terminal 
heptapeptide repeats of Arabidopsis RNAPII largest subunit. 
The thioredoxin-His6 sandwich tagged CDKF;1 and CDKD protein kinases (Trx-CDKD;1-His, Trx-CDKD;2-
His, Trx-CDKD;3-His, and Trx-CDKF;1-His) were isolated by nickel affinity chromatography using the His6-
tag, whereas the GST-CTD kinase substrate was purified by glutathione-Sepharose affinity chromatography. The 
proteins were size separated on 10% SDS-PAGE and stained by Coomassie blue to control their purity.  
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We found that in these assays CDKF;1 underwent partial autoactivation by self-phosphorylation, as 
described for the leafy spurge Ee;CDKF;1 by Chao et al. (2006), and phosphorylated all three 
Arabidopsis CDKDs (CDKD;1, CDKD;2, and CDKD;3; Figure 14), but not the negative control 
thioredoxin protein (Figure 15). Subsequently, we used a T-loop mutated variant of CDKD;1 (T166A) 
as substrate for CDKF;1. Phosphorylation of the CDKD;1 (T166A) substrate was clearly lower 
compared to wild type CDKD;1, which suggested that CDKF;1 phosphorylates the threonine 166 
residue in the T-loop of CDKD;1 (Figure 16). Nevertheless, residual labelling of CDKD;1 (T166A) by 
32P indicated that the Thr166Ala substitution did not fully abolish CDKD;1 phosphorylation by 
CDKF;1.  
 
 
 
 
 
 
 
 
 
Figure 14. Phosphorylation of affinity-purified thioredoxin-fused CDK-activating CDKD kinases by the 
CAK-activating CDKF;1 kinase.  
Control assays were performed with CDKF;1 and each CDKD kinase independently, to exclude possible 
contamination with E. coli derived kinases. Following size separation of proteins from the kinase assays on 10% 
SDS-PAGE, the phosphorylated kinases were detected by autoradiography. Due to a short exposure time 
optimized for monitoring CDKF;1-mediated phosphorylation, lower levels of autophosphorylation of CDKDs 
were not detected under this condition.  
 
 
 
 
 
 
 
 
 
 
 
Figure 15. CDKF;1 and CDKD;2 do not phosphorylate the control glutathione-S-transferase (GST) and 
thioredoxin proteins.  
Purified GST and thioredoxin were subjected to kinase assays to test possible contamination with E. coli derived 
kinases and demonstrate specificity of CDKF;1-mediated phosphorylation of Thx-CDKD-His6 and GST-CTD 
(see: 3.3.2) substrates. 
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Figure 16. CDKF;1 mediates T-loop phosphorylation of CDKD;1 protein kinase. 
CDKF;1 phosphorylates only very weakly the T-loop mutated variant of CDKD;1 (T166A) kinase compared to 
wild type CDKD;1. 
 
This low level phosphorylation of CDKD;1 (T166A) is consistent with some previous reports 
suggesting that CDKF;1 could also phosphorylate partially the Ser168 residue preceding the T-loop 
sequences (Shimotohno et al., 2004, Umeda et al., 2005). Based on these data it was concluded that 
the previous studies of CDKF;1 substrates were not fully reliable concerning CDKF;1-mediated 
phosphorylation of CDKD;1, perhaps because in those experiments a maltose-binding protein (MBP) 
fusion was used for secretion and purification of CDKF;1, which in our hands results in a kinase with 
lower in vitro activity. 
 
3.3.2. The CTD domain of Arabidopsis RNA polymerase II largest subunit is phosphorylated by 
CDKF;1 and CDKD;2 
Previously, Bakó et al (2003) found that the alfalfa CAK2Ms kinase phosphorylates and co-
immunoprecipitates with the CTD of the largest subunit of RNAPII. Shimotohno et al. (2004) 
confirmed this observation by showing that Arabidopsis CDKD;2, an ortholog of alfalfa CAK2Ms, 
was also capable of phosphorylating CTD after co-immunoprecipitation from plant extracts with 
cyclin H. To characterize the CTD kinase activity of CDKF;1 and all three CDKD kinases, we first 
performed in vitro phosphorylation assays with a GST-CTD fusion protein as substrate (Figure 17). In 
addition to CDKD;2, we also found that CDKF;1 is also capable of phosphorylating the GST-CTD 
substrate, whereas neither CDKF;1 nor CDKD;2 phosphorylated the control glutathione-S-transferase 
protein (Figure 15). Using each protein kinase without substrate, as well as the GST-CTD substrate 
without kinase, in control assays demonstrated that all three purified CDKD kinases were able to 
undergo autophosphorylation and autoactivation in vitro (Figure 17). Autophosphorylation of CDKDs 
was however weak compared to CDKF;1. In any case, these results indicated that the CDKD protein 
kinases have some basic activity in the absence of their phosphorylation by CDKF;1 in vitro, and 
suggested that this may be the case also in the cdkf;1 mutants in vivo. 
The CTD domain of Arabidopsis RNAPII largest subunit consists of 15 consensus 
(YSPTSPS) and 26 variant tandem heptad repeats (Nawrath et al., 1990).  
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Figure 17. CDKF;1 and CDKD;2 phosphorylate the CTD of RNAPII largest subunit. 
The kinase assays were performed with purified CDKF;1 and CDKD protein kinases using GST-CTD as 
substrate and [γ-32P]ATP. To monitor autophosphorylation of the kinases, separate assays were performed with 
GST-CTD alone and each protein kinase in the absence of substrate (shown here only for CDKF;1). 
 
In mammals, the predominant phosphorylation occurs at serine residues Serine-2, Serine-5, and 
Serine-7 of CTD heptapeptide motives (Phatnani and Greenleaf, 2006; Chapman et al., 2007). To 
determine which serine positions of the consensus CTD heptapeptide are phosphorylated by the 
CDKD;2 and CDKF;1 kinases, we have used four different synthetic peptides as substrates (Table 3).  
 
Table 3. Wild type and mutant variants of consensus CTD heptapeptide used as substrates in kinase 
assays with CDKF;1 and CDKD;2. 
Peptide “a” corresponds to the wild type heptatpeptide, peptide “b” carries alanine exchanges of Serine-2 and 
Serine-5; in peptide “c” Serine-5 is exchanged for alanine, and in peptide “d” Serine-2 is replaced by alanine. 
Note that phosphorylation of peptide “b” specifically detects Serine-7 kinase activity. 
 
 
Compared to the wild type consensus heptapeptide sequence in peptide (a), alanine substitutions of 
either Serine-5, or Serine-2, and both Serine-2 and Serine-5 residues were introduced into peptides (c), 
(d), and (b), respectively. In comparison to phosphorylation of wild type peptide (a), CDKD;2 
phosphorylated peptide (d) more efficiently than peptide (c), but did not recognize peptide (b) as 
substrate (Figure 18A). These results showed that CDKD;2 phosphorylated both Serine-2 and Serine-5 
residues, but preferred Serine-5 over Serine-2. However, CDKD;2 was not capable to phosphorylate 
the Serine-7 residue of CTD heptapeptide.  
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Figure 18. CTD prhosphorylation specificities of CDKD;2 and CDKF;1 kinases in vitro. 
CDKD;2 phosphorylates Serine-5 of CTD heptapeptide repeats at higher efficiency compared to the Serine-2 
residue. (A) Kinase assay was performed with CDKD;2 and four different synthetic heptapeptides. CDKD;2 
phosphorylation of peptide “d” carrying Serine-2 to alanine replacement is more efficient compared to peptide 
“c”, which carries Serine-5 to alanine replacement. By contrast, peptide “b” carrying alanine replacement of both 
Serine-2 and Serine-5 residues is not phosphorylated by CDKD;2. (B) CDKF;1 phosphorylates with similar 
efficiency all four heptapeptide substrates, including peptide “b”, indicating that CDKF;1 is also capable to 
hosphorylate the Serine-7 residue of the CTD heptapeptide repeats.  
 
Moreover, CDKD;2 phosphorylated peptides (d) and (c) at significantly lower levels than the wild 
type peptide (a). This indicated that phosphorylation of one of the serine residues could have a positive 
effect on phosphorylation of another serine position. This observation supports the results of Jones et 
al. (2004) who showed that partially phosphorylated CTD heptapeptides were more efficient substrates 
for budding yeast CTDK-I compared to unphosphorylated heptapeptide substrates. 
 Unlike CDKD;2, CDKF;1 appeared to phosphorylate all four heptapeptide substrate variants 
with comparable efficiency (Figure 18B). Consequently, this result did not indicate the exact target(s) 
of CDKF;1 phosphorylation in the heptapeptide sequence. CDKF;1 is a serine/threonine kinase, there 
are two possible additional target residues (Thr4 and Ser7) for CDKF;1 in the mutated peptides. Since 
Serine-7 is one of the major CTD phosphorylation site in vivo, phosphorylation of peptide “b” carrying 
alanine replacement of both Serine-2 and Serine-5 residues suggested that CDKF;1 is likely a CTD 
Serine-7 kinase. In contrast to the report of Shimotohno et al. (2004), who failed to detect CTD 
phosphorylation by CDKF;1, our data strongly suggested that CDKF;1 is an important CTD kinase, in 
addition to its downstream CDKD;2 kinase target. 
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3.3.3. RNA polymerase II CTD phosphorylation in cdkf;1 and cdkd;2 mutant plants 
To verify that CDKF;1 and CDKD;2 indeed play important roles in CTD phosphorylation in vivo, we 
performed western blot analysis of proteins extracted from wild type control, cdkf;1 and cdkd;2 
mutant seedlings using primary rat monoclonal antibodies 3E10, 3E8/H14, and 4E12 (Chapman et al., 
2007; Egloff et al., 2007) that exclusively detect phosphoserine-2, phosphoserine-5, and 
phosphoserine-7 in the heptapeptide repeats of RNAPII CTD domain, respectively. The amount of 
RNAPII largest subunits was adjusted in the samples to equal using mouse a monoclonal antibody 
8WG16 (abcam, ab817).  
Whereas the cdkf;1 mutation caused a progressive delay in vegetative development after seed 
germination, the phenotype of the cdkd;2 mutant was indistinguishable from wild type. To standardize 
the CTD phosphorylation assay, therefore, proteins extracts were prepared from 7 days old wild type 
and mutant seedlings when, despite inhibition of root elongation, the size and development of cdkf;1-1 
mutant was fully comparable to those of wild type and cdkd;2-1 mutant seedlings that carried no 
leaves but only two fully expanded cotyledons. At this developmental stage, western blotting with the 
CTD phosphoserine-7 specific 4E12 antibody revealed that phosphorylation at Serine-7 residues of 
CTD heptapeptide repeats was specifically reduced in the cdkf;1-1 mutant, whereas the levels of CTD 
phosphoserine-7 were comparable in wild type and cdkd;2-1 mutant seedlings (Figure 19). In support 
of in vitro kinase assays, this data demonstrated that the CDKF;1 protein kinase is required in vivo for 
phosphorylation of Serine-7 residues of CTD heptapeptide repeats of RNAPII.  
To determine whether CTD phosphorylation levels would change during further seedling 
development, we have also performed western blot analysis of protein extracts that were prepared 
from 12 days old seedlings that carried four fully expanded leaves. At this developmental stage, the 
cdkf;1-1 mutant showed some slight but clearly recognizable delay in elongation growth compared to 
cdkd;2-1 and wild type seedlings (see: Figure 8C). In addition to maintenance of largely reduced 
phosphoserine-7 levels in the cdkf;1-1 mutant, we have observed a dramatic reduction of 
phosphoserine-5 levels in both cdkd;2-1 and cdkf,1-1 seedlings (Figure 19). In accordance with the 
results of in vitro kinase assyas, this observation showed that the CDKD;2 protein kinase is required 
for in vivo phosphorylation of CTD Serine-5 residues. Reduction of CTD-Serine-5 phosphorylation in 
cdkf;1-1 mutant seedlings confirmed the notion that CDKF;1 may indeed act in vivo as upstream 
activating kinase (CAKAK) of CAKs/CDKDs. In fact, the T-loop phosphorylation of CDKD;2 and 
CDKD;3 by CDKF;1 in vitro has been reported by (Shimotohno et al; 2004), and we found that 
CDKD;1 is also an in vitro substrate of CDKF;1 (Figure 16). Furthermore, CDKF;1 is detected in 
association with CDKD;2 in vivo (Van Leene et al., 2007). Therefore, CDKF;1/CAKAK is likely to 
mediate the activation of CDKDs/CAKs in their complexes with cyclins in vivo (Umeda et al., 1998; 
Shimothono et al., 2006).  
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Figure 19. Changes in the levels of Serine-7, Serine-5 and Serine-2 specific phosphorylation of RNAPII 
CTD in cdkf;1 and cdkd;2 mutant seedlings during early stages of seedling development 
Protein extracts were prepared from seedlings with fully expanded cotyledons but no leaves harvested at day 7 
after sawing, and from 12 days old seedlings carrying four expanded primary leaves. Western blot analyses of 
protein extracts (50 μg/lane) prepared from wild type, cdkf;1 and cdkd;2 seedlings were performed with 
antibodies recognizing specifically the phosphorylated Serine-7, Serine-5, and Serine-2 residues of RNAPII 
CTD heptapeptide repeats. The samples were standardized using an antibody, which recognizes the CTD 
independently of its phosphorylation status.  
 
Lower level of phosphoserine-5 in cdkf;1 compared to cdkd;2 mutant seedlings thus indicates 
CDKD;2 is not the only CDKF;1-activated kinase, which is involved in CTD-Serine-5 
phosphorylation. The CDKD;3 and CDKD;1 protein kinases are likely candidates for being 
responsible for residual phosphorylation of Serine-5 position of CTD in the cdkd;2 mutant. This 
should be further examined using the available double and triple cdkd mutants. Low level of Serine-5 
phosphorylation in the cdkf;1-1 mutant, on the other hand, suggests that the CDKD kinases have some 
basic activity even in the absence of CDKF;1. Therefore, it will be interesting to examine the effect of 
gradual inactivation of CDKDs in the cdkf;1 mutant background. 
Remarkable, neither Serine-5 nor Serine-2 residue of CTD show any reduction in their 
phosphorylation level in the cdkf;1-1 mutant seedlings 7 days after germination and prior initiation of 
leaf development. As CDKD;2 without its regulatory cyclin (CycH;1) subunit and CDKF;1-mediated 
activation showed in vitro phosphorylation of Serine-5 and at lower level Serine-2 residues of the 
CTD, it is possible that a gradual decline of the threshold of CDKD;2 kinase activity with together 
other unknown kinases in developing seedlings contribute to gradual manifestation of defective 
Serine-5 and Serine-2 phosphorylation in the cdkf;1-1 mutant. Thus, reduction of Serine-2 and Serine-
5 phosphorylation is not immediately detectable in cdkf;1-1 mutant seedlings 7 DAG. As at that stage 
only a reduction of CTD phosphoserine-7 levels is observed in the cdkf;1-1 mutant, the use of these 
very young seedlings provided an ideal tools to determine the regulatory effects of CTD Serine-7 
phosphorylation on the control of transcription. Therefore, we have performed an Affymetrix 
GeneChip transcript profiling experiment with RNA samples prepared from cdkf;1-1 mutant and wild 
type seedlings 7 DAG.  
Wild type cdkd;2 cdkf;1 Wild type cdkd;2 cdkf;1 
CTD (Serine 7p) 
CTD 
CTD (Serine 5p) 
CTD (Serine 2P) 
7 DAS Seedlings carrying four  
expanded  leaves 
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3.4. Transcript profiling of cdkf;1 mutant and wild type seedlings using Affymetrix ATH1 
microarray 
Comparative microarray transcript profiling of cdkf;1 mutant and wild type was performed by 
Affymetrix ATH1 GeneChip microarrays as described in section 2.2.24 to obtain three independent 
microarray datasets for both wild type and cdkf;1-1 samples. Analysis of the microarray data with the 
GeneSpring GX10 (Agilent) program using a cut-off value of 2.0-fold difference between transcript 
levels at a p value<0.05 in control wild type and cdkf;1-1 mutant samples resulted in 845 genes. From 
these 367 showed down-regulation and 478 upregulation in cdkf;1-1 seedlings. Subsequent statistical 
analysis of gene list has identified 37 Gene Onthology (GO) terms, which showed overrepresentation 
at a cut-off value <0.1. Testing the dataset for significant pathways compiled in the GeneSpring 
package has identified 42 pathways overrepresented at a p-value <0.01. Because some regulatory 
factors in the identified pathways showed changes in their transcript levels lower than 2-fold, but 
higher than 1.5-fold, we have repeated the statistical analyses allowing 1.5-fold difference at p-value 
<0.05 between wild type and cdkf;1-1 transcript levels. This resulted in 2383 genes (in cdkf;1-1 down-
regulated 1258 and upregulated: 1125) corresponding to 42 GO-terms (p<0.1) and the same 35 
significantly overrepresented pathways, which were obtained by using a cut-off of 2-fold change in the 
altered expression levels.  
 
3.4.1. Data mining – identification of pathways affected by the cdkf;1-1 mutation  
The analysis of GO-terms (Table 4) suggested that the cdkf;1-1 mutation primarily affected several 
stress response and redox-regulatory pathways and their coordinated control with a wide-range of 
metabolic and nuclearly encoded chloroplast functions. Subsequent manual annotation of the gene list 
to pathways compiled in the Annex and following sections helped to allocate precisely the gene 
functions to better defined pathways involved in the regulation of: light responses, circadian clock, 
flowering time; shoot-, root-, flower-, gametophyte-, embryo- and seed development; plant hormone 
(cytokinin, brassinosteroid, ABA, auxin, jasmonate and salicylic acid) biosynthesis and signalling; 
pathogen defence responses, senescence, cell death, synthesis of phenylpropanoids and anthocyanines, 
osmotic (salt and drought), cold and oxidative stress responses; mitochondrial and chloroplast 
function, including chlorophyll biosynthesis; RNA processing and biogenesis of small RNAs; cell 
cycle, DNA repair and replication, chromatin conformation and modifications, nuclear import, 
cytoskeleton organization, phospholipid and Ca2+ signalling, vesicular transport, protein folding and 
proteolysis, carbohydrate metabolism (glycolysis, gluconeogenesis, sugar transport), fatty acid-, cell 
wall- and amino acid metabolism and transport; glutathione-transferases, cytochrome P450 families, 
and metabolism and transport of ammonia, sulphate, phosphate, iron, and potassium. In addition, the 
cdkf;1-1 mutation affected the expression levels of 48 yet uncharacterized protein kinases, 76 
transcription factors and numerous other genes of unknown function. 
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Table 4. Genes showing 1.5-fold alteration in their transcript levels (p<0.05) between the cdkf;1-1 mutant 
and wild type were sorted to significantly overrepresented pathways according to GO-terms. 
The majority of GO-terms are related to pathways controlling plant responses to abiotic and biotic stimuli and 
oxidative stress indicating that transcription of many stress regulated genes are altered by the cdkf;1-1 mutation. 
 
GO ACCESSION GO Term p-value % Count in Total 
GO:0003824 catalytic activity 4.66E-06 43.2428 
GO:0050896 response to stimulus 4.14E-15 18.9136 
GO:0009536 Plastid 6.63E-08 16.481775 
GO:0009507 Chloroplast 1.97E-08 16.11017 
GO:0006950 response to stress 1.88E-14 10.962348 
GO:0042221 response to chemical stimulus 6.17E-09 10.006011 
GO:0016491 oxidoreductase activity 9.59E-18 7.776381 
GO:0055114 oxidation reduction 3.17E-17 6.19706 
GO:0005576 extracellular region 1.16E-14 4.568556 
GO:0006952 defense response 6.83E-07 3.9510355 
GO:0030312 external encapsulating structure 1.65E-12 3.4755998 
GO:0005618 cell wall 2.87E-12 3.4318814 
GO:0005506 iron ion binding 8.01E-11 3.4154873 
GO:0009055 electron carrier activity 4.29E-08 3.2132905 
GO:0009607 response to biotic stimulus 5.72E-06 3.076671 
GO:0019748 secondary metabolic process 5.49E-17 2.3443904 
GO:0005509 calcium ion binding 1.58E-05 2.1367288 
GO:0046906 tetrapyrrole binding 1.44E-08 2.0984752 
GO:0020037 heme binding 5.94E-08 1.9563911 
GO:0009605 response to external stimulus 6.72E-10 1.8744193 
GO:0006725 aromatic compound metabolic process 1.14E-05 1.7924477 
GO:0006979 response to oxidative stress 3.82E-16 1.5683917 
GO:0009505 plant-type cell wall 1.10E-10 1.4645609 
GO:0050660 FAD binding 5.03E-06 0.87436473 
GO:0009611 response to wounding 5.09E-07 0.86343515 
GO:0009698 phenylpropanoid metabolic process 1.24E-05 0.84157604 
GO:0015979 Photosynthesis 4.12E-06 0.83611125 
GO:0016209 antioxidant activity 5.32E-14 0.73228043 
GO:0000302 response to reactive oxygen species 5.65E-16 0.7104213 
GO:0004601 peroxidase activity 5.97E-14 0.6612383 
GO:0016684 oxidoreductase activity, acting on peroxide as acceptor 5.97E-14 0.6612383 
GO:0042542 response to hydrogen peroxide 2.66E-15 0.6393792 
GO:0006800 oxygen and reactive oxygen species metabolic process 3.09E-15 0.595661 
GO:0042743 hydrogen peroxide metabolic process 4.40E-17 0.4809006 
GO:0042744 hydrogen peroxide catabolic process 8.68E-18 0.46450627 
GO:0004364 glutathione transferase activity 8.86E-09 0.273239 
GO:0019757 glycosinolate metabolic process 1.10E-05 0.25684464 
GO:0016137 glycoside metabolic process 1.10E-05 0.25684464 
GO:0019760 glucosinolate metabolic process 1.10E-05 0.25684464 
GO:0009404 toxin metabolic process 5.37E-08 0.25137985 
GO:0009407 toxin catabolic process 5.37E-08 0.25137985 
GO:0043295 glutathione binding 4.00E-06 0.060112573 
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3.4.2. The cdkf;1-1 mutation results in transcriptional down-regulation of small RNA biogenesis 
pathways 
As shown in Figure 8D, in addition to other severe developmental defects, the cdkf;1-1 mutation 
resulted in alteration of leaf development characterized by upward curling serrated leaves. Similar leaf 
phenotype has been shown to be conferred by mutations affecting key enzymes in the microRNA 
biogenesis pathway, including DICER-LIKE 1 (DCL1), SERRATE (SE) and HYPONASTIC LEAF 
(HYL1) (for review see: Voinnet, 2009). Analysis of the microarray hybridization data in fact 
indicated that the cdkf;1-1 mutation caused 1.8-fold reduction in the transcript level of DCL1 encoding 
a key enzyme involved in pri-microRNA processing and microRNA-mediated cleavage of ta-siRNA 
precursors. In addition, a similar reduction was observed in the transcript levels of DCL2 involved in 
the nat-siRNA pathways and AGO1, a major component of RISC complexes catalysing microRNA 
and ta-siRNA mediated cleavage of target transcripts in Arabidopsis. As several critical functions in 
the small RNA pathways are not represented on the Arabidopsis ATH1 microarray, and because we 
have lowered the cut-off value of altered transcript levels from standard 2-fold to 1.5-fold (i.e., which 
could increase the false discovery rate), we have measured the mRNA levels of a set of genes acting in 
the four known Arabidopsis small RNA (miroRNA, ta-siRNA, nat-siRNA and ra-siRNA) pathways by 
quantitative real-time PCR (qRT-PCR). This has revealed 1.5 to 6-fold decrease in the transcript levels 
of four DICER-LIKE (DCL1, DCL2, DCL3, and DCL4), four ARGONAUTE (AGO1, AGO4, AGO6, 
and AGO7), and two RNA-dependent RNA polymerase II genes (RDR2 and RDR6), in addition to the 
HYL1, HEN1 (HUA ENHANCER 1), HST1 (HASTY), and DRD1 (DEFECTIVE IN RNA-
DIRECTED DNA METHYLATION 1) genes, in the cdkf;1-1 mutant (Figure 20). These results thus 
indicated that the cdkf;1-1 mutation most likely negatively affects all four small RNA pathways (i.e., 
DCL1, HYL1, HEN1, HST1 and AGO1 in microRNA processing and action; DCL1, RDR6, DCL4, 
HEN1, AGO1 and AGO7 in ta-siRNA processing and action; DCL1, DCL2, RDR6 and HEN1 in nat-
siRNA biogenesis; and DCL3, RDR2, HEN1, DRD1 and AGO4 in the ra-siRA pathway, Voinnet, 
2009). These results also predicted that through down-regulation of AGO4 and AGO6, which are 
effectors of siRNA-mediated DNA methylation, the cdkf;1-1 mutation could also affect the regulation 
of gene silencing (Zheng et al., 2007; He et al., 2009). 
To confirm that down-regulation of genes controlling the processing of small RNA 
precursors indeed leads to a reduction of mature small RNA levels, we have compared the amounts of 
microRNAs miR156, miR165 and miR172, as well as ta-siRNA 1 and ra-siRNA COPIA by northern 
blot hybridization in 7 days old wild type, cdkf;1-1 and cdkd;2-1 seedlings (Figure 21). Equal amount 
of input RNA samples was standardized by hybridization with an U6 snRNA probe. The hybridization 
data demonstrated that the levels of tested microRNAs, tas-siRNA 1 and ra-siRNA COPIA were 
indeed remarkably lower in the cdkf;1-1 mutant compared to wild type. On the other hand, the cdkd;2-
1 mutant displayed wild type levels of all tested mature small RNAs. As we showed that at day 7 of 
seedling development the cdkd;2-1 mutation does not result in any detectable alteration of RNAPII 
CTD phosphorylation, these data also indicated that reduced phosphorylation of Serine-7 CTD residue 
in the cdkf;1-1 mutant correlates with the observed down-regulation of small RNA biogenesis 
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pathways. To determine whether negative regulation of genes involved in small RNA processing 
results in the accumulation of small RNA precursors, we have compared the amounts of unprocessed 
mircoRNA and ta-siRNA precursors, including pri-miR162a, pri-miR165a, pri-miR172a/b/c, 
TAS1a/b, TAS2 and TAS3 in wild type and cdkf;1-1 mutant seedlings by qRT-PCR measurements 
(Figure 20).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20. Comparative analysis of transcript levels of genes acting in small RNA pathways in wild type 
and cdkf;1-1 seedlings 7DAG.  
Transcript levels of genes involved in the biogenesis and action of small RNAs, as well as those of selected pri-
mircoRNAs and TAS source genes of ta-siRNAs were compared by qRT-PCR measurement using ubiquitin 
UBQ5 (At3g62250) as standard. Each measurement was performed in triplicates. Bars indicate standard 
deviations. 
 
 
Surprisingly, the data indicated that transcription of tested small RNA genes was also reduced by 2 to 
6-fold in the cdkf;1-1 mutant. This indicated that deficiency of Serine-7 phosphorylation of RNAPII 
CTD during early seedling development in the cdkf;1-1 mutant results in coordinate down-regulation 
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of transcription of small RNA source genes, as well as genes involved in processing of their primary 
transcripts to mature small RNAs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21. Comparison of levels of selected small RNAs in wild type, cdkd;2-1 and cdkf;1-1 seedlings. 
Northern RNA hybridization of RNA samples from 7 days old wild type, cdkd;2-1 and cdkf;1-1 seedlings was 
peformed with oligonucleotide probes complementary to miR156, miR165, miR172, ra-siRNA COPIA and ta-
siRNA 1 as described in section 2.2.25. The first panel shows ethidium bromide stained image of RNA samples 
separated in a 15% PAGE containing 7M urea. The amount of samples was standardized by hybridization with 
an U6 snRNA probe.  
 
3.4.3. Altered transcription of genes acting in light perception in the cdkf;1-1 mutant 
The microarray and confirmatory qRT-PCR data (Table 5) indicated simultaneous down-regulation of 
transcript levels several genes encoding photoreceptors and their signalling partners in the cdkf;1-1 
mutant. These included the blue-light receptor PHOT2, twin LOV/ PLPB (PAS/LOV PROTEIN B), 
two members of the phototropic-responsive NPH3 family protein, and phytochromes PHYA, PHYC, 
PHYD, and PHYE, which showed 1.5 to 2.9-fold lower expression in the cdkf;1-1 mutant compared to 
wild type. The decrease in the transcript levels of phytochromes correlated with a reduction of 
expression of HEME OXYGANASE 2 (HO2) and ELONGATED HYPOCOTYL 2 (HY2) genes that 
code for enzymes involved in the biosynthesis of phytochrome chromophore required for light 
perception (Davis et al., 2001). As a possible feedback mechanism compensating down-regulation of 
phytochrome expression, genes encoding the PHYTOCHROME KINASE SUBSTRATE 1 (PKS1) 
and PKS2, which fine-tune the PHYA activated state, root phototropism, and gravitropism 
(Boccalandro et al., 2008; Lariguet et al., 2003), were up-regulated in the cdkf;1 mutant. Despite a 
marginal decrease in PHYA transcript levels, preliminary testing of different light responses of the 
U6
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cdkf;1-1 mutant indicated an enhanced sensitivity to far-red light and slightly reduced sensitivity to 
blue light (Figure 22). Hypocotyl elongation of the cdkf;1-1 is reduced to about 50% of wild type in 
the darkness, and this defect is not compensated by plant hormones, such as 0.1 μM Brassinolide and 
10 μM GA3. Remarkably, inhibition of hypocotyl elongation of cdkf;1-1 seedlings is highly enhanced 
by even low dose of far-red light that induces hypocotyl thickening, which is accompanied by 
formation of leaf-primordium-like structures appearing in addition to the cotyledons and enhanced 
anthocyanin formation. This suggests the potential enhancement of PHYA signalling pathway. By 
contrast, in low dose of blue light, causing incomplete inhibition of hypocotyl elongation of wild type, 
the difference in hypocotyl length between wild type and mutant is diminished. Whether or not this 
reflects some decrease in blue light sensitivity remains to be established.  
 
 
 
 
 
 
  
   
 
Figure 22. Hypocotyl elongation responses of cdkf;1-1 mutant compared to wild type to different light 
regimes. 
Seedlings were grown for 7 days under FRC – constant far-red, RC – constant red, BC – constant blue 
illumination. 
 
Remarkably, hypocotyl lengths of wild type and cdkf;1-1 mutant were similar when seedlings were 
grown under short day conditions in white light (Figure 23). In contrast, similar light conditions in 
long days resulted in enhanced inhibition of cdkf;1-1 hypocotyl elongation compared to wild type. 
This suggests a day-length dependent regulation of hypocotyl growth by the CDKF;1 function. 
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Figure 23. Comparison of hypocotyl lengths of control wild type and cdkf;1-1 mutant seedlings grown 
under different light conditions. 
Hypocotyl lengths of seedlings grown in white light under short day (SD, 8g light/16h darkness) condition, 
constant far-red (FRC), constant red (RC), constant blue (BC) illumination and darkness for 7 days. 
 
In potential relationship with this, our transcript profiling data indicated 2 to 4-fold upregulation of 
transcription of two central positive regulators of photomorphogenesis, ELONGATED 
HYPOCOTYL5 (HY5) and HY5 HOMOLOG (HYH) in the cdkf;1-1mutant (Table 5). Activation of 
HY5 controlling anthocyanin biosynthesis is also consistent with higher level of transcription of 
numerous genes acting in the anthocyanin/flavonid pathways in the cdkf;1-1 mutant (Vandenbussche 
et al., 2007; Table 5). 
 
Table 5. The list of differentially expressed genes involved in light signaling, circadian clock, flowering 
time and flower development pathways. 
Reproducibility of differences observed in transcript levels by microarray hybridization between wild type and 
cdkf;1-1 mutant was verified by qRT-PCR measurements. Green colour indicates down-regulated genes, purple 
marks up-regulated transcripts. 
 
AGI Short /Full name 
Fold change 
 
Affymetrix 
Chip Data RT-qPCR 
Light signaling 
AT5G58140 PHOT2 1.71846 1.07698 
AT2G02710 PLPB  1.978388 1.63074 
AT1G75100 JAC1  1.524982  
AT3G19850 phototropic-responsive NPH3 family protein 1.74752 1.304647 
 
AT3G15570 phototropic-responsive NPH3 family protein 3.007502 3.04997 
AT1G76500 SOB3  2.068157 1.63776 
AT1G09570 PHYA  1.437115 
AT5G35840 PHYC  2.090195 2.95653 
AT4G16250 PHYD  1.617621 
AT4G18130 PHYE  1.608125 1.548439 
AT3G09150 HY2  1.649175 2.02203 
AT2G26550 HEME OXYGENASE 2 1.71529 2.17184 
AT2G02950 PKS1  2.118433 3.43448 
AT1G14280 PKS2  1.737654 
AT1G18810 phytochrome kinase substrate-related 2.035439  
AT2G24540 ATTENUATED FAR-RED RESPONSE 2.191512 2.84612 
AT4G29080 PAP2  1.842162 1.19394 
AT1G09530 PIF3  2.040161 2.13754 
AT2G43010 PIF4  2.256505 2.70038 
AT5G41790 CIP1  2.316819 1.91121 
AT5G11260 HY5  2.13102 3.46212 
AT3G17609 HYH  3.671373 4.73602 
AT1G78600 LZF1 3.271578 2.0358 
AT2G31380 STH 1.85505 1.7009 
Circadian clock 
AT2G46830 CCA1 3.019413 1.50248 
AT1G01060 LHY  3.650038 1.94039 
AT5G24470 APRR5 1.532648 1.36116 
AT5G02810 PRR7  4.774467 4.589 
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AGI Short /Full name 
Fold change 
 
Affymetrix 
Chip Data RT-qPCR 
AT1G22770 GIGANTEA 2.191684 1.81519 
AT5G37260 CIR1 5.292889 4.31392 
AT4G39260 CCR1  1.420341 
AT2G21660 CCR2 AtGPR7  1.636161 2.08296 
AT3G22420 WNK2  1.662158 1.42562 
AT3G18750 WNK6  2.403382 2.79786 
Flowering time 
AT5G10140 FLOWERING LOCUS C 2.247264 2.19343 
AT5G15850 constans-like 1 3.158363 2.22442 
AT3G02380 constans-like 2 2.910838 1.74536 
AT3G07650 CONSTANS-LIKE 9 1.711383 1.92767 
AT5G15840 CO  1.540962 
AT5G39660 CDF2 (CYCLING DOF FACTOR 2) 2.099515 1.45951 
AT1G51700 ADOF1 1.724686  
AT5G62940 Dof-type zinc finger domain-containing 
protein 
1.764011  
AT2G28510 Dof-type zinc finger domain-containing 
protein 
1.821603  
AT1G26790 Dof-type zinc finger domain-containing 
protein 
3.950895  
AT3G54990 SMZ (SCHLAFMUTZE) 2.377229 2.5202 
AT2G39250 SNZ  1.364241 
AT5G67180 TOE3  3.797919 
AT1G65480 FLOWERING LOCUS T  10.52798 
AT2G22540 SVP (SHORT VEGETATIVE PHASE) 2.99947 4.78543 
AT2G45660 SOC1 3.333172 13.5992 
AT5G06100 MYB33  1.863911 2.98583 
At2g32460 MYB101  2.2737855 
AT1G13260 RAV1 2.650737  
Flower development 
AT5G13790 AGAMOUS-LIKE 15 1.517282  
AT2G21060 ATGRP2B  2.474226  
AT2G27550 ATC 2.233745 1.16389 
AT1G06180 ATMYB13  2.294585  
AT5G15230 GASA4  1.664284  
AT3G25655 IDL1  1.514651  
AT1G06520 GPAT1 1.572195  
AT4G24540 AGL24  2.238488 
AT4G18960 AGAMOUS  4.156866 
AT4G36920 APETALA 2 1.609219 3.03772 
AT3G54340 APETALA 3  5.227593 
AT5G20240 PISTILLATA  2.109287 
AT1G24260 SEPALLATA3 2.344792 4.2779 
AT2G03710 SEPALLATA 4 2.341351 5.74995 
AT4G37940 AGL21 1.842394  
AT4G28190 ULTRAPETALA1 1.767913 3.52046 
AT5G43270 SPL2 2.105046 1.76612 
AT1G27370 SPL10 1.594298  
AT2G45830 DTA2  1.588151  
AT2G22310 ATUBP4  1.652804  
AT3G02130 RECEPTOR-LIKE PROTEIN KINASE 2 1.675311  
Phenylpropanoid/Flavonoid/Anthocyanin 
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AGI Short /Full name 
Fold change 
 
Affymetrix 
Chip Data RT-qPCR 
AT1G71030 MYBL2  2.735058  
AT5G04230 PAL3  1.607179  
AT3G51240 F3H  2.1829  
AT5G42800 DFR  2.254091  
AT5G13930 TT4 (TRANSPARENT TESTA 4) 2.839279  
AT4G39230 isoflavone reductase, putative 1.616363  
AT5G19440 cinnamyl-alcohol dehydrogenase 1.621758  
AT1G80820 CINNAMOYL COA REDUCTASE 1.735608  
AT2G30490 CINNAMATE-4-HYDROXYLASE 1.616198  
AT4G37970 CAD6  2.123842  
AT3G21240 4CL2  1.611799  
AT1G65060 4CL3 (4-coumarate-CoA ligase) 1.791232  
AT5G61160 AACT1 2.772888  
AT5G54060 UF3GT 1.692318  
AT2G22990 SNG1 (SINAPOYLGLUCOSE 1 2.614454  
 
3.4.4. Altered regulation of genes in the circadian clock and flowering time pathways in the 
cdkf;1-1 mutant 
In Arabidopsis, four major genetic pathways, the photoperiodic, vernalization, autonomous, and 
gibberellin pathways, control flowering time. Control of the timing of floral induction by the 
photoperiodic pathway involves the central regulator CONSTANS (CO), which promotes flowering by 
activating the transcription of flowering time integrators genes FLOWERING LOCUS T (FT) and 
SUPPRESSOR OF OVEREXPRESSION OF CONSTANS1 (SOC1) (Yoo et al., 2005).  
Transcription of CO is regulated by the circadian clock together with the stability of CO 
protein, and therefore also by the photoreceptors PHYA, PHYB, CRY1, and CRY2. Regulation of CO 
represents thus a key mechanism of day-length measurement and flowering time regulation (Valverde 
et al., 2004; Corbesier and Coupland, 2006; Más, 2008). Our microarray and qRT_PCR data indicated 
simultaneous upregulation of two core genes of the circadian clock, CIRCADIAN CLOCK-
ASSOCIATED PROTEIN 1 (CCA1) and LATE ELONGATED HYPOCOTYL (LHY) (Table 5). 
Enhancement of CCA1 and LHY1 transcription is consistent with an increase of transcript level of 
PHYTOCHROME-INTERACTING FACTOR 3 (PIF3) and decrease of PRR5 and PRR7 expression, 
which is negatively regulated by CCA1 and LHY1 (Nakamichi et al., 2007). PIF3 is proposed to 
recruit the active form of PHYB to G-box containing promoters and it is functionally required for 
PHYB-induced transcription of CCA1 and LHY (Alabadi et al., 2001; Martinez-Garcia et al., 2000). 
GIGANTEA (GI), which is repressed by CCA1 and LHY but required for CO activation (Quail, 2002), 
is also down-regulated in the cdkf;1 mutant (Table 5). In the GI-dependent but CO-independent 
flowering pathway, in which miR172 negatively regulates the functions of TOE1 homologues, the 
transcription of SCHLAFMÜTZE (SMZ) encoding a floral repressor is down-regulated but other 
TOE1-related repressors are unaffected or upregulated, such as TOE3.  
RESULTS  64 
 
In addition to alterations in the regulation of genes acting in the photoperiodic pathway, the 
expression of FLC encoding a central repressor of floral integrator genes (Lee et al., 2000), is 
upregulated in the cdkf;1-1. mutant. In accordance, transcript levels of floral integrator genes FT and 
SOC1 show 10- and 13-fold decrease in cdkf;1-1 compared to wild type seedlings (Table 5). Despite 
the fact that these data derived from short day grown (7 DAG), some of the observed regulatory 
changes seem to be relevant as they are consistent with the cdkf;1-1 flowering phenotype. Unless 
treated with gibberellin, the cdkf;1-1 mutant never blooms in short days, and in long days develops 
flower buds only after 56±10 days. 
From the framework of genes controlling flower development downstream of the flowering 
time pathways ULTRAPETALA 1 (ULT1), AGAMOUS LIKE 24 (AGL24), AGAMOUS (AG), 
APETALA 2 (AP2), APETALA 3 (AP3), SEPALLATA 3 (SEP3), and SEPALLATA 4 (SEP4) showed 
reduced expression in the cdkf;1-1 mutant (Table 5). SHORT VEGETATIVE STAGE (SVP), which is 
an interacting partner of FLC in a co-repressor complex showing direct binding to the SOC1 promoter 
(Li et al., 2008), is down-regulated in cdkf;1-1. Thus, SVP cannot account for strong repression of 
SOC1 in the mutant. SVP together with AGL24 are direct repressors of APETALA1 (AP1) and 
CAULIFLOWER (CAL), and the ap1 agl24 svp triple mutants produces inflorescence meristems in 
place of flowers (Gregis et al., 2008). This is fully consistent with that the cdkf;1-1 mutant produces 
only single terminal flowers on side branches of inflorescence stem (see Figure 8). Nevertheless, it is 
clear that for establishment of further correlations between flowering traits and altered gene regulation 
in the cdkf;1-1 mutant it will be necessary to examine plants in a later developmental stage exposed to 
induction of flowering. A huge difference between development of wild type and cdkf;1-1 mutant at 
flowering would however prevent reaching meaningful conclusions. Therefore, this experiment can 
only be performed using the estradiol-inducible vector pER8-GW described in 3.2.3 to obtain a 
genetically complemented cdkf;1-1 mutant grown on estradiol, and subsequent depletion of CDKF;1 
transcript levels by withdrawing estradiol before induction of flowering. 
 
3.4.5. Effects of cdkf;1-1 mutation on genes controlling hormone biosynthesis and signal 
transduction pathways 
The microarray data indicated altered the expression of several genes acting in the cytokinin signal 
transduction pathway in the cdkf;1-1 mutant (Table 6). Cytokinin signal transduction is mediated by a 
two-component system, in which cytokinin perception and autophosphorylation of a conserved His 
residue takes place in Arabidopsis HISTIDIN KINASEs (AHKs). Subsequently, the phosphoryl group 
is transferred to a conserved Asp residue within the receiver domain of AHKs. Transphosphorylation 
of HISTIDINE-CONTAINING PHOSPHOTRANSFERASEs (AHPs) by AHKs triggers their import 
into the nucleus, where they transmit the phosphoryl group to type-B Arabidopsis RESPONSE 
REGULATORS (ARRs), which activate the expression of cytokinin-responsive genes and type-A 
ARRs. In turn, type-A ARRs mediate negative feedback regulation of cytokinin signaling (Lohrmann 
and Harter, 2002; Hwang, et al., 2002; Kakimoto, 2003). In the cdkf;1 mutant, HP (AHP1), one out of 
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6 AHPs, two from 12 type-B ARRs (ARR12 and ARR14) and four from 11 type-A ARRs (ARR3, ARR4, 
ARR8, and ARR9) are down-regulated. A potential clue to further understanding of these changes is 
provided by the observations that ARR4 can directly interact with PHYB and that loss of ARR3 and 
ARR4 functions directly affect the circadian clock by lengthening the normal period (Salomé et al., 
2006). The fact that transcription of ARR7 (type-A), the Cytokinin RESPONSE FACTORs CRF5 and 
CRF6, and the Cytokinin-RESPONSIVE GATA FACTOR1 (CGA1), which positively regulate a large 
fraction of cytokinin-responsive genes (Rashotte et al., 2006; Naito et al., 2007; Table 6), are up-
regulated in the mutant indicates that cytokinin responses are not completely compromised by the 
cdf;1-1 mutation. 
Down-regulation of the HY2 and HO2 genes involved in phytochrome chromophore 
biosynthesis has been demonstrated to trigger overproduction of jasmonic acid (JA) and activation of 
JA-induced genes (Zhai et al., 2007). This is also indicated by upregulation of JA-responsive 
PHOSPHOLIPASE A 2A(PLA2), LYPOXIGEASE (LOX2), CORONATINE INDUCED 1 (CORI1), 
JASMONATE RESPONSIVE 1 (JR1), PDF2.1 etc. target genes in the mutant (see Annex). Among 
these, the activation of JA-induced ANTHRANILATE SYNTHASE ALPHA SUBUNIT 1 (ASA1) gene, 
which encodes a rate-limiting enzyme of tryptophan biosynthesis is accompanied by upregulation of 
TRYPTOPHAN SYNTHASE BETA SUBUNIT 2 (TSB2) and TRYPTOPHAN AMINOTRANSFERASE 
OF ARABIDOPSIS 1, and several genes involved in the biosynthesis of indole glucosinolates 
(CYTOCHROME P450 83A1, CYP83A1; CYTOCHROME P450 81F2, CYP81F2; INDOLE-3-
ACETATE BETA-D-GLUCOSYLTRANSFERASE, IAGLU; EPITHIOSPECIFIER MODIFIER 1, 
ESM1) (Niyogi and Fink, 1992; Bak et al., 2001; Teale et al., 2006; Chandler, 2009). As only few 
auxin-responsive genes showed altered regulation in the mutant, this data suggested that upregulation 
of tryptophan-derived IAA synthesis channels the IAA pool into the glucosinolate biosynthesis.  
The cdkf;1-1 mutation caused also changes in the transcription of numerous genes 
controlling ABA biosynthesis and signalling, and downstream targets in the ABA-dependent osmotic 
stress response pathways (Table 6; Annex; Niyogi et al., 1998). The first step of ABA biosynthesis is 
regulated by ABA DEFICIENT 1 (ABA1), which showed around 3-fold reduction in expression in the 
mutant. In addition, NINE-CIS-EPOXYCAROTENOID DIOXYGENASE 4 (NCDE4) and ALDEHYDE 
OXIDASE 2 (AAO2), which encode close homologues of two key enzymes of ABA biosynthesis 
NCDE3 and AAO3 (Nambara and Marion-Poll, 2005), showed 7- and 2-fold down-regulation, 
respectively. Partial deregulation of ABA-responses is also indicated by a decrease in transcript levels 
of GLUTAMATE RECEPTOR 1.1 (GLR1.1; regulates ABA biosynthesis and signalling; Kang et al., 
2004), the ABA-responsive transcription factor ABSCISIC ACID RESPONSIVE ELEMENT-BINDING 
FACTOR 1 (ABF1), and several ABA-inducible target genes encoding the CALCIUM-DEPENDENT 
PROTEIN KINASE 6 (CPK6), CBL-INTERACTING PROTEIN KINASE 20 (CIPK20), DELAY OF 
GERMINATION 1 (DOG1), PLANT U-BOX 9 (PUB9), and ATDR4. On the other hand, as part of a 
potential compensatory mechanism, several genes acting in ABA signalling showed higher transcript 
levels in the cdkf;1-1 mutant. These included the NUCLEAR FACTOR Y SUBUNIT C2 (NF-YC2), 
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Arabidopsis thaliana SERINE/THREONINE PROTEIN KINASE 1 (ATSR1), RING-H2 FINGER 
PROTEIN 2B (RHA2B), and ABI FIVE BINDING PROTEIN 2 (AFP2). Activation of the hypoxia-
linked ABA response pathway was indicated by simultaneously elevated transcript levels of 
ALCOHOL DEHYDROGENASE (ADH1) and its activating bZIP transcription factor GBF3. 
Furthermore, transcript level of the TWO OR MORE ABRES-CONTAINING GENE 2 (TMAC2) gene, 
which is highly ABA-inducible, was 2-fold higher in the cdkf;1-1 mutant compared to wild type. This 
gene negatively regulates ABA signalling and its overexpression reduces the expression level of SOC1 
and SEP3 genes (Huang and Wu, 2006), which is fully consistent both microarray data and the 
observed cdkf;1 phenotype.  
The cdkf;1-1 mutation causes only minor changes in the expression of genes controlling the 
ethylene and gibberellin pathways. Among the five genes showing differential expression in the 
ethylene biosynthesis and signalling pathways, transcript level of the ETHYLENE-FORMING 
ENZYME (EFE) gene, encoding a key enzyme of ethylene biosynthesis, shows a marginal 1.7 increase 
in cdkf;1-1 seedlings (Table 6).  
 
Table 6. Differential expression of hormone-related genes in the cdkf;1-1 mutant. 
Comparison of differences in transcript levels between wild type and cdkf;1-1 mutant observed by microarray 
hybridization and qRT-PCR. Green colour indicates down-regulated genes, purple marks up-regulated 
transcripts. 
 
AGI Short /Full name 
Fold change 
 
Affymetrix 
Chip Data RT-qPCR 
Cytokinin 
AT1G19050 ARR7 (RESPONSE REGULATOR 7) 2.005949  
AT1G59940 ARR3 (RESPONSE REGULATOR 3) 1.570101 7.7204 
AT1G10470 
 
ARR4 (RESPONSE REGULATOR 4)  1.843903 
AT3G57040 ARR9 (RESPONSE REGULATOR 9) 1.933676 2.36305 
AT2G25180 ARR12 (RESPONSE REGULATOR 12) 1.720893 2.49203 
AT2G01760 ARR14 (RSPONSE REGULATOR 14) 1.595503 2.48388 
AT2G41310 ATRR3/ARR8 (RESPONSE REGULATOR 
3) 
2.109085 4.47897 
AT3G21510 AHP1  2.43281 2.70815 
AT4G29740 CKX4 (CYTOKININ OXIDASE 4) 1.716478  
AT2G46310 CRF5 (CYTOKININ RESPONSE FACTOR 
5) 
1.787357 2.12204 
AT3G61630 CRF6 (CYTOKININ RESPONSE FACTOR 
6) 
2.551048 2.70008 
AT4G26150 CGA1 (CYTOKININ-RESPONSIVE GATA 
FACTOR 1) 
2.09657 5.93395 
Auxin/tryptophan 
AT5G05730 ASA1 1.896081 1.76674 
AT4G27070 TSB2 1.930539  
AT4G39950 CYP79B2 2.08635 1.05275 
AT5G57220 CYP81F2 2.605483  
AT4G13770 CYP83A1  1.641514  
AT4G15550 IAGLU  1.578305  
AT2G47000 ABCB4 1.805203  
AT3G14210 ESM1 (epithiospecifier modifier 1) 1.751925 2.72782 
AT1G70560 TAA1 1.834745  
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AGI Short /Full name 
Fold change 
 
Affymetrix 
Chip Data RT-qPCR 
AT4G24670 TAR2  1.882579  
AT3G59900 ARGOS  1.848169  
AT2G46990 IAA20  1.63337  
AT2G46530 ARF11 (AUXIN RESPONSE FACTOR 11) 2.915711  
AT3G04730 IAA16 1.543862  
AT4G32280 IAA29  1.592003  
AT4G12550 AIR1 3.601185  
AT3G07390 AIR12 1.712879  
AT3G25290 auxin-responsive family protein 1.55307  
AT4G12410 auxin-responsive family protein 1.600831  
AT1G16510 auxin-responsive family protein 1.624749  
AT3G12830 auxin-responsive family protein 1.787623  
AT3G60690 auxin-responsive family protein 2.084724  
AT4G34770 auxin-responsive family protein 2.347394  
AT1G75590 auxin-responsive family protein 3.571218  
AT4G36110 auxin-responsive protein, putative 3.482878  
AT4G00880 auxin-responsive family protein 2.572448  
AT2G37030 auxin-responsive family protein 2.810369  
AT1G76520 auxin efflux carrier family protein 1.705095  
ABA 
AT3G02140 TMAC2  2.014552  
AT1G56170 NF-YC2  1.512972  
AT1G13740 AFP2 (ABI FIVE BINDING PROTEIN 2) 1.967505 1.57501 
AT3G29575 AFP3 (ABI FIVE BINDING PROTEIN 3) 1.767525 1.02929 
AT4G38530 ATPLC1  1.500047  
AT5G01540 LECRKA4.1 1.583252  
AT1G15100 RHA2A;  2.543912 1.33174 
AT2G01150 RHA2B  2.550761 1.71894 
AT5G01820 ATSR1 (CIPK14)  1.881711 1.74123 
AT2G17290 CPK6 1.87901 2.80004 
AT5G45820 CIPK20/PKS18  9.525643 5.14657 
AT3G04110 GLR1.1  1.934274  
AT5G67030 ABA1 (ABA DEFICIENT 1) 2.432254 2.92544 
AT4G19170 NCED4  4.18439 6.8079 
AT3G43600 AAO2 (ALDEHYDE OXIDASE 2) 1.992733  
AT1G49720 ABF1  1.615398 3.59847 
AT5G45830 DOG1 (DELAY OF GERMINATION 1) 1.567339  
AT3G07360 PUB9 (PLANT U-BOX 9) 1.656021  
AT1G73330 ATDR4 10.53311 20.4879 
Ethylene 
AT3G24500 MBF1C 1.940762  
AT4G26200 ACS7 2.136188  
AT1G05010 EFE (ETHYLENE-FORMING ENZYME) 1.707715  
AT1G12010 ACC oxidase, putative 1.766575  
AT5G43850 ARD4 1.549809   
GA 
AT5G14920 gibberellin-regulated family protein 2.762983  
AT2G14900 gibberellin-regulated family protein 2.969134  
 
RESULTS  68 
 
3.4.6. The cdkf;1-1 mutation has minimal effect on genes in cell cycle control 
Unexpectedly, the cdkf;1-1 mutation resulted only in very modest changes in the transcription of genes 
involved in cell cycle control (Table 7). As a unique case, we have observed an about 10-fold 
difference between our Affymetrix microarray hybridization and qRT-PCR measurements of KRP2 
transcript levels, which showed a remarkable 13-fold increase by qRT-PCR in the cdkf;1-1 mutant. 
This indicated that measurement of transcript levels of KRP homologues is likely not accurate using 
the Affymetrix chip. Overexpression of KRP2 was reported to decrease the number of lateral roots and 
the rate of cell division through the reduction of CDKA;1 activity, leading to the onset of endo-
reduplication and increase of DNA ploidy level (Verkes et al., 2005). During phenotypic 
characterization of the cdkf;1-1 mutant (section 3.3.2) we have observed a reduction in the number and 
size of leaf epidermal cells and a dramatic decrease in formation of lateral roots, which is consistent 
with upregulation of KRP2 expression. However, in contrast to the results of Verkes et al. (2005), we 
found no enhancement of endoreduplication, which suggests that despite remarkable overexpression at 
the level of transcription, the KRP2 protein could be efficiently degraded (e.g., due to marginal 
overexpression of the mitosis specific CDKB;1 kinase in cdkf;1-1). Further immunoblotting studies 
are therefore required to clarify this discrepancy.  
 
3.4.7. Inhibition of cell elongation correlates with down-regulation of genes controlling 
cytoskeleton functions in the cdkf;1-1 mutant 
In addition to potential defects in light signalling discussed in 3.4.3, cell elongation defects observed 
in the cdkf;1-1 mutant also correlated with a general reduction in the transcription of genes encoding 
cytoskeleton-related proteins (Table 7). These included ACTIN 11 (ACT11), ACTIN 
DEPOLYMERIZING FACTORs ADF8 and ADF11; FORMIN HOMOLOGY proteins AFH1 and 
AtFIM1; RHO-RELATED PROTEIN FROM PLANTS 2 (ROP2I); TONNEAU 1A (TON1AI); 
MICROTUBULE-ASSOCIATED PROTEINS AtMAP65-1 and AtMAP70-4; ZWICHEL (ZWI); two 
MYOSIN HEAVY CHAIN-RELATED and three KINESIN MOTOR PROTEIN-RELATED genes. 
ACTIN 11 (ACT11) is a structural constituent of cytoskeleton, which is expressed in young 
and developing tissues, including elongating hypocotyls, expanding leaves, floral organ primordia, 
emerging floral buds, and developing ovules (Huang et al., 1997). AFH1 plays a key role in initiation 
and organization of acting cables (Michelot et al., 2005). Both ADF8 and ADF11 are specifically 
expressed in root trichoblast cells, developing root hairs and mature pollens (Kandasamy et al., 2007). 
The latter actin depolymerizing factors together with acting bundling proteins play crucial roles in the 
regulation of cytoskeleton organization and dynamics, and thereby cell division and intracellular 
trafficking in the root hair. AtFIM1, an actin filament cross-linking protein stabilizes actin filaments 
(Kovar et al., 2000). The Arabidopsis ROP2 GTPase positively regulates different stages of root hair 
development (Jones et al., 2002). Loss of function of TONNEAU 1 leads to an extreme dwarf 
phenotype; the ton1 mutants have defects in random orientation, cell elongation and cell division. 
AtMAP65-1 bundles microtubules during the cell cycle (interphase, anaphase, and telophase, but not 
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in prometaphase and metaphase). This event is probably mediated by phosphorylation and inactivation 
of AtMAP65-1, and required for metaphase to anaphase transition (Smertenko et al., 2006). 
ZWICHEL, a kinesin-like protein, is expressed in root hairs, trichomes, and pollen grains, as well as 
dividing cells. The zwichel mutant develops trichomes with only two branches showing a defect in 
trichome morphogenesis (Oppenheimer, 1997; Reddy and Reddy, 2004). The above described 
functional defects, including deficiency of root elongation, lack of root hairs, development of aberrant 
trichomes with single or two branches, the defect of epidermal cell expansion and extreme dwarf 
phenotype represent major phenotypic characteristics of the cdkf;1-1 mutant.  
 
Table 7. Altered transcription of genes involved in cell cycle control and regulation of cytoskeleton 
organization in the cdkf;1-1mutant. 
Green colour indicates down-regulated genes, purple marks up-regulated transcripts. 
 
AGI Short /Full name 
Fold change 
 
Affymetrix 
Chip Data RT-qPCR 
Cell Cycle 
AT5G04470 SIAMASE 1.966066 1.416683 
AT3G50630 KRP2 1.620258 13.44091 
AT4G37490 CYCB1;1 1.613603  
AT1G47210 cyclin family protein 1.521937  
AT3G21870 CYCP2;1 (cyclin p2;1) 1.792875  
AT5G67260 CYCD3;2  1.60564  
AT3G19650 cyclin-related 1.814348  
AT1G27630 CYCT1;3  1.529668  
Cytoskeleton 
AT3G53760 tubulin family protein 1.614687  
AT3G12110 ACT11 (actin-11) 1.651488  
AT1G01750 ADF11  3.861768  
AT4G00680 ADF8  4.741093  
AT3G25500 AFH1  1.531936  
AT4G26700 ATFIM1 1.719208  
AT1G20090 ROP2  1.54212  
AT3G55000  TON1A (TONNEAU 1) 2.288211  
AT5G55230 ATMAP65-1  1.755587  
AT1G14840 ATMAP70-4  1.735414  
AT5G27950 kinesin motor protein-related 1.622855  
AT5G10470 kinesin motor protein-related 1.782079  
AT2G21380 kinesin motor protein-related 1.892213  
AT2G37080 myosin heavy chain-related 1.564108  
AT3G13190 myosin heavy chain-related 1.661566  
AT5G65930 ZWI (ZWICHEL) 2.099097 2.09174 
 
3.5. CDKF;1 is a VirD2 kinase controlling Agrobacterium-mediated tumour formation in 
plants 
Bakó et al. (2003) have found that CAK2Ms, an alfalfa orthologue of Arabidopsis CDKD;2/CAK4 
kinase phosphorylates the VirD2 protein that plays a pivotal role in Agrobacterium-mediated 
transformation of plants. During processing of the T-DNA borders in bacteria, the VirD2 protein 
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covalently binds to the 5’-end of the single-stranded T-DNA intermediate (T-strand) and aids its 
transfer into plant host cells through T4SS T-pili assembled from components of the VirB/D4 type 4 
secretion system. Genetic studies show that virD2 mutations dramatically reduce nuclear import of the 
T-strand, as well as the frequency of T-DNA integration into plant chromosomes, and result in the 
formation of deletions at the right border (RB) junctions of T-DNA insertions (Mysore et al., 1998; 
Michielse et al., 2004). Therefore, VirD2 is thought to mediate precise linking the 5’-end of the T-
strand to free 3’-ends in the integration target sites of host chromosomes.  
Bakó et al. (2003) showed that upon its α-importin mediated nuclear import (Ziemienowicz 
et al., 2001), VirD2 interacts through its N-terminal domain with the TATA-binding protein TBP, 
which can be co-immunoprecipitated with the CTD of RNA polymerase II largest subunit. Bakó et al. 
also purified and identified a VirD2 kinase as CAK2Ms, and showed that HA-CAK2Ms 
immunoprecipitated from plant extracts phosphorylates the CTD domain of RNA polymerase II and 
the VirD2 protein in vitro. However, CAK2Ms expressed in and purified from E. coli has not been 
tested for VirD2 phosphorylation. To determine, whether Arabidopsis CDKD2 and any other member 
of the CDKD kinase family would phosphorylate VirD2 in vitro, we have performed kinase assays 
with purified thioredoxin-His6-tagged fusions of CDKD;1, CDKD;2 and CDKD;3, and purified HA-
VirD2 as substrate. Unexpectedly, we found that none of the Arabidopsis CDKD kinases was capable 
to phosphorylate the HA-VirD2 protein.  
CDKD2 kinases purified from both Arabidopsis and rice have been detected in tight 
association with the CDKF;1 (Van Leene et al., 2007; Ding et al., 2009) and the cdkf;1-1 mutation was 
found to reduce dramatically the level of CDKD2 protein in Arabidopsis (Takatsuka et al., 2009). 
Therefore, it appeared to be plausible that in the experiments of Bakó et al. (2003) CAK2Ms was 
immunoprecipitated with an alfalfa orthologue of CDKF;1, which was responsible for the observed 
VirD2 kinase activity. To test this possibility, we performed an in vitro kinase assay with purified 
thioredoxin-His6-tagged Arabidopsis CDKF;1 and the HA-VirD2 substrate (Figure 24).  
 
 
 
 
 
 
 
 
 
 
 
Figure 24. CDKF;1 phosphorylates the HA-VirD2 protein in vitro.  
Phosphorylation of HA-VirD2 substrate was performed with purified CDKF;1 kinase in the presence of [γ-
32P]ATP). Control phosphorylation assays contained either CDKF;1 or HA-VirD2 alone.  
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This experiment demonstrated that in fact CDKF;1 could efficiently phosphorylate HA-VirD2 in vitro. 
To examine the biological relevance of CDKF;1 phosphorylation sites in the VirD2 protein and study 
the effects of their mutations on T-DNA integration, we have initiated mapping of the phosphorylated 
VirD2 residues. The phosphorylated VirD2 protein isoforms were separated by 2D electrophoresis, 
and then the phosphoprotein spots were visualized by phosphostaining, and subsequent CBB staining 
(Figure 25). The phosphorylated VirD2 spots were excised from gel, to identify the phosphorylation 
sites followed affinity capture of phosphopeptides and their identification by MALDI Q-TOF 
degradation. This approach has lead to the identification of 6 phosphorylation sites in the VirD2 
protein in close vicinity of the C-terminal nuclear localization signals (data not shown).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25. Resolution of CDKF;1 phosphorylated HA-VirD2 isoforms, carrying different number of 
phosphorylated residues, by two-dimensional gel electrophoresis.  
In the first dimension, isoelectric focusing was performed on an IPG strip using a linear gradient of pH 4-7. In 
the second dimension, the proteins were separated on a 12% SDS-PAGE along with phosphorylated molecular 
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mass markers. The autophosphorylated CDKF;1 kinase and phosphorylated HA-VirD2 substrate were visualized 
by phosphoprotein stain. Arrows indicate protein bands subjected to analysis by iontrap MALDI mass 
spectrometry.  
 
3.5.1. CDKF;1 phosphorylates the CDKD kinases and VirD2 with similar efficiency  
To compare the CDKD and VirD2 substrate specificity of CDKF;1, we performed standardized 
comparative kinase assays by combining purified CDKF;1 and HA-VirD2 with different CDKD 
substrates. CDKF;1 phosphorylated all three CDKDs and the HA-VirD2 protein with very similar 
efficiency (Figure 26). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26. CDKF;1 phosphorylates VirD2 and CDKD substrate with similar efficency in vitro. 
The kinase assays contained CDKF;1 and HA-VirD2 in combination with either CDKD;1; CDKD;2 or CDKD;3.  
 
3.5.2. The cdkf;1 and cdkd;2 mutants are defective in Agrobacterium-mediated tumorigenesis 
Whereas we failed to demonstrate that CDKD;2, a likely functional orthologue of alfalfa CAK2Ms 
(Bako et al., 2003), is a VirD2 kinase, we have observed efficient phosphorylation of VirD2 by 
CDKF;1 in our assays. Because CDKF;1 is an upstream activator of CDKD;2 in vivo, our data does 
not exclude a potential role of CDKD;2 in VirD2 phosphorylation. To test possible involvement of 
CDKF;1 and CDKD kinases in the control of Agrobacterium-mediated transformation, the oncogenic 
Agrobacterium tumefaciences C58 strain was used for hypocotyl tumorigenesis assay with cdkd;1-1, 
cdkd;2-1, cdkd;3-1, and cdkf;1-1 mutant and wild type plants. The number of infected plants was 
150±4 in each experiment (Figure 27). The overall efficiency of tumour formation was 81% in wild 
type, 83% in cdkd;1-1 and 82% in cdkd;3-1 plants. By contrast, the frequency of tumour formation 
was reduced to 7% in cdkf;1-1 and 18% in cdkd;2-1 mutants indicating that both CDKF;1 and 
CDKD;2 play a role in the control of Agrobacterium-mediated plant transformation. These results 
strongly suggest that the CDKD;2 kinase is most likely required for recruitment of VirD2 to the 
CDKF;1 kinase. If fact Bakó et al. (2003) noted a close similarity between N-terminal VirD2 
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sequences and the histidine-triad protein interaction domain of HINT proteins that mediate their 
interactions with yeast Kin28 and human CDK7 orthologues of Arabidopsis CDKDs (Korsisaari and 
Mäkelä, 2000).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27. Comparison of frequency of tumour formation by hypocotyl agroinfection in wild type, cdkf;1 
and cdkd mutant seedlings.  
The hycotyl tumorigenesis assays were performed with an oncogenic Agrobacterium tumefaciences C58 strain 
by infection of 15 days old plants. 
 
As the structures of eukaryotic CAKs are remarkably similar, it is likely that the histidine-triad domain 
plays a role in recruitment of VirD2 by CDKD;2, which is associated with the VirD2 kinase CDKF;1. 
The observation that inactivation of CDKF;1 leads to enhanced proteolysis of CDKD;2, as proposed 
by Takatsuka et al. (2009), suggests that the CDKD;2-cyclinH complex is stable only in the presence 
of CDKF;1. Thus, mutations affecting both CDKF;1 and CDKD;2 could destabilize the complex 
preventing the recognition of VirD2 protein. Further purification of CDKF;1-CDKD;2-cyclin-(TFIIH) 
complex and studying its in vivo interaction with VirD2 should help to confirm this model. In any 
case, our current data show that the CDKF;1 function mediating VirD2 phosphorylation is necessary 
together with CDKD;2 for Agrobacterium-mediated tumour formation in Arabidopsis. 
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4. DISCUSSION 
4.1. Arabidopsis CDKF;1 phosphorylates CDKDs and RNA polymerase II CTD 
C-terminal heptapeptide repeats of the largest subunit of RNAPII are known to provide a scaffold for 
assembly of numerous factors that regulate the initiation, elongation, and termination of transcription, 
mRNA processing (5' capping, 3' polyadenylation, and splicing) and histone methylation in yeast and 
mammals (Belostotsky and Rose, 2005; Xiao et al., 2003). Overall conservation of CTD and many of 
its binding factors suggests that the CTD is implicated in similar processes also in plants. This is 
indicated by the fact that CTD kinases, including the TFIIH-associated CAKs that represent key 
regulators of the CTD code during transcription, are evolutionarily conserved in higher plants. 
Arabidopsis CDKD;2 and rice R2/CDKD;1 are closely related to human CDK7 and therefore thought 
to play important roles in transcription initiation and 5’ capping of nascent RNAs (Leene et al., 2008; 
Rohila et al., 2006). As human CDK7, rice R2 was shown to interact with cyclin H, which stimulates 
its kinase activity on Arabidopsis RNAPII CTD and heterologous human CDK2 substrates in vitro 
(Yamaguchi et al., 1998).  
In Arabidopsis three CAKs (CDKD;1, CDKD;2, and CDKD;3) were identified, which are 
closely related to rice R2 and human CDK7. When co-expressed in insect cells, cyclin H-binding was 
shown to increase the activity of Arabidopsis CDKD;2, which phosphorylates the human GST-CDK2 
and Arabidopsis GST-CTD substrates in vitro (Shimotono et al., 2006). In contrast to CDKD;2, 
CDKD;3 appears to phosphorylate both GST-CDK2 and GST-CTD in the absence of cyclin H 
binding. Nevertheless, the activity of CDKD;3 is also enhanced by co-expression of cyclin H;1 in 
insects cells. Compared to CDKD;2, CDKD;3 has low CTD-kinase activity but phosphorylates human 
CDK2 with higher efficiency. The third member of the CDKD family, CDKD;1 purified in fusion 
with the maltose-binding protein MBP, was reported to show no kinase activity with GST-CTD and 
GST-CDK2 substrates.  
 In Arabidopsis, rice, soybean and leafy spurge (Euphorbia esula L.) a fourth plant specific 
CAK-like kinase, CDKF;1, was identified, which suppresses the temperature sensitive cakts mutations 
in budding yeast (Umeda et al., 1998, 2005; Chao et al., 2007). It was reported that Arabidopsis 
CDKF;1 does not bind cyclin H and cannot phosphorylate the CTD of RNAPII (Shimotohno et al., 
2004). In addition, it was shown that CDKF;1 phosphorylates human CDK2, as well as the 
Arabidopsis CDKD;2 and CDKD;3 kinases on a highly conserved Thr residue in their T-loops, and 
that CDKF;1-mediated phosphorylation enhances the CTD kinase activity of CDKD;2 (Shimotohno et 
al., 2004). However, the same authors reported that CDKF;1 does not phosphorylate CDKD;1, the 
third member of Arabidopsis CDKD/CAK family, which apparently cannot phosphorylate the CTD 
and human CDK2, and is therefore thought to be an inactive kinase. These observations defined 
CDKF;1 as a novel CAK-activating kinase (CAKAK), which has not been so far identified in 
mammals. In their model, Umeda et al., (2005) suggested that CDKF;1 can control in two independent 
ways the activity of cyclin-dependent CDK kinases acting in cell cycle control: either by direct 
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phosphorylation of CDKs (i.e., either CDKA or CDKB or both) or by activation of CDK-activating 
CDKD kinases. This model predicts that inactivation of CDKF;1 should lead to lethality due to 
complete block of the cell cycle, as the lack of CDKF;1 should also prevent the activation of CDKDs 
and hence activation of CDKs through the second pathway. However, identification of cdkf;1 insertion 
mutants (sections 3.1.1 and 3.2.2) clearly demonstrated that the loss of CDKF;1 function reduces but 
does not completely block cell division activity. Nevertheless, the cdkf;1 mutations cause dramatic 
developmental effects characterized by reduction of cell number and cell elongation, hypersensitivity 
to sucrose, glucose and far-red light, aberrant root, leaf and flower development, extremely delayed 
flowering and male and female sterility. A further discrepancy in the proposed model has stemmed 
from the fact that members of the Arabidopsis CDKD kinase family show remarkable sequence 
conservation, including their activating T-loop regions, which serve as CDKF;1 phosphorylation site. 
This has predicted that conserved T-loop sequences of CDKD;1 should serve as CDKF;1 substrate, 
analogously those of CDKD;2 and CDKD;3 kinases. In addition, conservation of CDKD sequences 
suggested potential functional similarity of these kinases. 
To clarify these discrepancies, we have repeated the CDKF;1 phosphorylation assays with 
purified CDKD kinases and have initiated functional characterization of the cdkd T-DNA insertion 
mutants. Instead of using fusions with the maltose binding protein of 42 kDa as Shimotohno et al. 
(2004; 2006), we exploited a sandwich tagging technology by generating CDKF and CDKD fusions to 
an N-terminal thioredoxin (Trx) tag of 12 kDa and a small C-terminal His6 tag. This technology 
allowed the purification of highly soluble forms of intact CDKF and CDKD kinases to apparent 
homogeneity. As expected, purified CDKF;1 proved to be active in the absence of a cyclin subunit as 
indicated by its high levels of autophosphorylation. Repetition of in vitro CDKF;1 kinase assays with 
purified Trx-CDKD-His6 substrate revealed that in contrast to the data of Shimotohno et al. (2004) 
CDKF;1 phosphorylated CDKD;1, as well as the CDKD;2 and CDKD;3 kinases. Control kinases 
assay with the (T166A) T-loop mutant version of CDKD;1 revealed as expected that CDKF;1 
mediated phosphorylation of the T-loop of this CAK, similarly to CDKD;2 and CDKD;3. 
Unexpectedly, we also found that all three Arabidopsis CDKD kinases showed low levels of 
autophosphorylation in the absence of cyclin subunit, which allowed testing their phosphorylation 
specificity using the GST-CTD substrate that carries the CTD repeats of Arabidopsis RNAPII largest 
subunit. These assays revealed that in addition to CDKD;2, CDKF;1 functioned in vitro as a CTD 
kinase in contrast to the observations of Shimotohno et al. (2004). In our assays, however, monomeric 
CDKDs and CDKF;1 failed to phosphorylate Arabidopsis CDKA;1, which suggested that recognition 
of the CDK substrates may require their association with cyclin or the formation of CDKD-cyclin 
complexes. Recently, Takatsuka et al. (2009) found that CDKF;1 cannot phosphorylate human CDK2 
even in vitro correcting the previous data from Shimotohno et al. (2004, 2006). This, together with the 
phosphorylation of CDKD;1 by CDKF;1 indicated that CDKF;1 is a likely upstream activating kinase 
(CAKAK) of all three CDKDs/CAKs, but cannot alone function as an independent CDK-activating 
kinase (CAK).  
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The fact that CDKD;1 showed a low level autophosphorylation in our assays indicates that is 
an active kinase. This observation directs further attention to the functional characterization of 
CDKD;1, the expression of which peaks at both G1-S and G2-M checkpoint boundaries (Menges et 
al., 2005). Data from the in vitro kinase assays should however be handled with necessary caution. 
The fact that CDKD;1 and CDKD;3 showed no CTD kinase activity in vitro would suggest that in this 
respect the function of these kinases cannot be redundant with that of CDKD;2. However, we found 
that phenotypes of cdkd;1 and cdkd;3 insertion mutants is indistinguishable from wild type and that of 
the cdkd;2 single mutant, which suggests that if CDKD;1 is an active kinase, its functions should be 
overlapping with that of either CDKD;2 or CDKD;3. Functional similarity between the three 
Arabidopsis CDKD kinases is also indicated by the fact that all three combinations of double mutants 
(cdkd;1cdkd;2, cdkd;1cdkd;3, cdkd;2cdkd;3) show no developmental defect and any alteration 
compared to wild type. By contrast, minor decrease of CDKD;3 transcript level by combination of the 
leaky cdkd;3-2 mutation with both cdkd;1-1 and cdkd;2-1 mutations caused a significant delay in plant 
development. This suggests that all CDKDs, including CDKD;1, are active kinases and perform 
largely overlapping functions. Further characterization of various allelic combinations of triple cdkd 
mutants and well as detailed biochemical characterization of CDKD complexes isolated from 
Arabidopsis is expected to provide more insight into in vivo roles of CDKDs in the activation of CDKs 
and phosphorylation of RNAPII CTD.  
 
4.2. CDKF;1 is a major regulator of CTD phosphorylation code 
Our data show that the CTD domain of the largest subunit of RNAPII is phosphorylated by both 
CDKF;1 and CDKD;2 protein kinases. To determine their phosphorylation target sites within the 
consensus CTD heptapeptide repeat, we conducted a series of kinase assays using wild type and 
mutated heptapeptide substrates. These assays indicated that CDKD;2 phosphorylates both Serine-2 
and Serine-5 residues of the CTD, but prefers the Serine-5 position over Serine-2. In comparison, 
CDKF;1 could equally phosphorylate mutant heptapeptides that carried alanine replacements of either 
Serine-2, or Serine-5 or both, indicating that this kinase phosphorylates either the Serine-7 residue or, 
which is less likely, Thr-4. To confirm the CTD-code specificity of CDKD;2 and CDKF;1, we have 
examined the phosphorylation levels of specific CTD serine residues by western blotting using CTD 
phosphoSerine-2, phosphoSerine-5 and phsophoSerine-7 specific monoclonal antibodies in cdkf;1-1 
and cdkd;2-1 mutant seedlings compared to wild type. In this experiment, we have considered that fact 
that the cdkf;1-1 mutation causes a gradually manisfesting general developmental defect soon after 
seed germination. Therefore, we have examined two subsequent developmental stages: i) seedlings 
carrying two cotyledons but no leaves at day 7 after germination, which showed retarded root growth 
but no difference of hypocotyl elongation and cotyledon expansion in the cdkf;1-1 mutant compared to 
wild type and cdkd;2-1 seedlings; and ii) 12 days old seedlings, showing a clear retardation of 
hypocotyl growth, leaf development and root elongation of cdkf;1-1 mutant. During early stage of 
seedling development, we have observed a reduction of CTD phosphorylation only at the Serine-7 
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position in the cdkf;1-1 mutant compared to wild type CTD phosphorylation in the cdkd;2-1 mutant. 
This clearly demonstrated that the cdkf;1-1 mutation affects specific phosphorylation of Serine-7 
position of CTD heptapeptide repeats. Five days later in seedling development, the cdkf;1-1 mutant 
showed a deficiency of both Serine-5 and Serine-7 CTD phosphorylation, whereas reduced 
phosphorylation of only Serine-5 CTD position was observed in the cdkd;2 mutant. This indicated that 
CDKD;2 is primarily responsible for phosphorylation of the Serine-5 residue. Reduction of Serine-5 
CTD phosphorylation in the cdkf;1-1 mutant is likely due to absent activation of CDKD;2 by CDKF;1 
in vivo.  
At day 12 after germination, a significant reduction of Serine-2 CTD phosphorylation was also 
observed in the cdkf;1-1 mutant, which suggests a likely involvement of a yet unknown Serine-2 
specific CTD kinase, which represents a putative substrate for CDKF;1 mediated activation. 
Nevertheless, based on our in vitro kinase assays we cannot exclude that CDKF;1 could also 
phosphorylate the Serine-2 and/or Serine-5 position. Combination of in vitro kinase assays with 
antibodies, which are able to differentiate different phosphorylation on the CTD domain, when GST-
CTD is substrate of CDKF;1 could uncover/exclude possible direct phosphorylation of Serine-2 and/or 
Serine-5 by CDKF;1. Alternatively, further characterization of CTD phosphorylation patterns in the 
double and triple cdkd mutants will help to verify that CDKF;1 is solely responsible for 
phosphorylation of the Serine-7 CTD position. Our current data is however fully consistent with the 
conclusion that CDKF;1 acts as upstream activating kinase (CAKAK) of CDKD;2 in vivo, and 
probably this conclusion can also be extended to the other CAK/CDKD kinases.  
Residual phosphorylation of Serine-5 CTD residue in the cdkd;2-1 mutant indicates the 
existence of another Serine-5 kinase. CDKD;3 is a likely candidate for Serine-5 CTD phosphorylation, 
as it is very closely related to CDKD;2 and because Shimotohno et al. (2004) observed that CDKD;3 
immunoprecipitated from Arabidopsis cell culture is able to phosphorylate the GST-CTD substrate in 
vitro (Shimotohno et al., 2004). In metazoans, Serine-2 phosphorylation is catalysed by CDK9. In 
Arabidopsis, CDKC;1 and CDKC;2 represent potential functional orthologues of CDK9 and additional 
targets for activation by CDKF;1. Taken together, these results demonstrate CDKF;1 is responsible for 
fine-tuning of RNAPII CTD phosphorylation in Arabidopsis and thereby it is involved in different 
steps of transcription regulation that have dramatic effect on plant development.  
 
4.3. Are cyclin-dependent kinases (CDKs) targets of CDKDs/ CAKs? 
As human CDK7, Arabidopsis CDKF;1, CDKD;2, and CDKD;3 have been reported to mediate 
phosphorylation of human CDK2 in vitro. Therefore, Umeda et al. (2005) suggested that CDKF;1 and 
CDKDs are directly involved in the activation of CDKs, such as CDKA;1, in Arabidopsis. More 
remarkably, Shimotohno et al. (2006) also found that CDKF;1 is capable of activating Arabidopsis 
CDKA;1 in vivo, when these two kinases are co-expressed in Arabidopsis cell culture. As mentioned 
above, these results have been recently revised by the same group showing that CDKF;1 is not 
involved in T-loop phosphorylation of the Arabidopsis CDKA;1, CDKB;1 and CDKB;2 kinases 
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(Takatsuka et al., 2009). Our in vitro kinase assays also indicate CDKF;1 and CDKDs are not able to 
phosphorylate CDKA;1 in vitro (data not shown).  
As cyclin dependency of CDKs and CAKs may largely influence the results of in vitro kinase 
assays, these discrepancies should rather be clarified by genetic means. One evident option is to 
express site-specifically mutated CDKD kinase genes, in which the codon of phosphorylated Thr in 
the T-loop is exchanged for either Asn or Gln. As these amino acid exchanges mimic phosphorylation 
of the T-loop, the products of these mutant genes will be dominantly activated (i.e. being phosphatase 
resistant) CDKD kinases, which can be tested for suppression of the cdkf;1 mutant phenotype. 
Analogously activated CDKA and CDKB kinases can be used for testing suppression of cell cycle 
defects caused by cdkf;1 and triple cdkd mutations.  
Our microarray data revealed little effect of cdkf;1-1 mutation on transcriptional regulation of 
cell cycle related genes. The only change, which may deserve attention is a 13-fold upregulation of 
KRP2 transcript levels in the cdkf;1-1 mutant. KRP2 interacts with CDKA;1 and reduces CDKA;1 
activity, which leads to onset of endoreduplication and increase of cell’s DNA ploidy level (Verkes et 
al., 2005), as well as to inhibition of lateral root formation (Himanen et al., 2002). The abundance of 
KRP2 protein is regulated through phosphorylation by CDKB1;1, which targets KRP2 to proteosomal 
degradation. Although viable, the cdkf;1 mutant has a cell division defect, as characterization of the 
mutant seedlings indicates a reduction of cell number in the epidermal layers of leaves and hypocotyls. 
Although this defect is also accompanied by a significant reduction of cell elongation, we have found 
no evidence for change in the level of endoreduplication. Although root elongation and defect of 
lateral root development in the cdkf;1-1 mutant show similarities to KRP2 overexpressing plants, it 
remains to be necessary to confirm KRP2 overproduction in the cdkf;1-1 mutant by western blotting 
and demonstrate its effect of the regulation of CDKA;1 activity. On the other hand, to determine 
whether CDKF;1 plays a direct role in cell cycle regulation, it will be necessary to generate 
synchronisable cell cultures from our conditionally complemented cdkf;1-1 mutant, which expresses 
CDKF;1 under an estradiol-inducible promoter in the mutant background. Depletion of CDKF;1 
expression in actively dividing synchronized cells is expected to provide information on whether 
CDKF;1 has any effect on the control of cell cycle progression and the activity of phase specific 
CDKA and CDKB kinases. 
 
4.4. Regulation of small RNA pathways by CDKF;1-mediated phosphorylation of Serine-7 
position of RNA polymerase II CTD 
The observation that the cdkf;1-1 mutation specifically reduces the CTD phosphoserine-7 levels in 
very young seedlings (7 DAG) provided us a unique tool to examine the role played by Serine-7 CTD 
phosphorylation in the control of transcription. Comparative Affymetrix ATH1 microarray 
hybridization analysis of RNA samples from wild type and cdkf;1-1 mutant seedlings demonstrated 
that reduced CTD Serine-7 phosphorylation does not cause overall down-regulation of transcription. 
From a total of 2383 genes, 1258 showed reduced and 1125 at least 1.5-fold increased transcript levels 
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in the cdkf;1-1 mutant. As CTD Serine-7 phosphorylation has been reported to affect specifically the 
3’-end processing and transcription of small noncoding nuclear RNA U2G in mammalian cells (Egloff 
and Murphy, 2007), we have first searched for changes, which could affect the functions involved in 
RNA processing and/or biogenesis of small RNAs. Among the RNA processing functions affected by 
the cdkf;1-1 mutation, we found that transcript levels of DICER-LIKE DCL1 and DCL2, as well as 
ARGONAUTE 1 (AGO1) and RNA-DEPENDENT RNA POLYMERASE 6 (RDR6) acting in the 
microRNA and ta-siRNA pathways showed 1.7 to 1.8 reduction in the cdkf;1-1mutant. As these 
changes appeared to be decent, and because we reduced the cut-off value of filtering of expression 
differences from standard 2-fold change to 1.5, we performed a series of confirmatory qRT-PCR 
experiments by measuring the transcript levels of these genes, as well as other genes acting in the four 
known small RNA pathways characterized in Arabidopsis.  
Remarkably, the observed data revealed a general down-regulation of expression of key genes 
involved in all four small RNA biogenesis pathways and associated DNA methylation/silencing 
functions. These included DCL1, HYL1, HEN1, HST1 and AGO1 in the microRNA and, RDR6, 
DCL4, HEN1, AGO1 and AGO7 in the ta-siRNA pathway; DCL1, DCL2, RDR6 and HEN1 in nat-
siRNA and DCL3, RDR2, HEN1, DRD1 and AGO4 in ra-siRA biogenesis (Voinnet, 2009). As down-
regulation of small RNA biogenesis pathways predicted a consequent decrease in the levels of 
processed mature small RNAs, we have performed northern RNA hybridizations with probes detecting 
some representatives of three small RNA classes, including miR156, miR165, miR172, ta-siRNA, and 
rai-siRNA COPIA. All tested mature small RNAs showed remarkably reduced levels in the cdkf;1-1 
mutant compared to wild type. Because mutations abolishing key functions in the small RNA 
processing pathways result in the accumulation of unprocessed pri-microRNAs and source transcripts 
of ta-siRNAs and ra-siRNAs, we have determined the levels of unprocessed polyadenylated transcripts 
of pri-miR156, pri-miR165, pri-miR172, TAS1a and COPIA genes. Surprisingly, we found that also 
the levels of small RNA precursors have been reduced in the cdkf;1-1 mutant, indicating that alteration 
of Serine-7 phosphorylation of RNAPII CTD has a direct effect on their transcription. Overall 
reduction of transcription of noncoding small RNA genes and protein coding genes involved in their 
processing indicates the existence of a highly coordinated control mechanism by which synthesis of 
small RNA precursors and their processing is regulated by an RNAPII modulating function. As 
CDKF;1 is an upstream activating kinase of CDKD;2 which is a TFIIH-associated protein kinase 
controlling transcription and DNA repair (Leene et al., 2008), compromised CDKD;2 activity could 
represent a reason for the observed transcription regulatory defect in the cdkf;1-1mutant. However, 
this possibility can be excluded as at the examined early developmental stage the levels of CDKD;2-
mediated Serine-5 CTD phosphorylation is comparable to wild type in the cdkf;1-1 mutant, which 
suggests that the CDKD;2-TFIIH complex is fully active. Therefore, taken together, these data 
demonstrate that Serine-7 phosphorylation of the CTD domain by the CDKF;1 protein kinase is 
required for proper transcription and processing of small RNAs in Arabidopsis.  
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4.5. Correlations between cdkf;1 mutant phenotype, CDKF;1 kinase function and 
transcript profiling data 
In contrast to the single cdkd mutants, which result in no alteration of wild type phenotype, the cdkf;1 
insertion mutants display dramatic morphological alterations and develop to extreme dwarf plants that 
fail to flower in short days. Even in long days, the cdkf;1 mutants flower only after two months, twice 
the generation time of control wild type plants. Flowers of the cdkf;1-1 mutant lack petals, develop 
petal-like sepals, varying number of aberrant and sterile pistils, and short similarly aberrant and sterile 
carpels. Single terminal flowers appear on side-branches of inflorescence, which correspond to 
elongated receptacle structures. Despite very early developmental stage of seedlings used in our 
transcript profiling experiments, some of the observed changes in transcript levels show logical 
correlation with the observed phenotypic traits. Thus, both confirmatory qRT-PCR and Affymetrix 
transcript profiling data indicate that transcript levels of FT and SOC1 floral integrator genes are 
reduced by 10- to 13-fold in the cdkf;1-1 mutant.  
The alteration of FT and SOC1 transcript levels reflect much more complex underlying 
changes, including upregulation of flowering time repressor FLC and changes in the expression of 
numerous key genes in the circadian clock and photoperiod dependent flowering time pathways. In 
cdkf;1-1 seedlings, the expression level of all phytochromes except PHYB is marginally down-
regulated along with coordinate increase of PIF3, CCA1 and LHY, transcript levels. This data is 
consistent with the notion that PIF3 is functionally required for transcription of CCA1 and LHY 
(Alabadi et al., 2001; Martinez-Garcia et al., 2000). Furthermore, GIGANTEA (GI), another clock 
function which is repressed by CCA1 and LHY (Quail, 2002), shows down-regulation in the cdkf;1-1 
mutant analogously to the PRR5 and PRR7genes, which are positively controlled by CCA1 and LHY, 
and known activate CO transcription (Nakamichi et al., 2007). Thus, up-regulation of CCA1 and LHY, 
together with down-regulation of GI, PRR5 and PRR7 well correlates with extreme late flowering 
phenotype of cdkf;1 mutants.  
As CO, which acts in the central core of photoperiodic pathway shows slight up-regulation 
(1.54-fold) rather than decrease in the cdkf;1-1 mutant, it appears that down-regulation of FT and 
SOC1 at this early stage of development is regulated through a CO-independent pathway. Based on 
current knowledge, GI is capable of enhancing FT and SOC1 expression by stimulating the production 
of miR172 (Jung et al., 2007; Mathieu et al., 2009), which inhibits the translation of a set of AP2-like 
flowering time repressor genes (TOE1, TOE2, TOE3, SMZ, and SNZ). These AP2-like transcription 
factors repress the transcription of FT and SOC1 and consequently delay the time of flower formation 
(Schmid et al., 2003; Aukerman and Sakai, 2003; Mathieu et al., 2009; Chen, 2003; Kasschau et al., 
2003; Schwab et al., 2005). Intriguingly, the cdkf;1-1 mutation down-regulates both GI transcription 
and the whole miRNA pathway, hence decreasing the level of mature miR172, which consequently 
predicts up-regulation of protein levels of AP2-like flowering time repressors of FT and SOC1 genes. 
On the other hand, the cdkf;1-1 mutation also down-regulates the expression of several genes (e.g., 
DCL4, HST, RDR6, AGO1, and AGO7), which are involved in phase transition from juvenile to adult 
stage. Although down-regulation of these genes and low abundance of miR156 is predicted to 
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accelerate juvenile to adult transition (Peragine et al., 2004; Telfer and Poethig, 1998; Xie et al., 2005; 
Hunter et al., 2003; Fornara and Coupland, 2009), this is accompanied by aberrant leaf development 
and failure in proper induction of flowering in the cdkf;1-1 mutant.  
A reduction of miR156 level is concomitant with an increase in the expression of SPL 
transcription factor genes, including SPL9 and SPL10, which would activate the transcription of 
miRNA172 precursor and thereby enhance FT and SOC1 expression (Fornara and Coupland, 2009. 
However, this pathway is inhibited by down-regulation of microRNA biogenesis and pri-miR172 
expression in the mutant. Reduction of FT and SOC1 transcription could also reflect the enhanced 
FLC expression in cdkf;1-1, although functions in the autonomous and vernalization-dependent 
pathways and FLC enhancers (SWR1 complex, Paf1 complex, and FRIGIDA) are apparently 
unaffected by the mutation. Therefore, upregulation of FLC could reflect a silencing/epigenetic defect 
due to lower transcription of DCL1, DCL3, and HEN1 in the cdkf;1 mutant (Schmitz et al., 2007; Xie 
et al., 2003; Liu et al., 2004). As key genes acting in all four small RNA biogenesis pathways, 
including RNA-directed DNA methylation, are down-regulated in cdkf;1-1,, DNA methylation and 
thereby H3K9 methylation of the FLC locus could be specifically affected. 
Interestingly, the TMAC2 gene, which is highly inducible by ABA shows elevated transcript 
levels in the mutant. TMAC2 negatively regulates ABA signalling and its overexpression reduces the 
expression levels of the SOC1 and SEP3 genes (Huang and Wu, 2006). Taken together, these data 
suggests that the observed reduction in FT and SOC1 expression is likely caused by overexpression of 
FLC and very low abundance of miR172.  
As described in section 3.4.3, our preliminary data indicate that the cdkf;1-1 mutation results 
in enhanced sensitivity to far-red (FR) light, which triggers aberrant hypocotyl tickening and enhanced 
anthocyanin pigment accumulation in developing seedlings. The transcript profiling data indicate that 
the expression levels of HY5 and PIF3 are increased in the cdkf;1-1 mutant when grown in short days 
under normal white light conditions. Activation of HY5 and PIF3 controlling anthocyanin biosynthesis 
is consistent with significantly increased transcription of numerous genes acting in the 
anthocyanin/flavonid pathways (Shin et al., 2007; Vandenbussche et al., 2007). PHYA as FR light 
photoreceptor promotes HY5 protein stability and probably enhances PIF3 expression (Quail, 2002; 
Shin et al., 2007). Therefore, hypersensitivity of cdkf;1-1 to constant FR could reflect higher activity 
of HY5 and PIF3, despite marginal down-regulation of PHYA in the mutant. Interestingly, ARR4 
which inhibits dark conversion of Pfr form of PHYB to its Pr form shows lower transcript level in 
cdkf;1-1 seedlings compared to wild type (Martinez-Garcia et al., 2000; Hanano et al., 2006). 
Moreover, negative regulators of PHYB-connected light-signalling pathways, including PIF3, CCA1, 
and LHY, are simultaneously upregulated in the mutant, which is consistent with lower expression of 
PRR5 and PRR7 that are positive regulators of PHYB-mediated light-signal transduction pathway (Ito 
et al., 2000). These data suggest that the activity of PHYB signalling could also be compromised by 
the cdkf;1-1 mutation.  
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The cdkf;1 mutations results in dramatic developmental defects characterized by inhibition of 
root elongation, reduction of number of root hairs, development of few and aberrantly short lateral 
roots, appearance of trichomes carrying single or two branches, defect of epidermal cell expansion, 
reduction of cell number in epidermal layers of leaves, hypocotyls and roots. In addition, at early 
developmental stages cdkf;1 seedlings can be easily recognized based on their short hypocotyls length 
in different constant light regimes (FRC, RC, and BC), as well as in darkness. Interestingly, the 
hypocotyl length of cdkf;1-1 mutant is similar to wild type under short day conditions in white light. 
This suggests a day length dependent (and possibly light quality dependent) control of hypocotyl 
elongation, as this defect cannot be compensated by either 0.1 μM brassinolide or 10 μM GA3 
treatments in the cdkf;1 mutants.  
In potential relevance to the cell elongation defects, the microarray profiling data indicate a 
general reduction in the expression of ADF8, ADF11, AFH1, AtFIM1, ROP2, TON1A, AtMAP65-1, 
AtMAP70-4, and ZWI genes encoding important cytoskeleton constituents and cytoskeleton-related 
proteins in the cdkf;1-1 mutant. Actin depolymerizing factors (ADF8 and ADF11) regulate cell 
division and intracellular trafficking in the root hair through cytoskeleton, modulating the actin 
bundling proteins. Both ADF8 and ADF11 are highly expressed in the root trichoblast cells and 
developing root hairs (Kandasamy et al., 2007), thus their down-regulation may contribute to root 
developmental defects of the cdkf;1 mutants. The initiation and organization of actin cables is 
regulated by AFH1 (Michelot et al., 2005), whereas AtFIM1, an actin filament crosslinking protein, 
stabilizes actin filaments (Kovar et al., 2000). The Arabidopsis ROP2 GTPase positively regulates 
different stages of root hair development (Jones et al., 2002), while TONA1 controls cell elongation 
and cell division, and its mutation confers a dwarf phenotype. AtMAP65-1 binds to microtubules 
during the cell cycle (interphase, anaphase, and telophase) and its inactivation, which probably takes 
place by phosphorylation, is required for metaphase to anaphase transition (Smertenko et al., 2006). 
ZWICHEL is one of the major regulators of trichome morphogenesis and its mutation reduces the 
number of trichome branches from three to two (Oppenheimer, 1997; Reddy and Reddy, 2004).  
Finally, ACT11, encoding a structural constituent of cytoskeleton, plays an important role in root hair 
development and cell elongation (Kandasamy et al., 2009), and is highly expressed in young and 
developing tissues, including elongating hypocotyls, expanding leaves, floral organ primordia, 
emerging floral buds, and developing ovules (Huang et al., 1997). Taken together, coordinate down-
regulation of these genes correlates with the observed cell elongation, root hair and trichome 
developmental defects and, in addition to deregulation of small RNA pathways, contribute to the 
observed developmental aberrations in the cdkf;1 mutant. 
 
4.6. Control of VirD2 phosphorylation and Agrobacterium-mediated tumorigenesis by 
CDKF;1  
Current models of Agrobacterium-mediated T-DNA integration into host chromosomes are based on 
previous studies of the effects of host mutations on the T-DNA integration process in yeast and 
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Arabidopsis, and analysis of sequence junctions formed during illegitimate recombination of the T-
DNA ends with chromosomal target sites in fungal and plant host genomes. These studies show that 
the 3’-end of the T-strand, which corresponds to T-DNA left border junctions, frequently suffers 
deletions during the integration process. By contrast, the 5’-end of the T-strand, which defines the 
right T-DNA junctions, corresponds in the majority of cases to the position of VirD2-mediated 
cleavage site that is protected by the covalently bound VirD2 protein during T-DNA transfer 
(Mayerhofer et al., 1991; Tinland et al., 1995). Mutations of VirD2 largely prevent T-DNA 
integration, but in those few cases where mutant VirD2 assisted the integration process, larger 
deletions were identified also in the right T-DNA border junctions. T-DNA sequences covered by the 
single-stranded DNA-binding protein VirE2, but lacking VirD2, can be imported into host nuclei 
where they integrate into the host genome by illegitimate recombination. This process is mediated by 
the host non-homologous end-joining recombination system (NHEJ), which likely mediates also the 
formation of linkage between the unprotected 3’end of the T-strand and host DNA forming the T-
DNA LB junctions. Mutations affecting various components of the NHEJ recombination pathway 
reduce but do not fully abolish T-DNA integration and their effects are less dramatic compared those 
of vird2 mutations (van Attikum et al., 2001). These data suggest that the VirD2 protein, which is 
covalently bound to the 5’-end of the T-strand and responsible for efficient nuclear import of this T-
DNA transfer intermediate, plays also a distinguished role in the T-DNA integration process (Gelvin, 
2000). Based on this assumption, it is also evident that the VirD2-mediated linkage of 5’-end of the T-
strand must involve VirD2-interacting host factors, which may differ from those that mediate 
stabilization of the 3’-end of the T-strand. 
Current reviews discuss two slightly different models describing the proposed mode of T-
DNA integration: the Single-Stranded-Gap-Repair (SSGR) and Double-Strand-Break-Repair (DSBR) 
models (Tinland et al., 1995; Tzfira et al., 2004). In the SSGR model, first the 3'-end of T-strand is 
annealed to the target sequence by finding short complementary sequence (i.e., microhomology). This 
is followed by nicking and partial degradation of the target sequence in the plant DNA, and finally the 
3’-end is integrated in to the genome by NHEJ. A clear weakness of the SSGR model from Tinland et 
al (1995) is that it assumes that annealing of the VirD2 protected 5' end of the T-strand is mediated by 
pairing of a single base, which is highly unrealistic because terminal nucleotides in the 5’-end of T-
strand are covered by the VirD2 protein, which is covalently bound by phosphotyrosine bound 
between its Tyr29 residue and the last T-strand nucleotide. The SSGR model suggests that the latter 
electrophylic center contributes to the generation of a nick in the target sequence generating a free 3'-
OH group as nucleophilic center. Subsequently, these electrophilic and nucleophilic centers attract 
each other and finally create a new bond there. Thus, according to the SSGR model, the two ends of 
the T-DNA are integrated into the genome based on different mechanisms, but the integration of the 
5’-end is largely based on promiscuous action of the VirD2 protein in the absence of any plant factor. 
In fact, Pansegrau et al. (1993) showed that VirD2 has ligase like activity in vivo, whereas 
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Ziemienowicz et al., (2000) failed to observed VirD2-mediated ligation of the T-strand to model 
nucleotides in the absence of added DNA ligase.  
The second DSBR model proposed for T-DNA integration assumes that on its way to the 
nucleus through the cytoplasm the single-stranded T-DNA (T-strand) is protected by the VirD2 
protein on its 5’-end and along its full length by the VirE2 protein. This model attributes the various 
deletions observed at the 3’-end to insufficient nuclease protection during the transfer process. Upon 
nuclear import, the DSBR model assumes that the T-strand is converted to double-stranded T-DNA, 
which is prerequisite for T-DNA integration by the NHEJ system. Unfortunately, the DSBR model 
fails to answer the critical questions how DNA synthesis is primed on the T-strand and where is the 
putative replication origin for bidirectional DNA synthesis on the T-DNA. 
In their study, aiming at the identification of a nuclear receptor for the T-strand linked VirD2 
protein, Bakó et al. (2003) found that VirD2 can specifically interact with the TATA-binding protein 
TBP in vivo and demonstrated that TBP co-immuniprecipitates from Arabidopsis with the CTD of 
RNAPII. Furthermore, Bakó et al. (2003) purified a protein kinase, which phosphorylates VirD2, from 
alfalfa and found that this protein kinase cross-reacts with an antibody recognizing Arabidopsis 
CDKD;2. Using this antibody, a cDNA clone encoding CAK2Ms was isolated and used for 
overexpression of a HA-epitope tagged version of the CAK2Ms kinase in alfalfa protoplasts, in order 
to combine it with its native cyclin subunit. Following immunopreciptation with anti-HA antibody, the 
pulled down HA-CAK2Ms kinase was demonstrated to phosphorylate GST-VirD2, as well as GST-
CTD. Subsequenty, CAK2Ms was shown to co-immuniprecipitate with the CTD of RNAPII. 
To follow up these studies, we performed kinase assays to identify which of the Arabidopsis 
CDKD kinases correspond to functional orthologue of the CAK2Ms VirD2 kinase. To our surprise, we 
have found that that none of the CDKD kinases, including the CTD kinase CDKD;2, could 
phosphorylate the GST-VirD2 substrate in vivo. As Bakó et al. (2003) used an immunoprecipitated 
CAK2Ms kinase from alfalfa cells for GST-VirD2 phosphorylation and, at the meanwhile purified 
Arabidopsis CDKD;2 was found in a tight complex with cyclin H and CDKF,1 by mass spectrometry 
studies (van Leene et al., 2007), we have assumed that the immunoprecipitated CAK2Ms complex 
carried an associated CDKF;1 subunit. Therefore, were have assayed phosphorylation of the GST-
VirD2 substrate with purified Arabidopsis CDKF;1 and indeed found that CDKF,1 can phosphorylate 
VirD2 with similar efficacy as its three CDKD substrates.  
Subsequently, we have shown by 2D PAGE analysis that CDKF;1 phosphorylates VirD2 at 
multiple positions, and by mass spectrometry analysis of purified VirD2 phosphopeptides we have 
identified 6 phosphorylated Thr residues located close to the critical C-terminal nuclear localization 
signal in VirD2. This experiment has identified the bona fide VirD2 kinase and suggested that the 
nuclear receptor involved in the recognition of T-strand-associated VirD2 in plants is likely a TFIIH 
complex carrying the interacting CDKF;1 and CDKD;2 kinases. While this latter assumption is being 
verified by future characterization of the CDKD;2-cyclin H-CDKF;1 complex, we have set out to test 
the biological significance of our finding by performing Agrobacterium-induced hypocotyl 
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tumorigenesis assays with the cdkf;1-1 and cdkd;2-1 insertion mutants. These assays indicated that 
both cdkf;1-1 and cdkd;2-1 mutations drastically reduced the frequency of Agrobacterium-mediated 
plant transformation and subsequent tumorigenesis.  
As mentioned above, the absence of VirD2 in the presence of all other components of T-
DNA transfer apparatus hugely reduces but does not abolish completely Agrobacterium-mediated 
transformation and tumour formation. Therefore, if CDKF;1 and CDKD;2 kinases only affect the role 
of VirD2 in T-DNA integration, their absence can be expected to reduce dramatically, but not 
completely, Agrobacterium-mediated T-DNA transformation and tumorigenesis. Our data show that 
compared to cdkf;1-1 the cdkd;2-1 mutation is somewhat less efficient in reducing the frequency of 
tumour formation. This appears to be logical since VirD2 is not phosphorylated by CDKD;2, but this 
kinase may just act as a mediator stabilizing the CDKF;1-CDKD;2. complex. Alternatively, as noted 
by Bakó et al. (2003), CDKD;2 may mediate direct recognition of a histidine triad motif in the N-
terminal domain of VirD2, which has also been identified in several CAK-binding HINT proteins 
(Korsisaari and Mäkelä, 2000). More severe effect of cdkf;1-1 mutation on the frequency of tumour 
formation can also be explained by recent observation of Takatsuka et al. (2009), who found that the 
CDKD;2 protein levels are dramatically decreased by the cdkf;1-1 mutation. 
Assuming that the CDKF;1/CAKAK-CDKD;2/CAK complex is similarly part of TFIIH in 
Arabidopsis as in other eukaryotes, our data suggest that the nuclear VirD2 receptor is the RNAPII 
associated TFIIH complex, which is a central regulator of DNA repair. Interaction of VirD2 with TBP 
shown by Bakó et al. (2003) is relevant in the light of data demonstrating that TBP is capable to 
recognize different DNA lesions, such as kinked DNA, and recruit to these subsequently the TFIIH 
DNA repair complex. Therefore, our data suggest a new model for VirD2-mediated T-DNA 
integration. This predicts that linkage of the VirD2 protein to the 5’-end of the T-strand mimics a 
DNA lesion which recruits the VirD2-interacting TBP protein and, through CDKD;2, the CDKF;1-
associated TFIIH complex. Subsequently, CDKF;1-mediated phosphorylation of VirD2 probably 
deactivates the covalent bond between the 5’-end of the T-strand and VirD2, which leads to the release 
of VirD2 and TFIIH-mediated repair-ligation of free 5’end of the T-strand to a TBP recruited 3’-end in 
in the chromosomal target sequence. Ultimately, the phosphorylated VirD2 could be targeted for 
proteasomal degradation. Whereas many steps in this model should be confirmed by further 
experimentation, the available data already demonstrate that CDKF;1 also plays a pivotal role in the 
control of DNA repair mechanism mediating Agrobacterium-mediated T-DNA transformation and 
subsequent tumour formation in Arabidopsis. 
 In analogy to recent models of co-transcriptional modifications of RNAPII CTD and 
concerning TFIIH-associated nucleotide excision repair activity, Figure  28 depicts a schematic view 
of major functions of CDKF;1 and CDKD;2 kinases discussed above. 
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Figure 28. The mode of action of CDKF;1 in modulation of phosphorylation of RNAPII CTD during 
transcription (A) and T-DNA integration through phosphorylation of VirD2 (B). 
(A) Unphosphorylated form of RNAPII CTD (RNAPIIA) is recruited by pre-initiation complex to the promoter 
region. Subsequently, Serine-5 phosphorylation of the CTD domain probably takes place by CDKD;2, a subunit 
of TFIIH and unknown kinase(s), the functions of which are positively regulated by the CAK-activating CDKF;1 
kinase. Serine-5 phosphorylation is required for transcription initiation and 5’-capping. In a later step, Serine-2 is 
phosphorylated by another unknown kinase(s), which represent putative target(s) of CDKF;1. Serine-2 
phosphorylation activates transcription elongation and it is required for splicing and polyadenylation in yeast and 
mammals. CDKF;1 phosphorylates Serine-7 residues of the CTD and thereby fine-tunes miRNA and siRNA 
biogenesis. At the end of transcription cycle, after dephosphorylation of the CTD, the RNAPII is recycled for 
initiation of a new round of transcription. (B) The VirD2 protein covalently linked to the 5’-end of the T-strand 
mimics a type of DNA lesion and recruits TBP, which is able to recognize different DNA lesions. Subsequently, 
TBP recruits TFIIH with the associated CDKF;1 and CDKD;2 kinases. CDKF;1 attached to TFIIH complex 
phosphorylates the VirD2 protein. The covalent bond between T-strand and VirD2 is deactivated and then the 
phosphorylated VirD2 protein is released and likely targeted for proteosomal degradation. In later step, the NER 
(i.e., nucleotide excision repair) machinery is also recruited and integrates the free 5’ end of the T-strand in to 
the genome, while the 3’ end is integrated by NHEJ system. 
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Table 8. List of remaining microarray data showing altered transcript levels of genes in pathways affected 
by the cdkf;1-1 mutation, which have not mentioned in the text.  
Green colour indicates down-regulated genes, purple colour marks up-regulated transcripts. 
 
Probe Set 
ID 
AGI Short/Full name Fold change RT-
qPCR 
Gametophyte, embryo & seed development 
260716_at AT1G48130 ATPER1 1.5171459  
253414_at AT4G33050 EDA39 2.3444316  
253274_at AT4G34200 EDA9 1.5678797  
247410_at AT5G62990 embryo defective 1692 1.7676998  
263899_at AT2G21710 embryo defective 2219 1.5491735  
249462_at AT5G39680 EMBRYO DEFECTIVE 2744 1.5104511  
249404_at AT5G40160 embryo defective 506 1.5177532  
266392_at AT2G41280 M10 3.213478  
266393_at AT2G41260 M17 4.8909497  
260814_at AT1G43710 embryo defective 1075 1.6492357  
249900_at AT5G22640 embryo defective 1211 1.5246706  
258149_at AT3G18110 embryo defective 1270 1.508755  
254427_at AT4G21190 embryo defective 1417 1.7842361  
264224_at AT1G67440 embryo defective 1688 2.6102033  
256613_at AT3G29290 embryo defective 2076 2.9803932  
263220_at AT1G30610 embryo defective 2279 2.8456154  
255328_at AT4G04350 EMBRYO DEFECTIVE 2369 1.6819196  
265896_at AT2G25660 embryo defective 2410 2.3018644  
252904_at AT4G39620 embryo defective 2453 1.946124  
260523_at AT2G41720 EMBRYO DEFECTIVE 2654 1.8424145  
253758_at AT4G29060 embryo defective 2726 1.6786925  
263593_at AT2G01860 EMBRYO DEFECTIVE 975 1.6491799  
253061_at AT4G37610 BT5 1.5798665  
263305_at AT2G01930 BPC1 1.8067896  
262848_at AT1G14685 BPC2 1.6872642  
267461_at AT2G33830 dormancy/auxin associated family protein 2.48564  
265478_at AT2G15890 maternal effect embryo arrest 14 4.53966  
256715_at AT2G34090 maternal effect embryo arrest 18 1.6517748  
251936_at AT3G53700 maternal effect embryo arrest 40 1.5911878  
259328_at AT3G16440 ATMLP-300B 1.5908215  
251642_at AT3G57520 AtSIP2 1.8636701  
258136_at AT3G24560 RASPBERRY 1.9350811  
257127_at AT3G20070 TTN9 (TITAN9) 1.5399364  
255695_at AT4G00080 unfertilized embryo sac 11 2.3878458  
Apical meristem & shoot development 
257600_at AT3G24770 CLE41 (CLAVATA3/ESR-RELATED 41) 1.8970978  
254761_at AT4G13195 CLE44 (CLAVATA3/ESR-RELATED 44) 2.003524  
267380_at AT2G26170 CYP711A1 2.1980453 2.0933478 
256099_at AT1G13710 CYP78A5 1.7315377  
263285_at AT2G36120 DOT1 1.9534844  
267485_at AT2G02820 MYB88 (myb domain protein 88) 1.6811703 2.1265517 
248861_at AT5G46700 TRN2 (TORNADO 2) (TETRASPANNIN) 1.9384732 1.7855305 
248059_at AT5G55540 TRN1 (TORNADO 1); LOP1 1.8210139 3.4932781 
266797_at AT2G22840 AtGRF1 1.8893403  
263914_at AT2G36400 AtGRF3 (GROWTH-REGULATING FACTOR 3) 1.5839064  
253411_at AT4G32980 ATH1 2.3988056 1.9032154 
249309_at AT5G41410 BEL1 (BELL 1) 1.8528721 1.9552852 
261120_at AT1G75410 BLH3 (BEL1-LIKE HOMEODOMAIN 3) 1.7001191 2.7946142 
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Probe Set 
ID 
AGI Short/Full name Fold change RT-
qPCR 
265724_at AT2G32100 OFP16 2.417903 3.4330189 
256734_at AT3G29390 RIK (RS2-Interacting KH protein) 1.5768218 1.8939216 
263598_at AT2G01850 EXGT-A3;XTH27 hydrolase 1.8724773  
265545_at AT2G28250 NCRK; kinase 1.5091894  
Root development 
245711_at AT5G04340 ZAT6 1.7659798 1.5386741 
259961_at AT1G53700 WAG1 1.5346467  
265337_at AT2G18390 TTN5/ARL2 (TITAN 5) 1.7527206  
253056_at AT4G37650 SHR (SHORT ROOT) 2.154016 1.772481 
264752_at AT1G23010 LPR1 (Low Phosphate Root1) 1.920951  
245113_at AT2G41660 MIZ1 (mizu-kussei 1) 1.5070195  
260097_at AT1G73220 AtOCT1 2.2212842  
255698_at AT4G00150 scarecrow-like transcription factor 6 (SCL6) 1.6455067  
261866_at AT1G50420 SCL3 1.9253527 2.8049471 
247707_at AT5G59450 SCL11 1.633932  
256199_at AT1G58250 SAB (SABRE) 1.5897368  
264029_at AT2G03720 MRH6 (morphogenesis of root hair 6) 1.9323962  
261953_at AT1G64440 ROOT HAIR DEFECTIVE 1 1.7259554  
261505_at AT1G71696 SOL1 (SUPPRESSOR OF LLP1 1) 1.5239848  
Brassinosteroid/sterols 
266996_at AT2G34490 CYP710A2 2.612973  
251321_at AT3G61460 BRH1 1.7820951  
254333_at AT4G22753 SMO1-3 2.053144  
249775_at AT5G24160 SQE6 2.1477501  
264042_at AT2G03760 ST; brassinosteroid sulfotransferase 4.0453663 5.7641329 
259388_at AT1G13420 ST4B (SULFOTRANSFERASE 4B) 1.5820786  
249773_at AT5G24140 SQP2 1.5277069  
266831_at AT2G22830 SQE2 1.7715586  
261076_at AT1G07420 SMO2-1 1.5662668  
266495_at AT2G07050 CAS1 (cycloartenol synthase 1) 1.6527143  
Sugar regulation 
263202_at AT1G05630 5PTASE13 1.514334  
264472_at AT1G67140 SWEETIE 1.956425 3.0382622 
Hypoxia/CO2 
264953_at AT1G77120 ADH1 (ALCOHOL DEHYDROGENASE 1) 2.1709154 2.3071211 
266555_at AT2G46270 GBF3 (G-BOX BINDING FACTOR 3) 1.6148728 1.3030978 
263096_at AT2G16060 AHB1 (ARABIDOPSIS HEMOGLOBIN 1) 6.327405 5.5222335 
252401_at AT3G48030 hypoxia-responsive family protein 1.5307045  
264734_at AT1G62280 SLAH1 (SLAC1 HOMOLOGUE 1); transporter 3.1680465 4.0004441 
253828_at AT4G27970 SLAH2 (SLAC1 HOMOLOGUE 2); transporter 1.5702078  
Dark regulated 
252265_at AT3G49620 DIN11 (DARK INDUCIBLE 11) 2.9445071  
251428_at AT3G60140 DIN2 (DARK INDUCIBLE 2) 2.2731857  
246114_at AT5G20250 DIN10 (DARK INDUCIBLE 10) 2.2377107  
Glucosinolate-nonauxin 
265121_at AT1G62560 FMO GS-OX3 1.7285726  
265119_at AT1G62570 FMO GS-OX4 1.5539628  
248713_at AT5G48180 NSP5 (NITRILE SPECIFIER PROTEIN 5) 1.5501223  
257021_at AT3G19710 BCAT4 1.8383998  
255773_at AT1G18590 SOT17 (SULFOTRANSFERASE 17) 1.6149743  
260385_at AT1G74090 SOT18 1.6743921  
260993_at AT1G12140 FMO GS-OX5 1.7042922  
255438_at AT4G03070 AOP1 2.0027516  
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Jasmonate 
245038_at AT2G26560 PLA2A (PHOSPHOLIPASE A 2A) 6.2667813 6.0841451 
256321_at AT1G55020 LOX1; lipoxygenase 1.6868287 1.0086607 
265530_at AT2G06050 OPR3 (OPDA-REDUCTASE 3) 1.5712544 1.0812224 
259366_at AT1G13280 AOC4 (ALLENE OXIDE CYCLASE 4) 2.2661138 1.2569037 
246236_at AT4G36470 S-adenosyl-L-methionine 1.9207426  
256017_at AT1G19180 JAZ1 2.0314522 1.4166325 
250292_at AT5G13220 JAZ10 1.5389376  
260205_at AT1G70700 TIFY7  1.5986685  
254232_at AT4G23600 CORI3  2.0143182  
259383_at AT3G16470 JR1 1.7075812  
246225_at AT4G36910 LEJ2 1.7360142  
260429_at AT1G72450 JAZ6  1.5137014  
255786_at AT1G19670 ATCLH1 2.4289212  
250662_at AT5G07010 ST2A (SULFOTRANSFERASE 2A) 3.2196193 1.3258419 
250657_at AT5G07000 ST2B (SULFOTRANSFERASE 2B) 1.7866082  
249645_at AT5G36910 THI2.2 (THIONIN 2.2); toxin receptor binding 1.8420254  
256527_at AT1G66100 thionin, putative 2.2041745  
Salicylic acid 
250286_at AT5G13320 PBS3 (AVRPPHB SUSCEPTIBLE 3) 3.2876549 28.492686 
Pathogenic responses 
264647_at AT1G09090 ATRBO 1.9695027  
248719_at AT5G47910 RBOHD 1.5924876  
252373_at AT3G48090 EDS1 1.5372425 2.1603046 
246510_at AT5G15410 DND1 (DEFENSE NO DEATH 1) 1.5857527  
267191_at AT2G44110 MLO15 2.303784  
245845_at AT1G26150 PERK10 1.982029  
262254_at AT1G53920 GLIP5 2.0244954  
252485_at AT3G46530 RPP13 2.1109254  
245448_at AT4G16860 RPP4 4.5284386  
245456_at AT4G16950 RPP5 2.1889265  
252210_at AT3G50410 OBP1 1.5500985  
251806_at AT3G55370 OBP3 1.5631398  
248270_at AT5G53450 ORG1 1.5141984  
247199_at AT5G65210 TGA1 1.6765685  
255953_at AT1G22070 TGA3 1.931243  
250463_at AT5G10030 TGA4 1.8354293  
245258_at AT4G15340 ATPEN1 1.6683017  
258277_at AT3G26830 PAD3 5.551125  
257751_at AT3G18690 MKS1 (MAP kinase substrate 1) 1.6468377  
247038_at AT5G67160 EPS1 1.7517453  
263065_at AT2G18170 ATMPK7 1.6121398  
254241_at AT4G23190 CRK11 1.9614013  
258002_at AT3G28930 AIG2 2.5425074  
249754_at AT5G24530 DMR6 1.7103013  
256497_at AT1G31580 ECS1 2.020975  
259071_at AT3G11650 NHL2 1.583974  
250676_at AT5G06320 NHL3 2.0663536  
261135_at AT1G19610 PDF1.4 2.611171  
266141_at AT2G02120 PDF2.1 4.694844  
250670_at AT5G06860 PGIP1 1.6090173  
250669_at AT5G06870 PGIP2 1.5472852  
256576_at AT3G28210 PMZ 2.0096269  
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258791_at AT3G04720 PR4 2.637618  
247205_at AT5G64890 PROPEP2 1.5030729  
247215_at AT5G64905 PROPEP3 1.6278282  
259925_at AT1G75040 PR5 1.5272574  
245041_at AT2G26530 AR781 1.6181748  
246099_at AT5G20230 ATBCB 2.328329  
251895_at AT3G54420 ATEP3 1.5635811  
256243_at AT3G12500 ATHCHIB 3.7629106  
260560_at AT2G43590 chitinase, putative 2.197413  
260568_at AT2G43570 chitinase, putative 5.2857018  
260556_at AT2G43620 chitinase, putative 29.559217  
246821_at AT5G26920 CBP60G 2.2415211  
267545_at AT2G32690 GRP23 1.9725178  
265560_at AT2G05520 GRP-3 2.021071  
257679_at AT3G20470 GRP5 6.275385  
247575_at AT5G61030 GR-RBP3 1.6348057  
252058_at AT3G52470 harpin-induced family protein 1.8302335  
249915_at AT5G22870 harpin-induced protein-related 1.5691336  
266118_at AT2G02130 LCR68 2.6165984  
266119_at AT2G02100 LCR69 2.9240267  
248932_at AT5G46050 PTR3 3.3541954  
250493_at AT5G09800 U-box domain-containing protein 2.4560103  
254159_at AT4G24240 WRKY7 1.5596933  
245051_at AT2G23320 WRKY15 2.200501  
253485_at AT4G31800 WRKY18 2.7839494  
263536_at AT2G25000 WRKY60 2.0139513  
248611_at AT5G49520 WRKY48 2.1066833  
246104_at AT5G28650 WRKY74 1.7966839  
260432_at AT1G68150 WRKY9 1.7055966  
260403_at AT1G69810 WRKY36 2.292045  
261429_at AT1G18860 WRKY61 1.5777873  
262381_at AT1G72900 disease resistance protein 1.812351  
245768_at AT1G33590 LRR protein-related 2.5433743  
259655_at AT1G55210 disease resistance response 3.1758099  
256781_at AT3G13650 disease resistance response 4.0735445  
254907_at AT4G11190 dirigent family protein 4.671053  
263437_at AT2G28670 fibroin-related 1.8179097  
246395_at AT1G58170 dirigent protein-related 2.0880437  
247413_at AT5G63020 disease resistance protein 2.0455496  
264910_at AT1G61100 disease resistance protein 1.5549846  
256303_at AT1G69550 disease resistance protein 1.8827975  
262366_at AT1G72890 disease resistance protein 1.738103  
254553_at AT4G19530 disease resistance protein 2.6902409  
260312_at AT1G63880 disease resistance protein 2.6633203  
248875_at AT5G46470 disease resistance protein 1.7612915  
252648_at AT3G44630 disease resistance protein 1.9751819  
245450_at AT4G16880 disease resistance protein-related 4.903388  
Senescence 
256300_at AT1G69490 NAP (NAC-like, activated by AP3/PI) 2.3724163  
266292_at AT2G29350 SAG13; alcohol dehydrogenase/ oxidoreductase 2.8962815  
255479_at AT4G02380 SAG21; AtLEA05 2.9276352  
252117_at AT3G51430 YLS2; strictosidine synthase 1.8107271  
266167_at AT2G38860 YLS5 2.696613  
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249759_at AT5G24380 YSL2 (YELLOW STRIPE LIKE 2) 2.0327816  
248276_at AT5G53550 YSL3 (YELLOW STRIPE LIKE 3) 1.6124862  
Cell Death 
259100_at AT3G04870 /// 
AT3G04880 
ZDS (ZETA-CAROTENE DESATURASE) 1.5684819  
262482_at AT1G17020 SRG1 (SENESCENCE-RELATED GENE 1) 1.6551807  
246831_at AT5G26340 MSS1 1.8323759  
266447_at AT2G43290 MSS3 1.6086613  
254021_at AT4G25650 ACD1-LIKE (ACD1-LIKE) 1.5956136  
246194_at AT4G37000 ACD2 (ACCELERATED CELL DEATH 2) 1.567585  
246304_at AT3G51840 ACX4 (ACYL-COA OXIDASE 4) 1.6010183  
Drought/salt/osmotic stress 
247655_at AT5G59820 RHL41, ZAT2 1.5891399  
261564_at AT1G01720 ATAF1 1.604277  
254085_at AT4G24960 ATHVA22D 1.8341898  
254889_at AT4G11650 ATOSM34 (osmotin 34) 2.966169  
257022_at AT3G19580 AZF2 2.0028732  
249139_at AT5G43170 AZF3 1.7434927  
251870_at AT3G54510 ERD protein-related 1.9896985  
246594_at AT5G14800 P5CR 1.5408386  
263918_at AT2G36590 ProT3 2.6118112  
255795_at AT2G33380 RD20 3.8504097  
246908_at AT5G25610 RD22 1.6832224  
258498_at AT3G02480 ABA-responsive protein-related 2.4454384  
248155_at AT5G54390 AHL 1.8904647  
267069_at AT2G41010 ATCAMBP25 1.8647299  
248607_at AT5G49480 ATCP1 2.0608647  
250351_at AT5G12030 AT-HSP17.6A 2.3679368  
266464_at AT2G47800 ATMRP4 1.9282628  
266225_at AT2G28900 ATOEP16-1 2.1373036  
260551_at AT2G43510 ATTI1r 3.3028703  
252988_at AT4G38410 dehydrin, putative 4.0390625  
247352_at AT5G63650 SNRK2.5 1.8931242  
267254_at AT2G23030 SNRK2.9 1.8098142  
247043_at AT5G66880 SNRK2.3 2.0553129  
246911_at AT5G25810 tny (TINY) 1.8862898  
253412_at AT4G33000 CBL10 1.8076532  
267467_at AT2G30580 DRIP2 1.5764848  
257315_at AT3G30775 ERD5 1.9173123  
254239_at AT4G23400 PIP1;5 2.03393  
247586_at AT5G60660 PIP2;4 2.4168193  
245399_at AT4G17340 TIP2;2 2.4190283  
266649_at AT2G25810 TIP4;1 1.5940753  
255381_at AT4G03510 RMA1 2.1095874  
267180_at AT2G37570 SLT1 2.4638617  
Cold stress 
261196_at AT1G12860 SCRM2 (SCREAM 2) 2.1826549  
253129_at AT4G36020 CSDP1 1.6218647  
265480_at AT2G15970 COR413-PM1 1.5814444  
252135_at AT3G50830 COR413-PM2 1.5400985  
259789_at AT1G29395 COR414-TM1 1.7639424  
252102_at AT3G50970 LTI30 1.760735  
248337_at AT5G52310 LTI78 1.7038006  
Heat stress 
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246214_at AT4G36990 HSF4 (HEAT SHOCK FACTOR 4) 1.6289104  
Oxidative stress 
261648_at AT1G27730 STZ; ZAT10 (salt tolerance zinc finger) 2.751101  
255500_at AT4G02390 APP 1.8697174  
250633_at AT5G07460 PMSR2 2.0908616  
245253_at AT4G15440 HPL1 (HYDROPEROXIDE LYASE 1) 1.51994  
260706_at AT1G32350 AOX1D (alternative oxidase 1D) 2.7287993  
250412_at AT5G11150 ATVAMP713 1.7295301  
259517_at AT1G20630 CAT1 (CATALASE 1); catalase 1.9759789  
253174_at AT4G35090 CAT2 (CATALASE 2); catalase 1.8638768  
259965_at AT1G53670 MSRB1 (methionine sulfoxide reductase B 1) 1.6690862  
253237_at AT4G34240 ALDH3I1  1.5484588  
259511_at AT1G12520 ATCCS (COPPER CHAPERONE FOR SOD1) 1.7520342  
257227_at AT3G27820 MDAR4 1.6878024  
260408_at AT1G69880 ATH8 (thioredoxin H-type 8) 4.0228195  
251985_at AT3G53220 thioredoxin family protein 3.582015  
255230_at AT4G05390 ATRFNR1 (ROOT FNR 1); FAD binding 2.4147942  
253382_at AT4G33040 glutaredoxin family protein 1.6712667  
261958_at AT1G64500 glutaredoxin family protein 2.3616302  
253112_at AT4G35970 APX5 (ASCORBATE PEROXIDASE 5) 1.5473253  
253223_at AT4G35000 APX3 (ASCORBATE PEROXIDASE 3) 1.5035471  
252862_at AT4G39830 L-ascorbate oxidase, putative 1.8905897  
246021_at AT5G21100 L-ascorbate oxidase, putative 1.6500018  
264001_at AT2G22420 peroxidase 17 (PER17) (P17) 3.0378993  
265471_at AT2G37130 peroxidase 21 (PER21) (P21) (PRXR5) 2.003713  
257952_at AT3G21770 peroxidase 30 (PER30) (P30) (PRXR9) 1.9234072  
249227_at AT5G42180 peroxidase 64 (PER64) (P64) (PRXR4) 1.6612618  
247091_at AT5G66390 peroxidase 72 (PER72) (P72) (PRXR8) 2.732552  
249459_at AT5G39580 peroxidase, putative 4.622013  
246228_at AT4G36430 peroxidase, putative 15.421506  
254914_at AT4G11290 peroxidase, putative 1.6758393  
255110_at AT4G08770 peroxidase, putative 2.035024  
255111_at AT4G08780 peroxidase, putative 3.771507  
246149_at AT5G19890 peroxidase, putative 5.769599  
261606_at AT1G49570 peroxidase, putative 5.8492837  
253332_at AT4G33420 peroxidase, putative 2.0883129  
259276_at AT3G01190 peroxidase 27 (PER27) (P27) (PRXR7) 1.8958764  
250059_at AT5G17820 peroxidase 57 (PER57) (P57) (PRXR10) 3.4667926  
246991_at AT5G67400 peroxidase 73 (PER73) (P73) (PRXR11) 3.1703987  
247327_at AT5G64120 peroxidase, putative 1.8913475  
253667_at AT4G30170 peroxidase, putative 2.1206048  
266941_at AT2G18980 peroxidase, putative 2.1883948  
261157_at AT1G34510 peroxidase, putative 2.2025516  
247297_at AT5G64100 peroxidase, putative 2.4834049  
266191_at AT2G39040 peroxidase, putative 2.5197608  
247326_at AT5G64110 peroxidase, putative 2.6830137  
253998_at AT4G26010 peroxidase, putative 3.2920783  
249934_at AT5G22410 peroxidase, putative 3.613305  
250157_at AT5G15180 peroxidase, putative 1.6550885  
252238_at AT3G49960 peroxidase, putative 3.7340977  
Mitochondrial functions 
257947_at AT3G21720 ICL (ISOCITRATE LYASE) 7.436195  
248434_at AT5G51440 23.5 kDa mitochondrial small heat shock protein 3.236556  
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255259_at AT4G05020 NDB2 (NAD(P)H dehydrogenase B2) 1.7576138  
265422_at AT2G20800 NDB4 (NAD(P)H dehydrogenase B4) 2.0660262  
265188_at AT1G23800 ALDH2B7 1.5168648  
252131_at AT3G50930 BCS1 (CYTOCHROME BC1 SYNTHESIS) 2.09492  
264000_at AT2G22500 UCP5 (UNCOUPLING PROTEIN 5) 1.5354886  
245716_at AT5G08740 NDC1 (NAD(P)H dehydrogenase C1) 1.7873391  
256765_at AT3G22200 POP2 (POLLEN-PISTIL INCOMPATIBILITY 2) 1.8130904  
Chlorophyll biosynthesis 
255941_at AT1G20350 ATTIM17-1 3.4753091  
258321_at AT3G22840 EARLY LIGHT-INDUCABLE PROTEIN 7.935653  
245306_at AT4G14690 EARLY LIGHT-INDUCIBLE PROTEIN 2 4.5258865  
249325_at AT5G40850 UPM1 (UROPHORPHYRIN METHYLASE 1) 2.6233687  
245242_at AT1G44446 CH1 (CHLORINA 1); chlorophyllide a oxygenase 1.8794883  
248920_at AT5G45930 CHLI2 (MAGNESIUM CHELATASE I2) 1.8307958  
256020_at AT1G58290 HEMA1; glutamyl-tRNA reductase 1.6662487  
255826_at AT2G40490 HEME2; uroporphyrinogen decarboxylase 1.74545  
264839_at AT1G03630 POR C 2.0824742  
Chloroplast 
263715_at AT2G20570 GPRI1; GLK1 1.722119  
259129_at AT3G02150 PTF1 (PLASTID TRANSCRIPTION FACTOR 1) 1.5384945  
245528_at AT4G15530 PPDK (pyruvate orthophosphate dikinase) 1.8343517  
265742_at AT2G01290 ribose-5-phosphate isomerase 1.9409654  
249266_at AT5G41670 6-phosphogluconate dehydrogenase 1.8136183  
260285_at AT1G80560 3-isopropylmalate dehydrogenase 1.6410071  
245878_at AT1G26190 phosphoribulokinase/uridine kinase family protein 1.5347071  
260284_at AT1G80380 phosphoribulokinase/uridine kinase-related 1.8263346  
262648_at AT1G14030 RUBISCO 1.6315974  
259185_at AT3G01550 PPT2 (PHOSPHOENOLPYRUVATE (PEP) 2.179108  
263491_at AT2G42600 ATPPC2 1.5495543  
255587_at AT4G01480 AtPPa5 1.8697146  
265382_at AT2G16790 shikimate kinase family protein 1.7897999  
266463_at AT2G47840 tic20 protein-related 2.1186688  
255430_at AT4G03320 tic20-IV 1.8815329  
245193_at AT1G67810 SUFE2 (SULFUR E 2); enzyme activator 4.479765  
248493_at AT5G51100 FSD2 (FE SUPEROXIDE DISMUTASE 2) 1.9135171  
265722_at AT2G40100 LHCB4.3 (light harvesting complex PSII) 2.4080374  
257093_at AT3G20570 plastocyanin-like domain-containing protein 2.137312  
259801_at AT1G72230 plastocyanin-like domain-containing protein 2.1558871  
261975_at AT1G64640 plastocyanin-like domain-containing protein 2.251465  
248236_at AT5G53870 plastocyanin-like domain-containing protein 3.8572476  
257948_at AT3G21740 APO4 2.2425325  
262202_at AT2G01110 APG2 1.7118134  
249927_at AT5G19220 APL1 1.6962466  
263256_at AT1G10500 ATCPISCA 1.5240275  
248459_at AT5G51020 CRL (CRUMPLED LEAF) 1.8223033  
248402_at AT5G52100 crr1 (chlororespiration reduction 1) 2.063625  
248075_at AT5G55740 CRR21 (chlororespiratory reduction 21) 2.9938445  
260821_at AT1G06820 CRTISO (CAROTENOID ISOMERASE) 1.825648  
259193_at AT3G01480 CYP38 (cyclophilin 38) 1.6426872  
267471_at AT2G30390 FC2 (FERROCHELATASE 2); ferrochelatase 1.8871746  
248962_at AT5G45680 FK506-binding protein 1 (FKBP13) 1.6426774  
261218_at AT1G20020 FNR2 1.6792315  
254181_at AT4G23940 FtsH protease, putative 1.5250738  
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262473_at AT1G50250 FTSH1 (FtsH protease 1) 1.8584148  
246226_at AT4G37200 HCF164 1.6135795  
255764_at AT1G16720 HCF173 1.6241134  
251814_at AT3G54890 LHCA1; chlorophyll binding 1.5695097  
252430_at AT3G47470 LHCA4 1.6398041  
258239_at AT3G27690 LHCB2.3; chlorophyll binding 1.5767919  
251969_at AT3G53130 LUT1 (LUTEIN DEFICIENT 1) 1.6673442  
247936_at AT5G57030 LUT2 (LUTEIN DEFICIENT 2) 1.805604  
262506_at AT1G21640 NADK2; NAD+ kinase/ calmodulin binding 2.1550481  
253479_at AT4G32360 NADP adrenodoxin-like ferredoxin reductase 1.5828353  
261788_at AT1G15980 NDF1 2.3510303  
264799_at AT1G08550 NPQ1 2.814829  
245118_at AT2G41680 NTRC 1.5442413  
255982_at AT1G34000 OHP2 (ONE-HELIX PROTEIN 2) 1.5868531  
246508_at AT5G16150 PGLCT (PLASTIDIC GLC TRANSLOCATOR) 1.5717859  
254298_at AT4G22890 PGR5-LIKE A 2.2330859  
245368_at AT4G15510 photosystem II reaction center PsbP 1.5976424  
258223_at AT3G15840 PIFI 2.364555  
266767_at AT2G46910 plastid-lipid associated protein PAP 1.6563066  
245744_at AT1G51110 plastid-lipid associated protein PAP 1.9713004  
245745_at AT1G51110 plastid-lipid associated protein PAP 2.2062986  
266979_at AT2G39470 PPL2 (PsbP-like protein 2); calcium ion binding 1.9862783  
255720_at AT1G32060 PRK (PHOSPHORIBULOKINASE) 1.8166684  
261746_at AT1G08380 PSAO (photosystem I subunit O) 1.5407245  
252130_at AT3G50820 PSBO2 (PHOTOSYSTEM II SUBUNIT O-2) 1.6019964  
255248_at AT4G05180 PSBQ-2; calcium ion binding 1.5585603  
259038_at AT3G09210 PTAC13 1.5069318  
254727_at AT4G13670 PTAC5 1.5192653  
253251_at AT4G34730 ribosome-binding factor A family protein 2.0939846  
261801_at AT1G30520 AAE14 (Acyl-Activating Enzyme 14) 2.0332632  
264963_at AT1G60600 ABC4 1.7971622  
265998_at AT2G24270 ALDH11A3 1.8835961  
250133_at AT5G16400 ATF2; enzyme activator 1.7738445  
264383_at AT2G25080 ATGPX1 (GLUTATHIONE PEROXIDASE 1) 2.4333675  
252516_at AT3G46100 ATHRS1 (HISTIDYL-TRNA SYNTHETASE 1) 1.5882456  
249864_at AT5G22830 ATMGT10 (MAGNESIUM (MG) 2.0820243  
264641_at AT1G09130 ATP-dependent Clp protease proteolytic subunit 1.5446063  
261141_at AT1G19740 protease La (LON) domain-containing protein 1.9699486  
261118_at AT1G75460 protease La (LON) domain-containing protein 2.3165329  
254460_at AT4G21210 ATRP1 2.156923  
261751_at AT1G76080 CDSP32 1.8513979  
257222_at AT3G27925 DEGP1 (DegP protease 1) 1.8611999  
247401_at AT5G62790 DXR 1.7201169  
247637_at AT5G60600 HDS 1.7690102  
262612_at AT1G14150 oxygen evolving enhancer 3 (PsbQ) family protein 2.6030343  
258956_at AT3G01440 oxygen evolving enhancer 3 (PsbQ) family protein 1.5868988  
264781_at AT1G08540 RNA POLYMERASE SIGMA SUBUNIT 2 1.8304433  
250255_at AT5G13730 SIG4 (SIGMA FACTOR 4); DNA binding 1.7574803  
262879_at AT1G64860 SIGA (SIGMA FACTOR A); DNA binding 1.7211034  
251929_at AT3G53920 RNA POLYMERASE SIGMA-SUBUNIT C 1.9482684  
262526_at AT1G17050 SPS2 (Solanesyl diphosphate synthase 2) 1.6165422  
260036_at AT1G68830 STN7 (Stt7 homolog STN7) 2.2916005  
259707_at AT1G77490 TAPX 1.5298173  
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264185_at AT1G54780 thylakoid lumen 18.3 kDa protein 1.5544248  
248224_at AT5G53490 thylakoid lumenal 17.4 kDa protein, chloroplast 1.7080461  
251701_at AT3G56650 thylakoid lumenal 20 kDa protein 1.6188306  
264959_at AT1G77090 thylakoid lumenal 29.8 kDa protein 1.5188398  
255482_at AT4G02510 TOC159 1.5132418  
258607_at AT3G02730 TRXF1 (THIOREDOXIN F-TYPE 1) 2.0225306  
258398_at AT3G15360 TRX-M4 1.6238353  
267196_at AT2G30950 VAR2 (VARIEGATED 2) 2.064759  
Peroxisome 
262629_at AT1G06460 ALPHA-CRYSTALLIN DOMAIN 32.1 2.0360222  
267512_at AT2G45690 SSE1 (SHRUNKEN SEED 1) 1.6312973  
Vacuole 
251649_at AT3G57330 ACA11 (autoinhibited Ca2+-ATPase 11) 1.6595609  
250336_at AT5G11720 alpha-glucosidase 1 (AGLU1) 1.6601692  
257719_at AT3G18440 AtALMT9 1.9045236  
266782_at AT2G29120 ATGLR2.7 1.9702756  
256541_at AT1G42540 ATGLR3.3 1.8697137  
264587_at AT1G05200 ATGLR3.4 2.4336822  
Endoplasmic reticulum 
266326_at AT2G46650 CB5-C (CYTOCHROME B5 ISOFORM C) 2.8620958  
264655_at AT1G09070 SRC2 1.8971463  
267318_at AT2G34770 FAH1 (FATTY ACID HYDROXYLASE 1) 1.913421  
RNA processing 
250538_at AT5G08620 STRS2 (STRESS RESPONSE SUPPRESSOR 2) 1.9279337  
252679_at AT3G44260 CCR4-NOT transcription complex protein 1.5028583  
254475_at AT4G20440 smB 1.5297631  
251956_at AT3G53460 CP29; RNA binding / poly(U) binding 1.5359806  
266510_at AT2G47990 SWA1 (SLOW WALKER1); nucleotide binding 1.6792594  
261603_at AT1G49600 ATRBP47A 1.7240838  
245518_at AT4G15850 ATRH1 1.5379623  
259347_at AT3G03920 Gar1 RNA-binding region family protein 1.9525925  
264868_at AT1G24090 RNase H domain-containing protein 1.9281441  
262906_at AT1G59760 ATP-dependent RNA helicase, putative 1.5660385  
262931_at AT1G65700 small nuclear ribonucleoprotein, putative 2.4171515  
267627_at AT2G42270 U5 small nuclear ribonucleoprotein helicase 1.594383  
246139_at AT5G19900 PRLI-interacting factor A, putative 2.653985  
264255_at AT1G09140 SF2/ASF-like splicing modulator (SRP30) 1.5387652  
259666_at AT1G55310 SR33 1.537532  
254131_at AT4G24740 AFC2 1.6263895  
252100_at AT3G51110 crooked neck protein, putative 1.791988  
259585_at AT1G28090 polynucleotide adenylyltransferase family protein 1.5173122  
248106_at AT5G55100 SWAP (Suppressor-of-White-APricot) 1.9796064  
253095_at AT4G37510 ribonuclease III family protein 1.566916  
250367_s_at AT5G11170 /// AT5G11200 1.5078006  
260525_at AT2G47250 RNA helicase, putative 1.857975  
254679_at AT4G18120 AML3 (ARABIDOPSIS MEI2-LIKE 3) 1.6065916  
259147_at AT3G10360 APUM4 (Arabidopsis Pumilio 4); RNA binding 1.5701797  
245605_at AT4G14300 heterogeneous nuclear ribonucleoprotein, putative 1.5056263  
258643_at AT3G08010 ATAB2; RNA binding 1.5536424  
246493_at AT5G16180 CRS1 1.9728875  
263014_at AT1G23400 CAF2; RNA splicing factor 2.012493  
265484_at AT2G15820 OTP51 1.510979  
248815_at AT5G46920 intron maturase, type II family protein 2.1412392  
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261652_at AT1G01860 PFC1 (PALEFACE 1) 1.634756  
259919_at AT1G72560 PSD (PAUSED); nucleobase, nucleoside 1.6979415  
259825_at AT1G66260 RNA and export factor-binding protein, putative 1.5458808  
247653_at AT5G59950 RNA and export factor-binding protein, putative 1.9658543  
245512_at AT4G15770 RNA binding / protein binding 1.9107213  
258634_at AT3G08000 RNA-binding protein, putative 1.6864842  
253748_at AT4G28990 RNA-binding protein-related 4.348943  
253686_at AT4G29750 RNA binding 1.8572518  
255969_at AT1G22330 RNA binding / nucleic acid binding 1.6440358  
247669_at AT5G60170 RNA binding / nucleic acid binding 1.5959642  
255411_at AT4G03110 RNA-binding protein, putative 1.6956824  
248905_at AT5G46250 RNA recognition motif (RRM)-containing protein 1.5347974  
252588_at AT3G45630 RNA recognition motif (RRM)-containing protein 1.5952182  
259209_at AT3G09160 RNA recognition motif (RRM)-containing protein 1.6368687  
248063_at AT5G55550 RNA recognition motif (RRM)-containing protein 1.7624593  
259984_at AT1G76460 RNA recognition motif (RRM)-containing protein 1.7856083  
251857_at AT3G54770 RNA recognition motif (RRM)-containing protein 1.8461534  
264698_at AT1G70200 RNA recognition motif (RRM)-containing protein 1.9179306  
266002_at AT2G37310 pentatricopeptide (PPR) repeat-containing protein 1.5073009  
258991_at AT3G08820 pentatricopeptide (PPR) repeat-containing protein 1.5091655  
263143_at AT1G03100 pentatricopeptide (PPR) repeat-containing protein 1.5244429  
260620_at AT1G08070 pentatricopeptide (PPR) repeat-containing protein 1.5521516  
246383_at AT1G77360 pentatricopeptide (PPR) repeat-containing protein 1.5551617  
264946_at AT1G77010 pentatricopeptide (PPR) repeat-containing protein 1.5572852  
267445_at AT2G33680 pentatricopeptide (PPR) repeat-containing protein 1.5589457  
249529_at AT5G38730 pentatricopeptide (PPR) repeat-containing protein 1.5777707  
266998_at AT2G34400 pentatricopeptide (PPR) repeat-containing protein 1.5798099  
257607_at AT3G13880 pentatricopeptide (PPR) repeat-containing protein 1.5812722  
250115_at AT5G16420 pentatricopeptide (PPR) repeat-containing protein 1.5847099  
248803_at AT5G47460 pentatricopeptide (PPR) repeat-containing protein 1.5859282  
258174_at AT3G21470 pentatricopeptide (PPR) repeat-containing protein 1.5867025  
246262_at AT1G31790 pentatricopeptide (PPR) repeat-containing protein 1.5937449  
246249_at AT4G36680 pentatricopeptide (PPR) repeat-containing protein 1.6020479  
260224_at AT1G74400 pentatricopeptide (PPR) repeat-containing protein 1.604175  
252245_at AT3G49710 pentatricopeptide (PPR) repeat-containing protein 1.6170187  
260217_at AT1G74600 pentatricopeptide (PPR) repeat-containing protein 1.6176622  
261277_at AT1G20230 pentatricopeptide (PPR) repeat-containing protein 1.6180508  
259003_at AT3G02010 pentatricopeptide (PPR) repeat-containing protein 1.6270918  
250283_at AT5G13270 pentatricopeptide (PPR) repeat-containing protein 1.6287106  
249436_at AT5G39980 pentatricopeptide (PPR) repeat-containing protein 1.6441641  
250523_at AT5G08510 pentatricopeptide (PPR) repeat-containing protein 1.6479119  
249222_at AT5G42450 pentatricopeptide (PPR) repeat-containing protein 1.65056  
263719_at AT2G13600 pentatricopeptide (PPR) repeat-containing protein 1.6519275  
264739_at AT1G62260 pentatricopeptide (PPR) repeat-containing protein 1.6560229  
255153_at AT4G08210 pentatricopeptide (PPR) repeat-containing protein 1.6711028  
246458_at AT5G16860 pentatricopeptide (PPR) repeat-containing protein 1.6775078  
251583_at AT3G58590 pentatricopeptide (PPR) repeat-containing protein 1.6878772  
257395_at AT2G15630 pentatricopeptide (PPR) repeat-containing protein 1.7147502  
245620_at AT4G14050 pentatricopeptide (PPR) repeat-containing protein 1.7446529  
264666_at AT1G09680 pentatricopeptide (PPR) repeat-containing protein 1.7446606  
256919_at AT3G18970 pentatricopeptide (PPR) repeat-containing protein 1.7737354  
249965_at AT5G19020 pentatricopeptide (PPR) repeat-containing protein 1.8101655  
247550_at AT5G61370 pentatricopeptide (PPR) repeat-containing protein 1.8390801  
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257685_at AT3G12770 pentatricopeptide (PPR) repeat-containing protein 1.8735757  
253170_at AT4G35130 pentatricopeptide (PPR) repeat-containing protein 1.8928354  
259746_at AT1G71060 pentatricopeptide (PPR) repeat-containing protein 1.896853  
252899_at AT4G39530 pentatricopeptide (PPR) repeat-containing protein 1.9041903  
265931_at AT2G18520 pentatricopeptide (PPR) repeat-containing protein 1.9841715  
258088_at AT3G14580 pentatricopeptide (PPR) repeat-containing protein 2.0137677  
259945_at AT1G71460 pentatricopeptide (PPR) repeat-containing protein 2.0865412  
252386_at AT3G47840 pentatricopeptide (PPR) repeat-containing protein 2.105832  
248871_at AT5G46680 pentatricopeptide (PPR) repeat-containing protein 2.1581652  
256027_at AT1G34160 pentatricopeptide (PPR) repeat-containing protein 2.2145205  
245673_at AT1G56690 pentatricopeptide (PPR) repeat-containing protein 2.2939808  
246052_at AT5G08310 pentatricopeptide (PPR) repeat-containing protein 2.3351974  
259285_at AT3G11460 pentatricopeptide (PPR) repeat-containing protein 2.3613734  
253019_at AT4G38010 pentatricopeptide (PPR) repeat-containing protein 2.3969567  
247099_at AT5G66500 pentatricopeptide (PPR) repeat-containing protein 2.4061205  
257193_at AT3G13160 pentatricopeptide (PPR) repeat-containing protein 2.4998543  
249470_at AT5G39350 pentatricopeptide (PPR) repeat-containing protein 2.8430393  
248307_at AT5G52850 pentatricopeptide (PPR) repeat-containing protein 2.9527457  
266668_at AT2G29760 pentatricopeptide (PPR) repeat-containing protein 3.2904086  
246019_at AT5G10690 pentatricopeptide (PPR) repeat-containing protein  1.5256804  
253589_at AT4G30825 pentatricopeptide (PPR) repeat-containing protein 2.052063  
250164_at AT5G15280 pentatricopeptide (PPR) repeat-containing protein 1.5137926  
254483_at AT4G20740 pentatricopeptide (PPR) repeat-containing protein 1.5189918  
261762_at AT1G15510 pentatricopeptide (PPR) repeat-containing protein 1.6175226  
248640_at AT5G48910 pentatricopeptide (PPR) repeat-containing protein 1.6217076  
264177_at AT1G02150 pentatricopeptide (PPR) repeat-containing protein 1.7156695  
246901_at AT5G25630 pentatricopeptide (PPR) repeat-containing protein 1.7480935  
246572_at AT5G15010 pentatricopeptide (PPR) repeat-containing protein 1.7759691  
259295_at AT3G05340 pentatricopeptide (PPR) repeat-containing protein 1.8706292  
263550_at AT2G17033 pentatricopeptide (PPR) repeat-containing protein 1.8837788  
250257_at AT5G13770 pentatricopeptide (PPR) repeat-containing protein 2.0262036  
247100_at AT5G66520 pentatricopeptide (PPR) repeat-containing protein 2.0328872  
258804_at AT3G04760 pentatricopeptide (PPR) repeat-containing protein 2.049196  
246313_at AT1G31920 pentatricopeptide (PPR) repeat-containing protein 2.0515435  
258355_at AT3G14330 pentatricopeptide (PPR) repeat-containing protein 2.2108557  
249247_at AT5G42310 pentatricopeptide (PPR) repeat-containing protein 2.4218826  
253495_at AT4G31850 PGR3 (PROTON GRADIENT REGULATION 3) 4.0040317  
262658_at AT1G14220 ribonuclease T2 family protein 1.6136549  
DNA replication 
264674_at AT1G09815 POLD4 (POLYMERASE DELTA 4) 1.5576817  
248099_at AT5G55300 DNA TOPOISOMERASE I ALPHA 2.033682  
261471_at AT1G14460 DNA polymerase-related 1.5371673  
248891_at AT5G46280 DNA replication licensing factor, putative 1.7185278  
255513_at AT4G02060 PRL (PROLIFERA) MCM7; ATP binding 1.6089385  
266959_at AT2G07690 minichromosome maintenance family protein 1.6566215  
256374_at AT1G66730 ATP dependent DNA ligase family protein 1.6610441  
DNA repair 
248668_at AT5G48720 XRI1 (X-RAY INDUCED TRANSCRIPT 1) 1.652782  
256237_at AT3G12610 DRT100 1.5297197  
257701_at AT3G12710 methyladenine glycosylase family protein 2.0576632  
249848_at AT5G23220 NIC3 (NICOTINAMIDASE 3) 2.4771512  
248628_at AT5G48960 5' nucleotidase family protein 2.1187263  
259928_at AT1G34380 5'-3' exonuclease family protein 1.6525367  
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256077_at AT1G18090 exonuclease, putative 1.9185951  
265706_at AT2G03390 uvrB/uvrC motif-containing protein 1.6005719  
265707_at AT2G03390 uvrB/uvrC motif-containing protein 1.8039633  
266572_at AT2G23840 HNH endonuclease domain-containing protein 5.8171067  
258621_at AT3G02830 ZFN1 (ZINC FINGER PROTEIN 1) 1.6693206  
250128_at AT5G16540 ZFN3 (ZINC FINGER NUCLEASE 3) 1.5502117  
Chromatin&nuclear transport 
262600_at AT1G15340 MBD10; DNA binding / methyl-CpG binding 1.6571203  
255963_at AT1G22310 MBD8; methyl-CpG binding 1.508632  
253337_at AT4G33470 hda14 (histone deacetylase 14) 1.913197  
255843_at AT2G33540 CPL3 1.6693019  
258974_at AT3G01890 SWIB complex 1.671362  
263349_at AT2G13370 CHR5 1.7529496  
256091_at AT1G20693 HMGB2 1.7954547  
261782_at AT1G76110 high mobility group (HMG1/2) family protein 2.787873  
254233_at AT4G23800 high mobility group (HMG1/2) family protein 2.0431583  
257655_at AT3G13350 high mobility group (HMG1/2) family protein 1.8415569  
263412_at AT2G28720 histone H2B, putative 4.8085012  
252223_at AT3G49850 TRB3 transcription factor 1.5142031  
255718_at AT1G32070 ATNSI 1.7486756  
258333_at AT3G16000 MFP1 2.1555486  
259943_at AT1G71480 nuclear transport factor 2 (NTF2) family protein 2.4810266  
256852_at AT3G18610 ATRANGAP1 3.187492  
246061_at AT5G19320 RANGAP2 1.887825  
258085_at AT3G26100 regulator of chromosome condensation (RCC1) 2.2484763  
262375_at AT1G73100 SUVH3 (SU(VAR)3-9 HOMOLOG 3) 1.5443825  
265347_at AT2G22740 SUVH6; methyl-CpG binding 1.8774747  
259609_at AT1G52410 TSA1 (TSK-ASSOCIATING PROTEIN 1) 1.8927872  
253175_at AT4G35050 MSI3 (MULTICOPY SUPPRESSOR OF IRA1 3) 2.835047  
261130_at AT1G04870 PRMT10; methyltransferase 1.8114408  
257352_at AT2G34900 IMB1 (IMBIBITION-INDUCIBLE 1) 1.6762367  
266189_at AT2G39020 GCN5-related N-acetyltransferase 1.7571893  
265668_at AT2G32020 GCN5-related N-acetyltransferase 4.2181454  
253057_at AT4G37670 GCN5-related N-acetyltransferase 1.5850574  
266826_at AT2G22910 GCN5-related N-acetyltransferase 1.6283807  
253823_at AT4G28030 GCN5-related N-acetyltransferase 1.8288189  
Phospholipid/inositol signaling 
250848_at AT5G04510 PDK1 1.5635959  
252410_at AT3G47450 NOA1 (NO ASSOCIATED 1); GTPase 1.5326784  
251711_at AT3G56960 PIP5K4 1.6363449  
260636_at AT1G62430 ATCDS1; phosphatidate cytidylyltransferase 1.7991081  
262003_at AT1G64460 phosphatidylinositol 3- and 4-kinase 1.6059046  
259721_at AT1G60890 phosphatidylinositol-4-phosphate 5-kinase 1.5502559  
260466_at AT1G10900 phosphatidylinositol-4-phosphate 5-kinase f 2.6391344  
246180_at AT5G20840 phosphoinositide phosphatase family protein 1.7768534  
252737_at AT3G43220 phosphoinositide phosphatase family protein 1.8697897  
266693_at AT2G19800 MIOX2 (MYO-INOSITOL OXYGENASE 2) 2.580798  
258613_at AT3G02870 VTC4; 3'(2'),5'-bisphosphate nucleotidase 1.9894878  
GTPases/vesicle transport 
246524_at AT5G15860 ATPCME 1.6216416  
259398_at AT1G17700 PRA1.F1 2.7191083  
256785_at AT3G13720 PRA8 1.576094  
264395_at AT1G12070 Rho GDP-dissociation inhibitor family protein 1.8151741  
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247210_at AT5G65020 ANNAT2 (Annexin Arabidopsis 2) 1.569642  
253757_at AT4G28950 ROP9 1.9956322  
251960_at AT3G53610 ATRAB8; GTP binding 1.6453077  
259611_at AT1G52280 AtRABG3d 1.6104625  
259836_at AT1G52240 ROPGEF11 2.7483742  
245278_at AT4G17730 SYP23 (SYNTAXIN OF PLANTS 23) 1.5794866  
250740_at AT5G05760 SYP31 (SYNTAXIN OF PLANTS 31) 1.939873  
262695_at AT1G75850 VPS35B (VPS35 HOMOLOG B) 1.6601982  
Ca2/Calmodulin 
249583_at AT5G37770 TCH2 (TOUCH 2); calcium ion binding 1.7015792  
267083_at AT2G41100 TCH3 (TOUCH 3); calcium ion binding 2.7471566  
266421_at AT2G38540 LP1; calmodulin binding 1.5800452  
256129_at AT1G18210 calcium-binding protein, putative 2.0600157  
257024_at AT3G19100 calcium-dependent protein kinase, putative 1.5848745  
256839_at AT3G22930 calmodulin, putative 2.042213  
263795_at AT2G24610 ATCNGC14; calmodulin binding 1.8381972  
Polyamines 
245947_at AT5G19530 ACL5 (ACAULIS 5); spermine synthase 1.5266083  
246490_at AT5G15950 adenosylmethionine decarboxylase family protein 2.4277089  
Peptide factors & transporters 
247037_at AT5G67070 RALFL34 (ralf-like 34); signal transducer 1.711497  
247109_at AT5G65870 ATPSK5 (PHYTOSULFOKINE 5 PRECURSOR) 3.1584706  
247704_at AT5G59510 RTFL5 (ROTUNDIFOLIA LIKE 5) 4.6355066  
Transcription factors 
259908_at AT1G60850 ATRPAC42 1.5529155  
245569_at AT4G14660 NRPE7; DNA-directed RNA polymerase 1.7998123  
266135_at AT2G45100 RNA polymerase II transcription factor 1.5569211  
261942_at AT1G22590 AGL87 MADS-box family protein 2.1186974  
264148_at AT1G02220 ANAC003 1.9691254  
263584_at AT2G17040 anac036 1.6708747  
265260_at AT2G43000 anac042 2.356499  
250208_at AT5G14000 anac084 2.0146034  
258059_at AT3G29035 ATNAC3 1.9707448  
266175_at AT2G02450 ANAC035 1.5417438  
255585_at AT4G01550 anac069 1.872525  
264481_at AT1G77200 AP2 domain-containing transcription factor TINY 1.556843  
261327_at AT1G44830 AP2 domain-containing transcription factor TINY 1.7447348  
245173_at AT2G47520 AP2 domain-containing transcription factor 1.7755783  
255926_at AT1G22190 AP2 domain-containing transcription factor 2.0249312  
252859_at AT4G39780 AP2 domain-containing transcription factor 1.7038631  
260030_at AT1G68880 AtbZIP 2.1044636  
253064_at AT4G37730 AtbZIP7 1.5062675  
261114_at AT1G75390 AtbZIP44 1.5056126  
261815_at AT1G08320 bZIP family transcription factor 1.543994  
248208_at AT5G53980 ATHB52 2.7404675  
264974_at AT1G27050 ATHB54 1.7443026  
247182_at AT5G65410 HB25 (HOMEOBOX PROTEIN 25) 1.5300364  
261502_at AT1G14440 AtHB31 2.0245733  
257610_at AT3G13810 AtIDD11 2.073872  
252175_at AT3G50700 AtIDD2 1.7343242  
266120_at AT2G02070 AtIDD5 1.5172065  
248460_at AT5G50915 basic helix-loop-helix (bHLH) family protein 1.703447  
265034_at AT1G61660 basic helix-loop-helix (bHLH) family protein 1.8108397  
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263380_at AT2G40200 basic helix-loop-helix (bHLH) family protein 1.5832576  
247151_at AT5G65640 bHLH093 (beta HLH protein 93); DNA binding 2.2009866  
255579_at AT4G01460 basic helix-loop-helix (bHLH) family protein 1.63526  
259010_at AT3G07340 basic helix-loop-helix (bHLH) family protein 1.6697087  
261254_at AT1G05805 basic helix-loop-helix (bHLH) family protein 1.7145066  
254693_at AT4G17880 basic helix-loop-helix (bHLH) family protein 1.7788255  
248708_at AT5G48560 basic helix-loop-helix (bHLH) family protein 2.0067875  
265342_at AT2G18300 basic helix-loop-helix (bHLH) family protein 1.7024624  
248839_at AT5G46690 bHLH071 (beta HLH protein 71); DNA binding 1.9244549  
260451_at AT1G72360 ethylene-responsive element-binding protein 1.617021  
253746_at AT4G29100 ethylene-responsive family protein 1.8105271  
245362_at AT4G17460 HAT1; DNA binding / transcription factor 2.3220825  
251310_at AT3G61150 HDG1 (HOMEODOMAIN GLABROUS 1) 1.5354265  
248596_at AT5G49330 AtMYB111 (myb domain protein 111) 1.6339566  
252340_at AT3G48920 AtMYB45 (myb domain protein 45) 1.5394807  
266469_at AT2G31180 MYB14 (MYB DOMAIN PROTEIN 14) 1.5212485  
250099_at AT5G17300 myb family transcription factor 2.8898904  
259432_at AT1G01520 myb family transcription factor 1.8838267  
258724_at AT3G09600 myb family transcription factor 2.5073445  
258723_at AT3G09600 myb family transcription factor 3.297035  
246844_at AT5G26660 ATMYB86 (MYB DOMAIN PROTEIN 86) 1.7160784  
259379_at AT3G16350 myb family transcription factor 1.8814117  
248795_at AT5G47390 myb family transcription factor 1.7743194  
257698_at AT3G12730 myb family transcription factor 1.6269206  
247768_at AT5G58900 myb family transcription factor 1.6375049  
257645_at AT3G25790 myb family transcription factor 1.5123316  
255734_at AT1G25550 myb family transcription factor 1.840429  
250810_at AT5G05090 myb family transcription factor 1.9910599  
259365_at AT1G13300 myb family transcription factor 4.1732154  
250031_at AT5G18240 MYR1 (MYb-related protein 1) 1.510424  
249908_at AT5G22760 PHD finger family protein 1.610588  
258628_at AT3G02890 PHD finger protein-related 1.8801025  
250287_at AT5G13330 Rap2.6L (related to AP2 6L); DNA binding 4.3569613  
245966_at AT5G19790 RAP2.11 (related to AP2 11); DNA binding 1.6788306  
245237_at AT4G25520 SLK1 (SEUSS-LIKE 1); transcription regulator 1.5682606  
258326_at AT3G22760 SOL1; transcription factor 1.7401745  
267515_at AT2G45680 TCP family transcription factor, putative 1.8550841  
246011_at AT5G08330 TCP family transcription factor, putative 1.6977603  
256528_at AT1G66140 ZFP4 (ZINC FINGER PROTEIN 4) 1.5335499  
252009_at AT3G52800 zinc finger (AN1-like) family protein 1.6548063  
252924_at AT4G39070 zinc finger (B-box type) family protein 1.9309287  
257262_at AT3G21890 zinc finger (B-box type) family protein 1.9225402  
263739_at AT2G21320 zinc finger (B-box type) family protein 1.657842  
260431_at AT1G68190 zinc finger (B-box type) family protein 1.8366189  
266514_at AT2G47890 zinc finger (B-box type) family protein 1.9897336  
250119_at AT5G16470 zinc finger (C2H2 type) family protein 2.5470488  
258623_at AT3G02790 zinc finger (C2H2 type) family protein 5.1235013  
262969_at AT1G75710 zinc finger (C2H2 type) family protein 1.6278341  
Protein kinases 
261089_at AT1G07570 APK1A; kinase/ protein serine/threonine kinase 1.7313291  
261460_at AT1G07880 ATMPK13; MAP kinase/ kinase 1.808909  
260979_at AT1G53510 ATMPK18; MAP kinase 1.7666793  
256075_at AT1G18150 ATMPK8; MAP kinase 2.0078351  
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257771_at AT3G23000 CBL-INTERACTING PROTEIN KINASE 7 1.5217613  
247867_at AT5G57630 CIPK21 (CBL-interacting protein kinase 21) 2.248663  
258300_at AT3G23340 ckl10 (Casein Kinase I-like 10) 2.1701007  
267013_at AT2G39180 CCR2 1.6185986  
252378_at AT3G47570 leucine-rich repeat transmembrane protein kinase 1.6995085  
263913_at AT2G36570 leucine-rich repeat transmembrane protein kinase 1.9117078  
266663_at AT2G25790 leucine-rich repeat transmembrane protein kinase 2.142215  
259853_at AT1G72300 leucine-rich repeat transmembrane protein kinase 1.8671305  
248568_at AT5G49760 leucine-rich repeat family protein 1.553019  
256168_at AT1G51805 leucine-rich repeat protein kinase, putative 2.4942102  
253278_at AT4G34220 leucine-rich repeat transmembrane protein kinase 2.0262556  
261501_at AT1G28390 protein kinase family protein 1.8577633  
254869_at AT4G11890 protein kinase family protein 2.8670754  
258323_at AT3G22750 protein kinase, putative 1.6658193  
251621_at AT3G57700 protein kinase, putative 1.735013  
264284_at AT1G61860 protein kinase, putative 1.7510844  
252511_at AT3G46280 protein kinase-related 2.1890807  
256366_at AT1G66880 serine/threonine protein kinase family protein 2.0800824  
260728_at AT1G48210 serine/threonine protein kinase, putative 1.9111878  
251251_at AT3G62220 serine/threonine protein kinase, putative 2.1767385  
255488_at AT4G02630 protein kinase family protein 1.5342959  
251500_at AT3G59110 protein kinase family protein 1.549877  
256121_at AT1G18160 protein kinase family protein 1.5619036  
254251_at AT4G23300 protein kinase family protein 1.6193614  
260759_at AT1G49180 protein kinase family protein 1.6259619  
266080_at AT2G37840 protein kinase family protein 1.7070556  
255266_at AT4G05200 protein kinase family protein 1.8416061  
254242_at AT4G23200 protein kinase family protein 2.0038257  
254250_at AT4G23290 protein kinase family protein 2.4042754  
254931_at AT4G11460 protein kinase family protein 2.685335  
264240_at AT1G54820 protein kinase family protein 2.7370358  
247918_at AT5G57610 protein kinase family protein 1.6276243  
259671_at AT1G52290 protein kinase family protein 1.9044886  
255913_at AT1G66980 protein kinase family protein 2.004721  
267289_at AT2G23770 protein kinase family protein 1.5568035  
246371_at AT1G51940 protein kinase family protein 1.7363354  
248541_at AT5G50180 protein kinase, putative 1.5056021  
259887_at AT1G76360 protein kinase, putative 1.5181779  
267582_at AT2G41970 protein kinase, putative 1.9182208  
264767_at AT1G61380 SD1-29 (S-DOMAIN-1 29); carbohydrate binding 2.0148027  
262507_at AT1G11330 S-locus lectin protein kinase family protein 1.9403054  
265063_at AT1G61500 S-locus protein kinase, putative 1.5024632  
264754_at AT1G61400 S-locus protein kinase, putative 1.6865728  
259958_at AT1G53730 SRF6 (STRUBBELIG-RECEPTOR FAMILY 6) 2.0502498  
Protein phosphatases 
254923_at AT4G11240 TOPP7; protein serine/threonine phosphatase 1.7090288  
245194_at AT1G67820 protein phosphatase 2C, putative 1.9210184  
253834_at AT4G27800 protein phosphatase 2C PPH1 1.5257212  
246756_at AT5G27930 protein phosphatase 2C, putative 1.5112001  
256441_at AT3G10940 protein phosphatase-related 1.6026099  
Protein folding 
264947_at AT1G77020 DNAJ heat shock family protein 1.7164258  
252828_at AT4G39960 DNAJ heat shock family protein 1.5275946  
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247274_at AT5G64360 DNAJ heat shock family protein 1.5252781  
246817_at AT5G27240 DNAJ heat shock family protein 1.5880448  
245182_at AT5G12430 DNAJ heat shock family protein 1.7582313  
262194_at AT1G77930 DNAJ heat shock family protein 1.7883136  
255088_at AT4G09350 DNAJ heat shock family protein 2.1596444  
256221_at AT1G56300 DNAJ heat shock family protein 4.2814126  
252935_at AT4G39150 DNAJ heat shock family protein 1.5649503  
247733_at AT5G59610 DNAJ heat shock family protein 1.571172  
263985_at AT2G42750 DNAJ heat shock family protein 1.786167  
254458_at AT4G21180 ATERDJ2B; heat shock protein binding 1.5462997  
256088_at AT1G20810 immunophilin 1.7826933  
260542_at AT2G43560 immunophilin 1.9552286  
245266_at AT4G17070 peptidyl-prolyl cis-trans isomerase 2.013094  
264019_at AT2G21130 peptidyl-prolyl cis-trans isomerase 2.0560675  
248657_at AT5G48570 peptidyl-prolyl cis-trans isomerase, putative 3.1617744  
Proteasome & Ubiquitin 
251975_at AT3G53230 cell division cycle protein 48, putative 1.5332229  
267524_at AT2G30600 BTB/POZ domain-containing protein 3.4518275  
267523_at AT2G30600 BTB/POZ domain-containing protein 3.7407467  
260058_at AT1G78100 F-box family protein 1.5808727  
262552_at AT1G31350 F-box family protein 1.6987662  
257574_at AT3G20710 F-box protein-related 2.242951  
253945_at AT4G27050 F-box family protein 1.5262641  
267116_at AT2G32560 F-box family protein 1.5755385  
248586_at AT5G49610 F-box family protein 1.6213635  
257530_at AT3G03040 F-box family protein 1.6251596  
264539_at AT1G55590 F-box family protein 1.6748185  
248016_at AT5G56380 F-box family protein 1.6967508  
263556_at AT2G16365 F-box family protein 1.8947537  
257447_at AT2G04230 F-box family protein 2.8588653  
259067_at AT3G07550 F-box family protein (FBL12) 1.5127964  
257476_at AT1G80960 F-box protein-related 2.1671615  
254078_at AT4G25710 kelch repeat-containing F-box family protein 1.5405915  
262986_at AT1G23390 kelch repeat-containing F-box family protein 1.6843773  
252902_at AT4G39560 kelch repeat-containing F-box family protein 1.7246557  
266522_at AT2G16920 UBIQUITIN-CONJUGATING ENZYME 23 1.5000073  
256302_at AT1G69526 UbiE/COQ5 methyltransferase family protein 1.596123  
251530_at AT3G58520 ubiquitin thiolesterase 1.7568686  
255062_at AT4G08940 ubiquitin thiolesterase 1.60702  
258757_at AT3G10910 zinc finger (C3HC4-type RING finger) 1.6293161  
260770_at AT1G49200 zinc finger (C3HC4-type RING finger) 2.4817007  
248759_at AT5G47610 zinc finger (C3HC4-type RING finger) 3.4940007  
256093_at AT1G20823 zinc finger (C3HC4-type RING finger) 2.062815  
251454_at AT3G60080 zinc finger (C3HC4-type RING finger) 1.5951785  
266187_at AT2G38970 zinc finger (C3HC4-type RING finger) 1.5343205  
254349_at AT4G22250 zinc finger (C3HC4-type RING finger) 1.6796992  
246135_at AT5G20885 zinc finger (C3HC4-type RING finger) 1.7410158  
252751_at AT3G43430 zinc finger (C3HC4-type RING finger) 2.1931489  
249306_at AT5G41400 zinc finger (C3HC4-type RING finger) 2.2985487  
247615_at AT5G60250 zinc finger (C3HC4-type RING finger) 4.802965  
245329_at AT4G14365 zinc finger (C3HC4-type RING finger) 4.342832  
261376_at AT1G18660 zinc finger (C3HC4-type RING finger) 1.5307248  
259854_at AT1G72200 zinc finger (C3HC4-type RING finger) 1.6281432  
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261927_at AT1G22500 zinc finger (C3HC4-type RING finger) 1.9429344  
251314_at AT3G61180 zinc finger (C3HC4-type RING finger) 1.5479137  
260065_at AT1G73760 zinc finger (C3HC4-type RING finger) 1.6711143  
253539_at AT4G31450 zinc finger (C3HC4-type RING finger) 1.8673947  
255899_at AT1G17970 zinc finger (C3HC4-type RING finger) 1.8794426  
250005_at AT5G18760 zinc finger (C3HC4-type RING finger) 1.9176422  
249862_at AT5G22920 zinc finger (C3HC4-type RING finger) 1.9700798  
Proteolysis & proteases & protease inibitors 
250445_at AT5G10760 aspartyl protease family protein 1.5217872  
267592_at AT2G39710 aspartyl protease family protein 1.6254832  
261055_at AT1G01300 aspartyl protease family protein 1.9559478  
264741_at AT1G62290 aspartyl protease family protein 1.7775321  
248703_at AT5G48430 aspartic-type endopeptidase 1.521327  
253331_at AT4G33490 aspartic-type endopeptidase 1.5626373  
252241_at AT3G50050 aspartyl protease family protein 1.7069743  
261346_at AT1G79720 aspartyl protease family protein 2.0014377  
261224_at AT1G20160 ATSBT5.2; identical protein binding 2.889159  
247755_at AT5G59090 ATSBT4.12; identical protein binding 2.5497518  
246250_at AT4G36880 CP1 (CYSTEINE PROTEINASE1) 3.8489614  
265665_at AT2G27420 cysteine proteinase, putative 2.452016  
245483_at AT4G16190 cysteine proteinase, putative 1.5363972  
258005_at AT3G19390 cysteine proteinase, putative 1.5550758  
257646_at AT3G25740 MAP1B 1.6214749  
260475_at AT1G11080 scpl31 (serine carboxypeptidase-like 31) 1.7012368  
250517_at AT5G08260 scpl35 (serine carboxypeptidase-like 35) 3.1574316  
249216_at AT5G42240 scpl42 (serine carboxypeptidase-like 42) 2.0076272  
258923_at AT3G10450 SCPL7 (SERINE CARBOXYPEPTIDASE-LIKE 
7) 
1.7247046  
267264_at AT2G22970 serine carboxypeptidase S10 family protein 1.5056872  
249860_at AT5G22860 serine carboxypeptidase S28 family protein 2.0274544  
267265_at AT2G22980 serine-type carboxypeptidase 4.6234756  
NAD/P & ATP 
259632_at AT1G56430 NAS4 1.5032372  
264261_at AT1G09240 NAS3 3.2997446  
250498_at AT5G09660 PMDH2 2.1253552  
258998_at AT3G01820 adenylate kinase family protein 2.0053797  
246651_at AT5G35170 adenylate kinase family protein 2.4979532  
255299_at AT4G04880 adenosine/AMP deaminase family protein 1.549504  
252507_at AT3G46200 aTNUDT9 1.5809423  
247902_at AT5G57350 AHA3; ATPase/ hydrogen-exporting ATPase 1.7663449  
Purine&pyrimidine 
257680_at AT3G20330 aspartate carabmoyltransferase 1.6754414  
263239_at AT2G16570 ATASE1 1.6666312  
265943_at AT2G19570 CDA1 (CYTIDINE DEAMINASE 1) 1.6279646  
255529_at AT4G02120 CTP synthase, putative 1.5005956  
255310_at AT4G04955 ATALN (Arabidopsis allantoinase) 2.4221842  
263929_at AT2G36310 URH1 (URIDINE-RIBOHYDROLASE 1) 1.6056547  
Glycolysis/Gluconeogenesis 
250868_at AT5G03860 MLS (MALATE SYNTHASE); malate synthase 2.652906  
248138_at AT5G54960 PDC2 (pyruvate decarboxylase-2) 1.5255806  
252300_at AT3G49160 pyruvate kinase family protein 2.3063116  
262309_at AT1G70820 phosphoglucomutase, putative 6.04787  
247278_at AT5G64380 fructose-1,6-bisphosphatase family protein 1.5337827  
260837_at AT1G43670 fructose-1,6-bisphosphatase, putative 2.143109  
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251885_at AT3G54050 fructose-1,6-bisphosphatase, putative 1.6180179  
253971_at AT4G26530 fructose-bisphosphate aldolase, putative 4.485955  
253966_at AT4G26520 fructose-bisphosphate aldolase, cytoplasmic 1.984834  
247534_at AT5G61580 PFK4 (PHOSPHOFRUCTOKINASE 4) 1.5317184  
249694_at AT5G35790 G6PD1 1.9046711  
257144_at AT3G27300 G6PD5 (glucose-6-phosphate dehydrogenase 5) 1.5540537  
263954_at AT2G35840 sucrose-phosphatase 1 (SPP1) 1.6511269  
255016_at AT4G10120 ATSPS4F; sucrose-phosphate synthase 5.9214377  
256745_at AT3G29360 UDP-glucose 6-dehydrogenase, putative 1.5009668  
249469_at AT5G39320 UDP-glucose 6-dehydrogenase, putative 2.0031774  
252387_at AT3G47800 aldose 1-epimerase family protein 2.0090683  
Carbohydrate transport 
258869_at AT3G03090 AtVGT1 1.7495905  
247529_at AT5G61520 hexose transporter, putative 1.5755159  
257805_at AT3G18830 ATPLT5 (POLYOL TRANSPORTER 5) 1.7274072  
264400_at AT1G61800 GPT2; antiporter 7.832648  
246831_at AT5G26340 MSS1;STP13 1.8323759  
260143_at AT1G71880 SUC1 (Sucrose-proton symporter 1) 2.2869253  
260170_at AT1G71890 SUC5 2.0198724  
246783_at AT5G27360 SFP2 1.7462044  
Carbohydrate metabolism 
246829_at AT5G26570 ATGWD3; carbohydrate kinase 1.9452636  
254153_at AT4G24450 PWD (PHOSPHOGLUCAN, WATER 
DIKINASE) 
1.6267337  
245094_at AT2G40840 DPE2 (DISPROPORTIONATING ENZYME 2) 2.207608  
247094_at AT5G66280 GMD1 1.6792704  
266542_at AT2G35100 ARAD1 (ARABINAN DEFICIENT 1); 1.622582  
248976_at AT5G44930 ARAD2 (ARABINAN DEFICIENT 2); catalytic 1.9975545  
258507_at AT3G06500 beta-fructofuranosidase, putative 1.8309476  
265118_at AT1G62660 beta-fructosidase (BFRUCT3) 1.7112507  
256150_at AT1G55120 ATFRUCT5  1.6028806  
266157_at AT2G28100 ATFUC1 (alpha-L-fucosidase 1) 1.5503463  
260412_at AT1G69830 AMY3 (ALPHA-AMYLASE-LIKE 3) 2.549348  
250007_at AT5G18670 BMY3; beta-amylase/ catalytic/ cation binding 2.3159528  
264360_at AT1G03310 isoamylase, putative 2.199659  
246036_at AT5G08370 AtAGAL2 1.6113108  
245970_at AT5G20710 BGAL7 (beta-galactosidase 7) 2.3285499  
251996_at AT3G52840 BGAL2 (beta-galactosidase 2) 1.8747517  
247954_at AT5G56870 BGAL4 (beta-galactosidase 4) 2.6326864  
264978_at AT1G27120 galactosyltransferase family protein 1.680923  
252179_at AT3G50760 GATL2 (Galacturonosyltransferase-like 2) 1.715082  
255506_at AT4G02130 GATL6 1.64277  
251308_at AT3G61130 GAUT1 1.6645654  
248721_at AT5G47780 GAUT4 (Galacturonosyltransferase 4) 1.6035274  
251625_at AT3G57260 BGL2 (BETA-1,3-GLUCANASE 2) 1.5211234  
262118_at AT1G02850 BGLU11 (BETA GLUCOSIDASE 11) 2.7080963  
259640_at AT1G52400 BGLU18 (BETA GLUCOSIDASE 18) 1.8079282  
259173_at AT3G03640 BGLU25 (BETA GLUCOSIDASE 25) 2.1093333  
267645_at AT2G32860 BGLU33 (BETA GLUCOSIDASE 33) 2.7025967  
264280_at AT1G61820 BGLU46 (BETA GLUCOSIDASE 46) 2.9840348  
251230_at AT3G62750 BGLU8 (BETA GLUCOSIDASE 8) 2.3539953  
253835_at AT4G27820 BGLU9 (BETA GLUCOSIDASE 9) 1.6861207  
255517_at AT4G02290 AtGH9B13 1.8932191  
267595_at AT2G32990 AtGH9B8 1.5996066  
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260727_at AT1G48100 glycoside hydrolase family 28 protein 1.8607668  
258252_at AT3G15720 glycoside hydrolase family 28 protein 2.7296567  
260024_at AT1G30080 glycosyl hydrolase family 17 protein 1.7346468  
254536_at AT4G19720 glycosyl hydrolase family 18 protein 1.626181  
254544_at AT4G19820 glycosyl hydrolase family 18 protein 1.9479955  
254543_at AT4G19810 glycosyl hydrolase family 18 protein 4.4973717  
262181_at AT1G78060 glycosyl hydrolase family 3 protein 1.554483  
246184_at AT5G20950 glycosyl hydrolase family 3 protein 2.085196  
254575_at AT4G19460 glycosyl transferase family 1 protein 1.8447405  
248209_at AT5G53990 glycosyltransferase family protein 1.5361376  
260758_at AT1G48930 AtGH9C1 2.6073966  
249092_at AT5G43710 glycoside hydrolase family 47 protein 1.5484738  
257651_at AT3G16850 glycoside hydrolase family 28 protein 1.603693  
258528_at AT3G06770 glycoside hydrolase family 28 protein 1.6771386  
245039_at AT2G26600 glycosyl hydrolase family 17 protein 1.6142402  
264291_at AT1G78800 glycosyl transferase family 1 protein 1.8463682  
258917_at AT3G10630 glycosyl transferase family 1 protein 2.1696525  
265366_at AT2G13290 glycosyl transferase family 17 protein 1.8340052  
248622_at AT5G49360 BXL1 (BETA-XYLOSIDASE 1) 1.6894671  
257031_at AT3G19280 FUT11 (FUCOSYLTRANSFERASE 11) 1.5223789  
263847_at AT2G36970 UDP-glucoronosyl/UDP-glucosyl transferase 1.7329249  
245543_at AT4G15260 UDP-glucoronosyl/UDP-glucosyl transferase 1.8843406  
256252_at AT3G11340 UDP-glucoronosyl/UDP-glucosyl transferase 1.9577701  
248563_at AT5G49690 UDP-glucoronosyl/UDP-glucosyl transferase 1.9946315  
257954_at AT3G21760 UDP-glucoronosyl/UDP-glucosyl transferase 2.0197349  
267300_at AT2G30140 UDP-glucoronosyl/UDP-glucosyl transferase 2.2144022  
266532_at AT2G16890 UDP-glucoronosyl/UDP-glucosyl transferase 2.3206918  
261046_at AT1G01390 UDP-glucoronosyl/UDP-glucosyl transferase 3.0298839  
263231_at AT1G05680 UDP-glucoronosyl/UDP-glucosyl transferase 5.0169525  
245624_at AT4G14090 UDP-glucoronosyl/UDP-glucosyl transferase 1.6590099  
260955_at AT1G06000 UDP-glucoronosyl/UDP-glucosyl transferase 2.204128  
250751_at AT5G05890 UDP-glucoronosyl/UDP-glucosyl transferase 1.7943444  
257949_at AT3G21750 UGT71B1 2.4135714  
257950_at AT3G21780 UGT71B6 1.552376  
266669_at AT2G29750 UGT71C1 1.7044555  
256053_at AT1G07260 UGT71C3 1.5891291  
252183_at AT3G50740 UGT72E1 1.5287923  
264873_at AT1G24100 UGT74B1 1.5307554  
263184_at AT1G05560 UGT75B1 2.6724622  
250753_at AT5G05860 UGT76C2 2.0751503  
252487_at AT3G46660 UGT76E12 1.5816128  
247731_at AT5G59590 UGT76E2 1.5657152  
261804_at AT1G30530 UGT78D1 2.0900228  
246468_at AT5G17050 UGT78D2 2.0821283  
245352_at AT4G15490 UGT84A3; UDP-glycosyltransferase 1.5146614  
Trehalose 
260059_at AT1G78090 ATTPPB 2.1498985  
264339_at AT1G70290 ATTPS8 1.7521074  
252858_at AT4G39770 trehalose-6-phosphate phosphatase, putative 1.7632717  
Fatty acid synthesis, catabolism and transport 
260869_at AT1G43800 acyl-(acyl-carrier-protein) desaturase, putative 4.5019956  
258312_at AT3G16170 acyl-activating enzyme 13 (AAE13) 1.6488922  
266865_at AT2G29980 FAD3 (FATTY ACID DESATURASE 3) 1.7060461  
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245612_at AT4G14440 HCD1 1.9412233  
253285_at AT4G34250 KCS16 (3-KETOACYL-COA SYNTHASE 16) 1.71248  
259737_at AT1G64400 long-chain-fatty-acid--CoA ligase, putative 1.6898856  
260531_at AT2G47240 long-chain-fatty-acid--CoA ligase family protein 2.0547917  
267606_at AT2G26640 KCS11 (3-KETOACYL-COA SYNTHASE 11) 1.8931756  
245621_at AT4G14070 AAE15 (acyl-activating enzyme 15) 1.5558914  
264442_at AT1G27480 lecithin 2.0542965  
264613_at AT1G04640 LIP2 (LIPOYLTRANSFERASE 2) 1.649436  
248625_at AT5G48880 PKT2 2.8749459  
267496_at AT2G30550 lipase class 3 family protein 1.6232135  
258374_at AT3G14360 lipase class 3 family protein 1.8058681  
249999_at AT5G18640 lipase class 3 family protein 1.5248324  
249777_at AT5G24210 lipase class 3 family protein 1.7760361  
250008_at AT5G18630 lipase class 3 family protein 2.195962  
260393_at AT1G73920 lipase family protein 1.766429  
266816_at AT2G44970 lipase-related 3.9567423  
258589_at AT3G04290 LTL1 (LI-TOLERANT LIPASE 1) 1.8136711  
253344_at AT4G33550 lipid binding 2.9099202  
251065_at AT5G01870 lipid transfer protein, putative 5.909604  
267382_at AT2G44300 lipid transfer protein-related 2.6288798  
253553_at AT4G31050 lipoyltransferase (LIP2p) 1.5903158  
266415_at AT2G38530 LTP2 (LIPID TRANSFER PROTEIN 2 3.9623423  
247717_at AT5G59320 LTP3 (LIPID TRANSFER PROTEIN 3) 21.705334  
247718_at AT5G59310 LTP4 (LIPID TRANSFER PROTEIN 4) 1.8322208  
258675_at AT3G08770 LTP6; lipid binding 2.612193  
266168_at AT2G38870 protease inhibitor, putative 4.2506547  
265334_at AT2G18370 protease inhibitor/seed storage 2.0629373  
256937_at AT3G22620 protease inhibitor/seed storage 1.7680497  
254314_at AT4G22470 protease inhibitor/seed storage 1.9724306  
265656_at AT2G13820 protease inhibitor/seed storage 1.8205943  
254819_at AT4G12500 protease inhibitor/seed storage 2.628665  
266098_at AT2G37870 protease inhibitor/seed storage 3.3837452  
257066_at AT3G18280 protease inhibitor/seed storage 7.4893746  
254818_at AT4G12470 protease inhibitor/seed storage 2.7255445  
254832_at AT4G12490 protease inhibitor/seed storage 5.130086  
265111_at AT1G62510 protease inhibitor/seed storage 9.515188  
Cell wall 
265870_at AT2G01660 PDLP6 1.5154395  
260666_at AT1G19300 PARVUS (PARVUS) 1.5303742  
256825_at AT3G22120 CWLP 2.2254286  
266070_at AT2G18660 EXLB3 (EXPANSIN-LIKE B3 PRECURSOR) 1.8645772  
258003_at AT3G29030 EXPA5 (EXPANSIN A5) 2.082306  
263183_at AT1G05570 CALS1 (CALLOSE SYNTHASE 1) 1.7404894  
264146_at AT1G02205 CER1 (ECERIFERUM 1) 1.8760643  
253309_at AT4G33790 CER4 (ECERIFERUM 4) 1.6279298  
245228_at AT3G29810 COBL2 1.6580914  
245463_at AT4G17030 ATEXLB1 2.7514064  
261266_at AT1G26770 ATEXPA10 3.696503  
261226_at AT1G20190 ATEXPA11 3.385156  
258877_at AT3G03220 ATEXPA13 1.6513553  
255591_at AT4G01630 ATEXPA17 1.9336042  
253008_at AT4G38210 ATEXPA20 2.0299609  
267590_at AT2G39700 ATEXPA4 2.6575708  
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250992_at AT5G02260 ATEXPA9 1.5455763  
253815_at AT4G28250 ATEXPB3 2.0838115  
259525_at AT1G12560 ATEXPA7 1.8323361  
261099_at AT1G62980 ATEXPA18 1.9021115  
264960_at AT1G76930 ATEXT4 (EXTENSIN 4) 3.1801293  
245172_at AT2G47540 pollen Ole e 1 allergen and extensin 1.9031395  
250778_at AT5G05500 pollen Ole e 1 allergen and extensin 2.5833094  
255516_at AT4G02270 pollen Ole e 1 allergen and extensin 4.169347  
255080_at AT4G09030 AGP10 (ARABINOGALACTAN PROTEIN 10) 3.1623778  
253050_at AT4G37450 AGP18 (ARABINOGALACTAN PROTEIN 18) 1.9972172  
250002_at AT5G18690 AGP25 (ARABINOGALACTAN PROTEINS 25) 2.69579  
259550_at AT1G35230 AGP5 (ARABINOGALACTAN-PROTEIN 5) 1.5789971  
253957_at AT4G26320 AGP13 (arabinogalactan protein 13) 2.258545  
247965_at AT5G56540 AGP14 (ARABINOGALACTAN PROTEIN 14) 2.5982463  
248252_at AT5G53250 AGP22 (ARABINOGALACTAN PROTEIN 22) 3.2308464  
252833_at AT4G40090 AGP3 (arabinogalactan-protein 3) 2.3126295  
267457_at AT2G33790 AGP30 (ARABINOGALACTAN PROTEIN30) 3.435346  
246494_at AT5G16190 ATCSLA11; cellulose synthase 1.6844583  
265175_at AT1G23480 ATCSLA03  1.6370784  
265824_at AT2G35650 ATCSLA07 2.3389857  
251771_at AT3G56000 ATCSLA14 1.8989464  
248074_at AT5G55730 FLA1 1.5616577  
251395_at AT2G45470 FLA8 1.5586822  
249037_at AT5G44130 FLA13 3.4579248  
263376_at AT2G20520 FLA6 2.263993  
246004_at AT5G20630 GER3 (GERMIN 3); oxalate oxidase 1.9572812  
258938_at AT3G10080 germin-like protein, putative 1.9408653  
259478_at AT1G18980 germin-like protein, putative 2.8674588  
249476_at AT5G38910 germin-like protein, putative 8.380431  
259481_at AT1G18970 GLP4 (GERMIN-LIKE PROTEIN 4) 5.06411  
245567_at AT4G14630 GLP9 (GERMIN-LIKE PROTEIN 9) 3.448522  
254667_at AT4G18280 glycine-rich cell wall protein-related 1.6245792  
248862_at AT5G46730 glycine-rich protein 1.6213721  
261175_at AT1G04800 glycine-rich protein 1.7162492  
247541_at AT5G61660 glycine-rich protein 1.7663068  
253754_at AT4G29020 glycine-rich protein 2.0318565  
265511_at AT2G05540 glycine-rich protein 2.1505394  
254372_at AT4G21620 glycine-rich protein 2.2371469  
253629_at AT4G30450 glycine-rich protein 2.5668898  
253619_at AT4G30460 glycine-rich protein 3.0163438  
248817_at AT5G47020 glycine-rich protein 1.642331  
260007_at AT1G67870 glycine-rich protein 2.4513614  
267307_at AT2G30210 LAC3 (laccase 3); laccase 2.476108  
245706_at AT5G04310 pectate lyase family protein 1.528304  
248681_at AT5G48900 pectate lyase family protein 1.5509996  
245196_at AT1G67750 pectate lyase family protein 2.0206754  
258719_at AT3G09540 pectate lyase family protein 1.8806776  
248968_at AT5G45280 pectinacetylesterase, putative 1.6098166  
258888_at AT3G05620 pectinesterase family protein 1.5248581  
250490_at AT5G09760 pectinesterase family protein 1.5270602  
245965_at AT5G19730 pectinesterase family protein 1.6973633  
245052_at AT2G26440 pectinesterase family protein 1.7286155  
252740_at AT3G43270 pectinesterase family protein 1.7565587  
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250801_at AT5G04960 pectinesterase family protein 4.809166  
254573_at AT4G19420 pectinacetylesterase family protein 1.5066277  
249807_at AT5G23870 pectinacetylesterase family protein 1.8397686  
255524_at AT4G02330 ATPMEPCRB; pectinesterase 7.306496  
265246_at AT2G43050 ATPMEPCRD; enzyme inhibitor/ pectinesterase 2.6203375  
245151_at AT2G47550 pectinesterase family protein 1.6860898  
258765_at AT3G10710 pectinesterase family protein 1.7154429  
261834_at AT1G10640 polygalacturonase 2.8944  
262060_at AT1G80170 polygalacturonase, putative / pectinase, putative 1.6547911  
264007_at AT2G21140 ATPRP2 (PROLINE-RICH PROTEIN 2) 1.5851905  
252971_at AT4G38770 PRP4 (PROLINE-RICH PROTEIN 4) 1.7655076  
256352_at AT1G54970 ATPRP1 (PROLINE-RICH PROTEIN 1) 2.3563738  
251226_at AT3G62680 PRP3 (PROLINE-RICH PROTEIN 3) 3.558396  
251843_x_at AT3G54590 ATHRGP1 1.5639538  
245874_at AT1G26250 proline-rich extensin, putative 3.6301239  
246652_at AT5G35190 proline-rich extensin-like family protein 4.0810804  
254559_at AT4G19200 proline-rich family protein 1.6451728  
245479_at AT4G16140 proline-rich family protein 2.0561793  
265411_at AT2G16630 proline-rich family protein 2.5081246  
260335_at AT1G74000 SS3 (STRICTOSIDINE SYNTHASE 3) 1.7864653  
246682_at AT5G33290 XGD1 1.8007371  
264157_at AT1G65310 XTH17 1.8919324  
253608_at AT4G30290 XTH19 4.8782287  
254042_at AT4G25810 XTR6 2.1154673  
254044_at AT4G25820 XTR9 5.1012073  
253763_at AT4G28850 xyloglucan:xyloglucosyl transferase, putative 1.7921051  
247914_at AT5G57540 xyloglucan:xyloglucosyl transferase, putative 2.228443  
247871_at AT5G57530 xyloglucan:xyloglucosyl transferase, putative 3.308098  
Phloem proteins 
264213_at AT1G65390 AtPP2-A5 1.8578196  
264153_at AT1G65390 AtPP2-A5 1.8660928  
248978_at AT5G45070 AtPP2-A8 (Phloem protein 2-A8) 1.5868131  
266235_at AT2G02360 AtPP2-B10 (Phloem protein 2-B10) 2.2230031  
251356_at AT3G61060 AtPP2-A13 1.7588658  
248395_at AT5G52120 AtPP2-A14 (Phloem protein 2-A14) 1.6768422  
Amino acid metabolism & transport 
257516_at AT1G69040 ACR4 (ACT REPEAT 4); amino acid binding 1.7266415  
264040_at AT2G03730 ACR5; amino acid binding 1.7896264  
254300_at AT4G22780 ACR7; amino acid binding 1.6382418  
266984_at AT2G39570 ACT domain-containing protein 1.65027  
247218_at AT5G65010 ASN2 (ASPARAGINE SYNTHETASE 2) 1.6831523  
263350_at AT2G13360 AGT 1.6042578  
267035_at AT2G38400 AGT3 2.1032617  
260309_at AT1G70580 AOAT2 1.9173156  
264250_at AT1G78680 ATGGH2 2.233933  
266892_at AT2G26080 AtGLDP2 1.9592899  
265070_at AT1G55510 BCDH BETA1 1.5983752  
258527_at AT3G06850 BCE2 1.6640345  
253708_at AT4G29210 GGT4 1.719259  
252570_at AT3G45300 IVD (ISOVALERYL-COA-DEHYDROGENASE) 1.5179881  
258025_at AT3G19480 D-3-phosphoglycerate dehydrogenase, putative 1.8886664  
265305_at AT2G20340 tyrosine decarboxylase, putative 2.0137992  
253162_at AT4G35630 PSAT 1.8531084  
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259403_at AT1G17745 PGDH 2.682692  
258075_at AT3G25900 HMT-1; homocysteine S-methyltransferase 2.087862  
258160_at AT3G17820 ATGSKB6; copper ion binding 1.5132966  
245035_at AT2G26400 ATARD3 1.6447458  
252652_at AT3G44720 ADT4 (arogenate dehydratase 4) 2.4678078  
261758_at AT1G08250 ADT6 (arogenate dehydratase 6) 1.8287091  
261957_at AT1G64660 ATMGL 4.713349  
260602_at AT1G55920 ATSERAT2;1 1.5737426  
256022_at AT1G58360 AAP1; NAT2 (AMINO ACID PERMEASE 1) 1.5458914  
245891_at AT5G09220 AAP2 (AMINO ACID PERMEASE 2) 2.3070471  
246389_at AT1G77380 AAP3; amino acid transmembrane transporter 2.1610112  
248619_at AT5G49630 AAP6 (AMINO ACID PERMEASE 6) 1.5312438  
250161_at AT5G15240 amino acid transporter family protein 1.5630741  
263827_at AT2G40420 amino acid transporter family protein 1.9778428  
251024_at AT5G02180 amino acid transporter family protein 5.069423  
Ammonium & nitrate/nitrite 
267142_at AT2G38290 ATAMT2 (AMMONIUM TRANSPORTER 2) 2.1001482  
248551_at AT5G50200 WR3 NTR3.1 (WOUND-RESPONSIVE 3) 1.7959006  
248790_at AT5G47450 AtTIP2;3; ammonia transporter 2.1810217  
Sulfate 
255284_at AT4G04610 APR1 (APS REDUCTASE 1) 3.012217  
254343_at AT4G21990 APR3 (APS REDUCTASE 3) 2.4403985  
264901_at AT1G23090 AST91 (SULFATE TRANSPORTER 91) 3.6730144  
255443_at AT4G02700 SULTR3;2 (sulfate transporter 3;2) 3.0011868  
249752_at AT5G24660 LSU2 (RESPONSE TO LOW SULFUR 2) 1.9379992  
252870_at AT4G39940 AKN2 (APS-kinase 2) 2.0129018  
250475_at AT5G10180 AST68; sulfate transmembrane transporter 1.9763738  
250897_at AT5G03430 PAPS reductase family protein 1.8019344  
Phosphate 
263083_at AT2G27190 PAP12 (PURPLE ACID PHOSPHATASE 12) 1.6239426  
248499_at AT5G50400 PAP27 (PURPLE ACID PHOSPHATASE 27) 1.585133  
263594_at AT2G01880 PAP7 (PURPLE ACID PHOSPHATASE 7) 2.0512636  
245698_at AT5G04160 phosphate translocator-related 1.5208881  
253784_at AT4G28610 PHR1 1.997733  
266672_at AT2G29650 PHT4;1 2.2975836  
246122_at AT5G20380 PHT4;5 1.6487892  
Iron 
245296_at AT4G16370 ATOPT3 (OLIGOPEPTIDE TRANSPORTER) 1.5929965  
264751_at AT1G23020 FRO3; ferric-chelate reductase 1.850476  
266162_at AT2G28160 FRU, FIT1 1.76477  
254534_at AT4G19680 IRT2; iron ion transmembrane transporter 2.5508492  
267029_at AT2G38460 ATIREG1 (IRON-REGULATED PROTEIN 1) 1.7938256  
246847_at AT5G26820 ATIREG3 (IRON-REGULATED PROTEIN 3) 1.5174626  
Potassium 
254305_at AT4G22200 AKT2/3 1.8818417  
248888_at AT5G46240 KAT1 2.0739248  
261536_at AT1G01790 KEA1 (K EFFLUX ANTIPORTER 1) 2.001158  
255304_at AT4G04850 KEA3; potassium ion transmembrane transporte 2.0618465  
263699_at AT1G31120 KUP10 1.6845425  
Cu 
259008_at AT3G09390 MT2A (METALLOTHIONEIN 2A) 2.5382004  
266353_at AT2G01520 MLP328 (MLP-LIKE PROTEIN 328) 9.344566  
266330_at AT2G01530 MLP329 (MLP-LIKE PROTEIN 329) 7.071243  
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Zn 
257715_at AT3G12750 ZIP1 (ZINC TRANSPORTER 1 PRECURSOR) 1.6495275  
GSTs/detoxification 
250083_at AT5G17220 ATGSTF12 2.0011976  
267153_at AT2G30860 ATGSTF9 2.3232887  
260406_at AT1G69920 ATGSTU12 1.9119706  
264986_at AT1G27130 ATGSTU13 1.9338865  
260745_at AT1G78370 ATGSTU20 5.3771143  
262518_at AT1G17170 ATGSTU24 2.110414  
262517_at AT1G17180 ATGSTU25 2.422926  
252712_at AT3G43800 ATGSTU27 1.7964178  
266267_at AT2G29460 ATGSTU4 3.067291  
266299_at AT2G29450 ATGSTU5 1.7587159  
266271_at AT2G29440 ATGSTU6 2.2326825  
266296_at AT2G29420 ATGSTU7 1.6450101  
247435_at AT5G62480 ATGSTU9 2.4393306  
267154_at AT2G30870 GSTF10 1.5733571  
262103_at AT1G02940 GSTF5 2.4103403  
262516_at AT1G17190 ATGSTU26 2.501632  
Cytochromes 
267565_at AT2G30750 CYP71A12 7.1970477  
257623_at AT3G26210 CYP71B23 1.7270265  
266000_at AT2G24180 CYP71B6 1.5779507  
246620_at AT5G36220 CYP81D1 1.6036701  
253046_at AT4G37370 CYP81D8 6.188541  
253505_at AT4G31970 CYP82C2 7.0742583  
252911_at AT4G39510 CYP96A12 1.8052423  
263276_at AT2G14100 CYP705A13 1.6298617  
261878_at AT1G50560 CYP705A25 2.0263157  
248727_at AT5G47990 CYP705A5 2.3638315  
266307_at AT2G27000 CYP705A8 1.8074805  
253886_at AT4G27710 CYP709B3 2.6583161  
263970_at AT2G42850 CYP718 1.6765847  
257628_at AT3G26290 CYP71B26 2.5393703  
262780_at AT1G13090 CYP71B28 1.6996449  
256874_at AT3G26320 CYP71B36 1.8959353  
256875_at AT3G26330 CYP71B37 1.9189515  
257635_at AT3G26280 CYP71B4 5.5374107  
267505_at AT2G45560 CYP76C1 2.2589526  
256589_at AT3G28740 CYP81D1 2.1603959  
253073_at AT4G37410 CYP81F4 6.8489904  
255934_at AT1G12740 CYP87A2 3.4416482  
251699_at AT3G56630 CYP94D2 1.8480259  
Other membrane transporters 
246580_at AT1G31770 ABC transporter family protein 1.9730309  
267008_at AT2G39350 ABC transporter family protein 2.566301  
256969_at AT3G21080 ABC transporter-related 2.3224075  
261969_at AT1G65950 ABC1 family protein 1.6135421  
254133_at AT4G24810 ABC1 family protein 2.9282484  
250824_at AT5G05200 ABC1 family protein 1.7346252  
257184_at AT3G13090 ATMRP8; ATPase 1.9254594  
254389_s_at AT4G21910 MATE efflux family protein 1.7442601  
259743_at AT1G71140 MATE efflux family protein 2.5371232  
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263402_at AT2G04050 MATE efflux family protein 13.148077  
253732_at AT4G29140 MATE efflux protein-related 1.7562089  
262813_at AT1G11670 MATE efflux family protein 1.7307651  
261881_at AT1G80760 NIP6;1 1.9310266  
254606_at AT4G19030 NLM1 3.2738025  
263904_at AT2G36380 PDR6; ATPase 2.3716664  
251942_at AT3G53480 PDR9 (PLEIOTROPIC DRUG RESISTANCE 9) 1.5522633  
263403_at AT2G04040 TX1; antiporter/ multidrug efflux pump 5.8295665  
254396_at AT4G21680 proton-dependent oligopeptide transport (POT) 1.7033848  
260410_at AT1G69870 proton-dependent oligopeptide transport (POT) 2.2329843  
252537_at AT3G45710 proton-dependent oligopeptide transport (POT) 1.9248589  
261937_at AT1G22570 proton-dependent oligopeptide transport (POT) 1.6759167  
252536_at AT3G45700 proton-dependent oligopeptide transport (POT) 1.7202774  
261924_at AT1G22550 proton-dependent oligopeptide transport (POT) 1.8761805  
248931_at AT5G46040 proton-dependent oligopeptide transport (POT) 1.5114332  
255877_at AT2G40460 proton-dependent oligopeptide transport (POT) 1.5583557  
259846_at AT1G72140 proton-dependent oligopeptide transport (POT) 2.0643044  
Vitamines 
B1     
248128_at AT5G54770 THI1; protein homodimerization 1.6002518  
B5     
250842_at AT5G04490 VTE5 (vitamin E pathway gene5) 1.7911696  
B6     
258336_at AT3G16050 A37; atpdx1.2  protein heterodimerization 1.5637795  
B9/folate     
259880_at AT1G76730 5-formyltetrahydrofolate cyclo-ligase 1.5889016  
251759_at AT3G55630 ATDFD 2.138747  
Other unidentified functions   
264826_at AT1G03410 2A6; oxidoreductase 1.697283  
249125_at AT5G43450 2-oxoglutarate-dependent dioxygenase, putative 1.707935  
263668_at AT1G04350 2-oxoglutarate-dependent dioxygenase, putative 1.9663066  
249128_at AT5G43440 2-oxoglutarate-dependent dioxygenase, putative 2.2829196  
264843_at AT1G03400 2-oxoglutarate-dependent dioxygenase, putative 2.3380733  
262608_at AT1G14120 2-oxoglutarate-dependent dioxygenase, putative 2.6849072  
257587_at AT1G56310 3'-5' exonuclease domain-containing protein 1.6546757  
247235_at AT5G64580 AAA-type ATPase family protein 1.5090423  
256885_at AT3G15120 AAA-type ATPase family protein 1.7330844  
250062_at AT5G17760 AAA-type ATPase family protein 2.1659844  
263061_at AT2G18190 AAA-type ATPase family protein 2.618111  
259507_at AT1G43910 AAA-type ATPase family protein 8.189039  
255607_at AT4G01130 acetylesterase, putative 1.7913544  
266403_at AT2G38600 acid phosphatase class B family protein 1.5889264  
266395_at AT2G43100 aconitase C-terminal domain-containing protein 2.9457977  
248394_at AT5G52070 agenet domain-containing protein 2.2283592  
265902_at AT2G25590 agenet domain-containing protein 2.4366229  
261930_at AT1G22440 alcohol dehydrogenase, putative 2.6552603  
249242_at AT5G42250 alcohol dehydrogenase, putative 3.4687004  
254572_at AT4G19380 alcohol oxidase-related 1.7418289  
267181_at AT2G37760 aldo/keto reductase family protein 1.6703626  
248242_at AT5G53580 aldo/keto reductase family protein 1.5080645  
267168_at AT2G37770 aldo/keto reductase family protein 2.6112473  
254025_at AT4G25790 allergen V5/Tpx-1-related family protein 1.6914619  
264637_at AT1G65560 allyl alcohol dehydrogenase, putative 2.3500545  
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258692_at AT3G08640 alphavirus core protein family 1.6909297  
258708_at AT3G09580 amine oxidase family protein 1.5603275  
246786_at AT5G27410 aminotransferase class IV family protein 2.3825724  
262698_at AT1G75960 AMP-binding protein, putative 1.6665413  
263800_at AT2G24600 ankyrin repeat family protein 2.1288462  
263401_at AT2G04070 antiporter/ drug transporter/ transporter 2.2194757  
254011_at AT4G26370 antitermination NusB domain-containing protein 2.070251  
264865_at AT1G24120 ARL1 (ARG1-LIKE 1) 1.5243405  
250183_at AT5G14510 armadillo/beta-catenin repeat family protein 1.5762875  
251919_at AT3G53800 armadillo/beta-catenin repeat family protein 2.0672476  
266815_at AT2G44900 F-box family protein 1.6214632  
262413_at AT1G34780 ATAPRL4 (APR-like 4) 1.6149877  
266056_at AT2G40810 AtATG18c 1.5011361  
252316_at AT3G48700 ATCXE13 3.2641869  
261607_at AT1G49660 AtCXE5 (Arabidopsis thaliana carboxyesterase 5) 2.239359  
253531_at AT4G31540 ATEXO70G1 1.6114188  
263318_at AT2G24762 AtGDU4 3.7392206  
259982_at AT1G76410 ATL8; protein binding / zinc ion binding 2.0063088  
267397_at AT1G76170 ATP binding 1.536125  
261689_at AT1G50140 ATP binding / ATPase/ nucleoside-triphosphatase 2.0070138  
263435_at AT2G28600 ATP binding / ATP-dependent helicase/ 1.628543  
260089_at AT1G73170 ATP-dependent peptidase 2.063452  
245898_at AT5G11020 ATP binding / kinase/ protein kinase 1.7218764  
246375_at AT1G51830 kinase/ protein serine/threonine kinase 1.9952594  
262491_at AT1G21650 ATP binding / protein binding 2.5439658  
246449_at AT5G16810 ATP binding / protein kinase 1.7264867  
267152_at AT2G31040 ATP synthase protein I -related 1.7423064  
265660_at AT2G25470 AtRLP21 (Receptor Like Protein 21) 3.117673  
261469_at AT1G28340 AtRLP4 (Receptor Like Protein 4) 1.9119524  
261117_at AT1G75310 AUL1; heat shock protein binding 1.5842115  
258000_at AT3G28940 avirulence-responsive protein, putative 1.795438  
255980_at AT1G33970 avirulence-responsive protein, putative 2.2248392  
253545_at AT4G31310 avirulence-responsive protein-related 1.8188723  
249958_at AT5G18970 AWPM-19-like membrane family protein 1.5881103  
248410_at AT5G51570 band 7 family protein 1.5901918  
264899_at AT1G23130 Bet v I allergen family protein 2.4588633  
263836_at AT2G40330 Bet v I allergen family protein 1.5400413  
257908_at AT3G25410 bile acid:sodium symporter family protein 1.9376678  
260082_at AT1G78180 binding 1.758285  
262050_at AT1G80130 binding 7.73804  
264609_at AT1G04530 binding 1.5126605  
266617_at AT2G29670 binding 1.580042  
261075_at AT1G07280 binding 1.9651169  
253849_at AT4G28080 binding 2.1706831  
248584_at AT5G49960 binding / catalytic 1.5358564  
245793_at AT1G32220 binding / catalytic/ coenzyme binding 1.5929406  
256655_at AT3G18890 binding / catalytic/ coenzyme binding 1.674412  
248838_at AT5G46800 BOU (A BOUT DE SOUFFLE); binding 1.5002275  
247114_at AT5G65910 BSD domain-containing protein 1.6462499  
251563_at AT3G57880 C2 domain-containing protein 1.552272  
248058_at AT5G55530 C2 domain-containing protein 1.947283  
265394_at AT2G20725 CAAX amino terminal protease family protein 1.985684  
264260_at AT1G09210 calreticulin 2 (CRT2) 1.535019  
ANNEX  131 
 
Probe Set 
ID 
AGI Short/Full name Fold change RT-
qPCR 
259658_at AT1G55370 carbohydrate binding / catalytic 4.284847  
246396_at AT1G58180 carbonic anhydrase 1.8043814  
246462_at AT5G16940 carbon-sulfur lyase 2.549666  
258254_at AT3G26780 catalytic 1.8266963  
262215_at AT1G74790 catalytic 1.6430267  
261550_at AT1G63450 catalytic 1.584108  
245292_at AT4G15093 catalytic LigB subunit 1.6446886  
245533_at AT4G15130 catalytic/ choline-phosphate cytidylyltransferase 1.6558526  
251298_at AT3G62040 catalytic/ hydrolase 1.5185996  
246868_at AT5G26010 catalytic/ protein serine/threonine phosphatase 1.9128003  
259441_at AT1G02300 cathepsin B-like cysteine protease, putative 2.286734  
260489_at AT1G51610 cation efflux family protein 1.611809  
265102_at AT1G30870 cationic peroxidase, putative 3.171014  
245600_at AT4G14230 CBS domain-containing protein-related 2.480163  
261608_at AT1G49650 cell death associated protein-related 1.6614068  
255939_at AT1G12730 cell division cycle protein-related 1.7342563  
258494_at AT3G02450 cell division protein ftsH, putative 2.0969067  
253425_at AT4G32190 centromeric protein-related 2.5101156  
247742_at AT5G58980 ceramidase family protein 1.9044195  
245876_at AT1G26230 chaperonin, putative 1.8477997  
250446_at AT5G10770 chloroplast nucleoid DNA-binding protein 1.7385312  
260244_at AT1G74320 choline kinase, putative 1.6263523  
254998_at AT4G09760 choline kinase, putative 2.2607226  
256411_at AT1G66670 CLPP3; serine-type endopeptidase 1.5280855  
261259_at AT1G26660 c-myc binding protein, putative  1.8102262  
245197_at AT1G67800 copine-related 1.5191605  
262919_at AT1G79380 copine-related 1.7354932  
252698_at AT3G43670 copper amine oxidase, putative 1.7230642  
263438_at AT2G28660 copper-binding family protein 2.1850762  
252296_at AT3G48970 copper-binding family protein 4.0350776  
253880_at AT4G27590 copper-binding protein-related 3.5556974  
247367_at AT5G63290 coproporphyrinogen oxidase-related 1.6131994  
249983_at AT5G18470 curculin-like (mannose-binding) 1.932379  
245323_at AT4G16500 cysteine protease inhibitor family protein 2.0454054  
265672_at AT2G31980 cysteine proteinase inhibitor-related 4.252468  
262397_at AT1G49380 cytochrome c biogenesis protein family 1.8886644  
246840_at AT5G26610 D111/G-patch domain-containing protein 1.6291854  
250064_at AT5G17890 DAR4 (DA1-RELATED PROTEIN 4) 4.1392665  
256646_at AT3G13590 DC1 domain-containing protein 1.6206086  
266688_at AT2G19660 DC1 domain-containing protein 2.5089402  
254749_at AT4G13130 DC1 domain-containing protein 1.5044366  
252240_at AT3G50010 DC1 domain-containing protein 1.528202  
256774_at AT3G13760 DC1 domain-containing protein 1.5286545  
267384_at AT2G44370 DC1 domain-containing protein 1.637269  
249097_at AT5G43520 DC1 domain-containing protein 2.0458655  
249364_at AT5G40590 DC1 domain-containing protein 2.283682  
264616_at AT2G17740 DC1 domain-containing protein 2.752927  
258554_at AT3G06980 DEAD/DEAH box helicase, putative 1.7550753  
266920_at AT2G45750 dehydration-responsive family protein 1.6308354  
266439_s_at AT2G43200 dehydration-responsive family protein 1.7179196  
251713_at AT3G56080 dehydration-responsive protein-related 2.259453  
247780_at AT5G58770 dehydrodolichyl diphosphate synthase, putative 2.0186942  
258108_at AT3G23570 dienelactone hydrolase family protein 2.6046112  
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258782_at AT3G11750 dihydroneopterin aldolase, putative 2.2450833  
245122_at AT2G47420 dimethyladenosine transferase, putative 1.997435  
258622_at AT3G02720 DJ-1 family protein / protease-related 2.1540198  
261383_at AT1G05380 DNA binding 1.5680636  
257373_at AT2G43140 DNA binding / transcription factor 1.7488604  
267089_at AT2G38300 DNA binding / transcription factor 2.1650832  
251365_at AT3G61310 DNA-binding family protein 1.5192395  
263963_at AT2G36080 DNA-binding protein, putative 1.8686289  
249677_at AT5G35970 DNA-binding protein, putative 1.9056187  
245382_at AT4G17800 DNA-binding protein-related 1.6101971  
248564_at AT5G49700 DNA-binding protein-related 1.906567  
254492_at AT4G20260 DREPP 1.8598949  
249481_at AT5G38900 DSBA oxidoreductase family protein 2.9053075  
258460_at AT3G17330 ECT6 1.5817245  
266471_at AT2G31060 elongation factor family protein 1.5306209  
251360_at AT3G61210 embryo-abundant protein-related 1.9587549  
254318_at AT4G22530 embryo-abundant protein-related 2.052431  
266368_at AT2G41380 embryo-abundant protein-related 1.7430819  
266011_at AT2G37440 endonuclease/exonuclease/phosphatase 1.9019017  
252095_at AT3G51000 epoxide hydrolase, putative 1.8181264  
252478_at AT3G46540 clathrin assembly protein-related 2.1382337  
257104_at AT3G25040 ER lumen protein retaining receptor, putative 1.5125822  
246041_at AT5G19290 esterase/lipase/thioesterase family protein 1.5792025  
266977_at AT2G39420 esterase/lipase/thioesterase family protein 1.7146975  
266485_at AT2G47630 esterase/lipase/thioesterase family protein 1.7462125  
262561_at AT1G34340 esterase/lipase/thioesterase family protein 2.2193213  
245885_at AT5G09440 EXL4 (EXORDIUM LIKE 4) 1.8769915  
255526_at AT4G02350 exocyst complex subunit Sec15-like 1.5144876  
256858_at AT3G15140 exonuclease family protein 2.767486  
245961_at AT5G19670 exostosin family protein 1.7724173  
246162_at AT4G36400 FAD linked oxidase family protein 1.557801  
249045_at AT5G44380 FAD-binding domain-containing protein 1.7813766  
254432_at AT4G20830 FAD-binding domain-containing protein 2.9996667  
249051_at AT5G44390 FAD-binding domain-containing protein 1.6177428  
264527_at AT1G30760 FAD-binding domain-containing protein 1.9794489  
249046_at AT5G44400 FAD-binding domain-containing protein 2.0715802  
249047_at AT5G44410 FAD-binding domain-containing protein 2.2322073  
266711_at AT2G46740 FAD-binding domain-containing protein 2.2646441  
263228_at AT1G30700 FAD-binding domain-containing protein 2.316206  
261005_at AT1G26420 FAD-binding domain-containing protein 2.9316661  
261006_at AT1G26410 FAD-binding domain-containing protein 4.5728617  
261021_at AT1G26380 FAD-binding domain-containing protein 5.1133084  
261020_at AT1G26390 FAD-binding domain-containing protein 7.406141  
267005_at AT2G34460 flavin reductase-related 1.6524025  
248771_at AT5G47790 forkhead-associated domain-containing protein 1.7288586  
259021_at AT3G07540 formin homology 2 domain-containing protein 1.5233238  
245417_at AT4G17360 formyltetrahydrofolate deformylase 2.068856  
245954_at AT5G28530 FRS10 (FAR1-related sequence 10) 1.5495956  
262736_at AT1G28570 GDSL-motif lipase, putative 1.6749247  
262749_at AT1G28580 GDSL-motif lipase, putative 2.0619638  
252363_at AT3G48460 GDSL-motif lipase/hydrolase family protein 1.5116636  
259308_at AT3G05180 GDSL-motif lipase/hydrolase family protein 1.5186511  
248118_at AT5G55050 GDSL-motif lipase/hydrolase family protein 1.5395868  
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265261_at AT2G42990 GDSL-motif lipase/hydrolase family protein 1.6653017  
250918_at AT5G03610 GDSL-motif lipase/hydrolase family protein 1.7832047  
267121_at AT2G23540 GDSL-motif lipase/hydrolase family protein 1.7960296  
251968_at AT3G53100 GDSL-motif lipase/hydrolase family protein 1.8124875  
259786_at AT1G29660 GDSL-motif lipase/hydrolase family protein 1.8520976  
261981_at AT1G33811 GDSL-motif lipase/hydrolase family protein 1.963692  
253660_at AT4G30140 GDSL-motif lipase/hydrolase family protein 7.4966903  
264551_at AT1G09460 glucan endo-1,3-beta-glucosidase-related 1.6683868  
256746_at AT3G29320 glucan phosphorylase, putative 1.7916292  
249729_at AT5G24410 glucosamine 1.9019375  
251746_at AT3G56060 glucose-methanol-choline (GMC) oxidoreductase 1.5432793  
249337_at AT5G41080 glycerophosphoryl diester phosphodiesterase 2.770665  
258038_at AT3G21260 glycolipid transfer protein-related 1.9155457  
255814_at AT1G19900 glyoxal oxidase-related 3.178043  
251669_at AT3G57180 GTP binding 1.7122525  
258545_at AT3G07050 GTP-binding family protein 1.632295  
265330_at AT2G18440 GUT15 2.6652622  
252366_at AT3G48420 haloacid dehalogenase-like hydrolase 1.6154468  
251028_at AT5G02230 haloacid dehalogenase-like hydrolase 1.6959851  
256440_at AT3G10970 haloacid dehalogenase-like hydrolase 1.7318385  
266363_at AT2G41250 haloacid dehalogenase-like hydrolase 1.7418654  
265680_at AT2G32150 haloacid dehalogenase-like hydrolase 1.7935843  
254874_at AT4G11570 haloacid dehalogenase-like hydrolase 2.1254437  
259633_at AT1G56500 haloacid dehalogenase-like hydrolase 1.7464687  
257848_at AT3G13030 hAT dimerisation domain-containing protein 1.5180459  
248752_at AT5G47600 heat shock protein-related 1.9600347  
246095_at AT5G19310 homeotic gene regulator, putative 1.583775  
260014_at AT1G68010 HPR; glycerate dehydrogenase/ poly(U) binding 1.5117365  
265699_at AT2G03550 hydrolase 1.8759567  
262229_at AT1G68620 hydrolase 2.543345  
265341_at AT2G18360 hydrolase, alpha/beta fold family protein 1.5037339  
261661_at AT1G18360 hydrolase, alpha/beta fold family protein 1.5300606  
246199_at AT4G36530 hydrolase, alpha/beta fold family protein 1.5767158  
262151_at AT1G52510 hydrolase, alpha/beta fold family protein 1.6928821  
254783_at AT4G12830 hydrolase, alpha/beta fold family protein 2.082774  
257533_at AT3G10840 hydrolase, alpha/beta fold family protein 2.2293935  
253627_at AT4G30650 hydrophobic protein, putative 2.5433044  
250500_at AT5G09530 hydroxyproline-rich glycoprotein family protein 1.5303197  
254262_at AT4G23470 hydroxyproline-rich glycoprotein family protein 1.5904908  
245889_at AT5G09480 hydroxyproline-rich glycoprotein family protein 1.6455847  
248592_at AT5G49280 hydroxyproline-rich glycoprotein family protein 2.20266  
259318_at AT3G01100 HYP1 (HYPOTHETICAL PROTEIN 1) 1.7018777  
250967_at AT5G02790 In2-1 protein, putative 1.7648133  
250983_at AT5G02780 In2-1 protein, putative 1.6874177  
258905_at AT3G06390 integral membrane family protein 1.5671592  
260676_at AT1G19450 sugar transporter family protein 2.9154387  
265669_at AT2G32040 integral membrane transporter family protein 1.7816577  
254110_at AT4G25260 invertase/pectin methylesterase inhibitor 2.7632477  
266352_at AT2G01610 invertase/pectin methylesterase inhibitor 1.6530597  
257876_at AT3G17130 invertase/pectin methylesterase inhibitor 1.7989237  
252437_at AT3G47380 invertase/pectin methylesterase inhibitor 2.8411496  
247477_at AT5G62340 invertase/pectin methylesterase inhibitor 3.2749047  
250233_at AT5G13460 IQD11 (IQ-domain 11); calmodulin binding 1.6242057  
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250872_at AT5G03960 IQD12 (IQ-domain 12); calmodulin binding 2.7962704  
254293_at AT4G23060 IQD22 (IQ-domain 22); calmodulin binding 1.9595461  
247464_at AT5G62070 IQD23 (IQ-domain 23); calmodulin binding 1.6502906  
265051_at AT1G52100 jacalin lectin family protein 1.8570902  
266838_at AT2G25980 jacalin lectin family protein 1.9203633  
261133_at AT1G19715 jacalin lectin family protein 2.1856048  
249675_at AT5G35940 jacalin lectin family protein 2.71248  
265048_at AT1G52050 jacalin lectin family protein 3.2220354  
265050_at AT1G52070 jacalin lectin family protein 6.4247847  
266988_at AT2G39310 JAL22 (JACALIN-RELATED LECTIN 22) 2.0212276  
261674_at AT1G18270 ketose-bisphosphate aldolase class-II 1.7519495  
253964_at AT4G26480 KH domain-containing protein 2.2558699  
247994_at AT5G56140 KH domain-containing protein 2.646001  
254255_at AT4G23220 kinase 2.0102212  
267518_at AT2G30500 kinase interacting family protein 1.553191  
265673_at AT2G32090 lactoylglutathione lyase family protein 2.1757057  
262338_at AT1G64185 lactoylglutathione lyase family protein 2.6920807  
249258_at AT5G41650 lactoylglutathione lyase family protein 3.1532664  
247645_at AT5G60530 LEA protein-related 1.6222231  
247634_at AT5G60520 LEA protein-related 1.6878922  
248178_at AT5G54370 LEA protein-related 2.5462782  
252568_at AT3G45410 lectin protein kinase family protein 1.5151386  
257206_at AT3G16530 legume lectin family protein 5.8071656  
250942_at AT5G03350 legume lectin family protein 2.2060585  
261368_at AT1G53070 legume lectin family protein 2.9934235  
261367_at AT1G53080 legume lectin family protein 4.052662  
257924_at AT3G23190 lesion inducing protein-related 1.5400879  
248945_at AT5G45510 leucine-rich repeat family protein 1.7632282  
260041_at AT1G68780 leucine-rich repeat family protein 1.6515455  
245765_at AT1G33600 leucine-rich repeat family protein 1.8178284  
250277_at AT5G12940 leucine-rich repeat family protein 1.9258535  
261559_at AT1G01780 LIM domain-containing protein 2.2887518  
257666_at AT3G20270 lipid-binding serum glycoprotein family protein 1.5915501  
256652_at AT3G18850 LPAT5; acyltransferase 1.5570333  
256062_at AT1G07090 LSH6 (LIGHT SENSITIVE HYPOCOTYLS 6) 3.7674172  
254234_at AT4G23680 major latex protein-related / MLP-related 3.198264  
254225_at AT4G23670 major latex protein-related / MLP-related 2.6653914  
261177_at AT1G04770 male sterility MS5 family protein 1.7848606  
247621_at AT5G60340 maoC-like dehydratase domain-containing protein 1.6040436  
249817_at AT5G23820 ML domain-containing protein 2.8677351  
258831_at AT3G07080 membrane protein 1.5964475  
264584_at AT1G05140 membrane-associated zinc metalloprotease 1.5059772  
267061_at AT2G32480 membrane-associated zinc metalloprotease 1.6883101  
255626_at AT4G00780 MATH domain-containing protein 1.5964066  
256577_at AT3G28220 MATH domain-containing protein 1.703505  
264166_at AT1G65370 MATH domain-containing protein 1.8284982  
255025_at AT4G09900 MES12 (METHYL ESTERASE 12); hydrolase 2.2009983  
255026_at AT4G09900 MES12 (METHYL ESTERASE 12); hydrolase 2.588208  
245349_at AT4G16690 MES16 (METHYL ESTERASE 16) 1.9233598  
254385_s_at AT4G21830 /// 
AT4G21840 
SeIR domain-containing protein 3.6570303  
255298_at AT4G04840 SeIR domain-containing protein 1.8297799  
259179_at AT3G01660 methyltransferase 1.6056182  
253688_at AT4G29590 methyltransferase 2.022881  
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259842_at AT1G73600 phosphoethanolamine N-methyltransferase 1.8260796  
252944_at AT4G39320 microtubule-associated protein-related 1.7480888  
251029_at AT5G02050 mitochondrial glycoprotein family protein 1.5976824  
251106_at AT5G01500 mitochondrial substrate carrier family protein 1.6384698  
263943_at AT2G35800 mitochondrial substrate carrier family protein 1.6392478  
247498_at AT5G61810 mitochondrial substrate carrier family protein 1.7257828  
254120_at AT4G24570 mitochondrial substrate carrier family protein 1.5403104  
251090_at AT5G01340 mitochondrial substrate carrier family protein 1.9516838  
255465_at AT4G02990 mTERF family protein 1.5578307  
266899_at AT2G34620 mTERF-related 1.7264514  
259378_at AT3G16310 mitotic phosphoprotein N' end (MPPN) 2.125258  
262312_at AT1G70830 MLP28 (MLP-LIKE PROTEIN 28) 2.1161938  
262260_at AT1G70850 MLP34 (MLP-LIKE PROTEIN 34) 6.8695917  
263034_at AT1G24020 MLP423 (MLP-LIKE PROTEIN 423) 1.9996699  
262304_at AT1G70890 MLP43 (MLP-LIKE PROTEIN 43) 2.438423  
252993_at AT4G38540 monooxygenase, putative (MO2) 2.3280883  
247356_at AT5G63800 MUM2 (MUCILAGE-MODIFIED 2) 1.6005565  
260292_at AT1G63680 MURE 1.9144739  
263161_at AT1G54020 myrosinase-associated protein, putative 1.5144175  
251730_at AT3G56330 N2-dimethylguanosine tRNA methyltransferase 1.7325195  
251656_at AT3G57170 Gpi1 family protein 1.5587091  
254468_at AT4G20460 NAD-dependent epimerase/dehydratase 1.7526261  
250337_at AT5G11790 Ndr family protein 1.5089518  
258736_at AT3G05900 neurofilament protein-related 1.9242885  
251773_at AT3G55960 NLI interacting factor (NIF) family protein 1.817612  
257285_at AT3G29760 NLI interacting factor (NIF) family protein 2.0070488  
250217_at AT5G14120 nodulin family protein 1.5365392  
253215_at AT4G34950 nodulin family protein 1.8792892  
266993_at AT2G39210 nodulin family protein 1.9482728  
265414_at AT2G16660 nodulin family protein 2.3232033  
257272_at AT3G28130 nodulin MtN21 family protein 1.5701296  
265967_at AT2G37450 nodulin MtN21 family protein 1.5870719  
255129_at AT4G08290 nodulin MtN21 family protein 1.6862296  
255127_at AT4G08300 nodulin MtN21 family protein 1.822522  
255576_at AT4G01440 nodulin MtN21 family protein 1.954046  
257300_at AT3G28080 nodulin MtN21 family protein 1.9754423  
261335_at AT1G44800 nodulin MtN21 family protein 4.5414596  
258421_at AT3G16690 nodulin MtN3 family protein 1.8871633  
257823_at AT3G25190 nodulin, putative 1.8720144  
267268_at AT2G02570 nucleic acid binding 1.5000335  
267078_at AT2G40960 nucleic acid binding 3.128771  
257519_at AT3G01210 nucleic acid binding / oxidoreductase 1.5545285  
265249_at AT2G01940 nucleic acid binding 1.6878722  
266659_at AT2G25850 nucleotidyltransferase family protein 1.6012844  
257002_at AT3G14100 oligouridylate-binding protein, putative 1.5450536  
261216_at AT1G33030 O-methyltransferase family 2 protein 1.6022544  
251295_at AT3G62000 O-methyltransferase family 3 protein 1.9487283  
248330_at AT5G52810 ornithine cyclodeaminase 1.8949392  
247951_at AT5G57240 ORP4C 1.6136652  
251558_at AT3G57810 OTU-like cysteine protease family protein 1.9371134  
257009_at AT3G14160 oxidoreductase 1.5647548  
251057_at AT5G01780 oxidoreductase 1.5830094  
245418_at AT4G17370 oxidoreductase family protein 1.9951875  
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256647_at AT3G13610 oxidoreductase 1.9229063  
254975_at AT4G10500 oxidoreductase 3.6898186  
256892_at AT3G19000 oxidoreductase 1.5738422  
263135_at AT1G78550 oxidoreductase 1.6716243  
247774_at AT5G58660 oxidoreductase 1.8222377  
250793_at AT5G05600 oxidoreductase 1.8765954  
260072_at AT1G73650 oxidoreductase 3.4735532  
265182_at AT1G23740 oxidoreductase 1.5205878  
251402_at AT3G60290 oxidoreductase 1.6307861  
251408_at AT3G60340 palmitoyl protein thioesterase family protein 1.5001253  
248812_at AT5G47330 palmitoyl protein thioesterase family protein 1.8309441  
264850_at AT2G17340 pantothenate kinase-related 2.2918231  
262264_at AT1G42470 patched family protein 1.559238  
255160_at AT4G07820 pathogenesis-related protein, putative 2.283638  
261691_at AT1G50060 pathogenesis-related protein, putative 2.3849297  
253301_at AT4G33720 pathogenesis-related protein, putative 2.4503496  
253104_at AT4G36010 pathogenesis-related thaumatin family protein 1.8301865  
262727_at AT1G75800 pathogenesis-related thaumatin family protein 2.0470042  
261882_at AT1G80770 PDE318 (pigment defective 318) 1.7524595  
254805_at AT4G12480 pEARLI 1; lipid binding 1.9206252  
248899_at AT5G46390 peptidase S41 family protein 1.6332184  
250926_at AT5G03555 permease 1.5929358  
255429_at AT4G03410 peroxisomal membrane protein-related 1.543027  
260155_at AT1G52870 peroxisomal membrane protein-related 1.9809084  
253858_at AT4G27600 pfkB-type carbohydrate kinase family protein 1.6282749  
248381_at AT5G51830 pfkB-type carbohydrate kinase family protein 1.5446119  
261136_at AT1G19600 pfkB-type carbohydrate kinase family protein 1.5079275  
255450_at AT4G02850 phenazine biosynthesis PhzC 1.6423967  
264645_at AT1G08940 phosphoglycerate 1.5738606  
254150_at AT4G24350 phosphorylase family protein 1.6932391  
248333_at AT5G52390 photoassimilate-responsive protein, putative 1.5820667  
264807_at AT1G08700 presenilin family protein 1.7860678  
261070_at AT1G07390 protein binding 1.6383039  
247948_at AT5G57130 protein binding 2.2082217  
258899_at AT3G05675 protein binding 1.6586106  
252834_at AT4G40070 protein binding / zinc ion binding 1.7728797  
253071_at AT4G37880 protein binding / zinc ion binding 1.5191481  
258635_at AT3G08020 protein binding / zinc ion binding 1.5307742  
262512_at AT1G17145 protein binding / zinc ion binding 1.6337717  
252464_at AT3G47160 protein binding / zinc ion binding 2.6069381  
248344_at AT5G52280 protein transport protein-related 1.9159651  
250181_at AT5G14460 pseudouridine synthase/ transporter 1.6906081  
257534_at AT3G09670 PWWP domain-containing protein 1.6334084  
249409_at AT5G40340 PWWP domain-containing protein 2.5785995  
252671_at AT3G44190 pyridine nucleotide-disulphide oxidoreductase 1.808702  
253951_at AT4G26860 pyridoxal phosphate binding 1.6162548  
245626_at AT1G56700 pyrrolidone-carboxylate peptidase 1.5489781  
249797_at AT5G23750 remorin family protein 1.5486017  
246205_at AT4G36970 remorin family protein 1.7949919  
266553_at AT2G46170 reticulon family protein (RTNLB5) 1.5291336  
253860_at AT4G27700 rhodanese-like domain-containing protein 2.2411075  
258989_at AT3G08920 rhodanese-like domain-containing protein 1.670148  
249510_at AT5G38510 rhomboid family protein 2.0961738  
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258316_at AT3G22660 rRNA processing protein-related 1.5723357  
266503_at AT2G47780 rubber elongation factor (REF) protein-related 7.698143  
261945_at AT1G64530 RWP-RK domain-containing protein 1.7917091  
255104_at AT4G08685 SAH7 1.6410863  
248808_at AT5G47510 SEC14 cytosolic factor family protein 1.6942964  
259804_at AT1G72160 SEC14 cytosolic factor family protein 1.978014  
255923_at AT1G22180 SEC14 cytosolic factor family protein 2.0330088  
261116_at AT1G75370 SEC14 cytosolic factor, putative 1.7741582  
261151_at AT1G19650 SEC14 cytosolic factor, putative 1.811822  
252099_at AT3G51250 dehydration-associated protein-related 1.5681344  
260137_at AT1G66330 senescence-associated family protein 1.55733  
248820_at AT5G47060 senescence-associated protein-related 1.820954  
262162_at AT1G78020 senescence-associated protein-related 2.0303762  
247212_at AT5G65040 senescence-associated protein-related 2.5471683  
250170_at AT5G14260 SET domain-containing protein 1.6800432  
251309_at AT3G61220 short-chain dehydrogenase/reductase (SDR) 2.5179195  
254764_at AT4G13250 short-chain dehydrogenase/reductase (SDR) 1.5619106  
266265_at AT2G29340 short-chain dehydrogenase/reductase (SDR) 1.6101948  
254928_at AT4G11410 short-chain dehydrogenase/reductase (SDR) 1.7907891  
247178_at AT5G65205 short-chain dehydrogenase/reductase (SDR) 1.8288189  
267169_at AT2G37540 short-chain dehydrogenase/reductase (SDR) 2.6533062  
251013_at AT5G02540 short-chain dehydrogenase/reductase (SDR) 2.704926  
261956_at AT1G64590 short-chain dehydrogenase/reductase (SDR) 2.7543864  
254759_at AT4G13180 short-chain dehydrogenase/reductase (SDR) 1.8147951  
266015_at AT2G24190 short-chain dehydrogenase/reductase (SDR) 1.7103451  
246229_at AT4G37160 sks15 (SKU5 Similar 15); copper ion binding 2.4519784  
267287_at AT2G23630 sks16 (SKU5 Similar 16); copper ion binding 1.6582518  
252989_at AT4G38420 sks9 (SKU5 Similar 9); copper ion binding 2.2872217  
262536_at AT1G17100 SOUL heme-binding family protein 1.7806203  
266097_at AT2G37970 SOUL-1; binding 1.6485145  
252092_at AT3G51420 SSL4 (STRICTOSIDINE SYNTHASE-LIKE 4) 1.5502859  
254839_at AT4G12400 stress-inducible protein, putative 1.7276042  
246251_at AT4G37220 stress-responsive protein, putative 1.9983677  
260386_at AT1G74010 strictosidine synthase family protein 2.939677  
252068_at AT3G51440 strictosidine synthase family protein 1.7098526  
251658_at AT3G57020 strictosidine synthase family protein 1.9380662  
265768_at AT2G48020 sugar transporter, putative 1.7415645  
245702_at AT5G04220 SYTC 2.361894  
252043_at AT3G52390 tatD-related deoxyribonuclease family protein 1.9384363  
261985_at AT1G33750 terpene synthase/cyclase family protein 1.6383803  
255751_at AT1G31950 terpene synthase/cyclase family protein 2.1682253  
248736_at AT5G48110 terpene synthase/cyclase family protein 3.4629803  
260109_at AT1G63260 TET10 (TETRASPANIN10) 1.723309  
265935_at AT2G19580 TET2 (TETRASPANIN2) 1.7626134  
266526_at AT2G16980 tetracycline transporter 1.5247074  
257730_at AT3G18420 tetratricopeptide repeat (TPR) 1.8021008  
259549_at AT1G35290 thioesterase family protein 1.5565565  
248391_at AT5G52030 TraB protein-related 1.5164511  
250234_at AT5G13420 transaldolase, putative 1.5964099  
264264_at AT1G09250 transcription factor 1.8328258  
258511_at AT3G06590 transcription factor 1.9428674  
246230_at AT4G36710 transcription factor 1.7155933  
258742_at AT3G05800 transcription factor 3.6698554  
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265160_at AT1G31050 transcription factor 1.62774  
259562_at AT1G21200 transcription factor 1.7091235  
247419_at AT5G63080 transcription factor jumonji (jmjC) 1.6650364  
257985_at AT3G20810 transcription factor jumonji (jmjC) 2.4340158  
248559_at AT5G50010 transcription factor/ transcription regulator 1.887329  
260527_at AT2G47270 transcription factor/ transcription regulator 2.460366  
255666_at AT4G00390 transcription regulator 1.5307301  
253144_at AT4G35540 transcription regulator/ zinc ion binding 1.6888245  
254638_at AT4G18740 transcription termination factor 1.6777387  
245930_at AT5G09240 transcriptional coactivator p15 2.150679  
248347_at AT5G52250 transducin family protein 1.823144  
262641_at AT1G62730 transferase 2.447916  
248723_at AT5G47950 transferase family protein 1.523871  
257428_at AT1G78990 transferase family protein 1.5384805  
250550_at AT5G07870 transferase family protein 1.576951  
252199_at AT3G50270 transferase family protein 1.8419832  
250968_at AT5G02890 transferase family protein 2.122074  
249493_at AT5G39080 transferase family protein 2.1750736  
245556_at AT4G15400 transferase family protein 2.2525573  
251144_at AT5G01210 transferase family protein 2.4163227  
267337_at AT2G39980 transferase family protein 2.6798098  
249188_at AT5G42830 transferase family protein 3.505421  
249494_at AT5G39050 transferring acyl groups 2.3274262  
254910_at AT4G11175 translation initiation factor IF-1, 2.2514596  
264170_at AT1G02260 transmembrane protein, putative 1.6604066  
247415_at AT5G63060 transporter 2.0666943  
255181_at AT4G08110 transposable element gene 1.5947112  
248510_at AT5G50315 transposable element gene 1.7978995  
264824_at AT1G03420 transposable element gene 1.8487127  
256976_at AT3G21020 transposable element gene 1.9937522  
245449_at AT4G16870 transposable element gene 2.2619362  
259573_at AT1G20390 transposable element gene 2.7320194  
257057_at AT3G15310 transposable element gene 7.181499  
246852_at AT5G26880 tRNA/rRNA methyltransferase 1.6996483  
250763_at AT5G06060 tropinone reductase, putative 1.5482316  
266280_at AT2G29260 tropinone reductase, putative 1.8557602  
266275_at AT2G29370 tropinone reductase, putative 1.8900877  
266277_at AT2G29310 tropinone reductase, putative 2.086177  
266278_at AT2G29300 tropinone reductase, putative 2.3896403  
266293_at AT2G29360 tropinone reductase, putative 3.4145024  
245943_at AT5G19500 tryptophan/tyrosine permease family protein 1.5319026  
251584_at AT3G58620 TTL4 1.6946188  
253697_at AT4G29700 type I phosphodiesterase 2.2465868  
259371_at AT1G69080 universal stress protein (USP) family protein 1.6458726  
257672_at AT3G20300 unknown protein 1.6840833  
246125_at AT5G19875 unknown protein 1.8390685  
247754_at AT5G59080 unknown protein 2.2059689  
258419_at AT3G16670 unknown protein 2.667822  
262373_at AT1G73120 unknown protein 2.6890152  
259479_at AT1G19020 unknown protein 2.724898  
246547_at AT5G14970 unknown protein 1.5985608  
256114_at AT1G16850 unknown protein 1.7032913  
262045_at AT1G80240 unknown protein 1.7805847  
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262871_at AT1G65010 unknown protein 1.6278375  
245952_at AT5G28500 unknown protein 1.5000198  
260268_at AT1G68490 unknown protein 1.5012022  
255385_at AT4G03610 unknown protein 1.5026034  
255252_at AT4G04990 unknown protein 1.5032289  
254921_at AT4G11300 unknown protein 1.5046312  
262664_at AT1G13970 unknown protein 1.5066125  
253557_at AT4G31115 unknown protein 1.509913  
265734_at AT2G01260 unknown protein 1.5099281  
266618_at AT2G35480 unknown protein 1.510736  
259103_at AT3G11690 unknown protein 1.5139099  
257745_at AT3G29240 unknown protein 1.5149574  
256883_at AT3G26440 unknown protein 1.5157923  
249329_at AT5G40960 unknown protein 1.5159612  
265269_at AT2G42950 unknown protein 1.5164906  
259586_at AT1G28100 unknown protein 1.5168614  
254965_at AT4G11090 unknown protein 1.517856  
257477_at AT1G10660 unknown protein 1.5197606  
255331_at AT4G04330 unknown protein 1.5212206  
245864_at AT1G58070 unknown protein 1.525915  
245486_x_at AT4G16240 unknown protein 1.5275494  
262262_at AT1G70780 unknown protein 1.5297294  
257209_at AT3G14920 unknown protein 1.5316902  
246343_at AT3G56720 unknown protein 1.5326648  
255602_at AT4G01026 unknown protein 1.5376071  
245082_at AT2G23270 unknown protein 1.5383626  
246315_at AT3G56870 unknown protein 1.5436759  
250937_at AT5G03230 unknown protein 1.5440329  
251009_at AT5G02640 unknown protein 1.5444063  
266795_at AT2G03070 unknown protein 1.5446348  
249622_at AT5G37550 unknown protein 1.5458431  
266874_at AT2G44760 unknown protein 1.5484385  
265457_at AT2G46550 unknown protein 1.5490798  
253044_at AT4G37290 unknown protein 1.5491447  
259903_at AT1G74160 unknown protein 1.5493364  
253475_at AT4G32290 unknown protein 1.550332  
245502_at AT4G15640 unknown protein 1.5505278  
250009_at AT5G18440 unknown protein 1.553221  
254356_at AT4G22190 unknown protein 1.5538553  
247407_at AT5G62900 unknown protein 1.5563302  
250920_at AT5G03390 unknown protein 1.556647  
247734_at AT5G59400 unknown protein 1.5578818  
261170_at AT1G04910 unknown protein 1.5585661  
248286_at AT5G52870 unknown protein 1.5624181  
262544_at AT1G15420 unknown protein 1.5683378  
246736_at AT5G27560 unknown protein 1.568987  
257773_at AT3G29185 unknown protein 1.5709854  
251650_at AT3G57360 unknown protein 1.5710164  
248621_at AT5G49350 unknown protein 1.5808792  
247885_at AT5G57830 unknown protein 1.5823503  
245097_at AT2G40935 unknown protein 1.5850526  
259017_at AT3G07310 unknown protein 1.587893  
248167_at AT5G54530 unknown protein 1.5894237  
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254752_at AT4G13160 unknown protein 1.5916077  
247903_at AT5G57340 unknown protein 1.5927556  
253182_at AT4G35190 unknown protein 1.5945193  
251292_at AT3G61920 unknown protein 1.597092  
253283_at AT4G34090 unknown protein 1.5982443  
251142_at AT5G01015 unknown protein 1.5984621  
252204_at AT3G50340 unknown protein 1.5998857  
257248_at AT3G24150 unknown protein 1.6019279  
248291_at AT5G53020 unknown protein 1.6040497  
248218_at AT5G53710 unknown protein 1.6110489  
249747_at AT5G24600 unknown protein 1.611057  
246158_at AT5G19855 unknown protein 1.6135173  
260995_at AT1G12120 unknown protein 1.6142612  
262396_at AT1G49470 unknown protein 1.6157355  
257567_at AT3G23930 unknown protein 1.6191151  
258608_at AT3G03020 unknown protein 1.6211892  
265312_at AT2G20240 unknown protein 1.6216489  
252533_at AT3G46110 unknown protein 1.6287366  
248694_at AT5G48340 unknown protein 1.629458  
250265_at AT5G12900 unknown protein 1.6358489  
248282_at AT5G52900 unknown protein 1.6398712  
266738_at AT2G47010 unknown protein 1.6409137  
261509_at AT1G71740 unknown protein 1.6414264  
252552_at AT3G45900 unknown protein 1.641753  
262313_at AT1G70900 unknown protein 1.6436312  
262533_at AT1G17090 unknown protein 1.6489546  
260442_at AT1G68220 unknown protein 1.649894  
250850_at AT5G04550 unknown protein 1.6500795  
250689_at AT5G06610 unknown protein 1.6514302  
266898_at AT2G45990 unknown protein 1.6520272  
267037_at AT2G38320 unknown protein 1.653777  
256599_at AT3G14760 unknown protein 1.6573522  
255900_at AT1G17830 unknown protein 1.663229  
252659_at AT3G44430 unknown protein 1.6635442  
257412_at AT1G22980 unknown protein 1.6635509  
256262_at AT3G12150 unknown protein 1.6643635  
248663_at AT5G48590 unknown protein 1.6659697  
246748_at AT5G27730 unknown protein 1.669295  
251725_at AT3G56260 unknown protein 1.6719729  
247899_at AT5G57345 unknown protein 1.6781341  
253654_at AT4G30060 unknown protein 1.680983  
247556_at AT5G61040 unknown protein 1.6873323  
262945_at AT1G79510 unknown protein 1.6969974  
253782_at AT4G28590 unknown protein 1.7089949  
251684_at AT3G56410 unknown protein 1.7144289  
263709_at AT1G09310 unknown protein 1.7152784  
255456_at AT4G02920 unknown protein 1.722859  
261641_at AT1G27670 unknown protein 1.7229744  
245181_at AT5G12420 unknown protein 1.7254591  
248709_at AT5G48470 unknown protein 1.7257975  
256076_at AT1G18060 unknown protein 1.73328  
253893_at AT4G27390 unknown protein 1.7362646  
255318_at AT4G04190 unknown protein 1.7373198  
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263115_at AT1G03055 unknown protein 1.7376374  
245730_at AT1G73470 unknown protein 1.7434653  
267602_at AT2G32970 unknown protein 1.7466255  
259180_at AT3G01680 unknown protein 1.7475153  
249136_at AT5G43180 unknown protein 1.747964  
246487_at AT5G16030 unknown protein 1.7525514  
259460_at AT1G44000 unknown protein 1.7544745  
264909_at AT2G17300 unknown protein 1.7546452  
261558_at AT1G01770 unknown protein 1.7575872  
250122_at AT5G16520 unknown protein 1.7576779  
252353_at AT3G48200 unknown protein 1.7578527  
258211_at AT3G17890 unknown protein 1.7598815  
245421_at AT4G17430 unknown protein 1.7651693  
249340_at AT5G41140 unknown protein 1.7671824  
247486_at AT5G62140 unknown protein 1.7752998  
245432_at AT4G17100 unknown protein 1.775504  
249988_at AT5G18310 unknown protein 1.7760909  
262574_at AT1G15230 unknown protein 1.7767262  
245906_at AT5G11070 unknown protein 1.7770673  
264024_at AT2G21180 unknown protein 1.7789516  
256066_at AT1G06980 unknown protein 1.7802259  
245028_at AT2G26570 unknown protein 1.7841861  
249230_at AT5G42070 unknown protein 1.7843037  
265999_at AT2G24100 unknown protein 1.7870593  
251445_at AT3G59870 unknown protein 1.7870636  
247194_at AT5G65480 unknown protein 1.7904397  
264207_at AT1G22750 unknown protein 1.790994  
251039_at AT5G02020 unknown protein 1.7924706  
256090_at AT1G20816 unknown protein 1.7978451  
246446_at AT5G17640 unknown protein 1.8019776  
253796_at AT4G28460 unknown protein 1.8054652  
254200_at AT4G24110 unknown protein 1.808258  
258124_at AT3G18215 unknown protein 1.8087167  
264096_at AT1G78995 unknown protein 1.817065  
256266_at AT3G12320 unknown protein 1.8270901  
257540_at AT3G21520 unknown protein 1.8342046  
249701_at AT5G35460 unknown protein 1.8390228  
245795_at AT1G32160 unknown protein 1.8499662  
252866_at AT4G39840 unknown protein 1.8538244  
249167_at AT5G42860 unknown protein 1.8565569  
260359_at AT1G69210 unknown protein 1.8598208  
246231_at AT4G37080 unknown protein 1.8625839  
254208_at AT4G24175 unknown protein 1.8681204  
254561_at AT4G19160 unknown protein 1.8708191  
254797_at AT4G13030 unknown protein 1.8737469  
254697_at AT4G17970 unknown protein 1.8744797  
246057_at AT5G08400 unknown protein 1.8783635  
267199_at AT2G30990 unknown protein 1.8874519  
248624_at AT5G48790 unknown protein 1.8998588  
264343_at AT1G11850 unknown protein 1.9027596  
246919_at AT5G25460 unknown protein 1.9028807  
265628_at AT2G27290 unknown protein 1.903366  
255528_at AT4G02090 unknown protein 1.9117486  
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265387_at AT2G20670 unknown protein 1.9146509  
261292_at AT1G36940 unknown protein 1.9194002  
250438_at AT5G10580 unknown protein 1.9340395  
249384_at AT5G39890 unknown protein 1.9544474  
259624_at AT1G43020 unknown protein 1.9561497  
251117_at AT3G63390 unknown protein 1.9565588  
261456_at AT1G21050 unknown protein 1.9599565  
261638_at AT1G49975 unknown protein 1.9657371  
265192_at AT1G05060 unknown protein 1.9678109  
263227_at AT1G30750 unknown protein 1.9723508  
254317_at AT4G22510 unknown protein 1.9813095  
263640_at AT2G25270 unknown protein 1.9879594  
249610_at AT5G37360 unknown protein 1.996698  
255648_at AT4G00910 unknown protein 2.004879  
262873_at AT1G64700 unknown protein 2.0073297  
258424_at AT3G16750 unknown protein 2.0093713  
258988_at AT3G08890 unknown protein 2.014225  
267409_at AT2G34910 unknown protein 2.0210664  
255774_at AT1G18620 unknown protein 2.030881  
247977_at AT5G56850 unknown protein 2.0383523  
246989_at AT5G67350 unknown protein 2.0404007  
247177_at AT5G65300 unknown protein 2.0455291  
250098_at AT5G17350 unknown protein 2.0545843  
254982_at AT4G10470 unknown protein 2.073476  
267549_at AT2G32640 unknown protein 2.0780742  
251219_at AT3G62390 unknown protein 2.083068  
251788_at AT3G55420 unknown protein 2.0961692  
260656_at AT1G19380 unknown protein 2.0992165  
250728_at AT5G06440 unknown protein 2.1041198  
248685_at AT5G48500 unknown protein 2.1041849  
247049_at AT5G66440 unknown protein 2.1049533  
260332_at AT1G70470 unknown protein 2.1067495  
245336_at AT4G16515 unknown protein 2.1079345  
253548_at AT4G30993 unknown protein 2.112447  
267003_at AT2G34340 unknown protein 2.1374886  
246998_at AT5G67370 unknown protein 2.16518  
245629_at AT1G56580 unknown protein 2.180044  
245893_at AT5G09270 unknown protein 2.2169614  
245948_at AT5G19540 unknown protein 2.2199244  
260004_at AT1G67860 unknown protein 2.2330606  
257502_at AT1G78110 unknown protein 2.2464082  
259856_at AT1G68440 unknown protein 2.2539241  
263002_at AT1G54200 unknown protein 2.2869596  
257061_at AT3G18250 unknown protein 2.3201556  
249918_at AT5G19240 unknown protein 2.3213508  
251372_at AT3G60520 unknown protein 2.3425806  
255825_at AT2G40475 unknown protein 2.3524852  
253298_at AT4G33560 unknown protein 2.357098  
248257_at AT5G53410 unknown protein 2.3813617  
257026_at AT3G19200 unknown protein 2.386547  
266364_at AT2G41230 unknown protein 2.3882363  
246892_at AT5G25500 unknown protein 2.404707  
259166_at AT3G01670 unknown protein 2.4329562  
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251113_at AT5G01370 unknown protein 2.438628  
246997_at AT5G67390 unknown protein 2.461085  
260682_at AT1G17510 unknown protein 2.4637716  
264342_at AT1G12080 unknown protein 2.478165  
250211_at AT5G13880 unknown protein 2.4787962  
246792_at AT5G27290 unknown protein 2.5191965  
265276_at AT2G28400 unknown protein 2.5473936  
261247_at AT1G20070 unknown protein 2.559162  
263287_at AT2G36145 unknown protein 2.56717  
259207_at AT3G09050 unknown protein 2.5780766  
261500_at AT1G28400 unknown protein 2.5951643  
256725_at AT2G34070 unknown protein 2.6062582  
265083_at AT1G03820 unknown protein 2.6358678  
260232_at AT1G74640 unknown protein 2.636958  
247882_at AT5G57785 unknown protein 2.6791136  
248509_at AT5G50335 unknown protein 2.681272  
266707_at AT2G03310 unknown protein 2.6897855  
249355_at AT5G40500 unknown protein 2.762228  
245341_at AT4G16447 unknown protein 2.778537  
249211_at AT5G42680 unknown protein 2.7822497  
259791_at AT1G29700 unknown protein 2.7959661  
266222_at AT2G28780 unknown protein 2.806333  
267063_at AT2G41120 unknown protein 2.827714  
259325_at AT3G05320 unknown protein 2.8446975  
247252_at AT5G64770 unknown protein 2.8525653  
266017_at AT2G18690 unknown protein 2.9324787  
246001_at AT5G20790 unknown protein 3.1062589  
251050_at AT5G02440 unknown protein 3.110206  
261951_at AT1G64490 unknown protein 3.1261227  
264738_at AT1G62250 unknown protein 3.202438  
264725_at AT1G22885 unknown protein 3.3233588  
260841_at AT1G29195 unknown protein 3.3327844  
252539_at AT3G45730 unknown protein 3.419017  
247959_at AT5G57080 unknown protein 3.4983752  
258397_at AT3G15357 unknown protein 3.5400052  
259520_at AT1G12320 unknown protein 3.6129613  
257517_at AT3G16330 unknown protein 3.7596514  
257724_at AT3G18510 unknown protein 3.7643797  
265611_at AT2G25510 unknown protein 3.9686885  
245642_at AT1G25275 unknown protein 4.015522  
256442_at AT3G10930 unknown protein 4.2193384  
260522_x_at AT2G41730 unknown protein 4.3004494  
251155_at AT3G63160 unknown protein 4.939906  
253155_at AT4G35720 unknown protein 7.702714  
264635_at AT1G65500 unknown protein 11.868725  
253197_at AT4G35250 vestitone reductase-related 1.5650331  
260261_at AT1G68450 VQ motif-containing protein 1.9467709  
256793_at AT3G22160 VQ motif-containing protein 2.0984254  
246289_at AT3G56880 VQ motif-containing protein 2.653596  
256741_at AT3G29375 XH domain-containing protein 1.8893478  
263773_at AT2G21370 xylulose kinase, putative 1.5614374  
263106_at AT2G05160 zinc finger (CCCH-type) family protein 2.01636  
255508_at AT4G02220 zinc finger (MYND type) family protein 1.5025324  
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246891_at AT5G25490 zinc finger (Ran-binding) family protein 1.9844438  
258689_at AT3G07940 zinc finger and C2 domain protein, putative 1.5401341  
260484_at AT1G68360 zinc finger protein-related 1.5231078  
252770_at AT3G42860 zinc knuckle (CCHC-type) family protein 1.771376  
261711_at AT1G32700 zinc-binding family protein 1.5265605  
252592_at AT3G45640 /// AT3G45650 1.6365851  
260130_s_at AT1G66270 /// AT1G66280 2.5901647  
262427_s_at AT1G47600 /// AT1G51470 2.4435294  
265174_s_at AT1G23460 /// AT1G23470 1.5196569  
267162_s_at AT2G05140 /// AT2G37690 1.5840219  
257723_at AT3G18500  2.9387205  
246987_at AT5G67300 /// AT5G67310 1.5580493  
258975_at AT3G01970 /// AT3G01980 3.8601267  
245414_at AT4G17300 /// AT4G17310 1.5349134  
258861_at AT3G02050 /// AT3G02060 1.5138731  
246654_s_at AT5G35210 /// AT5G35220 1.5972536  
252291_s_at AT3G49110 /// AT3G49120 1.9528763  
267621_at AT2G39680  1.8358631  
251741_at AT3G56020 /// AT3G56040 2.2387109  
256145_at AT1G48750 /// AT1G48760 3.4479098  
248523_s_at AT5G50580 /// AT5G50680 1.5305419  
253764_s_at AT4G28860 /// AT4G28880 1.5962869  
259362_s_at AT1G13350 /// AT3G53640 1.6043737  
254265_s_at AT4G23140 /// AT4G23160 2.029639  
260774_at AT1G78290  1.6049348  
258632_s_at AT3G07980 /// AT3G13530 1.6109595  
263111_s_at AT1G65190 /// AT1G65250 1.710509  
265886_at AT2G25610 /// AT2G25620 1.577344  
266772_s_at AT2G03020 /// AT4G16540 1.8624344  
262503_at AT1G21670  1.9367385  
264365_s_at AT1G03220 /// AT1G03230 1.5526906  
257500_s_at AT1G73300 /// AT5G36180 2.9779527  
254915_s_at AT4G11310 /// AT4G11320 9.502294  
261457_at AT1G21060 /// AT1G21065 1.5512079  
265899_s_at AT1G20140 /// AT2G25700 2.1909149  
260950_s_at AT1G06090 /// AT1G06120 1.9207387  
246252_s_at AT4G37060 /// AT4G37070 1.7759867  
251146_at AT3G63510 /// AT3G63520 1.6183947  
262649_at AT1G14040  2.2172267  
249152_s_at AT5G43350 /// AT5G43370 3.2685668  
266184_s_at AT2G38940 /// AT3G54700 2.5263484  
265435_s_at AT1G31885 /// AT2G21020 1.7832983  
257162_s_at AT3G24290 /// AT3G24300 1.5634049  
254820_s_at AT4G12510 /// AT4G12520 1.9467537  
248844_s_at AT5G46890 /// AT5G46900 13.179846  
267238_at AT2G44130 /// AT2G44140 1.8292723  
264885_s_at AT1G61180 /// AT1G61190 /// AT1G61300 /// AT1G61310 2.0084157  
266743_at AT2G02990 /// AT2G16300 1.7609993  
262119_s_at AT1G02920 /// AT1G02930 3.4493015  
249195_s_at AT5G42500 /// AT5G42510 1.9160825  
265920_s_at AT2G15120 /// AT2G15220 3.4168923  
267596_s_at AT2G33050 /// AT2G33060 1.6867723  
262374_s_at AT1G72910 /// AT1G72930 1.8660525  
ANNEX  145 
 
Probe Set 
ID 
AGI Short/Full name Fold change RT-
qPCR 
263063_s_at AT2G18140 /// AT2G18150 5.9758935  
267053_s_at AT2G38380 /// AT2G38390 1.8735954  
264567_s_at AT1G05240 /// AT1G05250 4.2234864  
254431_at AT4G20830 /// AT4G20840 2.0844178  
254283_s_at AT4G22870 /// AT4G22880 2.2960758  
253340_s_at AT4G33260 /// AT4G33270 1.7477918  
265439_at AT2G21045  1.6798288  
252208_at AT3G50380  1.5150273  
266643_s_at AT2G29710 /// AT2G29730 1.5902697  
266279_at AT2G29280 /// AT2G29290 1.9058206  
255436_at AT4G03140 /// AT4G03150 2.1078105  
256304_at AT1G69523 /// AT1G69526 2.1525755  
258977_s_at AT3G02020 /// AT5G14060 1.9851284  
255895_at AT1G17990 /// AT1G18020 2.2360113  
257638_at AT3G25820 /// AT3G25830 2.971062  
256994_s_at AT3G25820 /// AT3G25830 10.150962  
265200_s_at AT2G36790 /// AT2G36800 3.5977175  
253268_s_at AT4G34131 /// AT4G34135 1.7849458  
263706_s_at AT1G31180 /// AT5G14200 1.7178859  
257175_s_at AT3G23470 /// AT3G23480 1.6862503  
254163_s_at AT4G24340 /// AT4G24350 1.7582254  
266746_s_at AT2G02930 /// AT4G02520 2.1706898  
248566_s_at AT5G49730 /// AT5G49740 4.227658  
261144_s_at AT1G19660 /// AT1G75380 2.5843263  
261663_at AT1G18330 /// AT3G10113 1.9896438  
247544_at AT5G61670  1.514426  
248636_at   2.0504756  
267126_s_at AT2G23590 /// AT2G23600 1.7098467  
261149_s_at AT1G19550 /// AT1G19570 1.5242447  
249417_at AT5G39670 /// AT5G39680 1.7274963  
254053_s_at AT4G25300 /// AT4G25310 1.5300661  
267290_at AT2G23740 /// AT2G23750 1.760763  
259381_s_at AT3G16390 /// AT3G16400 /// AT3G16410 2.9245532  
262377_at AT1G73100 /// AT1G73110 1.5196246  
253160_at AT4G35760  1.725482  
251124_s_at AT5G01040 /// AT5G01050 2.1428976  
247321_s_at AT5G09350 /// AT5G64070 1.680062  
251279_at AT3G61800  1.5074337  
252481_at AT3G46630  1.5080398  
266660_at AT2G25920  1.5143076  
250773_at AT5G05430  1.5150957  
263268_at   1.5171072  
248226_at AT5G53750  1.5205069  
253424_at AT4G32330  1.5216349  
253687_at AT4G29520  1.5226287  
259300_at AT3G05100  1.5262424  
266596_at AT2G46150  1.5333906  
261868_s_at AT1G11450 /// AT1G11460 1.5360944  
251400_at AT3G60420  1.5364997  
245601_at AT4G14240  1.5381271  
254750_at AT4G13140  1.5396694  
248191_at AT5G54120 /// AT5G54130 1.5436493  
249237_at AT5G42050  1.550877  
ANNEX  146 
 
Probe Set 
ID 
AGI Short/Full name Fold change RT-
qPCR 
249358_at AT5G40510  1.5547956  
253437_at AT4G32460  1.556685  
262700_at AT1G76020  1.5646147  
266355_at AT2G01400 /// AT2G01410 1.5704137  
267520_at AT2G30460  1.570654  
256332_at AT1G76890  1.5720258  
253752_at AT4G28910  1.5731462  
256215_at AT1G50900  1.5828607  
262205_at AT2G01080  1.585504  
254364_at AT4G22020  1.5874676  
244951_s_at AT2G07723  1.590135  
252039_at AT3G52155  1.5912727  
251879_at AT3G54200  1.5948136  
260553_at AT2G41800  1.5973891  
251461_at AT3G59780  1.6075972  
261205_at AT1G12790  1.6090313  
250887_at   1.6168001  
247488_at AT5G61820  1.6213262  
251516_s_at AT3G59310 /// AT3G59320 1.6219981  
253025_at AT4G38110 /// AT4G38120 1.6300201  
244934_at   1.6346385  
251951_s_at AT1G55710 /// AT3G53630 /// AT4G18690 1.6388726  
265217_s_at AT1G05090 /// AT4G20720 1.6440159  
257334_at   1.6455638  
257611_at AT3G26580  1.6569904  
246898_at AT5G25580  1.6595087  
246982_s_at AT2G10560 /// AT5G04860 1.6623924  
251211_s_at AT3G62470 /// AT3G62540 /// AT5G14820 1.6670395  
264299_s_at AT1G78850 /// AT1G78860 1.6725248  
260586_at AT2G43630  1.6816547  
256824_at   1.6821725  
267130_at AT2G23390  1.6932073  
264288_at AT1G62045  1.7114049  
256356_s_at AT1G66500 /// AT5G43620 1.7210673  
261221_at AT1G19960  1.7287238  
264086_at AT2G31190  1.7294381  
255962_at AT1G22330 /// AT1G22335 1.7399623  
267161_at AT2G37680  1.7463719  
251349_s_at AT3G11030 /// AT3G61020 1.7615092  
255600_s_at AT4G01020 /// AT5G10370 1.7961302  
252473_s_at AT3G46610 /// AT5G14350 1.7991248  
250307_at AT5G12160 /// AT5G12170 1.8001164  
249628_at AT5G37580  1.8008771  
264475_s_at AT1G77150 /// AT1G77170 1.8074992  
267057_at AT2G32500  1.814274  
255621_at AT4G01390  1.8187162  
253804_at AT4G28220 /// AT4G28230 1.8198683  
246173_s_at AT3G61520 /// AT5G28370 /// AT5G28460 1.8267562  
253294_at AT4G33750  1.839282  
253421_at AT4G32340  1.865585  
249894_at AT5G22580  1.8683914  
266426_x_at AT2G07140  1.8940682  
260277_at AT1G80520  1.9186556  
ANNEX  147 
 
Probe Set 
ID 
AGI Short/Full name Fold change RT-
qPCR 
250306_at AT5G12160 /// AT5G12170 1.9239167  
247166_at AT5G65840  1.9297134  
251095_at AT5G01510  1.9431716  
251072_at AT5G01740  1.9452783  
245638_s_at AT1G24822 /// AT1G24996 /// AT1G25097 /// AT1G25170 1.9646324  
266956_at AT2G34510  1.9758885  
245565_at AT4G14605  1.987652  
246476_at AT5G16730  2.0241868  
267644_s_at AT2G32870 /// AT2G32880 2.0249925  
263941_at AT2G35870  2.067356  
260446_at AT1G72420  2.0680113  
260919_at AT1G21525  2.1609073  
259546_at AT1G35350  2.1652515  
250268_s_at AT5G12950 /// AT5G12960 2.2346313  
254580_at AT4G19390  2.3098097  
257761_at AT3G23090  2.3494432  
260028_at AT1G29980  2.353944  
266071_at AT2G18670 /// AT2G18680 2.4063714  
256906_at AT3G24000  2.41309  
257860_at AT3G13062  2.4297645  
264251_at AT1G09190  2.4338202  
257772_at AT3G23080  2.5390007  
256603_at AT3G28270  2.602393  
258609_at AT3G02910  2.6031966  
260112_at AT1G63310  2.6101959  
247950_at AT5G57230  2.6282492  
261785_at AT1G08230  2.6394556  
261542_at AT1G63560  2.7287333  
249784_at AT5G24280  2.7441578  
260048_at AT1G73750  2.8286943  
252246_at AT3G49730  2.926025  
256376_s_at AT1G66690 /// AT1G66700 2.9702606  
253004_at AT4G38280 /// AT4G38290 /// AT4G38330 3.0117996  
259411_at AT1G13410  3.2663643  
251438_s_at AT3G59930 /// AT5G33355 3.436262  
249191_at AT5G42760  3.4524345  
247339_at AT5G63690  3.5374858  
266806_at AT2G30000  3.5416448  
256096_at AT1G13650  5.255266  
265049_at AT1G52060  5.303386  
266680_s_at AT2G19850 /// AT3G54730 8.906418  
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